sn,material,shape,coat_functional_group,synthesis_method,surface_charge,size_in_medium_nm,zeta_in_medium_mv,no_of_cells_cells_well,human_animal,cell_source,cell_tissue,cell_morphology,cell_age,time_hr,concentration,test,test_indicator,viability_%,doi,article_list,core_nm,hydrodynamic_nm,potential_mv,cell_type,journal_name,publisher,year,title,journal_is_oa,is_oa,oa_status,pdf,access
0,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,1.95,MTT,TetrazoliumSalt,113.67,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
1,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,3.9,MTT,TetrazoliumSalt,97.265,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
2,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,7.8,MTT,TetrazoliumSalt,108.73,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
3,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,15.6,MTT,TetrazoliumSalt,98.451,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
4,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,31.2,MTT,TetrazoliumSalt,98.056,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,62.5,MTT,TetrazoliumSalt,100.43,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
6,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,125,MTT,TetrazoliumSalt,95.881,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
7,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,250,MTT,TetrazoliumSalt,79.473,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
8,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,500,MTT,TetrazoliumSalt,94.893,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
9,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,12,1000,MTT,TetrazoliumSalt,79.275,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
10,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,1.95,MTT,TetrazoliumSalt,105.21,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
11,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,3.9,MTT,TetrazoliumSalt,120.85,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
12,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,7.8,MTT,TetrazoliumSalt,117.25,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
13,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,15.6,MTT,TetrazoliumSalt,106.06,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
14,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,31.2,MTT,TetrazoliumSalt,84.93,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
15,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,62.5,MTT,TetrazoliumSalt,96.127,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
16,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,125,MTT,TetrazoliumSalt,94.225,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
17,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,250,MTT,TetrazoliumSalt,103.94,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
18,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,500,MTT,TetrazoliumSalt,79.014,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
19,SiO2,Sphere,CTAB,Precipitation,Negative,90.09,,5000,A,Rat,,,,24,1000,MTT,TetrazoliumSalt,63.803,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
20,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,1.95,MTT,TetrazoliumSalt,97.463,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
21,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,3.9,MTT,TetrazoliumSalt,95.486,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
22,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,7.8,MTT,TetrazoliumSalt,89.951,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
23,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,15.6,MTT,TetrazoliumSalt,105.96,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
24,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,31.2,MTT,TetrazoliumSalt,95.091,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
25,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,62.5,MTT,TetrazoliumSalt,96.474,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
26,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,125,MTT,TetrazoliumSalt,94.3,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
27,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,250,MTT,TetrazoliumSalt,72.356,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
28,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,500,MTT,TetrazoliumSalt,70.774,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
29,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,12,1000,MTT,TetrazoliumSalt,71.763,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
30,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,1.95,MTT,TetrazoliumSalt,103.52,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
31,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,3.9,MTT,TetrazoliumSalt,96.761,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
32,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,7.8,MTT,TetrazoliumSalt,109.86,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
33,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,15.6,MTT,TetrazoliumSalt,122.75,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
34,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,31.2,MTT,TetrazoliumSalt,104.58,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
35,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,62.5,MTT,TetrazoliumSalt,118.73,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
36,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,125,MTT,TetrazoliumSalt,94.648,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
37,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,250,MTT,TetrazoliumSalt,103.1,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
38,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,500,MTT,TetrazoliumSalt,105.63,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
39,SiO2,Sphere,Ph,Precipitation,Negative,135.83,,5000,A,Rat,,,,24,1000,MTT,TetrazoliumSalt,80.493,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
40,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,1.95,MTT,TetrazoliumSalt,120,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
41,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,3.9,MTT,TetrazoliumSalt,119.41,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
42,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,7.8,MTT,TetrazoliumSalt,109.52,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
43,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,15.6,MTT,TetrazoliumSalt,111.3,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
44,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,31.2,MTT,TetrazoliumSalt,114.86,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
45,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,62.5,MTT,TetrazoliumSalt,116.05,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
46,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,125,MTT,TetrazoliumSalt,106.95,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
47,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,250,MTT,TetrazoliumSalt,73.74,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
48,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,500,MTT,TetrazoliumSalt,93.904,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
49,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,12,1000,MTT,TetrazoliumSalt,76.31,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
50,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,1.95,MTT,TetrazoliumSalt,104.15,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
51,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,3.9,MTT,TetrazoliumSalt,102.89,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
52,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,7.8,MTT,TetrazoliumSalt,102.04,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
53,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,15.6,MTT,TetrazoliumSalt,94.225,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
54,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,31.2,MTT,TetrazoliumSalt,90.423,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
55,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,62.5,MTT,TetrazoliumSalt,91.056,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
56,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,125,MTT,TetrazoliumSalt,100.77,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
57,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,250,MTT,TetrazoliumSalt,96.761,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
58,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,500,MTT,TetrazoliumSalt,103.94,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
59,SiO2,Sphere,NH2,Precipitation,Positive,142.11,,5000,A,Rat,,,,24,1000,MTT,TetrazoliumSalt,85.775,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanisms and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
60,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,1,CellTiterBlue,AlamarBlue,107.59,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
61,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,10,CellTiterBlue,AlamarBlue,100.81,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
62,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,100,CellTiterBlue,AlamarBlue,70.11,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
63,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,1000,CellTiterBlue,AlamarBlue,22.617,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
64,SiO2,,,Commercial,,10,,,A,Mouse,,,,24,1,XTT,TetrazoliumSalt,123.42,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
65,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,10,XTT,TetrazoliumSalt,114.38,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
66,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,100,XTT,TetrazoliumSalt,82.714,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
67,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,1000,XTT,TetrazoliumSalt,25.525,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
68,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,1,LDH,LDHrelease,4.5234,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
69,SiO2,Sphere,,Commercial,Negative,10,,2600,A,Mouse,,,,24,10,LDH,LDHrelease,6.1389,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
70,SiO2,,,Commercial,,10,,,A,Mouse,,,,24,100,LDH,LDHrelease,22.294,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
71,SiO2,,,Commercial,,10,,,A,Mouse,,,,24,1000,LDH,LDHrelease,69.467,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
72,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,1,Live/Dead,PropidiumIodide,95.315,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
73,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,10,Live/Dead,PropidiumIodide,86.268,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
74,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,100,Live/Dead,PropidiumIodide,69.467,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
75,SiO2,,,Commercial,,10,,,A,Mouse,,,,24,1000,Live/Dead,PropidiumIodide,9.6931,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
76,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,1,Live/Dead,CalceinAM,94.023,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
77,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,10,Live/Dead,CalceinAM,91.761,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
78,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,100,Live/Dead,CalceinAM,71.729,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
79,SiO2,Sphere,,Commercial,Negative,10,,6000,A,Mouse,,,,24,1000,Live/Dead,CalceinAM,44.265,10.5402/2012/454072,2,,10,-27,RAW264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
92,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,100,MTT,TetrazoliumSalt,102,10.1002/jbm.b.33068,3,,18,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
93,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,200,MTT,TetrazoliumSalt,105.08,10.1002/jbm.b.33068,3,,18,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
94,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,300,MTT,TetrazoliumSalt,100,10.1002/jbm.b.33068,3,,18,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
95,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,400,MTT,TetrazoliumSalt,100,10.1002/jbm.b.33068,3,,18,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
96,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,500,MTT,TetrazoliumSalt,80,10.1002/jbm.b.33068,3,,18,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
97,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,100,MTT,TetrazoliumSalt,101.97,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
98,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,200,MTT,TetrazoliumSalt,115.09,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
99,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,300,MTT,TetrazoliumSalt,115.09,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
100,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,400,MTT,TetrazoliumSalt,100.1,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
101,Fe3O4,Sphere,Dextran,Thermal Decomposition,,,,10000,A,,,,,24,500,MTT,TetrazoliumSalt,118.08,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
102,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,100,MTT,TetrazoliumSalt,80,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
103,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,200,MTT,TetrazoliumSalt,75.077,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
104,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,300,MTT,TetrazoliumSalt,50,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
105,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,400,MTT,TetrazoliumSalt,38,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
106,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,500,MTT,TetrazoliumSalt,34.923,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
107,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,100,MTT,TetrazoliumSalt,89.986,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
108,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,200,MTT,TetrazoliumSalt,80.245,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
109,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,300,MTT,TetrazoliumSalt,31.916,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
110,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,400,MTT,TetrazoliumSalt,30.043,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
111,Fe3O4,Sphere,PEG,Thermal Decomposition,,,,10000,A,,,,,24,500,MTT,TetrazoliumSalt,30.043,10.1002/jbm.b.33068,3,,18,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
112,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,97.16,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
113,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,86.296,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
114,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,55.802,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
115,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,99.256,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
116,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,87.593,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
117,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,71.712,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
118,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,95.11,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
119,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,87.164,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
120,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,54.156,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
121,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,96.429,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
122,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,92.989,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
123,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,67.857,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
124,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,99.383,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
125,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,70,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
126,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,48.642,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
127,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,99.256,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
128,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,82.878,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
129,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,77.916,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
130,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,93.521,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
131,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,78.24,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
132,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,48.533,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
133,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,93.651,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
134,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,83.73,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
135,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,71.825,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
136,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,99.383,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
137,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,83.951,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
138,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,59.506,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
139,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,98.511,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
140,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,94.169,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
141,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,77.171,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
142,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,99.389,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
143,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,92.176,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
144,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,63.692,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
145,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,98.28,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
146,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,93.519,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
147,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,75.529,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
148,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,98.395,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
149,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,87.778,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
150,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,66.667,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
151,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,98.387,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
152,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,91.935,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
153,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,78.164,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
154,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,96.21,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
155,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,88.875,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
156,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,72.983,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
157,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,97.354,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
158,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,92.063,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
159,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,MTT,TetrazoliumSalt,78.175,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
160,Bi,Sphere,,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,90.617,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
161,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,75.802,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
162,Bi,Sphere,,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,55.556,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
163,Bi,Sphere,,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,34.568,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
164,Bi,Sphere,,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,22.963,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
165,Bi,Sphere,,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,93.223,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
166,Bi,Sphere,,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,87.414,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
167,Bi,Sphere,,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,71.369,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
168,Bi,Sphere,,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,54.633,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
169,Bi,Sphere,,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,45.92,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
170,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,91.111,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
171,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,69.63,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
172,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,48.519,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
173,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,22.346,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
174,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,5.8025,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
175,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,92.531,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
176,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,82.434,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
177,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,69.848,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
178,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,58.091,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
179,Bi,Sphere,NH2,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,34.44,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
180,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,92.593,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
181,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,83.951,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
182,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,59.259,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
183,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,46.914,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
184,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,32.593,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
185,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,94.053,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
186,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,93.776,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
187,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,77.04,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
188,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,63.209,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
189,Bi,Sphere,Silica,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,56.708,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
190,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,90.617,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
191,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,85.185,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
192,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,66.173,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
193,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,54.815,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
194,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,46.173,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
195,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,12,,Live/Dead,CalceinAM,95.021,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
196,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,24,,Live/Dead,CalceinAM,91.425,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
197,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,48,,Live/Dead,CalceinAM,77.87,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
198,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,72,,Live/Dead,CalceinAM,66.667,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
199,Bi,Sphere,PEG,Precipitation,,,,20000,H,,,,,96,,Live/Dead,CalceinAM,54.08,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
200,Au,Sphere,,Chemical Reduction,Positive,,,15000,H,,,,,24,,MTS,TetrazoliumSalt,28.349,10.1021/nl101140t,5,,2,24.4,BEC,Nano Letters,American Chemical Society (ACS),2010,Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond,FALSE,TRUE,green,5_arvizo2010.pdf,1
201,Au,Sphere,,Chemical Reduction,Positive,,,15000,H,,,,,24,,MTS,TetrazoliumSalt,54.984,10.1021/nl101140t,5,,2,24.4,ASM,Nano Letters,American Chemical Society (ACS),2010,Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond,FALSE,TRUE,green,5_arvizo2010.pdf,1
202,Au,,,,Positive,,,15000,H,Human,,Epithelial,,24,,MTS,TetrazoliumSalt,24.611,10.1021/nl101140t,5,,2,24.4,BEC,Nano Letters,American Chemical Society (ACS),2010,Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond,FALSE,TRUE,green,5_arvizo2010.pdf,1
203,Au,,,,Positive,,,15000,H,Human,,,,24,,MTS,TetrazoliumSalt,30.218,10.1021/nl101140t,5,,2,24.4,ASM,Nano Letters,American Chemical Society (ACS),2010,Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond,FALSE,TRUE,green,5_arvizo2010.pdf,1
204,Au,,,,Positive,,,15000,H,Human,,Epithelial,,24,,MTS,TetrazoliumSalt,21.028,10.1021/nl101140t,5,,2,24.4,BEC,Nano Letters,American Chemical Society (ACS),2010,Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond,FALSE,TRUE,green,5_arvizo2010.pdf,1
205,Au,,,,Positive,,,15000,H,Human,,,,24,,MTS,TetrazoliumSalt,19.938,10.1021/nl101140t,5,,2,24.4,ASM,Nano Letters,American Chemical Society (ACS),2010,Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond,FALSE,TRUE,green,5_arvizo2010.pdf,1
206,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,5,CellTiterBlue,AlamarBlue,88.421,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
207,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,5,CellTiterBlue,AlamarBlue,78.421,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
208,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,5,CellTiterBlue,AlamarBlue,39.737,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
209,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,10,CellTiterBlue,AlamarBlue,68.158,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
210,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,10,CellTiterBlue,AlamarBlue,49.737,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
211,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,10,CellTiterBlue,AlamarBlue,24.474,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
212,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,25,CellTiterBlue,AlamarBlue,33.947,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
213,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,25,CellTiterBlue,AlamarBlue,5.5263,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
214,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,25,CellTiterBlue,AlamarBlue,4.2105,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
215,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,50,CellTiterBlue,AlamarBlue,20.526,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
216,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,50,CellTiterBlue,AlamarBlue,0.26316,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
217,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,50,CellTiterBlue,AlamarBlue,2.6316,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
218,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,100,CellTiterBlue,AlamarBlue,10.789,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
219,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,100,CellTiterBlue,AlamarBlue,0.26316,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
220,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,100,CellTiterBlue,AlamarBlue,2.3684,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
221,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,5,CellTiterBlue,AlamarBlue,107.42,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
222,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,5,CellTiterBlue,AlamarBlue,98.516,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
223,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,5,CellTiterBlue,AlamarBlue,96.142,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
224,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,10,CellTiterBlue,AlamarBlue,101.09,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
225,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,10,CellTiterBlue,AlamarBlue,90.603,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
226,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,10,CellTiterBlue,AlamarBlue,64.491,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
227,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,25,CellTiterBlue,AlamarBlue,93.966,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
228,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,25,CellTiterBlue,AlamarBlue,80.91,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
229,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,25,CellTiterBlue,AlamarBlue,43.323,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
230,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,50,CellTiterBlue,AlamarBlue,72.601,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
231,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,50,CellTiterBlue,AlamarBlue,54.797,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
232,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,50,CellTiterBlue,AlamarBlue,26.706,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
233,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,24,100,CellTiterBlue,AlamarBlue,43.323,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
234,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,30,100,CellTiterBlue,AlamarBlue,26.706,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
235,Ag,Sphere,CKK,Precipitation,,,,10000,H,Human,Colon,,,48,100,CellTiterBlue,AlamarBlue,5.9347,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
236,Fe3O4,Sphere,,Precipitation,,,,10000,H,Human,Lung,Epithelial,,24,10,MTT,TetrazoliumSalt,84,10.1016/j.colsurfb.2014.06.064,7,,22,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
237,Fe3O4,Sphere,,Precipitation,,,,10000,H,Human,Lung,Epithelial,,24,25,MTT,TetrazoliumSalt,72,10.1016/j.colsurfb.2014.06.064,7,,22,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
238,Fe3O4,Sphere,,Precipitation,,,,10000,H,Human,Lung,Epithelial,,24,50,MTT,TetrazoliumSalt,56,10.1016/j.colsurfb.2014.06.064,7,,22,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
239,Fe3O4,Sphere,,Precipitation,,,,10000,H,Human,Lung,Epithelial,,24,10,NRU,NeutralRed,87,10.1016/j.colsurfb.2014.06.064,7,,22,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
240,Fe3O4,Sphere,,Precipitation,,,,10000,H,Human,Lung,Epithelial,,24,25,NRU,NeutralRed,79,10.1016/j.colsurfb.2014.06.064,7,,22,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
241,Fe3O4,Sphere,,Precipitation,,,,10000,H,Human,Lung,Epithelial,,24,50,NRU,NeutralRed,65,10.1016/j.colsurfb.2014.06.064,7,,22,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
242,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,1.35,MTS,TetrazoliumSalt,84.91,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
243,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,2.7,MTS,TetrazoliumSalt,82.481,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
244,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,5.39,MTS,TetrazoliumSalt,77.621,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
245,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,13.48,MTS,TetrazoliumSalt,27.621,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
246,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,1.35,MTS,TetrazoliumSalt,86.189,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
247,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,2.7,MTS,TetrazoliumSalt,85.55,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
248,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,5.39,MTS,TetrazoliumSalt,84.655,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
249,Ag,Sphere,,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,13.48,MTS,TetrazoliumSalt,8.0563,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
250,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,1.35,MTS,TetrazoliumSalt,102.89,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
251,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,2.7,MTS,TetrazoliumSalt,95.921,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
252,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,5.39,MTS,TetrazoliumSalt,75.395,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
253,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,24,13.48,MTS,TetrazoliumSalt,17.895,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
254,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,1.35,MTS,TetrazoliumSalt,102.89,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
255,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,2.7,MTS,TetrazoliumSalt,77.632,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
256,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,5.39,MTS,TetrazoliumSalt,32.763,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
257,Ag,Sphere,PVP,Chemical Reduction,Negative,,,20000,H,Human,Skin,Epithelial,Adult,48,13.48,MTS,TetrazoliumSalt,5.3947,10.1007/s11051-014-2726-2,8,,36.4,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
258,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,Adult,6,0.008,MTT,TetrazoliumSalt,99.883,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
259,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,Adult,6,0.08,MTT,TetrazoliumSalt,98.659,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
260,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,0.8,MTT,TetrazoliumSalt,96.91,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
261,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,8,MTT,TetrazoliumSalt,95.335,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
262,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,80,MTT,TetrazoliumSalt,93.061,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
263,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,0.008,MTT,TetrazoliumSalt,98.659,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
264,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,0.08,MTT,TetrazoliumSalt,99.883,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
265,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,0.8,MTT,TetrazoliumSalt,88.338,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
266,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,8,MTT,TetrazoliumSalt,83.44,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
267,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,80,MTT,TetrazoliumSalt,80.466,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
268,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,0.008,MTT,TetrazoliumSalt,97.609,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
269,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,0.08,MTT,TetrazoliumSalt,96.385,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
270,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,0.8,MTT,TetrazoliumSalt,85.015,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
271,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,8,MTT,TetrazoliumSalt,74.169,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
272,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,80,MTT,TetrazoliumSalt,68.222,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
273,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,0.008,NRU,NeutralRed,98.754,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
274,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,0.08,NRU,NeutralRed,99.344,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
275,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,0.8,NRU,NeutralRed,92.262,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
276,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,8,NRU,NeutralRed,91.672,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
277,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,6,80,NRU,NeutralRed,90.295,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
278,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,0.008,NRU,NeutralRed,97.574,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
279,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,0.08,NRU,NeutralRed,93.836,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
280,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,0.8,NRU,NeutralRed,88.328,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
281,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,8,NRU,NeutralRed,85.377,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
282,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,24,80,NRU,NeutralRed,77.508,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
283,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,0.008,NRU,NeutralRed,97.574,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
284,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,0.08,NRU,NeutralRed,93.049,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
285,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,0.8,NRU,NeutralRed,85.77,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
286,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,8,NRU,NeutralRed,74.951,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
287,TiO2,,,Commercial,Negative,171.4,-11.5,10000,H,Human,Skin,Epithelial,,48,80,NRU,NeutralRed,65.311,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
288,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,96.951,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
289,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,95.654,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
290,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,94.214,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
291,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,92.053,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
292,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,94.934,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
293,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,84.706,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
294,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Rat,,,,24,,MTT,TetrazoliumSalt,77.647,10.1002/ppsc.201300357,10,,4.6,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
295,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,94.934,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
296,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,96.807,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
297,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,94.646,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
298,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,91.909,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
299,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,86.002,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
300,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,72.029,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
301,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,H,Human,Umbilical Vein,Endothelial,,24,,MTT,TetrazoliumSalt,53.733,10.1002/ppsc.201300357,10,,4.6,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
302,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,91.477,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
303,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,93.637,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
304,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,95.51,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
305,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,92.341,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
306,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,88.739,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
307,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,82.545,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
308,Au,Sphere,PEG,Chemical Reduction,Negative,,,50000,A,Mouse,Cerebellum,Neuronal,,24,,MTT,TetrazoliumSalt,71.597,10.1002/ppsc.201300357,10,,4.6,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
586,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.2,MTT,TetrazoliumSalt,98.827,10.1016/j.jphotobiol.2020.111778,11,,38,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
587,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.4,MTT,TetrazoliumSalt,91.134,10.1016/j.jphotobiol.2020.111778,11,,38,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
588,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.8,MTT,TetrazoliumSalt,79.531,10.1016/j.jphotobiol.2020.111778,11,,38,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
589,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.2,MTT,TetrazoliumSalt,91.134,10.1016/j.jphotobiol.2020.111778,11,,46,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
590,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.4,MTT,TetrazoliumSalt,87.223,10.1016/j.jphotobiol.2020.111778,11,,46,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
591,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.8,MTT,TetrazoliumSalt,47.849,10.1016/j.jphotobiol.2020.111778,11,,46,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
592,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.2,MTT,TetrazoliumSalt,91.134,10.1016/j.jphotobiol.2020.111778,11,,60,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
593,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.4,MTT,TetrazoliumSalt,87.353,10.1016/j.jphotobiol.2020.111778,11,,60,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
594,Au,spherical,,Chemical Reduction,,,,50000,,,,,,24,0.8,MTT,TetrazoliumSalt,56.845,10.1016/j.jphotobiol.2020.111778,11,,60,,MG-63,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2020,Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal,FALSE,FALSE,closed,11_10.1016@j.jphotobiol.2020.111778.pdf,0
595,TiO2,Lentil,,Commercial,,,,160000,H,Human,,,,24,5,MTT,TetrazoliumSalt,99.234,10.1016/j.jtemb.2019.126413,12,,5,,SH-SY5Y,Journal of Trace Elements in Medicine and Biology,Elsevier BV,2020,Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells,FALSE,FALSE,closed,12_ferraro2019.pdf,0
596,TiO2,Lentil,,Commercial,,,,160000,H,Human,,,,24,10,MTT,TetrazoliumSalt,104.44,10.1016/j.jtemb.2019.126413,12,,5,,SH-SY5Y,Journal of Trace Elements in Medicine and Biology,Elsevier BV,2020,Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells,FALSE,FALSE,closed,12_ferraro2019.pdf,0
597,TiO2,Lentil,,Commercial,,,,160000,H,Human,,,,24,50,MTT,TetrazoliumSalt,136.91,10.1016/j.jtemb.2019.126413,12,,5,,SH-SY5Y,Journal of Trace Elements in Medicine and Biology,Elsevier BV,2020,Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells,FALSE,FALSE,closed,12_ferraro2019.pdf,0
598,TiO2,Lentil,,Commercial,,,,160000,H,Human,,,,24,100,MTT,TetrazoliumSalt,162.02,10.1016/j.jtemb.2019.126413,12,,5,,SH-SY5Y,Journal of Trace Elements in Medicine and Biology,Elsevier BV,2020,Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells,FALSE,FALSE,closed,12_ferraro2019.pdf,0
599,TiO2,Sphere,,Sol-Gel Method,Negative,,,,H,Human,,,,24,1,MTT,TetrazoliumSalt,87.472,10.1016/j.procbio.2019.08.004,13,,60,-51.9,THP-1,Process Biochemistry,Elsevier BV,2019,Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study,FALSE,FALSE,closed,13_madhubala2019.pdf,0
600,TiO2,Sphere,,Sol-Gel Method,Negative,,,,H,Human,,,,24,10,MTT,TetrazoliumSalt,61.197,10.1016/j.procbio.2019.08.004,13,,60,-51.9,THP-1,Process Biochemistry,Elsevier BV,2019,Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study,FALSE,FALSE,closed,13_madhubala2019.pdf,0
601,TiO2,Sphere,,Sol-Gel Method,Negative,,,,H,Human,,,,24,20,MTT,TetrazoliumSalt,51.774,10.1016/j.procbio.2019.08.004,13,,60,-51.9,THP-1,Process Biochemistry,Elsevier BV,2019,Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study,FALSE,FALSE,closed,13_madhubala2019.pdf,0
602,TiO2,Sphere,,Sol-Gel Method,Negative,,,,H,Human,,,,24,50,MTT,TetrazoliumSalt,44.9,10.1016/j.procbio.2019.08.004,13,,60,-51.9,THP-1,Process Biochemistry,Elsevier BV,2019,Cytotoxic and immunomodulatory effects of the low concentration of titanium dioxide nanoparticles (TiO2 NPs) on human cell lines - An in vitro study,FALSE,FALSE,closed,13_madhubala2019.pdf,0
603,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,125,MTT,TetrazoliumSalt,95.027,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
604,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,250,MTT,TetrazoliumSalt,106.05,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
605,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,500,MTT,TetrazoliumSalt,74.757,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
606,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,1000,MTT,TetrazoliumSalt,49.297,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
607,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,125,,TrypanBlue,91.304,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
608,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,250,,TrypanBlue,90.261,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
609,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,500,,TrypanBlue,78.957,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
610,ZnO,Sph/Tri/Hex,,Biosynthesis,,,,100000,H,Human,Blood,,,3,1000,,TrypanBlue,65.565,10.1007/s00449-013-0982-7,14,,75,,Lymphocyte,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
611,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,24,0.5,MTT,TetrazoliumSalt,88.907,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
612,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,24,1,MTT,TetrazoliumSalt,89.723,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
613,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,24,5,MTT,TetrazoliumSalt,93.312,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
614,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,24,10,MTT,TetrazoliumSalt,91.517,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
615,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,24,50,MTT,TetrazoliumSalt,80.914,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
616,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,24,100,MTT,TetrazoliumSalt,74.388,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
617,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,0.5,MTT,TetrazoliumSalt,88.699,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
618,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,1,MTT,TetrazoliumSalt,87.158,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
619,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,5,MTT,TetrazoliumSalt,86.473,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
620,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,10,MTT,TetrazoliumSalt,90.925,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
621,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,50,MTT,TetrazoliumSalt,88.014,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
622,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,100,MTT,TetrazoliumSalt,85.616,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
623,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,0.5,MTT,TetrazoliumSalt,87.873,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
624,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,1,MTT,TetrazoliumSalt,86.455,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
625,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,5,MTT,TetrazoliumSalt,83.445,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
626,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,10,MTT,TetrazoliumSalt,91.639,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
627,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,50,MTT,TetrazoliumSalt,85.786,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
628,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,100,MTT,TetrazoliumSalt,84.114,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
629,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,48,0.5,MTT,TetrazoliumSalt,105.22,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
630,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,48,1,MTT,TetrazoliumSalt,96.9,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
631,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,48,5,MTT,TetrazoliumSalt,94.29,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
632,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,48,10,MTT,TetrazoliumSalt,89.886,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
633,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,48,50,MTT,TetrazoliumSalt,86.949,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
634,Fe3O4,Sphere,PEG,Solvothermal Process,,,,100000,H,Human,,,,48,100,MTT,TetrazoliumSalt,82.545,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
635,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,48,0.5,MTT,TetrazoliumSalt,98.288,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
636,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,48,1,MTT,TetrazoliumSalt,99.144,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
637,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,48,5,MTT,TetrazoliumSalt,93.151,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
638,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,48,10,MTT,TetrazoliumSalt,92.979,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
639,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,48,50,MTT,TetrazoliumSalt,88.87,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
640,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,48,100,MTT,TetrazoliumSalt,86.473,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
641,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,48,0.5,MTT,TetrazoliumSalt,93.144,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
642,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,48,1,MTT,TetrazoliumSalt,87.793,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
643,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,48,5,MTT,TetrazoliumSalt,88.629,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
644,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,48,10,MTT,TetrazoliumSalt,90.301,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
645,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,48,50,MTT,TetrazoliumSalt,85.786,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
646,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,48,100,MTT,TetrazoliumSalt,83.445,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
647,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,0.5,LDH,LDHrelease,96.743,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
648,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,1,LDH,LDHrelease,83.225,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
649,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,5,LDH,LDHrelease,82.573,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
650,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,10,LDH,LDHrelease,80.945,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
651,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,50,LDH,LDHrelease,80.945,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
652,Fe3O4,Sphere,PEG-FA,Solvothermal Process,Negative,362.8,-9.4,100000,H,Human,,,,24,100,LDH,LDHrelease,79.316,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
653,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,0.5,LDH,LDHrelease,96.743,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
654,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,1,LDH,LDHrelease,82.573,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
655,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,5,LDH,LDHrelease,76.873,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
656,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,10,LDH,LDHrelease,76.873,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
657,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,50,LDH,LDHrelease,91.205,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
658,Fe3O4,Sphere,Silica-FA,Solvothermal Process,Negative,567.3,-7.6,100000,H,Human,,,,24,100,LDH,LDHrelease,91.205,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
659,Au,Rod,,Commercial,,,,3000,A,Mouse,Embryo,Fibroblast,Embryonic,72,0.036,MTS,TetrazoliumSalt,80.385,10.1016/j.jhazmat.2013.11.031,16,,,,NIH3T3,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
660,Au,Rod,,Commercial,,,,3000,A,Mouse,Embryo,Fibroblast,Embryonic,72,0.72,MTS,TetrazoliumSalt,72.957,10.1016/j.jhazmat.2013.11.031,16,,,,NIH3T3,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
661,Au,Rod,,Commercial,,,,3000,A,Mouse,Embryo,Fibroblast,Embryonic,72,0.18,MTS,TetrazoliumSalt,56.616,10.1016/j.jhazmat.2013.11.031,16,,,,NIH3T3,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
662,Au,Rod,,Commercial,,,,3000,A,Mouse,Embryo,Fibroblast,Embryonic,72,0.36,MTS,TetrazoliumSalt,49.684,10.1016/j.jhazmat.2013.11.031,16,,,,NIH3T3,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
663,Au,Rod,,Commercial,,,,3000,A,Mouse,Embryo,Fibroblast,Embryonic,72,0.72,MTS,TetrazoliumSalt,42.256,10.1016/j.jhazmat.2013.11.031,16,,,,NIH3T3,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
664,Au,Rod,,Commercial,,,,3000,A,Mouse,Embryo,Fibroblast,Embryonic,72,1,MTS,TetrazoliumSalt,42.586,10.1016/j.jhazmat.2013.11.031,16,,,,NIH3T3,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
665,Au,Rod,,Commercial,,,,3000,A,Porcine,Kidney,Epithelial,,72,0.36,MTS,TetrazoliumSalt,108.98,10.1016/j.jhazmat.2013.11.031,16,,,,PK-15,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
666,Au,Rod,,Commercial,,,,3000,A,Porcine,Kidney,Epithelial,,72,0.72,MTS,TetrazoliumSalt,106.23,10.1016/j.jhazmat.2013.11.031,16,,,,PK-15,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
667,Au,Rod,,Commercial,,,,3000,A,Porcine,Kidney,Epithelial,,72,0.18,MTS,TetrazoliumSalt,102.5,10.1016/j.jhazmat.2013.11.031,16,,,,PK-15,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
668,Au,Rod,,Commercial,,,,3000,A,Porcine,Kidney,Epithelial,,72,0.36,MTS,TetrazoliumSalt,90.126,10.1016/j.jhazmat.2013.11.031,16,,,,PK-15,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
669,Au,Rod,,Commercial,,,,3000,A,Porcine,Kidney,Epithelial,,72,0.72,MTS,TetrazoliumSalt,63.619,10.1016/j.jhazmat.2013.11.031,16,,,,PK-15,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
670,Au,Rod,,Commercial,,,,3000,A,Porcine,Kidney,Epithelial,,72,1,MTS,TetrazoliumSalt,47.518,10.1016/j.jhazmat.2013.11.031,16,,,,PK-15,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
671,Au,Rod,,Commercial,,,,3000,A,Monkey,Kidney,Epithelial,,72,0.036,MTS,TetrazoliumSalt,101.35,10.1016/j.jhazmat.2013.11.031,16,,,,VERO,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
672,Au,Rod,,Commercial,,,,3000,A,Monkey,Kidney,Epithelial,,72,0.072,MTS,TetrazoliumSalt,91.689,10.1016/j.jhazmat.2013.11.031,16,,,,VERO,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
673,Au,Rod,,Commercial,,,,3000,A,Monkey,Kidney,Epithelial,,72,0.18,MTS,TetrazoliumSalt,67.636,10.1016/j.jhazmat.2013.11.031,16,,,,VERO,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
674,Au,Rod,,Commercial,,,,3000,A,Monkey,Kidney,Epithelial,,72,0.36,MTS,TetrazoliumSalt,41.527,10.1016/j.jhazmat.2013.11.031,16,,,,VERO,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
675,Au,Rod,,Commercial,,,,3000,A,Monkey,Kidney,Epithelial,,72,0.72,MTS,TetrazoliumSalt,27.959,10.1016/j.jhazmat.2013.11.031,16,,,,VERO,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
676,Au,Rod,,Commercial,,,,3000,A,Monkey,Kidney,Epithelial,,72,1,MTS,TetrazoliumSalt,28.37,10.1016/j.jhazmat.2013.11.031,16,,,,VERO,Journal of Hazardous Materials,Elsevier BV,2014,Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines,FALSE,FALSE,closed,16_chueh2014.pdf,0
677,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Skin,Epithelial,Adult,72,25,MTT,TetrazoliumSalt,88.973,10.1177/0960327112459206,17,,15,,A431,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
678,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Skin,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,76.933,10.1177/0960327112459206,17,,15,,A431,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
679,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Skin,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,59.949,10.1177/0960327112459206,17,,15,,A431,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
680,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Skin,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,48.923,10.1177/0960327112459206,17,,15,,A431,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
681,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Lung,Epithelial,Adult,72,25,MTT,TetrazoliumSalt,87.072,10.1177/0960327112459206,17,,15,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
682,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Lung,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,74.018,10.1177/0960327112459206,17,,15,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
683,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Lung,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,58.048,10.1177/0960327112459206,17,,15,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
684,SiO2,Sphere,,Commercial,Negative,96,,10000,H,Human,Lung,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,44.994,10.1177/0960327112459206,17,,15,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2013,"Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells",FALSE,FALSE,closed,17_ahamed2013.pdf,0
685,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,1,MTT,TetrazoliumSalt,96.842,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
686,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,5,MTT,TetrazoliumSalt,95,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
687,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,91.184,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
688,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,25,MTT,TetrazoliumSalt,79.342,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
689,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,71.316,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
690,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,63.816,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
691,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,55.263,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
692,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,1,NRU,NeutralRed,96.708,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
693,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,5,NRU,NeutralRed,95.61,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
694,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,10,NRU,NeutralRed,92.455,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
695,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,25,NRU,NeutralRed,78.326,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
696,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,50,NRU,NeutralRed,71.605,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
697,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,100,NRU,NeutralRed,65.021,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
698,SiO2,Sphere,,Commercial,Negative,96,-28,10000,H,Human,Liver,Epithelial,Adult,72,200,NRU,NeutralRed,58.848,10.1016/j.taap.2011.12.020,18,,14.23,-25,HepG2,Toxicology and Applied Pharmacology,Elsevier BV,2012,Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2,FALSE,FALSE,closed,18_ahmad2012.pdf,0
699,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,50,AlamarBlue,AlamarBlue,91.683,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
700,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,117.41,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
701,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,113.35,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
702,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,500,AlamarBlue,AlamarBlue,128.05,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
703,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,50,AlamarBlue,AlamarBlue,94.523,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
704,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,69.258,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
705,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,42.933,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
706,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,500,AlamarBlue,AlamarBlue,40.636,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
707,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,50,AlamarBlue,AlamarBlue,88.508,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
708,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,36.878,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
709,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,34.305,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
710,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,24,500,AlamarBlue,AlamarBlue,28.473,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
711,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,97.485,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
712,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,110.44,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
713,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,108.12,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
714,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,500,AlamarBlue,AlamarBlue,107.74,10.3390/nano9081081,19,,289.76,-28,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
715,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,96.82,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
716,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,93.64,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
717,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,82.862,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
718,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,48,500,AlamarBlue,AlamarBlue,76.678,10.3390/nano9081081,19,,578.27,8,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
719,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,98.113,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
720,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,81.475,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
721,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,82.676,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
722,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Colon,Epithelial,Adult,48,500,AlamarBlue,AlamarBlue,79.417,10.3390/nano9081081,19,,345.2,-13,Caco-2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
723,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,50,AlamarBlue,AlamarBlue,88.516,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
724,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,83.569,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
725,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,81.625,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
726,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,500,AlamarBlue,AlamarBlue,93.11,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
727,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,50,AlamarBlue,AlamarBlue,99.824,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
728,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,63.269,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
729,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,52.9,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
730,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,500,AlamarBlue,AlamarBlue,78.383,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
731,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,50,AlamarBlue,AlamarBlue,103.09,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
732,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,86.942,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
733,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,90.722,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
734,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,24,500,AlamarBlue,AlamarBlue,77.32,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
735,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,92.403,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
736,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,98.057,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
737,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,101.59,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
738,SiO2,Sphere,,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,500,AlamarBlue,AlamarBlue,100.35,10.3390/nano9081081,19,,289.76,-28,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
739,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,99.473,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
740,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,89.455,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
741,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,85.764,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
742,SiO2,Sphere,Chitosan,Hydrolysis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,48,500,AlamarBlue,AlamarBlue,92.794,10.3390/nano9081081,19,,578.27,8,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
743,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,97.938,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
744,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,95.876,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
745,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,95.361,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
746,SiO2,Sphere,SodiumAlginate,Hydrolysis,Negative,,,5000,H,Human,Liver,Epithelial,Adult,48,500,AlamarBlue,AlamarBlue,90.893,10.3390/nano9081081,19,,345.2,-13,HepG2,Nanomaterials,MDPI AG,2019,The Influence of Polysaccharide Coating on the Physicochemical Parameters and Cytotoxicity of Silica Nanoparticles for Hydrophilic Biomolecules Delivery,TRUE,TRUE,gold,19_10.3390@nano9081081.pdf,1
747,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,76.923,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
748,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,67.494,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
749,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,61.29,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
750,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,62.283,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
751,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,63.275,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
752,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,100.99,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
753,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,72.705,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
754,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,70.471,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
755,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,64.02,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
756,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,62.283,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
757,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,89.826,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
758,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,70.471,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
759,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,71.464,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
760,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,65.757,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
761,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,72.705,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
762,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,75.186,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
763,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,63.027,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
764,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,62.283,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
765,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,62.779,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
766,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,61.042,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
767,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,58.542,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
768,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,50.797,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
769,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,49.886,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
770,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,50.569,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
771,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,44.647,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
772,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,96.583,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
773,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,53.303,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
774,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,49.886,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
775,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,31.435,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
776,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,15.718,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
777,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,68.337,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
778,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,54.214,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
779,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,51.708,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
780,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,55.353,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
781,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,53.531,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
782,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,66.287,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
783,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,50.569,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
784,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,50.114,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
785,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,50.797,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
786,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Lung,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,45.33,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
787,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,10,MTT,TetrazoliumSalt,65.366,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
788,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,50,MTT,TetrazoliumSalt,50,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
789,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,100,MTT,TetrazoliumSalt,44.39,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
790,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,38.049,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
791,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,500,MTT,TetrazoliumSalt,34.146,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
792,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,10,MTT,TetrazoliumSalt,108.05,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
793,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,50,MTT,TetrazoliumSalt,54.146,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
794,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,100,MTT,TetrazoliumSalt,49.512,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
795,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,42.683,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
796,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,500,MTT,TetrazoliumSalt,5.122,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
797,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,10,MTT,TetrazoliumSalt,53.902,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
798,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,50,MTT,TetrazoliumSalt,44.878,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
799,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,100,MTT,TetrazoliumSalt,34.878,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
800,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,30.244,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
801,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,500,MTT,TetrazoliumSalt,29.024,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
802,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,10,MTT,TetrazoliumSalt,50,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
803,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,50,MTT,TetrazoliumSalt,40.732,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
804,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,100,MTT,TetrazoliumSalt,32.683,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
805,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,24.878,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
806,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,24,500,MTT,TetrazoliumSalt,24.878,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
807,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,10,MTT,TetrazoliumSalt,45.578,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
808,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,50,MTT,TetrazoliumSalt,38.095,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
809,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,100,MTT,TetrazoliumSalt,34.921,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
810,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,200,MTT,TetrazoliumSalt,27.891,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
811,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,500,MTT,TetrazoliumSalt,17.007,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
812,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,10,MTT,TetrazoliumSalt,87.528,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
813,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,50,MTT,TetrazoliumSalt,32.2,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
814,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,100,MTT,TetrazoliumSalt,30.839,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
815,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,200,MTT,TetrazoliumSalt,23.356,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
816,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,500,MTT,TetrazoliumSalt,1.1338,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
817,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,10,MTT,TetrazoliumSalt,42.63,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
818,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,50,MTT,TetrazoliumSalt,34.467,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
819,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,100,MTT,TetrazoliumSalt,31.973,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
820,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,200,MTT,TetrazoliumSalt,27.891,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
821,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,500,MTT,TetrazoliumSalt,17.234,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
822,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,10,MTT,TetrazoliumSalt,42.177,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
823,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,50,MTT,TetrazoliumSalt,29.252,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
824,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,100,MTT,TetrazoliumSalt,24.943,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
825,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,200,MTT,TetrazoliumSalt,22.676,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
826,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,A,Mouse,Embryo,Fibroblast,Embryonic,72,500,MTT,TetrazoliumSalt,12.245,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,NIH3T3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
827,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,68.856,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
828,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,61.071,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
829,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,59.611,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
830,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,59.124,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
831,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,58.151,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
832,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,99.757,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
833,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,67.397,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
834,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,66.423,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
835,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,62.774,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
836,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,53.041,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
837,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,68.613,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
838,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,66.423,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
839,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,65.207,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
840,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,63.99,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
841,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,64.477,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
842,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,68.856,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
843,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,63.504,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
844,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,62.287,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
845,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,60.584,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
846,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,24,500,MTT,TetrazoliumSalt,58.151,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
847,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,57.011,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
848,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,55.172,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
849,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,55.172,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
850,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,49.425,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
851,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,46.437,10.1016/j.nano.2015.03.004,20,,21.06,-24.5,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
852,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,95.172,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
853,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,65.747,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
854,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,60.92,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
855,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,54.713,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
856,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,42.299,10.1016/j.nano.2015.03.004,20,,59.72,-38.1,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
857,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,66.437,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
858,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,58.161,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
859,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,56.322,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
860,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,56.322,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
861,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,55.862,10.1016/j.nano.2015.03.004,20,,100.33,-31.7,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
862,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,64.138,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
863,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,55.172,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
864,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,54.023,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
865,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,51.264,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
866,SiO2,Sphere,,Sol-Gel Method,Negative,,,50000,H,Human,Liver,Epithelial,Adult,72,500,MTT,TetrazoliumSalt,51.034,10.1016/j.nano.2015.03.004,20,,199.89,-36.3,HepG2,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015,"Toxicity of silica nanoparticles depends on size, dose, and cell type",FALSE,FALSE,closed,20_kim2015.pdf,0
867,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,20,MTS,TetrazoliumSalt,99.06,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
868,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,60,MTS,TetrazoliumSalt,96.9,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
869,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,180,MTS,TetrazoliumSalt,98.5,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
870,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,360,MTS,TetrazoliumSalt,88.5,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
871,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,20,MTS,TetrazoliumSalt,95,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
872,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,60,MTS,TetrazoliumSalt,91,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
873,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,180,MTS,TetrazoliumSalt,83.9,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
874,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,360,MTS,TetrazoliumSalt,70.5,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
875,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,20,MTS,TetrazoliumSalt,90,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
876,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,60,MTS,TetrazoliumSalt,86,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
877,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,180,MTS,TetrazoliumSalt,68.25,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
878,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,360,MTS,TetrazoliumSalt,54.15,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
879,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,20,NRU,NeutralRed,97.666,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
880,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,60,NRU,NeutralRed,98.423,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
881,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,180,NRU,NeutralRed,93.205,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
882,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,6,360,NRU,NeutralRed,90.852,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
883,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,20,NRU,NeutralRed,91.798,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
884,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,60,NRU,NeutralRed,89.148,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
885,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,180,NRU,NeutralRed,86.877,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
886,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,360,NRU,NeutralRed,78.17,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
887,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,20,NRU,NeutralRed,93.691,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
888,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,60,NRU,NeutralRed,80.631,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
889,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,180,NRU,NeutralRed,73.628,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
890,Pt,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,48,360,NRU,NeutralRed,58.297,10.1177/1559325818807382,21,,24.6,-11,HEK293,Dose-Response,SAGE Publications,2018,"Green Platinum Nanoparticles Interaction With HEK293 Cells: Cellular Toxicity, Apoptosis, and Genetic Damage",TRUE,TRUE,gold,21_3c8805ef2a3d99c34dd3823dfe1e3bbc.pdf,1
891,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,24,2.5,MTT,TetrazoliumSalt,95,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
892,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,78.548,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
893,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,60.645,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
894,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,37.903,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
895,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,24,40,MTT,TetrazoliumSalt,35.968,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
896,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,30.968,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
897,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,48,2.5,MTT,TetrazoliumSalt,90,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
898,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,48,5,MTT,TetrazoliumSalt,70,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
899,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,49.194,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
900,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,48,20,MTT,TetrazoliumSalt,36.29,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
901,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,48,40,MTT,TetrazoliumSalt,26.935,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
902,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,24.032,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
903,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,72,2.5,MTT,TetrazoliumSalt,83.871,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
904,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,72,5,MTT,TetrazoliumSalt,67.581,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
905,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,72,10,MTT,TetrazoliumSalt,48.226,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
906,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,72,20,MTT,TetrazoliumSalt,25.806,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
907,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,72,40,MTT,TetrazoliumSalt,21.452,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
908,Pt,Sphere,,Green Synthesis,,,,50000,H,Human,Breast,Epithelial,Adult,72,50,MTT,TetrazoliumSalt,15.484,10.1016/j.colsurfb.2017.12.042,22,,20.12,,MCF-7,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2018,Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line,FALSE,FALSE,closed,22_10.1016@j.colsurfb.2017.12.042.pdf,0
909,Pt,Sphere,,Biosynthesis,,,,100000,H,Human,Blood,Monocyte,,24,25,CCK-8,TetrazoliumSalt,100,10.3390/cells8050444,23,,1.5,,THP-1,Cells,MDPI AG,2019,The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line,TRUE,TRUE,gold,23_10.3390@cells8050444.pdf,1
910,Pt,Sphere,,Biosynthesis,,,,100000,H,Human,Blood,Monocyte,,24,50,CCK-8,TetrazoliumSalt,80.027,10.3390/cells8050444,23,,1.5,,THP-1,Cells,MDPI AG,2019,The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line,TRUE,TRUE,gold,23_10.3390@cells8050444.pdf,1
911,Pt,Sphere,,Biosynthesis,,,,100000,H,Human,Blood,Monocyte,,24,75,CCK-8,TetrazoliumSalt,59.783,10.3390/cells8050444,23,,1.5,,THP-1,Cells,MDPI AG,2019,The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line,TRUE,TRUE,gold,23_10.3390@cells8050444.pdf,1
912,Pt,Sphere,,Biosynthesis,,,,100000,H,Human,Blood,Monocyte,,24,100,CCK-8,TetrazoliumSalt,40.082,10.3390/cells8050444,23,,1.5,,THP-1,Cells,MDPI AG,2019,The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line,TRUE,TRUE,gold,23_10.3390@cells8050444.pdf,1
913,Pt,Sphere,,Biosynthesis,,,,100000,H,Human,Blood,Monocyte,,24,125,CCK-8,TetrazoliumSalt,19.973,10.3390/cells8050444,23,,1.5,,THP-1,Cells,MDPI AG,2019,The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line,TRUE,TRUE,gold,23_10.3390@cells8050444.pdf,1
914,Pt,Sphere,,Biosynthesis,,,,100000,H,Human,Blood,Monocyte,,24,150,CCK-8,TetrazoliumSalt,10.054,10.3390/cells8050444,23,,1.5,,THP-1,Cells,MDPI AG,2019,The Effects of Apigenin-Biosynthesized Ultra-Small Platinum Nanoparticles on the Human Monocytic THP-1 Cell Line,TRUE,TRUE,gold,23_10.3390@cells8050444.pdf,1
915,Pt,Sphere,Citrate,Commercial,Negative,112.4,-12.2,30000,H,Human,Liver,,,24,5,MTS,TetrazoliumSalt,100,10.1155/2018/1367801,24,,68.3,-40.6,HepG2,Journal of Toxicology,Wiley,2018,"Toxicological Implications of Platinum Nanoparticle Exposure: Stimulation of Intracellular Stress, Inflammatory Response, and Akt Signaling In Vitro",TRUE,TRUE,gold,24_f49b4c3eccf090acd4d0bf7d19be972f.pdf,1
916,Pt,Sphere,Citrate,Commercial,Negative,112.4,-12.2,30000,H,Human,Liver,,,24,25,MTS,TetrazoliumSalt,94.475,10.1155/2018/1367801,24,,68.3,-40.6,HepG2,Journal of Toxicology,Wiley,2018,"Toxicological Implications of Platinum Nanoparticle Exposure: Stimulation of Intracellular Stress, Inflammatory Response, and Akt Signaling In Vitro",TRUE,TRUE,gold,24_f49b4c3eccf090acd4d0bf7d19be972f.pdf,1
917,Pt,Sphere,Citrate,Commercial,Negative,112.4,-12.2,30000,H,Human,Liver,,,24,100,MTS,TetrazoliumSalt,68.646,10.1155/2018/1367801,24,,68.3,-40.6,HepG2,Journal of Toxicology,Wiley,2018,"Toxicological Implications of Platinum Nanoparticle Exposure: Stimulation of Intracellular Stress, Inflammatory Response, and Akt Signaling In Vitro",TRUE,TRUE,gold,24_f49b4c3eccf090acd4d0bf7d19be972f.pdf,1
918,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,24,5,MTT,TetrazoliumSalt,96.2,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
919,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,24,10,MTT,TetrazoliumSalt,86.01,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
920,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,24,20,MTT,TetrazoliumSalt,70,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
921,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,24,30,MTT,TetrazoliumSalt,49.7,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
922,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,48,5,MTT,TetrazoliumSalt,92.96,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
923,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,48,10,MTT,TetrazoliumSalt,79.9,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
924,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,48,20,MTT,TetrazoliumSalt,58.43,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
925,CuO,Sphere,,Commercial,Negative,68.5,-32.8,10000,H,Human,Skin,Keratinocyte,Adult,48,30,MTT,TetrazoliumSalt,30.4,10.1177/1091581813487563,25,,55.8,,HaCat,International Journal of Toxicology,SAGE Publications,2013,Cytotoxicity and Genotoxicity of Copper Oxide Nanoparticles in Human Skin Keratinocytes Cells,FALSE,FALSE,hybrid,25_alarifi2013.pdf,0
926,TiO2,Sphere,,Commercial,,780,,60000,A,Rabbit,Cornea,,,24,1,MTT,TetrazoliumSalt,98.308,10.5487/tr.2019.35.3.287,26,,6,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
927,TiO2,Sphere,,Commercial,,780,,60000,A,Rabbit,Cornea,,,24,10,MTT,TetrazoliumSalt,94.416,10.5487/tr.2019.35.3.287,26,,6,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
928,TiO2,Sphere,,Commercial,,780,,60000,A,Rabbit,Cornea,,,24,12.5,MTT,TetrazoliumSalt,93.232,10.5487/tr.2019.35.3.287,26,,6,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
929,TiO2,Sphere,,Commercial,,780,,60000,A,Rabbit,Cornea,,,24,25,MTT,TetrazoliumSalt,92.047,10.5487/tr.2019.35.3.287,26,,6,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
930,TiO2,Sphere,,Commercial,,780,,60000,A,Rabbit,Cornea,,,24,50,MTT,TetrazoliumSalt,89.34,10.5487/tr.2019.35.3.287,26,,6,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
931,TiO2,Sphere,,Commercial,,780,,60000,A,Rabbit,Cornea,,,24,100,MTT,TetrazoliumSalt,87.31,10.5487/tr.2019.35.3.287,26,,6,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
932,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,24,1,MTT,TetrazoliumSalt,93.57,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
933,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,24,10,MTT,TetrazoliumSalt,85.448,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
934,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,24,12.5,MTT,TetrazoliumSalt,61.083,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
935,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,24,25,MTT,TetrazoliumSalt,15.736,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
936,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,24,50,MTT,TetrazoliumSalt,9.6447,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
937,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,24,100,MTT,TetrazoliumSalt,5.9222,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
938,SiO2,Sphere,,Commercial,,224,,60000,A,Rabbit,Cornea,,,24,1,MTT,TetrazoliumSalt,96.277,10.5487/tr.2019.35.3.287,26,,18.3,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
939,SiO2,Sphere,,Commercial,,224,,60000,A,Rabbit,Cornea,,,24,10,MTT,TetrazoliumSalt,94.247,10.5487/tr.2019.35.3.287,26,,18.3,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
940,SiO2,Sphere,,Commercial,,224,,60000,A,Rabbit,Cornea,,,24,12.5,MTT,TetrazoliumSalt,95.601,10.5487/tr.2019.35.3.287,26,,18.3,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
941,SiO2,Sphere,,Commercial,,224,,60000,A,Rabbit,Cornea,,,24,25,MTT,TetrazoliumSalt,97.293,10.5487/tr.2019.35.3.287,26,,18.3,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
942,SiO2,Sphere,,Commercial,,224,,60000,A,Rabbit,Cornea,,,24,50,MTT,TetrazoliumSalt,96.447,10.5487/tr.2019.35.3.287,26,,18.3,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
943,SiO2,Sphere,,Commercial,,224,,60000,A,Rabbit,Cornea,,,24,100,MTT,TetrazoliumSalt,93.57,10.5487/tr.2019.35.3.287,26,,18.3,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
944,CeO2,Sphere,,Commercial,,299,,60000,A,Rabbit,Cornea,,,24,1,MTT,TetrazoliumSalt,97.8,10.5487/tr.2019.35.3.287,26,,33,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
945,CeO2,Sphere,,Commercial,,299,,60000,A,Rabbit,Cornea,,,24,10,MTT,TetrazoliumSalt,97.8,10.5487/tr.2019.35.3.287,26,,33,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
946,CeO2,Sphere,,Commercial,,299,,60000,A,Rabbit,Cornea,,,24,12.5,MTT,TetrazoliumSalt,95.77,10.5487/tr.2019.35.3.287,26,,33,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
947,CeO2,Sphere,,Commercial,,299,,60000,A,Rabbit,Cornea,,,24,25,MTT,TetrazoliumSalt,95.77,10.5487/tr.2019.35.3.287,26,,33,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
948,CeO2,Sphere,,Commercial,,299,,60000,A,Rabbit,Cornea,,,24,50,MTT,TetrazoliumSalt,95.601,10.5487/tr.2019.35.3.287,26,,33,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
949,CeO2,Sphere,,Commercial,,299,,60000,A,Rabbit,Cornea,,,24,100,MTT,TetrazoliumSalt,92.555,10.5487/tr.2019.35.3.287,26,,33,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
950,Ag,Sphere,,Commercial,,129.7,,60000,A,Rabbit,Cornea,,,24,1,MTT,TetrazoliumSalt,95.601,10.5487/tr.2019.35.3.287,26,,16.7,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
951,Ag,Sphere,,Commercial,,129.7,,60000,A,Rabbit,Cornea,,,24,10,MTT,TetrazoliumSalt,93.232,10.5487/tr.2019.35.3.287,26,,16.7,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
952,Ag,Sphere,,Commercial,,129.7,,60000,A,Rabbit,Cornea,,,24,12.5,MTT,TetrazoliumSalt,92.047,10.5487/tr.2019.35.3.287,26,,16.7,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
953,Ag,Sphere,,Commercial,,129.7,,60000,A,Rabbit,Cornea,,,24,25,MTT,TetrazoliumSalt,91.709,10.5487/tr.2019.35.3.287,26,,16.7,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
954,Ag,Sphere,,Commercial,,129.7,,60000,A,Rabbit,Cornea,,,24,50,MTT,TetrazoliumSalt,87.817,10.5487/tr.2019.35.3.287,26,,16.7,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
955,Ag,Sphere,,Commercial,,129.7,,60000,A,Rabbit,Cornea,,,24,100,MTT,TetrazoliumSalt,72.927,10.5487/tr.2019.35.3.287,26,,16.7,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
956,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,3,1,MTT,TetrazoliumSalt,97.504,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
957,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,3,10,MTT,TetrazoliumSalt,94.54,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
958,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,3,12.5,MTT,TetrazoliumSalt,89.392,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
959,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,3,25,MTT,TetrazoliumSalt,87.52,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
960,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,3,50,MTT,TetrazoliumSalt,80.187,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
961,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,3,100,MTT,TetrazoliumSalt,72.075,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
962,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,6,1,MTT,TetrazoliumSalt,96.568,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
963,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,6,10,MTT,TetrazoliumSalt,92.356,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
964,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,6,12.5,MTT,TetrazoliumSalt,87.207,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
965,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,6,25,MTT,TetrazoliumSalt,83.151,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
966,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,6,50,MTT,TetrazoliumSalt,66.615,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
967,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,6,100,MTT,TetrazoliumSalt,61.622,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
968,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,9,1,MTT,TetrazoliumSalt,96.1,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
969,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,9,10,MTT,TetrazoliumSalt,88.456,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
970,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,9,12.5,MTT,TetrazoliumSalt,80.655,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
971,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,9,25,MTT,TetrazoliumSalt,70.671,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
972,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,9,50,MTT,TetrazoliumSalt,49.922,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
973,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,9,100,MTT,TetrazoliumSalt,39.938,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
974,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,12,1,MTT,TetrazoliumSalt,91.888,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
975,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,12,10,MTT,TetrazoliumSalt,84.867,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
976,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,12,12.5,MTT,TetrazoliumSalt,61.154,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
977,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,12,25,MTT,TetrazoliumSalt,42.122,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
978,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,12,50,MTT,TetrazoliumSalt,27.613,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
979,ZnO,Sphere,,Commercial,,404,,60000,A,Rabbit,Cornea,,,12,100,MTT,TetrazoliumSalt,22.153,10.5487/tr.2019.35.3.287,26,,141,,SIRC,Toxicological ResearchВ,Koreal Association of Medical Journal Editors,2019,In VitroВ Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells,FALSE,FALSE,hybrid,26_lee2019.pdf,0
980,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,98.604,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
981,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,81.98,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
982,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,77.919,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
983,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,24,15,MTT,TetrazoliumSalt,68.655,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
984,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,24,25,MTT,TetrazoliumSalt,6.599,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
985,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,98.858,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
986,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,84.264,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
987,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,80.457,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
988,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,24,15,MTT,TetrazoliumSalt,68.782,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
989,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,24,25,MTT,TetrazoliumSalt,7.2335,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
990,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,99.629,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
991,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,90.853,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
992,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,87.639,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
993,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,24,15,MTT,TetrazoliumSalt,72.93,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
994,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,24,25,MTT,TetrazoliumSalt,19.778,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
995,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,96.701,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
996,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,48,5,MTT,TetrazoliumSalt,80.584,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
997,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,77.284,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
998,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,48,15,MTT,TetrazoliumSalt,67.386,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
999,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,48,25,MTT,TetrazoliumSalt,5.7107,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1000,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,97.462,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1001,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,48,5,MTT,TetrazoliumSalt,83.122,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1002,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,77.284,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1003,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,48,15,MTT,TetrazoliumSalt,68.401,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1004,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,48,25,MTT,TetrazoliumSalt,7.1066,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1005,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,99.135,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1006,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,48,5,MTT,TetrazoliumSalt,85.909,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1007,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,81.459,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1008,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,48,15,MTT,TetrazoliumSalt,71.199,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1009,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,48,25,MTT,TetrazoliumSalt,13.226,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1010,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,72,1,MTT,TetrazoliumSalt,96.193,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1011,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,72,5,MTT,TetrazoliumSalt,80.584,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1012,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,72,10,MTT,TetrazoliumSalt,74.112,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1013,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,72,15,MTT,TetrazoliumSalt,65.609,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1014,Au,Sphere,,Commercial,,70.4,,50000,H,Human,Skin,Fibroblast,Adult,72,25,MTT,TetrazoliumSalt,5.4569,10.1080/17458080.2015.1014934,27,,30,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1015,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,72,1,MTT,TetrazoliumSalt,96.701,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1016,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,72,5,MTT,TetrazoliumSalt,82.487,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1017,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,72,10,MTT,TetrazoliumSalt,77.03,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1018,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,72,15,MTT,TetrazoliumSalt,66.117,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1019,Au,Sphere,,Commercial,,96.3,,50000,H,Human,Skin,Fibroblast,Adult,72,25,MTT,TetrazoliumSalt,7.1066,10.1080/17458080.2015.1014934,27,,50,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1020,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,72,1,MTT,TetrazoliumSalt,97.775,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1021,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,72,5,MTT,TetrazoliumSalt,84.92,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1022,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,72,10,MTT,TetrazoliumSalt,81.459,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1023,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,72,15,MTT,TetrazoliumSalt,68.356,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1024,Au,Sphere,,Commercial,,125.1,,50000,H,Human,Skin,Fibroblast,Adult,72,25,MTT,TetrazoliumSalt,13.226,10.1080/17458080.2015.1014934,27,,90,,NHDF,Journal of Experimental Nanoscience,Informa UK Limited,2015,Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts,FALSE,FALSE,closed,27_mateo2015.pdf,0
1025,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,79.57,10.1186/s11671-019-2967-1,28,,8.7,42.28,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1026,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,80.645,10.1186/s11671-019-2967-1,28,,8.7,42.28,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1027,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,82.437,10.1186/s11671-019-2967-1,28,,8.7,42.28,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1028,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,82.079,10.1186/s11671-019-2967-1,28,,8.7,42.28,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1029,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,70.968,10.1186/s11671-019-2967-1,28,,8.7,42.28,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1030,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,88.53,10.1186/s11671-019-2967-1,28,,99,47.44,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1031,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,89.068,10.1186/s11671-019-2967-1,28,,99,47.44,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1032,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,85.484,10.1186/s11671-019-2967-1,28,,99,47.44,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1033,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,78.495,10.1186/s11671-019-2967-1,28,,99,47.44,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1034,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,48.746,10.1186/s11671-019-2967-1,28,,99,47.44,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1035,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,17.921,10.1186/s11671-019-2967-1,28,,,33.23,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1036,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,19.176,10.1186/s11671-019-2967-1,28,,,33.23,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1037,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,19.534,10.1186/s11671-019-2967-1,28,,,33.23,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1038,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,21.326,10.1186/s11671-019-2967-1,28,,,33.23,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1039,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Stomach,Epithelial,Adult,24,,MTT,TetrazoliumSalt,3.7634,10.1186/s11671-019-2967-1,28,,,33.23,AGS,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1040,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,107.26,10.1186/s11671-019-2967-1,28,,8.7,42.28,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1041,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,101.59,10.1186/s11671-019-2967-1,28,,8.7,42.28,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1042,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,98.761,10.1186/s11671-019-2967-1,28,,8.7,42.28,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1043,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,85.664,10.1186/s11671-019-2967-1,28,,8.7,42.28,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1044,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,67.257,10.1186/s11671-019-2967-1,28,,8.7,42.28,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1045,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,84.779,10.1186/s11671-019-2967-1,28,,99,47.44,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1046,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,83.54,10.1186/s11671-019-2967-1,28,,99,47.44,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1047,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,76.637,10.1186/s11671-019-2967-1,28,,99,47.44,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1048,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,60.885,10.1186/s11671-019-2967-1,28,,99,47.44,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1049,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,34.69,10.1186/s11671-019-2967-1,28,,99,47.44,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1050,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,5.4867,10.1186/s11671-019-2967-1,28,,,33.23,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1051,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,5.4867,10.1186/s11671-019-2967-1,28,,,33.23,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1052,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,5.4867,10.1186/s11671-019-2967-1,28,,,33.23,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1053,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,4.2478,10.1186/s11671-019-2967-1,28,,,33.23,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1054,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Cervix,Epithelial,Adult,24,,MTT,TetrazoliumSalt,4.2478,10.1186/s11671-019-2967-1,28,,,33.23,HeLa,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1055,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,71.45,10.1186/s11671-019-2967-1,28,,8.7,42.28,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1056,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,63.976,10.1186/s11671-019-2967-1,28,,8.7,42.28,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1057,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,50.673,10.1186/s11671-019-2967-1,28,,8.7,42.28,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1058,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,46.637,10.1186/s11671-019-2967-1,28,,8.7,42.28,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1059,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,36.921,10.1186/s11671-019-2967-1,28,,8.7,42.28,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1060,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,60.538,10.1186/s11671-019-2967-1,28,,99,47.44,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1061,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,59.791,10.1186/s11671-019-2967-1,28,,99,47.44,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1062,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,31.54,10.1186/s11671-019-2967-1,28,,99,47.44,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1063,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,1.9432,10.1186/s11671-019-2967-1,28,,99,47.44,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1064,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,3.5874,10.1186/s11671-019-2967-1,28,,99,47.44,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1065,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,4.6338,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1066,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,4.0359,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1067,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,2.9895,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1068,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,1.3453,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1069,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,1.1958,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1070,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,97.369,10.1186/s11671-019-2967-1,28,,8.7,42.28,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1071,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,95.658,10.1186/s11671-019-2967-1,28,,8.7,42.28,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1072,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,93.756,10.1186/s11671-019-2967-1,28,,8.7,42.28,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1073,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,92.805,10.1186/s11671-019-2967-1,28,,8.7,42.28,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1074,Au,Sphere,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,75.689,10.1186/s11671-019-2967-1,28,,8.7,42.28,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1075,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,99.271,10.1186/s11671-019-2967-1,28,,99,47.44,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1076,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,96.038,10.1186/s11671-019-2967-1,28,,99,47.44,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1077,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,89.952,10.1186/s11671-019-2967-1,28,,99,47.44,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1078,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,82.536,10.1186/s11671-019-2967-1,28,,99,47.44,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1079,Au,Star,Chitosan,Green Synthesis,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,48.875,10.1186/s11671-019-2967-1,28,,99,47.44,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1080,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,3.4231,10.1186/s11671-019-2967-1,28,,,33.23,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1081,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,3.4231,10.1186/s11671-019-2967-1,28,,,33.23,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1082,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,3.0428,10.1186/s11671-019-2967-1,28,,,33.23,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1083,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,1.9017,10.1186/s11671-019-2967-1,28,,,33.23,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1084,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Colon,Epithelial,Adult,24,,MTT,TetrazoliumSalt,2.2821,10.1186/s11671-019-2967-1,28,,,33.23,HT29,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1085,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,93.237,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1086,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,74.101,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1087,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,20.144,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1088,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,21.295,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1089,Au,Rod,Chitosan,Seed-Mediated Growth Method,Positive,,,5000,H,Human,Liver,Epithelial,Adult,24,,MTT,TetrazoliumSalt,15.108,10.1186/s11671-019-2967-1,28,,,33.23,HepG2,Nanoscale Research Letters,Springer Science and Business Media LLC,2019,Shape-dependent cytotoxicity and cellular uptake of gold nanoparticles synthesized using green tea extract,TRUE,TRUE,gold,28_10.1186@s11671-019-2967-1.pdf,1
1090,Au,Rod,,Commercial,,,,5000,H,Human,Lung,,,4,2.5,CCK-8,TetrazoliumSalt,96.783,10.1016/j.etap.2015.02.003,29,,25,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2015,In vitro cytotoxicity of gold nanorods in A549 cells,FALSE,FALSE,closed,29_tang2015.pdf,0
1091,Au,Rod,,Commercial,,,,5000,H,Human,Lung,,,4,5,CCK-8,TetrazoliumSalt,69.437,10.1016/j.etap.2015.02.003,29,,25,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2015,In vitro cytotoxicity of gold nanorods in A549 cells,FALSE,FALSE,closed,29_tang2015.pdf,0
1092,Au,Rod,,Commercial,,,,5000,H,Human,Lung,,,4,7.5,CCK-8,TetrazoliumSalt,21.716,10.1016/j.etap.2015.02.003,29,,25,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2015,In vitro cytotoxicity of gold nanorods in A549 cells,FALSE,FALSE,closed,29_tang2015.pdf,0
1093,Au,Rod,,Commercial,,,,5000,H,Human,Lung,,,4,10,CCK-8,TetrazoliumSalt,15.013,10.1016/j.etap.2015.02.003,29,,25,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2015,In vitro cytotoxicity of gold nanorods in A549 cells,FALSE,FALSE,closed,29_tang2015.pdf,0
1094,Au,Rod,,Commercial,,,,5000,H,Human,Lung,,,4,12.5,CCK-8,TetrazoliumSalt,7.7748,10.1016/j.etap.2015.02.003,29,,25,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2015,In vitro cytotoxicity of gold nanorods in A549 cells,FALSE,FALSE,closed,29_tang2015.pdf,0
1095,Au,Rod,,Commercial,,,,5000,H,Human,Lung,,,4,15,CCK-8,TetrazoliumSalt,6.9705,10.1016/j.etap.2015.02.003,29,,25,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2015,In vitro cytotoxicity of gold nanorods in A549 cells,FALSE,FALSE,closed,29_tang2015.pdf,0
1096,Ag,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,10,CCK-8,,79.17,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1097,Ag,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,25,CCK-8,,63.44,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1098,Ag,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,50,CCK-8,,66.41,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1099,Ag,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,100,CCK-8,,68.69,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1100,Ag,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,200,CCK-8,,63.25,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1101,ZnO,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,10,CCK-8,,27.99,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1102,ZnO,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,25,CCK-8,,25.73,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1103,ZnO,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,50,CCK-8,,18.21,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1104,ZnO,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,100,CCK-8,,17.87,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1105,ZnO,Sphere,,Commercial,,,,10000,H,Human,Colon,Epithelial,Adult,24,200,CCK-8,,14.34,10.1016/j.mrfmmm.2014.08.001,30,,90,,Caco-2,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,Elsevier BV,2014,In vitro cytotoxicity of silver nanoparticles and zinc oxide nanoparticles to human epithelial colorectal adenocarcinoma (Caco-2) cells,FALSE,FALSE,closed,30_song2014.pdf,0
1106,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,24,0.3,AlamarBlue,AlamarBlue,85.833,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1107,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,24,0.625,AlamarBlue,AlamarBlue,88.333,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1108,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,24,1.25,AlamarBlue,AlamarBlue,87.222,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1109,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,24,2.5,AlamarBlue,AlamarBlue,88.611,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1110,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,24,5,AlamarBlue,AlamarBlue,44.167,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1111,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,24,0.3,AlamarBlue,AlamarBlue,100.56,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1112,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,24,0.625,AlamarBlue,AlamarBlue,100.83,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1113,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,24,1.25,AlamarBlue,AlamarBlue,96.944,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1114,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,24,2.5,AlamarBlue,AlamarBlue,73.889,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1115,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,24,5,AlamarBlue,AlamarBlue,33.889,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1116,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,48,0.3,AlamarBlue,AlamarBlue,86.28,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1117,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,48,0.625,AlamarBlue,AlamarBlue,82.85,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1118,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,48,1.25,AlamarBlue,AlamarBlue,81.794,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1119,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,48,2.5,AlamarBlue,AlamarBlue,77.045,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1120,Ag,Sphere,,Chemical Reduction,Negative,79.15,-7.9,10000,H,Human,Blood,Monocyte,Adult,48,5,AlamarBlue,AlamarBlue,22.691,10.1002/jat.3566,31,,14.3,-26.5,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1121,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,48,0.3,AlamarBlue,AlamarBlue,85.752,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1122,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,48,0.625,AlamarBlue,AlamarBlue,85.752,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1123,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,48,1.25,AlamarBlue,AlamarBlue,82.586,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1124,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,48,2.5,AlamarBlue,AlamarBlue,30.343,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1125,Ag,Sphere,Liposome,Chemical Reduction,Negative,138.9,-0.61,10000,H,Human,Blood,Monocyte,Adult,48,5,AlamarBlue,AlamarBlue,13.984,10.1002/jat.3566,31,,82.73,-31.9,THP-1,Journal of Applied Toxicology,Wiley,2017,Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen speciesГўВЂВђindependent apoptosis,FALSE,FALSE,closed,31_yusuf2017.pdf,0
1126,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,5,MTT,TetrazoliumSalt,99.752,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1127,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,10,MTT,TetrazoliumSalt,103.22,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1128,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,25,MTT,TetrazoliumSalt,99.257,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1129,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,50,MTT,TetrazoliumSalt,100.25,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1130,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,75,MTT,TetrazoliumSalt,97.525,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1131,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,100,MTT,TetrazoliumSalt,98.267,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1132,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,150,MTT,TetrazoliumSalt,99.01,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1133,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,175,MTT,TetrazoliumSalt,98.267,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1134,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,200,MTT,TetrazoliumSalt,96.535,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1135,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,300,MTT,TetrazoliumSalt,97.277,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1136,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,5,MTT,TetrazoliumSalt,96.923,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1137,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,10,MTT,TetrazoliumSalt,97.788,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1138,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,25,MTT,TetrazoliumSalt,100.1,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1139,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,50,MTT,TetrazoliumSalt,93.173,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1140,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,75,MTT,TetrazoliumSalt,94.615,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1141,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,100,MTT,TetrazoliumSalt,96.346,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1142,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,150,MTT,TetrazoliumSalt,91.442,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1143,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,175,MTT,TetrazoliumSalt,93.173,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1144,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,200,MTT,TetrazoliumSalt,94.615,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1145,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,300,MTT,TetrazoliumSalt,96.346,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1146,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,5,MTT,TetrazoliumSalt,94.554,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1147,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,10,MTT,TetrazoliumSalt,101.73,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1148,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,25,MTT,TetrazoliumSalt,100.5,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1149,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,50,MTT,TetrazoliumSalt,96.287,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1150,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,75,MTT,TetrazoliumSalt,95.05,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1151,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,100,MTT,TetrazoliumSalt,100.99,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1152,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,150,MTT,TetrazoliumSalt,96.535,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1153,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,175,MTT,TetrazoliumSalt,95.792,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1154,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,200,MTT,TetrazoliumSalt,96.04,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1155,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,300,MTT,TetrazoliumSalt,96.04,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1156,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,5,MTT,TetrazoliumSalt,100.38,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1157,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,10,MTT,TetrazoliumSalt,96.923,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1158,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,25,MTT,TetrazoliumSalt,101.54,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1159,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,50,MTT,TetrazoliumSalt,96.346,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1160,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,75,MTT,TetrazoliumSalt,100.1,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1161,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,100,MTT,TetrazoliumSalt,100.38,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1162,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,150,MTT,TetrazoliumSalt,101.54,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1163,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,175,MTT,TetrazoliumSalt,98.654,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1164,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,200,MTT,TetrazoliumSalt,101.25,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1165,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,300,MTT,TetrazoliumSalt,100.1,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1166,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,5,MTT,TetrazoliumSalt,96.535,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1167,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,10,MTT,TetrazoliumSalt,89.109,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1168,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,25,MTT,TetrazoliumSalt,99.257,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1169,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,50,MTT,TetrazoliumSalt,93.069,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1170,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,75,MTT,TetrazoliumSalt,99.01,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1171,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,100,MTT,TetrazoliumSalt,103.22,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1172,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,150,MTT,TetrazoliumSalt,107.67,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1173,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,175,MTT,TetrazoliumSalt,107.18,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1174,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,200,MTT,TetrazoliumSalt,106.19,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1175,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,300,MTT,TetrazoliumSalt,96.04,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1176,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,5,MTT,TetrazoliumSalt,96.058,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1177,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,10,MTT,TetrazoliumSalt,88.558,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1178,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,25,MTT,TetrazoliumSalt,98.654,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1179,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,50,MTT,TetrazoliumSalt,92.596,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1180,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,75,MTT,TetrazoliumSalt,98.654,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1181,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,100,MTT,TetrazoliumSalt,102.69,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1182,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,150,MTT,TetrazoliumSalt,107.31,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1183,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,175,MTT,TetrazoliumSalt,106.44,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1184,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,200,MTT,TetrazoliumSalt,105.87,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1185,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,300,MTT,TetrazoliumSalt,95.481,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1186,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,5,NRU,NeutralRed,108.02,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1187,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,10,NRU,NeutralRed,99.543,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1188,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,25,NRU,NeutralRed,102.54,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1189,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,50,NRU,NeutralRed,111.02,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1190,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,75,NRU,NeutralRed,101.79,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1191,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,100,NRU,NeutralRed,106.78,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1192,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,150,NRU,NeutralRed,106.78,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1193,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,175,NRU,NeutralRed,103.78,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1194,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,200,NRU,NeutralRed,111.52,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1195,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,3,300,NRU,NeutralRed,101.79,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1196,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,5,NRU,NeutralRed,102.39,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1197,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,10,NRU,NeutralRed,103.76,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1198,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,25,NRU,NeutralRed,108.99,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1199,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,50,NRU,NeutralRed,107.61,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1200,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,75,NRU,NeutralRed,112.02,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1201,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,100,NRU,NeutralRed,109.82,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1202,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,150,NRU,NeutralRed,81.743,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1203,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,175,NRU,NeutralRed,111.74,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1204,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,200,NRU,NeutralRed,108.44,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1205,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,3,300,NRU,NeutralRed,115.87,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1206,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,5,NRU,NeutralRed,93.555,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1207,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,10,NRU,NeutralRed,101.29,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1208,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,25,NRU,NeutralRed,100.04,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1209,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,50,NRU,NeutralRed,98.295,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1210,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,75,NRU,NeutralRed,100.04,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1211,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,100,NRU,NeutralRed,95.8,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1212,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,150,NRU,NeutralRed,100.04,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1213,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,175,NRU,NeutralRed,102.54,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1214,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,200,NRU,NeutralRed,98.046,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1215,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,6,300,NRU,NeutralRed,94.553,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1216,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,5,NRU,NeutralRed,96.881,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1217,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,10,NRU,NeutralRed,101.01,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1218,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,25,NRU,NeutralRed,104.59,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1219,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,50,NRU,NeutralRed,99.633,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1220,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,75,NRU,NeutralRed,101.56,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1221,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,100,NRU,NeutralRed,94.679,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1222,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,150,NRU,NeutralRed,104.04,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1223,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,175,NRU,NeutralRed,103.76,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1224,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,200,NRU,NeutralRed,107.34,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1225,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,6,300,NRU,NeutralRed,97.982,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1226,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,5,NRU,NeutralRed,108.52,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1227,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,10,NRU,NeutralRed,108.02,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1228,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,25,NRU,NeutralRed,107.28,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1229,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,50,NRU,NeutralRed,105.53,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1230,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,75,NRU,NeutralRed,112.77,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1231,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,100,NRU,NeutralRed,107.28,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1232,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,150,NRU,NeutralRed,104.28,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1233,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,175,NRU,NeutralRed,98.046,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1234,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,200,NRU,NeutralRed,96.05,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1235,Fe3O4,Sphere,Silica,Reverse Microemulsion,Negative,111.1,-10.3,30000,H,Human,,,,24,300,NRU,NeutralRed,88.316,10.1002/jat.3213,32,,10,-31.8,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1236,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,5,NRU,NeutralRed,96.881,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1237,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,10,NRU,NeutralRed,105.96,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1238,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,25,NRU,NeutralRed,104.59,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1239,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,50,NRU,NeutralRed,104.04,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1240,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,75,NRU,NeutralRed,107.06,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1241,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,100,NRU,NeutralRed,105.69,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1242,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,150,NRU,NeutralRed,104.31,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1243,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,175,NRU,NeutralRed,102.39,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1244,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,200,NRU,NeutralRed,96.33,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1245,Fe3O4,Sphere,OleicAcid,Reverse Microemulsion,Negative,202.7,-11.6,30000,H,Human,,,,24,300,NRU,NeutralRed,97.431,10.1002/jat.3213,32,,10.9,-45.4,SHSY5Y,Journal of Applied Toxicology,Wiley,2015,<i>In vitro</i> cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests,FALSE,TRUE,green,32_costa2015.pdf,1
1246,ZnO,Sphere,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,10,MTT,TetrazoliumSalt,97.431,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1247,ZnO,Sphere,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,15,MTT,TetrazoliumSalt,90.711,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1248,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,20,MTT,TetrazoliumSalt,89.526,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1249,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,25,MTT,TetrazoliumSalt,76.877,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1250,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,30,MTT,TetrazoliumSalt,71.146,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1251,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,35,MTT,TetrazoliumSalt,64.822,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1252,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,40,MTT,TetrazoliumSalt,61.66,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1253,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,80,MTT,TetrazoliumSalt,48.419,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1254,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,10,MTT,TetrazoliumSalt,95.85,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1255,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,15,MTT,TetrazoliumSalt,86.759,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1256,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,20,MTT,TetrazoliumSalt,81.225,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1257,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,25,MTT,TetrazoliumSalt,72.53,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1258,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,30,MTT,TetrazoliumSalt,68.577,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1259,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,35,MTT,TetrazoliumSalt,61.067,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1260,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,40,MTT,TetrazoliumSalt,57.115,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1261,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,80,MTT,TetrazoliumSalt,30.435,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1262,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,10,MTT,TetrazoliumSalt,79.249,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1263,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,15,MTT,TetrazoliumSalt,80.237,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1264,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,20,MTT,TetrazoliumSalt,72.134,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1265,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,25,MTT,TetrazoliumSalt,14.625,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1266,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,30,MTT,TetrazoliumSalt,11.858,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1267,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,35,MTT,TetrazoliumSalt,9.6838,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1268,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,40,MTT,TetrazoliumSalt,9.2885,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1270,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,10,MTT,TetrazoliumSalt,77.273,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1271,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,15,MTT,TetrazoliumSalt,72.134,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1272,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,20,MTT,TetrazoliumSalt,56.719,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1273,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,25,MTT,TetrazoliumSalt,10.079,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1274,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,30,MTT,TetrazoliumSalt,9.0909,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1275,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,35,MTT,TetrazoliumSalt,7.9051,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1276,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,40,MTT,TetrazoliumSalt,7.9051,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1277,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,10,NRU,NeutralRed,101.97,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1278,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,15,NRU,NeutralRed,92.358,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1279,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,20,NRU,NeutralRed,86.463,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1280,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,25,NRU,NeutralRed,65.066,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1281,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,30,NRU,NeutralRed,56.769,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1282,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,35,NRU,NeutralRed,56.769,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1283,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,40,NRU,NeutralRed,50.437,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1284,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,3,80,NRU,NeutralRed,61.572,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1285,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,10,NRU,NeutralRed,104.8,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1286,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,15,NRU,NeutralRed,100.44,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1287,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,20,NRU,NeutralRed,105.9,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1288,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,25,NRU,NeutralRed,76.856,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1289,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,30,NRU,NeutralRed,60.262,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1290,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,35,NRU,NeutralRed,56.114,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1291,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,40,NRU,NeutralRed,53.275,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1292,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,6,80,NRU,NeutralRed,59.825,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1293,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,10,NRU,NeutralRed,104.8,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1294,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,15,NRU,NeutralRed,100,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1295,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,20,NRU,NeutralRed,92.795,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1296,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,25,NRU,NeutralRed,75.109,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1297,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,30,NRU,NeutralRed,70.742,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1298,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,35,NRU,NeutralRed,68.996,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1299,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,40,NRU,NeutralRed,69.432,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1300,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,24,80,NRU,NeutralRed,49.345,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1301,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,10,NRU,NeutralRed,96.288,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1302,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,15,NRU,NeutralRed,100.44,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1303,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,20,NRU,NeutralRed,82.314,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1304,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,25,NRU,NeutralRed,63.755,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1305,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,30,NRU,NeutralRed,60.262,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1306,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,35,NRU,NeutralRed,59.607,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1307,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,40,NRU,NeutralRed,64.192,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1308,ZnO,,,Commercial,Negative,273.4,-11.7,350000,H,Human,,,,48,80,NRU,NeutralRed,55.677,10.1016/j.envint.2013.02.013,33,,100,-8.23,SHSY5Y,Environment International,Elsevier BV,2013,Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles,FALSE,FALSE,closed,33_valdiglesias2013.pdf,0
1309,ZnO,Sphere,,Commercial,Negative,278.8,-11.5,400000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,1,MTT,TetrazoliumSalt,91.342,10.1016/j.tiv.2013.12.004,34,,50,,Macrophages,Toxicology in Vitro,Elsevier BV,2014,Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling,FALSE,FALSE,closed,34_roy2014.pdf,0
1310,ZnO,Sphere,,Commercial,Negative,278.8,-11.5,400000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,2.5,MTT,TetrazoliumSalt,61.905,10.1016/j.tiv.2013.12.004,34,,50,,Macrophages,Toxicology in Vitro,Elsevier BV,2014,Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling,FALSE,FALSE,closed,34_roy2014.pdf,0
1311,ZnO,Sphere,,Commercial,Negative,278.8,-11.5,400000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,5,MTT,TetrazoliumSalt,31.818,10.1016/j.tiv.2013.12.004,34,,50,,Macrophages,Toxicology in Vitro,Elsevier BV,2014,Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling,FALSE,FALSE,closed,34_roy2014.pdf,0
1312,ZnO,Sphere,,Commercial,Negative,278.8,-11.5,400000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,10,MTT,TetrazoliumSalt,15.152,10.1016/j.tiv.2013.12.004,34,,50,,Macrophages,Toxicology in Vitro,Elsevier BV,2014,Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling,FALSE,FALSE,closed,34_roy2014.pdf,0
1313,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,5,CVS,CrystalViolet,92.5,10.1186/s12951-019-0456-4,35,,21.8,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1314,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,10,CVS,CrystalViolet,80.208,10.1186/s12951-019-0456-4,35,,21.8,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1315,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,15,CVS,CrystalViolet,63.958,10.1186/s12951-019-0456-4,35,,21.8,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1316,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,20,CVS,CrystalViolet,45.417,10.1186/s12951-019-0456-4,35,,21.8,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1317,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,25,CVS,CrystalViolet,36.458,10.1186/s12951-019-0456-4,35,,21.8,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1318,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,5,CVS,CrystalViolet,97.292,10.1186/s12951-019-0456-4,35,,31.4,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1319,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,10,CVS,CrystalViolet,93.958,10.1186/s12951-019-0456-4,35,,31.4,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1320,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,15,CVS,CrystalViolet,87.083,10.1186/s12951-019-0456-4,35,,31.4,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1321,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,20,CVS,CrystalViolet,82.5,10.1186/s12951-019-0456-4,35,,31.4,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1322,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,25,CVS,CrystalViolet,74.167,10.1186/s12951-019-0456-4,35,,31.4,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1323,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,5,CVS,CrystalViolet,92.5,10.1186/s12951-019-0456-4,35,,56.7,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1324,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,10,CVS,CrystalViolet,90.625,10.1186/s12951-019-0456-4,35,,56.7,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1325,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,15,CVS,CrystalViolet,86.25,10.1186/s12951-019-0456-4,35,,56.7,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1326,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,20,CVS,CrystalViolet,84.167,10.1186/s12951-019-0456-4,35,,56.7,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1327,SiO2,Sphere,,Sol-Gel Method,,,,100000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,25,CVS,CrystalViolet,79.792,10.1186/s12951-019-0456-4,35,,56.7,,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2019,Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size,TRUE,TRUE,gold,35_10.1186@s12951-019-0456-4.pdf,1
1328,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,88.254,10.1016/j.scitotenv.2011.07.039,36,,71,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1329,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,67.143,10.1016/j.scitotenv.2011.07.039,36,,71,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1330,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,10,10.1016/j.scitotenv.2011.07.039,36,,71,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1331,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,11.587,10.1016/j.scitotenv.2011.07.039,36,,71,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1332,TiO2,Rho/Sph,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,90.794,10.1016/j.scitotenv.2011.07.039,36,,42.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1333,TiO2,Rho/Sph,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,94.921,10.1016/j.scitotenv.2011.07.039,36,,42.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1334,TiO2,Rho/Sph,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,115.4,10.1016/j.scitotenv.2011.07.039,36,,42.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1335,TiO2,Rho/Sph,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,103.17,10.1016/j.scitotenv.2011.07.039,36,,42.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1336,CuO,Sphere,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,5,MTT,TetrazoliumSalt,51.746,10.1016/j.scitotenv.2011.07.039,36,,28,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1337,CuO,Sphere,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,38.889,10.1016/j.scitotenv.2011.07.039,36,,28,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1338,CuO,Sphere,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,20.317,10.1016/j.scitotenv.2011.07.039,36,,28,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1339,CuO,Sphere,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,13.651,10.1016/j.scitotenv.2011.07.039,36,,28,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1340,Co3O4,Rho/Qua,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,70.635,10.1016/j.scitotenv.2011.07.039,36,,78.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1341,Co3O4,Rho/Qua,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,42.381,10.1016/j.scitotenv.2011.07.039,36,,78.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1342,Co3O4,Rho/Qua,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,23.968,10.1016/j.scitotenv.2011.07.039,36,,78.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1343,Co3O4,Rho/Qua,,Commercial,,,,60000,H,Human,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,12.063,10.1016/j.scitotenv.2011.07.039,36,,78.3,,HepG2,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1344,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,90.095,10.1016/j.scitotenv.2011.07.039,36,,71,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1345,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,85.333,10.1016/j.scitotenv.2011.07.039,36,,71,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1346,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,79.429,10.1016/j.scitotenv.2011.07.039,36,,71,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1347,ZnO,Sph/Rho/Rod,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,55.81,10.1016/j.scitotenv.2011.07.039,36,,71,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1348,TiO2,Rho/Sph,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,100.19,10.1016/j.scitotenv.2011.07.039,36,,42.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1349,TiO2,Rho/Sph,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,93.333,10.1016/j.scitotenv.2011.07.039,36,,42.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1350,TiO2,Rho/Sph,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,120.38,10.1016/j.scitotenv.2011.07.039,36,,42.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1351,TiO2,Rho/Sph,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,96.952,10.1016/j.scitotenv.2011.07.039,36,,42.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1352,CuO,Sphere,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,89.333,10.1016/j.scitotenv.2011.07.039,36,,28,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1353,CuO,Sphere,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,90.667,10.1016/j.scitotenv.2011.07.039,36,,28,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1354,CuO,Sphere,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,67.81,10.1016/j.scitotenv.2011.07.039,36,,28,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1355,CuO,Sphere,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,48.952,10.1016/j.scitotenv.2011.07.039,36,,28,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1356,Co3O4,Rho/Qua,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,137.9,10.1016/j.scitotenv.2011.07.039,36,,78.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1357,Co3O4,Rho/Qua,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,114.1,10.1016/j.scitotenv.2011.07.039,36,,78.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1358,Co3O4,Rho/Qua,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,82.095,10.1016/j.scitotenv.2011.07.039,36,,78.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1359,Co3O4,Rho/Qua,,Commercial,,,,60000,A,Catfish,Liver,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,70.095,10.1016/j.scitotenv.2011.07.039,36,,78.3,,Hepatocytes,Science of The Total Environment,Elsevier BV,2011,A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells,FALSE,TRUE,green,36_wang2011.pdf,1
1360,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,6,1,MTT,TetrazoliumSalt,100.97,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1361,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,6,5,MTT,TetrazoliumSalt,97.742,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1362,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,6,10,MTT,TetrazoliumSalt,95.161,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1363,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,6,50,MTT,TetrazoliumSalt,96.935,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1364,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,6,100,MTT,TetrazoliumSalt,95.161,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1365,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,97.742,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1366,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,95.645,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1367,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,92.19,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1368,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,87.07,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1369,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,84.34,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1370,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,48,1,MTT,TetrazoliumSalt,97.742,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1371,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,48,5,MTT,TetrazoliumSalt,92.742,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1372,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,88.72,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1373,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,82.34,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1374,TiO2,Sphere,,Commercial,Negative,434.1,-7.83,10000,H,Human,Lung,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,78.89,10.1177/0960327112462725,37,,25,,A549,Human &amp; Experimental Toxicology,SAGE Publications,2012,"Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549",FALSE,FALSE,closed,37_srivastava2012.pdf,0
1375,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,0.1,MTT,TetrazoliumSalt,89.374,10.1080/01480545.2018.1452930,38,,15.84,-43.29,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1376,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,3,MTT,TetrazoliumSalt,75.089,10.1080/01480545.2018.1452930,38,,15.84,-43.29,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1377,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,64.109,10.1080/01480545.2018.1452930,38,,15.84,-43.29,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1378,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,30,MTT,TetrazoliumSalt,25.4,10.1080/01480545.2018.1452930,38,,15.84,-43.29,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1379,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,14.71,10.1080/01480545.2018.1452930,38,,15.84,-43.29,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1380,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,5.51,10.1080/01480545.2018.1452930,38,,15.84,-43.29,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1381,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,0.1,MTT,TetrazoliumSalt,91.499,10.1080/01480545.2018.1452930,38,,24.59,-14.25,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1382,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,3,MTT,TetrazoliumSalt,80.283,10.1080/01480545.2018.1452930,38,,24.59,-14.25,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1383,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,64.7,10.1080/01480545.2018.1452930,38,,24.59,-14.25,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1384,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,30,MTT,TetrazoliumSalt,30.61,10.1080/01480545.2018.1452930,38,,24.59,-14.25,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1385,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,16.6,10.1080/01480545.2018.1452930,38,,24.59,-14.25,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1386,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,8.6,10.1080/01480545.2018.1452930,38,,24.59,-14.25,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1387,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,0.1,MTT,TetrazoliumSalt,93.152,10.1080/01480545.2018.1452930,38,,81.8,-8.6,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1388,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,3,MTT,TetrazoliumSalt,90.201,10.1080/01480545.2018.1452930,38,,81.8,-8.6,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1389,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,76.505,10.1080/01480545.2018.1452930,38,,81.8,-8.6,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1390,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,30,MTT,TetrazoliumSalt,57.4,10.1080/01480545.2018.1452930,38,,81.8,-8.6,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1391,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,37.61,10.1080/01480545.2018.1452930,38,,81.8,-8.6,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1392,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Lung,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,11.51,10.1080/01480545.2018.1452930,38,,81.8,-8.6,A549,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1393,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,0.1,MTT,TetrazoliumSalt,87.557,10.1080/01480545.2018.1452930,38,,15.84,-43.29,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1394,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,3,MTT,TetrazoliumSalt,75.452,10.1080/01480545.2018.1452930,38,,15.84,-43.29,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1395,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,60.52,10.1080/01480545.2018.1452930,38,,15.84,-43.29,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1396,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,30,MTT,TetrazoliumSalt,26.4,10.1080/01480545.2018.1452930,38,,15.84,-43.29,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1397,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,15.11,10.1080/01480545.2018.1452930,38,,15.84,-43.29,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1398,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,6,10.1080/01480545.2018.1452930,38,,15.84,-43.29,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1399,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,0.1,MTT,TetrazoliumSalt,90.724,10.1080/01480545.2018.1452930,38,,24.59,-14.25,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1400,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,3,MTT,TetrazoliumSalt,78.394,10.1080/01480545.2018.1452930,38,,24.59,-14.25,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1401,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,64.706,10.1080/01480545.2018.1452930,38,,24.59,-14.25,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1402,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,30,MTT,TetrazoliumSalt,41.17,10.1080/01480545.2018.1452930,38,,24.59,-14.25,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1403,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,20.61,10.1080/01480545.2018.1452930,38,,24.59,-14.25,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1404,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,11.425,10.1080/01480545.2018.1452930,38,,24.59,-14.25,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1405,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,0.1,MTT,TetrazoliumSalt,91.629,10.1080/01480545.2018.1452930,38,,81.8,-8.6,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1406,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,3,MTT,TetrazoliumSalt,87.557,10.1080/01480545.2018.1452930,38,,81.8,-8.6,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1407,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,78.733,10.1080/01480545.2018.1452930,38,,81.8,-8.6,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1408,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,30,MTT,TetrazoliumSalt,46.833,10.1080/01480545.2018.1452930,38,,81.8,-8.6,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1409,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,31.674,10.1080/01480545.2018.1452930,38,,81.8,-8.6,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1410,TiO2,Sphere,,Commercial,Negative,,,30000,H,Human,Colon,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,15.837,10.1080/01480545.2018.1452930,38,,81.8,-8.6,Caco-2,Drug and Chemical Toxicology,Informa UK Limited,2018,Nano titanium exposure induces dose- and size-dependent cytotoxicity on human epithelial lung and colon cells,FALSE,FALSE,closed,38_gandamalla2018.pdf,0
1411,Fe3O4,Sphere,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,1,XTT,TetrazoliumSalt,100,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1412,Fe3O4,Sphere,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,5,XTT,TetrazoliumSalt,98.305,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1413,Fe3O4,Sphere,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,25,XTT,TetrazoliumSalt,77.331,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1414,Fe3O4,Sphere,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,50,XTT,TetrazoliumSalt,65.89,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1415,Fe3O4,,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,100,XTT,TetrazoliumSalt,54.661,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1416,Fe3O4,,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,200,XTT,TetrazoliumSalt,45.975,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1417,Fe3O4,,Silica,Commercial,Negative,,-6.52,30000,H,Human,Kidney,Epithelial,Adult,24,400,XTT,TetrazoliumSalt,45.339,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1418,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,1,XTT,TetrazoliumSalt,106.28,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1419,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,5,XTT,TetrazoliumSalt,100,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1420,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,25,XTT,TetrazoliumSalt,91.498,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1421,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,50,XTT,TetrazoliumSalt,85.83,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1422,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,100,XTT,TetrazoliumSalt,80.162,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1423,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,200,XTT,TetrazoliumSalt,69.838,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1424,Fe3O4,,Silica-NH2,Commercial,Negative,,-9.77,30000,H,Human,Kidney,Epithelial,Adult,24,400,XTT,TetrazoliumSalt,52.227,10.1016/j.mrgentox.2019.05.015,39,,114,,HK-2,Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Elsevier BV,2019,"Silica coated iron oxide nanoparticles-induced cytotoxicity, genotoxicity and its underlying mechanism in human HK-2 renal proximal tubule epithelial cells",FALSE,TRUE,green,39_10.1016@j.mrgentox.2019.05.015.pdf,1
1425,Au,Sphere,Citrate,Chemical Reduction,,10,,15000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,50,CCK-8,TetrazoliumSalt,110.02,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1426,Au,Sphere,Citrate,Chemical Reduction,,10,,15000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,100,CCK-8,TetrazoliumSalt,123.42,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1427,Au,Sphere,Citrate,Chemical Reduction,,10,,15000,H,Human,Umbilical Vein,Endothelial,,24,200,CCK-8,,,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1428,Au,Sphere,Citrate,Chemical Reduction,,30,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,114.7,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1429,Au,Sphere,Citrate,Chemical Reduction,,30,,15000,H,Human,Umbilical Vein,Endothelial,,24,100,CCK-8,,,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1430,Au,Sphere,Citrate,Chemical Reduction,,30,,15000,H,Human,Umbilical Vein,Endothelial,,24,200,CCK-8,,108.89,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1431,Au,Sphere,Citrate,Chemical Reduction,,50,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,109.37,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1432,Au,Sphere,Citrate,Chemical Reduction,,50,,15000,H,Human,Umbilical Vein,Endothelial,,24,100,CCK-8,,108.89,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1433,Au,Sphere,Citrate,Chemical Reduction,,50,,15000,H,Human,Umbilical Vein,Endothelial,,24,200,CCK-8,,116.64,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1434,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,0.5,CCK-8,,91.139,10.2147/ijn.s208225,40,,5,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1435,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,1,CCK-8,,,10.2147/ijn.s208225,40,,5,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1436,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,2,CCK-8,,,10.2147/ijn.s208225,40,,5,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1437,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,4,CCK-8,,73.237,10.2147/ijn.s208225,40,,5,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1438,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,0.5,CCK-8,,90.958,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1439,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,1,CCK-8,,89.873,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1440,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,2,CCK-8,,88.608,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1441,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,4,CCK-8,,87.523,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1442,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,0.5,CCK-8,,98.192,10.2147/ijn.s208225,40,,70,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1443,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,1,CCK-8,,93.49,10.2147/ijn.s208225,40,,70,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1444,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,2,CCK-8,,91.628,10.2147/ijn.s208225,40,,70,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1445,Pt,Sphere,Citrate,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,4,CCK-8,,89.873,10.2147/ijn.s208225,40,,70,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1446,SiO2,Sphere,,Commercial,,202.37,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,87.687,10.2147/ijn.s208225,40,,20,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1447,SiO2,Sphere,,Commercial,,202.37,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,,10.2147/ijn.s208225,40,,20,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1448,SiO2,Sphere,,Commercial,,202.37,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,79.291,10.2147/ijn.s208225,40,,20,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1449,SiO2,Sphere,,Commercial,,202.37,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,82.276,10.2147/ijn.s208225,40,,20,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1450,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,96.828,10.2147/ijn.s208225,40,,50,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1451,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,,10.2147/ijn.s208225,40,,50,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1452,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,89.552,10.2147/ijn.s208225,40,,50,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1453,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,,10.2147/ijn.s208225,40,,50,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1454,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,101.49,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1455,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1456,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,95.522,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1457,SiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,102.8,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1458,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,98.556,10.2147/ijn.s208225,40,,25,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1459,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,,10.2147/ijn.s208225,40,,25,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1460,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,,10.2147/ijn.s208225,40,,25,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1461,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,43.863,10.2147/ijn.s208225,40,,25,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1462,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,88.267,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1463,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,79.964,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1464,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,78.7,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1465,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,,10.2147/ijn.s208225,40,,30,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1466,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,100.36,10.2147/ijn.s208225,40,,80,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1467,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,99.097,10.2147/ijn.s208225,40,,80,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1468,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,93.682,10.2147/ijn.s208225,40,,80,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1469,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,85.921,10.2147/ijn.s208225,40,,80,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1470,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,6.25,CCK-8,,87.726,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1471,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,12.5,CCK-8,,93.141,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1472,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,25,CCK-8,,83.574,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1473,TiO2,Sphere,,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,50,CCK-8,,87.184,10.2147/ijn.s208225,40,,100,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1474,C,Nanotube,COOH,Oxidation/Sonication,,128.5,,15000,H,Human,Umbilical Vein,Endothelial,,24,7.5,CCK-8,,91.682,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1475,C,Nanotube,COOH,Oxidation/Sonication,,128.5,,15000,H,Human,Umbilical Vein,Endothelial,,24,15,CCK-8,,91.682,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1476,C,Nanotube,COOH,Oxidation/Sonication,,128.5,,15000,H,Human,Umbilical Vein,Endothelial,,24,30,CCK-8,,92.25,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1477,C,Nanotube,COOH,Oxidation/Sonication,,128.5,,15000,H,Human,Umbilical Vein,Endothelial,,24,60,CCK-8,,86.767,10.2147/ijn.s208225,40,,,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1478,Fe3O4,Sphere,Dextran,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,30,CCK-8,,99.258,10.2147/ijn.s208225,40,,30.15,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1479,Fe3O4,Sphere,Dextran,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,60,CCK-8,,96.289,10.2147/ijn.s208225,40,,30.15,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1480,Fe3O4,Sphere,Dextran,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,120,CCK-8,,92.579,10.2147/ijn.s208225,40,,30.15,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1481,Fe3O4,Sphere,Dextran,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,240,CCK-8,,95.547,10.2147/ijn.s208225,40,,30.15,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1482,Fe3O4,Sphere,DMSA,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,30,CCK-8,,97.403,10.2147/ijn.s208225,40,,45.3,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1483,Fe3O4,Sphere,DMSA,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,60,CCK-8,,55.473,10.2147/ijn.s208225,40,,45.3,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1484,Fe3O4,Sphere,DMSA,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,120,CCK-8,,,10.2147/ijn.s208225,40,,45.3,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1485,Fe3O4,Sphere,DMSA,Commercial,,,,15000,H,Human,Umbilical Vein,Endothelial,,24,240,CCK-8,,,10.2147/ijn.s208225,40,,45.3,,HUVEC,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells,TRUE,TRUE,green,40_10.2147@IJN.S208225.pdf,1
1486,Au,Sphere,MSA,Chemical Reduction,Negative,,,,H,Human,Embryo,Spindle,Embryonic,24,10,Live/Dead,TrypanBlue,15.174,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1487,Au,Sphere,MSA,Chemical Reduction,Negative,7.6,,,H,Human,Embryo,Spindle,Embryonic,24,10,Live/Dead,TrypanBlue,98.172,10.1002/smll.201502346,41,,4.2,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1488,Au,Sphere,Citrate,Chemical Reduction,Negative,21.2,,,H,Human,Embryo,Spindle,Embryonic,24,10,Live/Dead,TrypanBlue,103.47,10.1002/smll.201502346,41,,13.6,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1489,Au,Sphere,MSA,Chemical Reduction,Negative,,,100000,H,Human,Embryo,Spindle,Embryonic,24,10,MTT,TetrazoliumSalt,14.259,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1490,Au,Sphere,MSA,Chemical Reduction,Negative,7.6,,100000,H,Human,Embryo,Spindle,Embryonic,24,10,MTT,TetrazoliumSalt,90.494,10.1002/smll.201502346,41,,4.2,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1491,Au,Sphere,Citrate,Chemical Reduction,Negative,21.2,,100000,H,Human,Embryo,Spindle,Embryonic,24,10,MTT,TetrazoliumSalt,79.087,10.1002/smll.201502346,41,,13.6,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1492,Au,Sphere,MSA,Chemical Reduction,Negative,,,,H,Human,Embryo,Spindle,Embryonic,24,0.001,Live/Dead,TrypanBlue,90.573,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1493,Au,Sphere,MSA,Chemical Reduction,Negative,,,,H,Human,Embryo,Spindle,Embryonic,24,0.01,Live/Dead,TrypanBlue,87.616,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1494,Au,Sphere,MSA,Chemical Reduction,Negative,,,,H,Human,Embryo,Spindle,Embryonic,24,0.1,Live/Dead,TrypanBlue,75.97,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1495,Au,Sphere,MSA,Chemical Reduction,Negative,,,,H,Human,Embryo,Spindle,Embryonic,24,1,Live/Dead,TrypanBlue,56.562,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1496,Au,Sphere,MSA,Chemical Reduction,Negative,,,,H,Human,Embryo,Spindle,Embryonic,24,10,Live/Dead,TrypanBlue,0.92421,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1497,Au,Sphere,MSA,Chemical Reduction,Negative,,,100000,H,Human,Embryo,Spindle,Embryonic,24,0.001,MTT,TetrazoliumSalt,80.591,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1498,Au,Sphere,MSA,Chemical Reduction,Negative,,,100000,H,Human,Embryo,Spindle,Embryonic,24,0.01,MTT,TetrazoliumSalt,66.174,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1499,Au,Sphere,MSA,Chemical Reduction,Negative,,,100000,H,Human,Embryo,Spindle,Embryonic,24,0.1,MTT,TetrazoliumSalt,62.477,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1500,Au,Sphere,MSA,Chemical Reduction,Negative,,,100000,H,Human,Embryo,Spindle,Embryonic,24,1,MTT,TetrazoliumSalt,38.078,10.1002/smll.201502346,41,,1.5,,WA09,Small,Wiley,2015,SizeГўВЂВђDependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives,FALSE,TRUE,green,41_senut2015.pdf,1
1504,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,,,,24,50,MTT,TetrazoliumSalt,96.19,10.1007/s10876-019-01695-5,42,,6,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1505,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,,,,24,100,MTT,TetrazoliumSalt,75.873,10.1007/s10876-019-01695-5,42,,6,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1506,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,,,,24,200,MTT,TetrazoliumSalt,47.09,10.1007/s10876-019-01695-5,42,,6,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1507,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,,,,24,400,MTT,TetrazoliumSalt,37.249,10.1007/s10876-019-01695-5,42,,6,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1508,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,,,,24,50,MTT,TetrazoliumSalt,98.836,10.1007/s10876-019-01695-5,42,,12.5,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1509,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,,,,24,100,MTT,TetrazoliumSalt,89.63,10.1007/s10876-019-01695-5,42,,12.5,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1510,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,,,,24,200,MTT,TetrazoliumSalt,78.836,10.1007/s10876-019-01695-5,42,,12.5,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1511,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,,,,24,400,MTT,TetrazoliumSalt,77.778,10.1007/s10876-019-01695-5,42,,12.5,,HeLa,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1512,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Kidney,,Embryonic,24,50,MTT,TetrazoliumSalt,94.301,10.1007/s10876-019-01695-5,42,,6,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1513,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Kidney,,Embryonic,24,100,MTT,TetrazoliumSalt,93.534,10.1007/s10876-019-01695-5,42,,6,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1514,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Kidney,,Embryonic,24,200,MTT,TetrazoliumSalt,89.918,10.1007/s10876-019-01695-5,42,,6,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1515,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Kidney,,Embryonic,24,400,MTT,TetrazoliumSalt,81.479,10.1007/s10876-019-01695-5,42,,6,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1516,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Kidney,,Embryonic,24,50,MTT,TetrazoliumSalt,87.945,10.1007/s10876-019-01695-5,42,,12.5,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1517,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Kidney,,Embryonic,24,100,MTT,TetrazoliumSalt,78.082,10.1007/s10876-019-01695-5,42,,12.5,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1518,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Kidney,,Embryonic,24,200,MTT,TetrazoliumSalt,66.904,10.1007/s10876-019-01695-5,42,,12.5,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1519,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Kidney,,Embryonic,24,400,MTT,TetrazoliumSalt,48.164,10.1007/s10876-019-01695-5,42,,12.5,,HEK293,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1520,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,50,MTT,TetrazoliumSalt,89.18,10.1007/s10876-019-01695-5,42,,6,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1521,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,100,MTT,TetrazoliumSalt,72.85,10.1007/s10876-019-01695-5,42,,6,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1522,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,200,MTT,TetrazoliumSalt,57.024,10.1007/s10876-019-01695-5,42,,6,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1523,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,400,MTT,TetrazoliumSalt,47.125,10.1007/s10876-019-01695-5,42,,6,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1524,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,50,MTT,TetrazoliumSalt,90.82,10.1007/s10876-019-01695-5,42,,12.5,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1525,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,100,MTT,TetrazoliumSalt,83.695,10.1007/s10876-019-01695-5,42,,12.5,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1526,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,200,MTT,TetrazoliumSalt,75.687,10.1007/s10876-019-01695-5,42,,12.5,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1527,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,400,MTT,TetrazoliumSalt,71.841,10.1007/s10876-019-01695-5,42,,12.5,,H1299,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1528,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Breast,,Adult,24,50,MTT,TetrazoliumSalt,86.145,10.1007/s10876-019-01695-5,42,,6,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1529,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Breast,,Adult,24,100,MTT,TetrazoliumSalt,69.675,10.1007/s10876-019-01695-5,42,,6,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1530,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Breast,,Adult,24,200,MTT,TetrazoliumSalt,43.917,10.1007/s10876-019-01695-5,42,,6,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1531,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Breast,,Adult,24,400,MTT,TetrazoliumSalt,32.09,10.1007/s10876-019-01695-5,42,,6,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1532,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Breast,,Adult,24,50,MTT,TetrazoliumSalt,91.84,10.1007/s10876-019-01695-5,42,,12.5,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1533,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Breast,,Adult,24,100,MTT,TetrazoliumSalt,84.568,10.1007/s10876-019-01695-5,42,,12.5,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1534,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Breast,,Adult,24,200,MTT,TetrazoliumSalt,75.632,10.1007/s10876-019-01695-5,42,,12.5,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1535,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Breast,,Adult,24,400,MTT,TetrazoliumSalt,68.711,10.1007/s10876-019-01695-5,42,,12.5,,MCF-7,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1536,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,50,MTT,TetrazoliumSalt,78.221,10.1007/s10876-019-01695-5,42,,6,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1537,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,100,MTT,TetrazoliumSalt,68.798,10.1007/s10876-019-01695-5,42,,6,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1538,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,200,MTT,TetrazoliumSalt,52.139,10.1007/s10876-019-01695-5,42,,6,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1539,Au,Sphere,,Biosynthesis,Negative,,,5000,H,Human,Lung,,Adult,24,400,MTT,TetrazoliumSalt,30.264,10.1007/s10876-019-01695-5,42,,6,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1540,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,50,MTT,TetrazoliumSalt,88.654,10.1007/s10876-019-01695-5,42,,12.5,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1541,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,100,MTT,TetrazoliumSalt,78.642,10.1007/s10876-019-01695-5,42,,12.5,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1542,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,200,MTT,TetrazoliumSalt,67.704,10.1007/s10876-019-01695-5,42,,12.5,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1543,Au,Sph/Hex/Ova,Citrate,Chemical Reduction,,,,5000,H,Human,Lung,,Adult,24,400,MTT,TetrazoliumSalt,60.805,10.1007/s10876-019-01695-5,42,,12.5,,A549,Journal of Cluster Science,Springer Science and Business Media LLC,2019,Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles,FALSE,FALSE,closed,42_10.1007@s10876-019-01695-5.pdf,0
1544,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,103.7,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1545,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,98.413,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1546,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,10,MTT,TetrazoliumSalt,85.185,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1547,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,25,MTT,TetrazoliumSalt,74.074,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1548,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,50,MTT,TetrazoliumSalt,41.799,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1549,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,75,MTT,TetrazoliumSalt,16.931,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1550,Ag,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,100,MTT,TetrazoliumSalt,18.519,10.3762/bxiv.2019.15.v1,43,,8,-56.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1551,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,1,MTT,TetrazoliumSalt,103.17,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1552,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,5,MTT,TetrazoliumSalt,77.249,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1553,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,10,MTT,TetrazoliumSalt,50.794,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1554,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,25,MTT,TetrazoliumSalt,23.81,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1555,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,50,MTT,TetrazoliumSalt,20.106,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1556,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,75,MTT,TetrazoliumSalt,16.931,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1557,Ag,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,100,MTT,TetrazoliumSalt,16.931,10.3762/bxiv.2019.15.v1,43,,6,-50.9,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1558,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,1,MTT,TetrazoliumSalt,105.29,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1559,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,5,MTT,TetrazoliumSalt,102.65,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1560,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,10,MTT,TetrazoliumSalt,104.23,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1561,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,25,MTT,TetrazoliumSalt,96.825,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1562,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,50,MTT,TetrazoliumSalt,90.476,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1563,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,100,MTT,TetrazoliumSalt,87.831,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1564,Au,Sphere,CYS,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,300,MTT,TetrazoliumSalt,69.312,10.3762/bxiv.2019.15.v1,43,,100,-46.8,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1565,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,1,MTT,TetrazoliumSalt,106.35,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1566,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,,,Fibroblast,,24,5,MTT,TetrazoliumSalt,109.52,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1567,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,,24,10,MTT,TetrazoliumSalt,106.88,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1568,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,,24,25,MTT,TetrazoliumSalt,102.12,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1569,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,,24,50,MTT,TetrazoliumSalt,92.063,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1570,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,,24,100,MTT,TetrazoliumSalt,95.238,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1571,Au,Sphere,GSH,Chemical Reduction,Negative,,,5000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,,24,300,MTT,TetrazoliumSalt,95.238,10.3762/bxiv.2019.15.v1,43,,100,-58,L929,,Beilstein Institut,2019,Interaction of Small Biothiols with Silver and Gold Nanoparticles,FALSE,TRUE,green,43_201915-pdf.pdf,1
1572,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,0.3,MTT,TetrazoliumSalt,84.876,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1573,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,0.6,MTT,TetrazoliumSalt,82.008,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1574,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,1.2,MTT,TetrazoliumSalt,79.27,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1575,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,2.5,MTT,TetrazoliumSalt,75.88,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1576,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,5,MTT,TetrazoliumSalt,72.49,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1577,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.3,MTT,TetrazoliumSalt,91.265,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1578,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.6,MTT,TetrazoliumSalt,90.352,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1579,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,1.2,MTT,TetrazoliumSalt,66.623,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1580,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,2.5,MTT,TetrazoliumSalt,44.329,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1581,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,5,MTT,TetrazoliumSalt,40.808,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1582,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.3,MTT,TetrazoliumSalt,99.739,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1583,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.6,MTT,TetrazoliumSalt,99.087,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1584,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,1.2,MTT,TetrazoliumSalt,97.523,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1585,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,2.5,MTT,TetrazoliumSalt,97.262,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1586,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,5,MTT,TetrazoliumSalt,96.61,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1587,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,0.3,NRU,NeutralRed,98.705,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1588,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,0.6,NRU,NeutralRed,100.29,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1589,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,1.2,NRU,NeutralRed,100.58,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1590,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,2.5,NRU,NeutralRed,96.547,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1591,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Osteoblast,,24,5,NRU,NeutralRed,72.806,10.1007/s10856-019-6221-2,44,,18,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1592,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.3,NRU,NeutralRed,98.993,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1593,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.6,NRU,NeutralRed,84.748,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1594,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,1.2,NRU,NeutralRed,77.41,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1595,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,2.5,NRU,NeutralRed,76.691,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1596,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,5,NRU,NeutralRed,41.727,10.1007/s10856-019-6221-2,44,,215,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1597,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.3,NRU,NeutralRed,100,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1598,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,0.6,NRU,NeutralRed,100.29,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1599,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,1.2,NRU,NeutralRed,99.424,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1600,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,2.5,NRU,NeutralRed,100.29,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1601,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Osteoblast,,24,5,NRU,NeutralRed,98.705,10.1007/s10856-019-6221-2,44,,6.3,,hFOB1.19,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1602,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,0.3,MTT,TetrazoliumSalt,94.416,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1603,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,0.6,MTT,TetrazoliumSalt,92.893,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1604,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,1.2,MTT,TetrazoliumSalt,88.198,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1605,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,2.5,MTT,TetrazoliumSalt,64.848,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1606,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,5,MTT,TetrazoliumSalt,66.244,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1607,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.3,MTT,TetrazoliumSalt,90.355,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1608,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.6,MTT,TetrazoliumSalt,88.198,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1609,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,1.2,MTT,TetrazoliumSalt,83.503,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1610,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,2.5,MTT,TetrazoliumSalt,23.223,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1611,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,5,MTT,TetrazoliumSalt,13.325,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1612,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.3,MTT,TetrazoliumSalt,99.112,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1613,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.6,MTT,TetrazoliumSalt,99.112,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1614,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,1.2,MTT,TetrazoliumSalt,99.112,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1615,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,2.5,MTT,TetrazoliumSalt,94.162,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1616,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,5,MTT,TetrazoliumSalt,95.305,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1617,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,0.3,NRU,NeutralRed,95.07,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1618,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,0.6,NRU,NeutralRed,90.645,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1619,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,1.2,NRU,NeutralRed,81.037,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1620,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,2.5,NRU,NeutralRed,80.025,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1621,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Fibroblast,,24,5,NRU,NeutralRed,74.21,10.1007/s10856-019-6221-2,44,,18,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1622,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.3,NRU,NeutralRed,99.747,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1623,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.6,NRU,NeutralRed,87.105,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1624,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,1.2,NRU,NeutralRed,82.427,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1625,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,2.5,NRU,NeutralRed,43.363,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1626,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,5,NRU,NeutralRed,26.422,10.1007/s10856-019-6221-2,44,,215,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1627,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.3,NRU,NeutralRed,99.747,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1628,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,0.6,NRU,NeutralRed,100,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1629,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,1.2,NRU,NeutralRed,99.494,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1630,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,2.5,NRU,NeutralRed,98.736,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1631,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Fibroblast,,24,5,NRU,NeutralRed,100,10.1007/s10856-019-6221-2,44,,6.3,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1632,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,0.3,MTT,TetrazoliumSalt,84.988,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1633,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,0.6,MTT,TetrazoliumSalt,86.849,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1634,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,1.2,MTT,TetrazoliumSalt,85.484,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1635,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,2.5,MTT,TetrazoliumSalt,70.72,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1636,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,5,MTT,TetrazoliumSalt,54.094,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1637,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.3,MTT,TetrazoliumSalt,67.99,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1638,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.6,MTT,TetrazoliumSalt,16.377,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1639,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,1.2,MTT,TetrazoliumSalt,16.377,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1640,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,2.5,MTT,TetrazoliumSalt,14.764,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1641,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,5,MTT,TetrazoliumSalt,13.896,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1642,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.3,MTT,TetrazoliumSalt,94.541,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1643,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.6,MTT,TetrazoliumSalt,89.578,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1644,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,1.2,MTT,TetrazoliumSalt,89.826,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1645,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,2.5,MTT,TetrazoliumSalt,88.834,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1646,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,5,MTT,TetrazoliumSalt,86.104,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1647,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,0.3,NRU,NeutralRed,101.63,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1648,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,0.6,NRU,NeutralRed,98.37,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1649,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,1.2,NRU,NeutralRed,98.37,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1650,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,2.5,NRU,NeutralRed,87.092,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1651,Au,Rod,,Seed-Mediated Growth Method,,,,10000,H,Human,Bone,Mixed,,24,5,NRU,NeutralRed,79.348,10.1007/s10856-019-6221-2,44,,18,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1652,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.3,NRU,NeutralRed,97.011,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1653,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.6,NRU,NeutralRed,82.337,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1654,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,1.2,NRU,NeutralRed,66.168,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1655,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,2.5,NRU,NeutralRed,26.223,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1656,Au,Star,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,5,NRU,NeutralRed,17.12,10.1007/s10856-019-6221-2,44,,215,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1657,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.3,NRU,NeutralRed,102.45,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1658,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,0.6,NRU,NeutralRed,101.36,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1659,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,1.2,NRU,NeutralRed,103.26,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1660,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,2.5,NRU,NeutralRed,102.99,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1661,Au,Sphere,,Chemical Reduction,,,,10000,H,Human,Bone,Mixed,,24,5,NRU,NeutralRed,103.26,10.1007/s10856-019-6221-2,44,,6.3,,143B,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2019,Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential,FALSE,TRUE,hybrid,44_10.1007@s10856-019-6221-2.pdf,1
1662,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,84.32,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1663,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,82.4,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1664,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,76.8,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1665,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,76.96,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1666,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,75.04,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1667,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,73.487,10.1016/j.toxlet.2012.09.025,45,,7.2,41,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1668,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,70.605,10.1016/j.toxlet.2012.09.025,45,,7.2,41,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1669,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,70.173,10.1016/j.toxlet.2012.09.025,45,,7.2,41,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1670,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,67.291,10.1016/j.toxlet.2012.09.025,45,,7.2,41,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1671,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Liver,,,24,,MTT,TetrazoliumSalt,52.45,10.1016/j.toxlet.2012.09.025,45,,7.2,41,HepG2,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1672,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,83.913,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1673,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,71.159,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1674,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,70.725,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1675,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,66.087,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1676,Au,Sphere,Citrate,Chemical Reduction,Negative,10.1,-1.2,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,62.609,10.1016/j.toxlet.2012.09.025,45,,7.3,-15,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1677,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,75.071,10.1016/j.toxlet.2012.09.025,45,,7.2,41,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1678,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,74.786,10.1016/j.toxlet.2012.09.025,45,,7.2,41,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1679,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,72.08,10.1016/j.toxlet.2012.09.025,45,,7.2,41,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1680,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,67.664,10.1016/j.toxlet.2012.09.025,45,,7.2,41,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1681,Au,Sphere,PAMAM,Chemical Reduction,Positive,12.1,-6.8,100000,H,Human,Blood,,,24,,MTT,TetrazoliumSalt,64.957,10.1016/j.toxlet.2012.09.025,45,,7.2,41,PBMC,Toxicology Letters,Elsevier BV,2012,Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells,FALSE,TRUE,hybrid,45_paino2012.pdf,1
1682,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,4,5,CellTiterBlue,AlamarBlue,124.78,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1683,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,4,10,CellTiterBlue,AlamarBlue,128.04,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1684,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,4,20,CellTiterBlue,AlamarBlue,126.3,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1685,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,4,40,CellTiterBlue,AlamarBlue,101.09,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1686,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,24,5,CellTiterBlue,AlamarBlue,110.22,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1687,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,24,10,CellTiterBlue,AlamarBlue,98.261,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1688,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,24,20,CellTiterBlue,AlamarBlue,45.217,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1689,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,24,40,CellTiterBlue,AlamarBlue,20,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1690,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,48,5,CellTiterBlue,AlamarBlue,100,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1691,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,48,10,CellTiterBlue,AlamarBlue,66.739,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1692,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,48,20,CellTiterBlue,AlamarBlue,17.609,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1693,CuO,,,Commercial,Positive,214,-10.5,,H,Human,Lung,Epithelial,Adult,48,40,CellTiterBlue,AlamarBlue,7.1739,10.1186/s12989-016-0160-6,46,,28.2,35.9,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2015,Copper oxide nanoparticle toxicity profiling using untargeted metabolomics,TRUE,TRUE,gold,46_boyles2015.pdf,1
1694,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,2,MTS,,95.629,10.1016/j.chemosphere.2019.124565,47,,30,-4.23,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1695,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,5,MTS,,86.713,10.1016/j.chemosphere.2019.124565,47,,30,-4.23,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1696,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,10,MTS,,78.322,10.1016/j.chemosphere.2019.124565,47,,30,-4.23,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1697,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,20,MTS,,67.308,10.1016/j.chemosphere.2019.124565,47,,30,-4.23,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1698,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,50,MTS,,56.294,10.1016/j.chemosphere.2019.124565,47,,30,-4.23,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1699,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,2,MTS,,98.776,10.1016/j.chemosphere.2019.124565,47,,30,-3.85,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1700,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,5,MTS,,94.755,10.1016/j.chemosphere.2019.124565,47,,30,-3.85,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1701,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,10,MTS,,88.462,10.1016/j.chemosphere.2019.124565,47,,30,-3.85,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1702,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,20,MTS,,81.993,10.1016/j.chemosphere.2019.124565,47,,30,-3.85,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1703,Ag,Wire,,Commercial,Negative,,-0.87,10000,A,Mouse,,Macrophage,,24,50,MTS,,67.133,10.1016/j.chemosphere.2019.124565,47,,30,-3.85,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1704,Ag,Wire,,Commercial,Negative,,-0.82,10000,A,Mouse,,Macrophage,,24,2,MTS,,100.7,10.1016/j.chemosphere.2019.124565,47,,30,-3.36,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1705,Ag,Wire,,Commercial,Negative,,-0.82,10000,A,Mouse,,Macrophage,,24,5,MTS,,97.727,10.1016/j.chemosphere.2019.124565,47,,30,-3.36,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1706,Ag,Wire,,Commercial,Negative,,-0.82,10000,A,Mouse,,Macrophage,,24,10,MTS,,88.462,10.1016/j.chemosphere.2019.124565,47,,30,-3.36,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1707,Ag,Wire,,Commercial,Negative,,-0.82,10000,A,Mouse,,Macrophage,,24,20,MTS,,83.042,10.1016/j.chemosphere.2019.124565,47,,30,-3.36,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1708,Ag,Wire,,Commercial,Negative,,-0.82,10000,A,Mouse,,Macrophage,,24,50,MTS,,73.427,10.1016/j.chemosphere.2019.124565,47,,30,-3.36,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1709,Ag,Wire,,Commercial,Negative,,-0.32,10000,A,Mouse,,Macrophage,,24,2,MTS,,98.427,10.1016/j.chemosphere.2019.124565,47,,50,-2.49,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1710,Ag,Wire,,Commercial,Negative,,-0.32,10000,A,Mouse,,Macrophage,,24,5,MTS,,97.028,10.1016/j.chemosphere.2019.124565,47,,50,-2.49,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1711,Ag,Wire,,Commercial,Negative,,-0.32,10000,A,Mouse,,Macrophage,,24,10,MTS,,90.385,10.1016/j.chemosphere.2019.124565,47,,50,-2.49,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1712,Ag,Wire,,Commercial,Negative,,-0.32,10000,A,Mouse,,Macrophage,,24,20,MTS,,88.986,10.1016/j.chemosphere.2019.124565,47,,50,-2.49,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1713,Ag,Wire,,Commercial,Negative,,-0.32,10000,A,Mouse,,Macrophage,,24,50,MTS,,76.224,10.1016/j.chemosphere.2019.124565,47,,50,-2.49,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1714,Ag,Wire,,Commercial,Negative,,-0.25,10000,A,Mouse,,Macrophage,,24,2,MTS,,102.1,10.1016/j.chemosphere.2019.124565,47,,100,-1.46,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1715,Ag,Wire,,Commercial,Negative,,-0.25,10000,A,Mouse,,Macrophage,,24,5,MTS,,103.67,10.1016/j.chemosphere.2019.124565,47,,100,-1.46,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1716,Ag,Wire,,Commercial,Negative,,-0.25,10000,A,Mouse,,Macrophage,,24,10,MTS,,102.8,10.1016/j.chemosphere.2019.124565,47,,100,-1.46,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1717,Ag,Wire,,Commercial,Negative,,-0.25,10000,A,Mouse,,Macrophage,,24,20,MTS,,99.65,10.1016/j.chemosphere.2019.124565,47,,100,-1.46,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1718,Ag,Wire,,Commercial,Negative,,-0.25,10000,A,Mouse,,Macrophage,,24,50,MTS,,76.399,10.1016/j.chemosphere.2019.124565,47,,100,-1.46,J774A.1,Chemosphere,Elsevier BV,2019,Length and diameter-dependent phagocytosis and cytotoxicity of long silver nanowires in macrophages,FALSE,FALSE,closed,47_wang2019.pdf,0
1719,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,50,MTT,TetrazoliumSalt,91.667,10.1016/j.matdes.2019.108187,48,,120,-5.21,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1720,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,100,MTT,TetrazoliumSalt,91.27,10.1016/j.matdes.2019.108187,48,,120,-5.21,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1721,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,200,MTT,TetrazoliumSalt,86.111,10.1016/j.matdes.2019.108187,48,,120,-5.21,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1722,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,500,MTT,TetrazoliumSalt,83.333,10.1016/j.matdes.2019.108187,48,,120,-5.21,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1723,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,50,MTT,TetrazoliumSalt,89.431,10.1016/j.matdes.2019.108187,48,,120,-28.7,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1724,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,100,MTT,TetrazoliumSalt,81.707,10.1016/j.matdes.2019.108187,48,,120,-28.7,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1725,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,200,MTT,TetrazoliumSalt,81.03,10.1016/j.matdes.2019.108187,48,,120,-28.7,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1726,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Lung,Epithelial,Adult,96,500,MTT,TetrazoliumSalt,84.959,10.1016/j.matdes.2019.108187,48,,120,-28.7,A549,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1727,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Ovary,Epithelial,Adult,96,50,MTT,TetrazoliumSalt,81.081,10.1016/j.matdes.2019.108187,48,,120,-5.21,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1728,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Ovary,Epithelial,Adult,96,100,MTT,TetrazoliumSalt,83.499,10.1016/j.matdes.2019.108187,48,,120,-5.21,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1729,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,,,,96,200,MTT,TetrazoliumSalt,84.637,10.1016/j.matdes.2019.108187,48,,120,-5.21,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1730,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,,,,96,500,MTT,TetrazoliumSalt,82.646,10.1016/j.matdes.2019.108187,48,,120,-5.21,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1731,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,,,,96,50,MTT,TetrazoliumSalt,90.15,10.1016/j.matdes.2019.108187,48,,120,-28.7,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1732,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,,,,96,100,MTT,TetrazoliumSalt,89.33,10.1016/j.matdes.2019.108187,48,,120,-28.7,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1733,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,,,,96,200,MTT,TetrazoliumSalt,85.226,10.1016/j.matdes.2019.108187,48,,120,-28.7,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1734,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,,,,96,500,MTT,TetrazoliumSalt,82.216,10.1016/j.matdes.2019.108187,48,,120,-28.7,A2780,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1735,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,50,MTT,TetrazoliumSalt,88.514,10.1016/j.matdes.2019.108187,48,,120,-5.21,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1736,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,100,MTT,TetrazoliumSalt,86.892,10.1016/j.matdes.2019.108187,48,,120,-5.21,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1737,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,200,MTT,TetrazoliumSalt,83.378,10.1016/j.matdes.2019.108187,48,,120,-5.21,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1738,SiO2,Sphere,,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,500,MTT,TetrazoliumSalt,82.973,10.1016/j.matdes.2019.108187,48,,120,-5.21,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1739,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,50,MTT,TetrazoliumSalt,96.138,10.1016/j.matdes.2019.108187,48,,120,-28.7,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1740,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,100,MTT,TetrazoliumSalt,90.013,10.1016/j.matdes.2019.108187,48,,120,-28.7,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1741,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,200,MTT,TetrazoliumSalt,90.679,10.1016/j.matdes.2019.108187,48,,120,-28.7,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1742,SiO2,Sphere,COOH,Soft Templating Method,Negative,,,10000,H,Human,Breast,,,96,500,MTT,TetrazoliumSalt,82.157,10.1016/j.matdes.2019.108187,48,,120,-28.7,MCF-7,Materials &amp; Design,Elsevier BV,2019,Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery,TRUE,TRUE,gold,48_park2019.pdf,1
1767,Fe3O4,Rod,Urea,Chemical Reduction,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,200,MTT,TetrazoliumSalt,55.577,10.1016/j.etp.2015.07.005,49,,150,,L929,Experimental and Toxicologic Pathology,Elsevier BV,2015,Investigating the cytotoxicity of iron oxide nanoparticles in in vivo and in vitro studies,FALSE,FALSE,closed,49_ghasempour2015.pdf,0
1768,Fe3O4,Rod,Urea,Chemical Reduction,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,400,MTT,TetrazoliumSalt,72.401,10.1016/j.etp.2015.07.005,49,,150,,L929,Experimental and Toxicologic Pathology,Elsevier BV,2015,Investigating the cytotoxicity of iron oxide nanoparticles in in vivo and in vitro studies,FALSE,FALSE,closed,49_ghasempour2015.pdf,0
1769,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,24,10,CCK-8,,95,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1770,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,24,20,CCK-8,,93,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1771,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,24,50,CCK-8,,102.4,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1772,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,24,100,CCK-8,,99,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1773,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,48,10,CCK-8,,184.82,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1774,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,48,20,CCK-8,,221.01,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1775,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,48,50,CCK-8,,234.63,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1776,Fe3O4,Sphere,Dextran,Co-precipitation,Negative,60,-11,150000,H,Human,Blood,Monocyte,Adult,48,100,CCK-8,,230.74,10.2147/ijn.s135189,50,,7.5,,Monocytes,International Journal of Nanomedicine,Dove Medical Press Ltd.,2017,Iron oxide nanoparticles and induced autophagy in human monocytes,TRUE,TRUE,green,50_wu2017.pdf,1
1777,SiO2,Sphere,,Soft Templating Method,Negative,61.8,-25.4,6000,H,Human,,,,48,10,MTT,TetrazoliumSalt,98.63,10.1016/j.talanta.2013.01.037,51,,55.6,,HeLa,Talanta,Elsevier BV,2013,"Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells",FALSE,FALSE,closed,51_zhu2013.pdf,0
1778,SiO2,Sphere,,Soft Templating Method,Negative,61.8,-25.4,6000,H,Human,,,,48,100,MTT,TetrazoliumSalt,94.894,10.1016/j.talanta.2013.01.037,51,,55.6,,HeLa,Talanta,Elsevier BV,2013,"Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells",FALSE,FALSE,closed,51_zhu2013.pdf,0
1779,SiO2,Sphere,,Soft Templating Method,Negative,164.2,-24,6000,H,Human,,,,48,10,MTT,TetrazoliumSalt,95.641,10.1016/j.talanta.2013.01.037,51,,167.8,,HeLa,Talanta,Elsevier BV,2013,"Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells",FALSE,FALSE,closed,51_zhu2013.pdf,0
1780,SiO2,Sphere,,Soft Templating Method,Negative,164.2,-24,6000,H,Human,,,,48,100,MTT,TetrazoliumSalt,96.887,10.1016/j.talanta.2013.01.037,51,,167.8,,HeLa,Talanta,Elsevier BV,2013,"Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells",FALSE,FALSE,closed,51_zhu2013.pdf,0
1781,SiO2,Sphere,,Soft Templating Method,Negative,342,-27.3,6000,H,Human,,,,48,10,MTT,TetrazoliumSalt,94.894,10.1016/j.talanta.2013.01.037,51,,307.6,,HeLa,Talanta,Elsevier BV,2013,"Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells",FALSE,FALSE,closed,51_zhu2013.pdf,0
1782,SiO2,Sphere,,Soft Templating Method,Negative,342,-27.3,6000,H,Human,,,,48,100,MTT,TetrazoliumSalt,94.894,10.1016/j.talanta.2013.01.037,51,,307.6,,HeLa,Talanta,Elsevier BV,2013,"Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells",FALSE,FALSE,closed,51_zhu2013.pdf,0
1783,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,8,CCK-8,TetrazoliumSalt,101.67,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1784,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,16,CCK-8,TetrazoliumSalt,103.04,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1785,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,32,CCK-8,TetrazoliumSalt,103.04,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1786,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,64,CCK-8,TetrazoliumSalt,104.41,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1787,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,128,CCK-8,TetrazoliumSalt,101.67,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1788,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,256,CCK-8,TetrazoliumSalt,79.62,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1789,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,8,CCK-8,TetrazoliumSalt,101.06,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1790,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,16,CCK-8,TetrazoliumSalt,102.73,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1791,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,32,CCK-8,TetrazoliumSalt,103.64,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1792,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,64,CCK-8,TetrazoliumSalt,106.22,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1793,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,128,CCK-8,TetrazoliumSalt,72.989,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1794,SiO2,Sphere,,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,256,CCK-8,TetrazoliumSalt,20.822,10.1016/j.ecoenv.2019.109770,52,,19.4,-21.77,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1795,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,8,CCK-8,TetrazoliumSalt,98.928,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1796,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,16,CCK-8,TetrazoliumSalt,98.622,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1797,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,32,CCK-8,TetrazoliumSalt,97.243,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1798,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,64,CCK-8,TetrazoliumSalt,98.315,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1799,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,Lung,Epithelial,Adult,24,128,CCK-8,TetrazoliumSalt,98.622,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1800,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,8,CCK-8,TetrazoliumSalt,93.539,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1801,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,16,CCK-8,TetrazoliumSalt,94.86,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1802,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,32,CCK-8,TetrazoliumSalt,95.448,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1803,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,64,CCK-8,TetrazoliumSalt,98.385,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1804,SiO2,Sphere,DPPC,Sol-Gel Method,Negative,,,40000,H,Human,RespiratoryTract,Epithelial,Adult,24,128,CCK-8,TetrazoliumSalt,92.364,10.1016/j.ecoenv.2019.109770,52,,19.4,-13.5,16HBE,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC,FALSE,FALSE,closed,52_10.1016@j.ecoenv.2019.109770.pdf,0
1805,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,0.028,WST-1,TetrazoliumSalt,83.921,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1806,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,0.061,WST-1,TetrazoliumSalt,83.357,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1807,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,0.131,WST-1,TetrazoliumSalt,88.011,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1808,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,0.281,WST-1,TetrazoliumSalt,91.537,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1809,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,0.604,WST-1,TetrazoliumSalt,92.102,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1810,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,1.298,WST-1,TetrazoliumSalt,93.371,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1811,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,2.791,WST-1,TetrazoliumSalt,95.769,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1812,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,6,WST-1,TetrazoliumSalt,71.227,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1813,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,0.028,NRU,NeutralRed,99.577,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1814,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,0.061,NRU,NeutralRed,96.897,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1815,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,0.131,NRU,NeutralRed,95.769,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1816,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,0.281,NRU,NeutralRed,97.884,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1817,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,0.604,NRU,NeutralRed,95.346,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1818,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,1.298,NRU,NeutralRed,97.461,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1819,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,2.791,NRU,NeutralRed,95.769,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1820,Au,Sphere,Citrate,Commercial,Negative,48,-7.7,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,6,NRU,NeutralRed,100.71,10.1016/j.tiv.2016.09.012,53,,13,-60.7,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1821,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,0.028,WST-1,TetrazoliumSalt,86.46,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1822,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,0.061,WST-1,TetrazoliumSalt,80.395,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1823,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,0.131,WST-1,TetrazoliumSalt,82.37,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1824,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,0.281,WST-1,TetrazoliumSalt,87.729,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1825,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,0.604,WST-1,TetrazoliumSalt,82.793,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1826,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,1.298,WST-1,TetrazoliumSalt,82.087,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1827,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,2.791,WST-1,TetrazoliumSalt,77.715,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1828,Au,Sphere,Citrate,Commercial,Negative,52,-9.3,12000,A,Rat,Lung,Macrophage,Adult,24,6,WST-1,TetrazoliumSalt,74.189,10.1016/j.tiv.2016.09.012,53,,13,-60.7,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1829,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,0.67,WST-1,TetrazoliumSalt,102.69,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1830,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,1,WST-1,TetrazoliumSalt,94.215,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1831,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,1.5,WST-1,TetrazoliumSalt,98.967,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1832,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,2.1,WST-1,TetrazoliumSalt,152.69,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1833,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,3.1,WST-1,TetrazoliumSalt,29.752,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1834,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,4.6,WST-1,TetrazoliumSalt,2.0661,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1835,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,6.8,WST-1,TetrazoliumSalt,2.2727,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1836,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,24,10,WST-1,TetrazoliumSalt,3.0992,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1837,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,0.67,NRU,NeutralRed,93.388,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1838,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,1,NRU,NeutralRed,92.562,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1839,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,1.5,NRU,NeutralRed,90.702,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1840,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,2.1,NRU,NeutralRed,89.463,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1841,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,3.1,NRU,NeutralRed,24.587,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1842,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,4.6,NRU,NeutralRed,0.61983,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1843,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,6.8,NRU,NeutralRed,0.20661,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1844,Ag,Irregular,PVP,Commercial,Negative,121,-9,2000,A,Mouse,Embryo,Fibroblast,Embryonic,48,10,NRU,NeutralRed,0.41322,10.1016/j.tiv.2016.09.012,53,,20,-17.1,BALB/c3T3,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1845,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,0.67,WST-1,TetrazoliumSalt,97.107,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1846,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,1,WST-1,TetrazoliumSalt,98.967,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1847,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,1.5,WST-1,TetrazoliumSalt,104.75,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1848,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,2.1,WST-1,TetrazoliumSalt,102.89,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1849,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,3.1,WST-1,TetrazoliumSalt,106.2,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1850,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,4.6,WST-1,TetrazoliumSalt,95.455,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1851,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,6.8,WST-1,TetrazoliumSalt,83.058,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1852,Ag,Irregular,PVP,Commercial,Negative,,-11.3,12000,A,Rat,Lung,Macrophage,Adult,24,10,WST-1,TetrazoliumSalt,48.76,10.1016/j.tiv.2016.09.012,53,,20,-17.1,NR8383,Toxicology in Vitro,Elsevier BV,2016,"The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes",FALSE,FALSE,closed,53_10.1016@j.tiv.2016.09.012.pdf,0
1853,SiO2,Sphere,,Sol-Gel Method,,,,,H,Human,Skin,Keratinocyte,Adult,4,25,MTT,TetrazoliumSalt,99.588,10.1002/jat.2953,54,,50,,HaCat,Journal of Applied Toxicology,Wiley,2013,Cytotoxicity of silica nanoparticles on HaCaT cells,FALSE,TRUE,bronze,54_liang2013.pdf,1
1854,SiO2,Sphere,,Sol-Gel Method,,,,,H,Human,Skin,Keratinocyte,Adult,4,75,MTT,TetrazoliumSalt,94.643,10.1002/jat.2953,54,,50,,HaCat,Journal of Applied Toxicology,Wiley,2013,Cytotoxicity of silica nanoparticles on HaCaT cells,FALSE,TRUE,bronze,54_liang2013.pdf,1
1855,SiO2,Sphere,,Sol-Gel Method,,,,,H,Human,Skin,Keratinocyte,Adult,4,100,MTT,TetrazoliumSalt,52.473,10.1002/jat.2953,54,,50,,HaCat,Journal of Applied Toxicology,Wiley,2013,Cytotoxicity of silica nanoparticles on HaCaT cells,FALSE,TRUE,bronze,54_liang2013.pdf,1
1856,SiO2,Sphere,,Sol-Gel Method,,,,,H,Human,Skin,Keratinocyte,Adult,4,200,MTT,TetrazoliumSalt,36.126,10.1002/jat.2953,54,,50,,HaCat,Journal of Applied Toxicology,Wiley,2013,Cytotoxicity of silica nanoparticles on HaCaT cells,FALSE,TRUE,bronze,54_liang2013.pdf,1
1857,SiO2,Sphere,,Sol-Gel Method,,,,,H,Human,Skin,Keratinocyte,Adult,4,400,MTT,TetrazoliumSalt,22.253,10.1002/jat.2953,54,,50,,HaCat,Journal of Applied Toxicology,Wiley,2013,Cytotoxicity of silica nanoparticles on HaCaT cells,FALSE,TRUE,bronze,54_liang2013.pdf,1
1858,SiO2,Sphere,,Sol-Gel Method,,,,,H,Human,Skin,Keratinocyte,Adult,4,500,MTT,TetrazoliumSalt,19.643,10.1002/jat.2953,54,,50,,HaCat,Journal of Applied Toxicology,Wiley,2013,Cytotoxicity of silica nanoparticles on HaCaT cells,FALSE,TRUE,bronze,54_liang2013.pdf,1
1859,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,72,1,MTT,TetrazoliumSalt,91.262,10.1016/j.toxlet.2012.07.009,55,,,,RAW264.7,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1860,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,72,3,MTT,TetrazoliumSalt,87.5,10.1016/j.toxlet.2012.07.009,55,,,,RAW264.7,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1861,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,72,10,MTT,TetrazoliumSalt,81.553,10.1016/j.toxlet.2012.07.009,55,,,,RAW264.7,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1862,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,72,30,MTT,TetrazoliumSalt,52.306,10.1016/j.toxlet.2012.07.009,55,,,,RAW264.7,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1863,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,72,100,MTT,TetrazoliumSalt,30.097,10.1016/j.toxlet.2012.07.009,55,,,,RAW264.7,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1864,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Macrophage,Adult,72,1,MTT,TetrazoliumSalt,108.01,10.1016/j.toxlet.2012.07.009,55,,,,J774A.1,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1865,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Macrophage,Adult,72,3,MTT,TetrazoliumSalt,107.14,10.1016/j.toxlet.2012.07.009,55,,,,J774A.1,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1866,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Macrophage,Adult,72,10,MTT,TetrazoliumSalt,106.26,10.1016/j.toxlet.2012.07.009,55,,,,J774A.1,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1867,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Macrophage,Adult,72,30,MTT,TetrazoliumSalt,94.072,10.1016/j.toxlet.2012.07.009,55,,,,J774A.1,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1868,Ag,Sphere,,Chemical Reduction,Negative,43.9,-16.2,10000,A,Mouse,Ascites,Macrophage,Adult,72,100,MTT,TetrazoliumSalt,64.764,10.1016/j.toxlet.2012.07.009,55,,,,J774A.1,Toxicology Letters,Elsevier BV,2012,"Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles",FALSE,FALSE,closed,55_singh2012.pdf,0
1869,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,0.5,CCK-8,TetrazoliumSalt,88.021,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1870,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,5,CCK-8,TetrazoliumSalt,85.069,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1871,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,50,CCK-8,TetrazoliumSalt,55.556,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1872,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,500,CCK-8,TetrazoliumSalt,12.5,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1873,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,0.5,CCK-8,TetrazoliumSalt,97.049,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1874,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,5,CCK-8,TetrazoliumSalt,94.444,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1875,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,50,CCK-8,TetrazoliumSalt,92.014,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1876,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,500,CCK-8,TetrazoliumSalt,5.9028,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1877,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,48,0.5,CCK-8,TetrazoliumSalt,83.505,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1878,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,48,5,CCK-8,TetrazoliumSalt,69.931,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1879,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,48,50,CCK-8,TetrazoliumSalt,49.485,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1881,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,0.5,CCK-8,TetrazoliumSalt,99.485,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1882,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,5,CCK-8,TetrazoliumSalt,89.519,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1883,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,50,CCK-8,TetrazoliumSalt,85.911,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1884,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,500,CCK-8,TetrazoliumSalt,3.9519,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1885,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,0.5,CCK-8,TetrazoliumSalt,82.847,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1886,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,5,CCK-8,TetrazoliumSalt,59.691,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1887,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,50,CCK-8,TetrazoliumSalt,39.108,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1888,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,500,CCK-8,TetrazoliumSalt,1.5437,10.1155/2012/160145,56,,20,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1889,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,0.5,CCK-8,TetrazoliumSalt,83.877,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1890,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,5,CCK-8,TetrazoliumSalt,81.818,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1891,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,50,CCK-8,TetrazoliumSalt,58.834,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1892,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,500,CCK-8,TetrazoliumSalt,2.4014,10.1155/2012/160145,56,,20,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1893,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,0.5,CCK-8,TetrazoliumSalt,87.13,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1894,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,5,CCK-8,TetrazoliumSalt,78.609,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1895,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,50,CCK-8,TetrazoliumSalt,55.13,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1896,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,24,500,CCK-8,TetrazoliumSalt,9.913,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1897,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,0.5,CCK-8,TetrazoliumSalt,98.087,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1898,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,5,CCK-8,TetrazoliumSalt,95.652,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1899,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,50,CCK-8,TetrazoliumSalt,96.522,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1900,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,500,CCK-8,TetrazoliumSalt,1.0435,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1901,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,48,0.5,CCK-8,TetrazoliumSalt,88.644,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1902,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,48,5,CCK-8,TetrazoliumSalt,90.169,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1903,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,48,50,CCK-8,TetrazoliumSalt,63.39,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1905,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,0.5,CCK-8,TetrazoliumSalt,92.542,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1906,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,5,CCK-8,TetrazoliumSalt,96.61,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1907,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,50,CCK-8,TetrazoliumSalt,96.102,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1908,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,48,500,CCK-8,TetrazoliumSalt,2.3729,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1909,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,0.5,CCK-8,TetrazoliumSalt,77.108,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1910,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,5,CCK-8,TetrazoliumSalt,75.559,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1911,Ag,Sphere,,Commercial,,,,10000,H,Human,Embryo,Fibroblast,Embryonic,72,50,CCK-8,TetrazoliumSalt,55.25,10.1155/2012/160145,56,,100,,EBF,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1913,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,0.5,CCK-8,TetrazoliumSalt,91.05,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1914,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,5,CCK-8,TetrazoliumSalt,91.91,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1915,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,50,CCK-8,TetrazoliumSalt,91.566,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1916,Ag,Sphere,,Commercial,,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,72,500,CCK-8,TetrazoliumSalt,11.876,10.1155/2012/160145,56,,100,,L929,Journal of Nanomaterials,Wiley,2012,Cytotoxicity of Silver Nanoparticles in Human Embryonic Stem CellГўВЂВђDerived Fibroblasts and an LГўВЂВђ929 Cell Line,FALSE,TRUE,hybrid,56_peng2012.pdf,1
1917,CaHCO3,Rod,,Precipitation,,567.86,,,H,Human,BoneMarrow,,,24,5,CCK-8,,98.864,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1918,CaHCO3,Rod,,Precipitation,,567.86,,,H,Human,BoneMarrow,,,24,10,CCK-8,,100,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1919,CaHCO3,Rod,,Precipitation,,567.86,,,H,Human,BoneMarrow,,,24,50,CCK-8,,91.136,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1920,CaHCO3,Rod,,Precipitation,,626.1,,,H,Human,BoneMarrow,,,24,5,CCK-8,,100,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1921,CaHCO3,Rod,,Precipitation,,626.1,,,H,Human,BoneMarrow,,,24,10,CCK-8,,99.318,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1922,CaHCO3,Rod,,Precipitation,,626.1,,,H,Human,BoneMarrow,,,24,50,CCK-8,,89.318,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1923,CaHCO3,Rod,,Precipitation,,1262.33,,,H,Human,BoneMarrow,,,24,5,CCK-8,,99.318,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1924,CaHCO3,Rod,,Precipitation,,1262.33,,,H,Human,BoneMarrow,,,24,10,CCK-8,,99.318,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1925,CaHCO3,Rod,,Precipitation,,1262.33,,,H,Human,BoneMarrow,,,24,50,CCK-8,,85.227,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1926,CaHCO3,Rod,,Precipitation,,567.86,,,H,Human,BoneMarrow,,,72,5,CCK-8,,100.45,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1927,CaHCO3,Rod,,Precipitation,,567.86,,,H,Human,BoneMarrow,,,72,10,CCK-8,,99.324,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1928,CaHCO3,Rod,,Precipitation,,567.86,,,H,Human,BoneMarrow,,,72,50,CCK-8,,90.541,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1929,CaHCO3,Rod,,Precipitation,,626.1,,,H,Human,BoneMarrow,,,72,5,CCK-8,,99.324,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1930,CaHCO3,Rod,,Precipitation,,626.1,,,H,Human,BoneMarrow,,,72,10,CCK-8,,99.324,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1931,CaHCO3,Rod,,Precipitation,,626.1,,,H,Human,BoneMarrow,,,72,50,CCK-8,,93.468,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1932,CaHCO3,Rod,,Precipitation,,1262.33,,,H,Human,BoneMarrow,,,72,5,CCK-8,,98.649,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1933,CaHCO3,Rod,,Precipitation,,1262.33,,,H,Human,BoneMarrow,,,72,10,CCK-8,,98.649,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1934,CaHCO3,Rod,,Precipitation,,1262.33,,,H,Human,BoneMarrow,,,72,50,CCK-8,,92.342,10.1155/2018/2036176,57,,,,hMSC,Stem Cells International,Wiley,2018,In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells,TRUE,TRUE,gold,57_yang2018.pdf,1
1935,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,53.263,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1936,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,22.458,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1937,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,65.554,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1938,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,91.047,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1939,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,96.662,10.1016/j.biomaterials.2009.09.088,58,,26,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1940,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,95.144,10.1016/j.biomaterials.2009.09.088,58,,45,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1941,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,94.537,10.1016/j.biomaterials.2009.09.088,58,,78,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1942,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,94.841,10.1016/j.biomaterials.2009.09.088,58,,175,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1943,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,24,200,MTT,TetrazoliumSalt,73.149,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1944,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,24,200,MTT,TetrazoliumSalt,52.044,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1945,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,24,200,MTT,TetrazoliumSalt,82.541,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1946,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,24,200,MTT,TetrazoliumSalt,94.917,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1947,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,53.37,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1948,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,22.32,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1949,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,73.481,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1950,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,48,200,MTT,TetrazoliumSalt,89.945,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1951,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,72,200,MTT,TetrazoliumSalt,48.066,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1952,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,72,200,MTT,TetrazoliumSalt,20.994,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1953,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,72,200,MTT,TetrazoliumSalt,70.718,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1954,CaHCO3,Sphere,,Sol-Gel Method,,,,100000,H,Human,Liver,,,72,200,MTT,TetrazoliumSalt,86.961,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
1955,CuO,Sphere,,Commercial,Negative,65.59,-39.67,10000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,75,10.1016/j.bbrc.2010.04.156,59,,52.51,,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
1956,CuO,Sphere,,Commercial,Negative,65.59,-39.67,10000,H,Human,Lung,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,66,10.1016/j.bbrc.2010.04.156,59,,52.51,,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
1957,CuO,Sphere,,Commercial,Negative,65.59,-39.67,10000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,48,10.1016/j.bbrc.2010.04.156,59,,52.51,,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
1958,CuO,Sphere,,Commercial,Negative,65.59,-39.67,10000,H,Human,Lung,Epithelial,Adult,24,10,NRU,NeutralRed,85,10.1016/j.bbrc.2010.04.156,59,,52.51,,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
1959,CuO,Sphere,,Commercial,Negative,65.59,-39.67,10000,H,Human,Lung,Epithelial,Adult,24,25,NRU,NeutralRed,69,10.1016/j.bbrc.2010.04.156,59,,52.51,,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
1960,CuO,Sphere,,Commercial,Negative,65.59,-39.67,10000,H,Human,Lung,Epithelial,Adult,24,50,NRU,NeutralRed,46,10.1016/j.bbrc.2010.04.156,59,,52.51,,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
1961,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,1.78,NRU,NeutralRed,78.035,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1962,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,3.16,NRU,NeutralRed,31.985,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1963,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,5.62,NRU,NeutralRed,10.405,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1964,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,10,NRU,NeutralRed,4.2389,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1965,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,17.8,NRU,NeutralRed,2.1195,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1966,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,31.6,NRU,NeutralRed,1.1561,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1967,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,56.2,NRU,NeutralRed,0.385,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1968,CuO,Sphere,,Commercial,Negative,310,-12.1,4500,H,Human,BoneMarrow,,,48,100,NRU,NeutralRed,0.385,10.3109/15376516.2014.928920,60,,30.09,-20,hMSC,Toxicology Mechanisms and Methods,Informa UK Limited,2014,Acute toxicity test of CuO nanoparticles using human mesenchymal stem cells,FALSE,FALSE,closed,60_ahamed2010.pdf,0
1969,CuO,Sphere,,Solvothermal Process,Negative,87,-25,1000,H,Human,Lung,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,81.514,10.1177/0748233713511512,61,,23,,A549,Toxicology and Industrial Health,SAGE Publications,2013,Dose-dependent genotoxicity of copper oxide nanoparticles stimulated by reactive oxygen species in human lung epithelial cells,FALSE,FALSE,closed,61_akhtar2013.pdf,0
1970,CuO,Sphere,,Solvothermal Process,Negative,87,-25,1000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,56.477,10.1177/0748233713511512,61,,23,,A549,Toxicology and Industrial Health,SAGE Publications,2013,Dose-dependent genotoxicity of copper oxide nanoparticles stimulated by reactive oxygen species in human lung epithelial cells,FALSE,FALSE,closed,61_akhtar2013.pdf,0
1971,CuO,Sphere,,Solvothermal Process,Negative,87,-25,1000,H,Human,Lung,Epithelial,Adult,24,15,MTT,TetrazoliumSalt,31.441,10.1177/0748233713511512,61,,23,,A549,Toxicology and Industrial Health,SAGE Publications,2013,Dose-dependent genotoxicity of copper oxide nanoparticles stimulated by reactive oxygen species in human lung epithelial cells,FALSE,FALSE,closed,61_akhtar2013.pdf,0
1972,CuO,Sphere,,Commercial,,644,,50000,H,Human,Colon,Epithelial,Adult,24,25,MTS,TetrazoliumSalt,114.06,10.3109/17435390.2011.625127,62,,40,,Caco-2,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1973,CuO,Sphere,,Commercial,,644,,50000,H,Human,Colon,Epithelial,Adult,48,25,MTS,TetrazoliumSalt,75.332,10.3109/17435390.2011.625127,62,,40,,Caco-2,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1974,CuO,Rod,,Commercial,,527,,50000,H,Human,Colon,Epithelial,Adult,24,25,MTS,TetrazoliumSalt,75.862,10.3109/17435390.2011.625127,62,,10,,Caco-2,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1975,CuO,Rod,,Commercial,,527,,50000,H,Human,Colon,Epithelial,Adult,48,25,MTS,TetrazoliumSalt,64.721,10.3109/17435390.2011.625127,62,,10,,Caco-2,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1976,CuO,Sphere,,Commercial,,644,,,H,Human,Lung,Epithelial,Adult,24,5,MTS,TetrazoliumSalt,100,10.3109/17435390.2011.625127,62,,40,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1977,CuO,Sphere,,Commercial,,644,,,H,Human,Lung,Epithelial,Adult,24,10,MTS,TetrazoliumSalt,102.87,10.3109/17435390.2011.625127,62,,40,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1978,CuO,Sphere,,Commercial,,644,,,H,Human,Lung,Epithelial,Adult,24,25,MTS,TetrazoliumSalt,94.702,10.3109/17435390.2011.625127,62,,40,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1979,CuO,Sphere,,Commercial,,644,,,H,Human,Lung,Epithelial,Adult,24,50,MTS,TetrazoliumSalt,85.872,10.3109/17435390.2011.625127,62,,40,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1980,CuO,Sphere,,Commercial,,644,,,H,Human,Lung,Epithelial,Adult,24,100,MTS,TetrazoliumSalt,52.759,10.3109/17435390.2011.625127,62,,40,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1981,CuO,Rod,,Commercial,,527,,,H,Human,Lung,Epithelial,Adult,24,5,MTS,TetrazoliumSalt,103.31,10.3109/17435390.2011.625127,62,,10,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1982,CuO,Rod,,Commercial,,527,,,H,Human,Lung,Epithelial,Adult,24,10,MTS,TetrazoliumSalt,98.455,10.3109/17435390.2011.625127,62,,10,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1983,CuO,Rod,,Commercial,,527,,,H,Human,Lung,Epithelial,Adult,24,25,MTS,TetrazoliumSalt,84.768,10.3109/17435390.2011.625127,62,,10,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1984,CuO,Rod,,Commercial,,527,,,H,Human,Lung,Epithelial,Adult,24,50,MTS,TetrazoliumSalt,56.291,10.3109/17435390.2011.625127,62,,10,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1985,CuO,Rod,,Commercial,,527,,,H,Human,Lung,Epithelial,Adult,24,100,MTS,TetrazoliumSalt,15.011,10.3109/17435390.2011.625127,62,,10,,A549,Nanotoxicology,Informa UK Limited,2011,Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape,FALSE,FALSE,closed,62_piret2011.pdf,0
1986,CeO2,Sphere,,Sol-Gel Method,,,,5000,,,,,,24,50,MTT,TetrazoliumSalt,105.86,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
1987,CeO2,Sphere,,Sol-Gel Method,,,,5000,,,,,,24,100,MTT,TetrazoliumSalt,103.06,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
1988,CeO2,Sphere,,Sol-Gel Method,,,,5000,,,,,,24,200,MTT,TetrazoliumSalt,104.97,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
1989,CeO2,Sphere,,Sol-Gel Method,,,,5000,,,,,,24,400,MTT,TetrazoliumSalt,100,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
1990,CeO2,Sphere,,Sol-Gel Method,,,,5000,,,,,,24,800,MTT,TetrazoliumSalt,96.943,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
1991,CeO2,Sphere,,Sol-Gel Method,,,,10000,A,Mouse,Brain,Neuronal,Adult,24,5.46,MTT,TetrazoliumSalt,82.4,10.1016/j.ceramint.2013.02.026,64,,4.7,,neuro2A,Ceramics International,Elsevier BV,2013,"Facile synthesis, characterization, and evaluation of neurotoxicity effect of cerium oxide nanoparticles",FALSE,FALSE,closed,64_darroudi2013.pdf,0
1992,CeO2,Sphere,,Sol-Gel Method,,,,10000,A,Mouse,Brain,Neuronal,Adult,24,10.93,MTT,TetrazoliumSalt,84.667,10.1016/j.ceramint.2013.02.026,64,,4.7,,neuro2A,Ceramics International,Elsevier BV,2013,"Facile synthesis, characterization, and evaluation of neurotoxicity effect of cerium oxide nanoparticles",FALSE,FALSE,closed,64_darroudi2013.pdf,0
1993,CeO2,Sphere,,Sol-Gel Method,,,,10000,,,,,,24,21.87,MTT,TetrazoliumSalt,74.933,10.1016/j.ceramint.2013.02.026,64,,4.7,,neuro2A,Ceramics International,Elsevier BV,2013,"Facile synthesis, characterization, and evaluation of neurotoxicity effect of cerium oxide nanoparticles",FALSE,FALSE,closed,64_darroudi2013.pdf,0
1994,CeO2,Sphere,,Sol-Gel Method,,,,10000,A,Mouse,Brain,Neuronal,Adult,24,43.75,MTT,TetrazoliumSalt,75.467,10.1016/j.ceramint.2013.02.026,64,,4.7,,neuro2A,Ceramics International,Elsevier BV,2013,"Facile synthesis, characterization, and evaluation of neurotoxicity effect of cerium oxide nanoparticles",FALSE,FALSE,closed,64_darroudi2013.pdf,0
1995,CeO2,Sphere,,Sol-Gel Method,,,,10000,A,Mouse,Brain,Neuronal,Adult,24,87.5,MTT,TetrazoliumSalt,67.733,10.1016/j.ceramint.2013.02.026,64,,4.7,,neuro2A,Ceramics International,Elsevier BV,2013,"Facile synthesis, characterization, and evaluation of neurotoxicity effect of cerium oxide nanoparticles",FALSE,FALSE,closed,64_darroudi2013.pdf,0
1996,CeO2,Sphere,,Sol-Gel Method,,,,10000,A,Mouse,Brain,Neuronal,Adult,24,175,MTT,TetrazoliumSalt,66.8,10.1016/j.ceramint.2013.02.026,64,,4.7,,neuro2A,Ceramics International,Elsevier BV,2013,"Facile synthesis, characterization, and evaluation of neurotoxicity effect of cerium oxide nanoparticles",FALSE,FALSE,closed,64_darroudi2013.pdf,0
1997,ZnO,Sphere,,Commercial,,54.17,,5000,H,Human,Lung,Epithelial,Adult,24,1,CCK-8,TetrazoliumSalt,96.943,10.1007/s11051-018-4333-0,65,,30,,A549,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,The time-dependent cellular response mechanism upon exposure to zinc oxide nanoparticles,FALSE,FALSE,closed,65_zhang2018.pdf,0
1998,ZnO,Sphere,,Commercial,,55.74,,5000,H,Human,Lung,Epithelial,Adult,24,2.5,CCK-8,TetrazoliumSalt,98.69,10.1007/s11051-018-4333-0,65,,30,,A549,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,The time-dependent cellular response mechanism upon exposure to zinc oxide nanoparticles,FALSE,FALSE,closed,65_zhang2018.pdf,0
1999,ZnO,Sphere,,Commercial,,56.53,,5000,H,Human,Lung,Epithelial,Adult,24,5,CCK-8,TetrazoliumSalt,101.16,10.1007/s11051-018-4333-0,65,,30,,A549,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,The time-dependent cellular response mechanism upon exposure to zinc oxide nanoparticles,FALSE,FALSE,closed,65_zhang2018.pdf,0
2000,ZnO,Sphere,,Commercial,,78.53,,5000,H,Human,Lung,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,89.52,10.1007/s11051-018-4333-0,65,,30,,A549,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,The time-dependent cellular response mechanism upon exposure to zinc oxide nanoparticles,FALSE,FALSE,closed,65_zhang2018.pdf,0
2001,ZnO,Sphere,,Commercial,,164.98,,5000,H,Human,Lung,Epithelial,Adult,24,25,CCK-8,TetrazoliumSalt,63.901,10.1007/s11051-018-4333-0,65,,30,,A549,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,The time-dependent cellular response mechanism upon exposure to zinc oxide nanoparticles,FALSE,FALSE,closed,65_zhang2018.pdf,0
2002,ZnO,Sphere,,Commercial,,270.46,,5000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,59.971,10.1007/s11051-018-4333-0,65,,30,,A549,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,The time-dependent cellular response mechanism upon exposure to zinc oxide nanoparticles,FALSE,FALSE,closed,65_zhang2018.pdf,0
2003,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,6,0.8,MTT,TetrazoliumSalt,99.051,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2004,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,6,4,MTT,TetrazoliumSalt,94.146,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2005,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,6,8,MTT,TetrazoliumSalt,103.16,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2006,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,6,14,MTT,TetrazoliumSalt,93.513,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2007,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,6,20,MTT,TetrazoliumSalt,75.949,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2008,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,12,0.8,MTT,TetrazoliumSalt,98.101,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2009,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,12,4,MTT,TetrazoliumSalt,104.43,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2010,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,12,8,MTT,TetrazoliumSalt,84.335,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2011,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,12,14,MTT,TetrazoliumSalt,72.31,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2012,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,12,20,MTT,TetrazoliumSalt,69.146,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2013,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,24,0.8,MTT,TetrazoliumSalt,103.64,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2014,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,24,4,MTT,TetrazoliumSalt,105.22,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2015,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,24,8,MTT,TetrazoliumSalt,59.335,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2016,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,24,14,MTT,TetrazoliumSalt,51.582,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2017,ZnO,Sphere,,Commercial,Negative,245,-15.8,10000,H,Human,Skin,Keratinocyte,Adult,24,20,MTT,TetrazoliumSalt,31.962,10.1166/jnn.2011.4250,66,,,,HEK,Journal of Nanoscience and Nanotechnology,American Scientific Publishers,2011,Zinc Oxide Nanoparticle Induced Genotoxicity in Primary Human Epidermal Keratinocytes,FALSE,FALSE,closed,66_sharma2011.pdf,0
2018,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,20,MTS,TetrazoliumSalt,120.46,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2019,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,40,MTS,TetrazoliumSalt,121.74,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2020,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,60,MTS,TetrazoliumSalt,117.14,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2021,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,80,MTS,TetrazoliumSalt,121.74,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2022,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,100,MTS,TetrazoliumSalt,116.62,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2023,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,120,MTS,TetrazoliumSalt,125.32,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2024,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,150,MTS,TetrazoliumSalt,108.95,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2025,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,20,MTS,TetrazoliumSalt,98.465,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2026,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,40,MTS,TetrazoliumSalt,103.32,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2027,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,60,MTS,TetrazoliumSalt,106.65,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2028,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,80,MTS,TetrazoliumSalt,108.95,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2029,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,100,MTS,TetrazoliumSalt,116.11,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2030,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,120,MTS,TetrazoliumSalt,119.44,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2031,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,150,MTS,TetrazoliumSalt,127.62,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2032,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,20,MTS,TetrazoliumSalt,112.79,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2033,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,40,MTS,TetrazoliumSalt,113.81,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2034,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,60,MTS,TetrazoliumSalt,108.95,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2035,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,80,MTS,TetrazoliumSalt,113.81,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2036,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,100,MTS,TetrazoliumSalt,121.48,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2037,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,120,MTS,TetrazoliumSalt,124.3,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2038,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,150,MTS,TetrazoliumSalt,100.51,10.1016/j.biopha.2013.08.006,67,,25,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2039,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,20,MTS,TetrazoliumSalt,105.23,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2040,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,40,MTS,TetrazoliumSalt,103.08,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2041,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,60,MTS,TetrazoliumSalt,103.69,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2042,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,80,MTS,TetrazoliumSalt,106.15,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2043,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,100,MTS,TetrazoliumSalt,98.462,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2044,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,120,MTS,TetrazoliumSalt,95.077,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2045,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,3,150,MTS,TetrazoliumSalt,100.62,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2046,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,20,MTS,TetrazoliumSalt,133.85,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2047,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,40,MTS,TetrazoliumSalt,132,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2048,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,60,MTS,TetrazoliumSalt,134.15,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2049,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,80,MTS,TetrazoliumSalt,128.31,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2050,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,100,MTS,TetrazoliumSalt,139.08,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2051,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,120,MTS,TetrazoliumSalt,135.38,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2052,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,6,150,MTS,TetrazoliumSalt,128,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2053,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,20,MTS,TetrazoliumSalt,107.08,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2054,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,40,MTS,TetrazoliumSalt,110.15,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2055,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,60,MTS,TetrazoliumSalt,109.54,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2056,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,80,MTS,TetrazoliumSalt,118.15,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2057,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,100,MTS,TetrazoliumSalt,118.46,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2058,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,120,MTS,TetrazoliumSalt,124,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2059,TiO2,Sphere,,Commercial,Negative,,,10000,H,Human,Stomach,Epithelial,Adult,24,150,MTS,TetrazoliumSalt,110.77,10.1016/j.biopha.2013.08.006,67,,21,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
2060,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,93.64,MTT,TetrazoliumSalt,92.676,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2061,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,140.5,MTT,TetrazoliumSalt,90.986,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2062,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,210.7,MTT,TetrazoliumSalt,90.141,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2063,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,316.1,MTT,TetrazoliumSalt,89.296,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2064,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,474.1,MTT,TetrazoliumSalt,88.451,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2065,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,711.1,MTT,TetrazoliumSalt,87.606,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2066,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,1067,MTT,TetrazoliumSalt,85.07,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2067,Ag,Sphere,,Commercial,Negative,31.89,-7.06,,H,Human,Liver,Epithelial,Adult,24,1600,MTT,TetrazoliumSalt,79.437,10.1002/jat.3199,68,,21.8,-16.8,HepG2,Journal of Applied Toxicology,Wiley,2015,Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,FALSE,FALSE,closed,68_xue2015.pdf,0
2068,MgO,Sphere,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,64.13,10.1007/s12010-019-03166-z,69,,47.9,-7.01,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2069,MgO,Sphere,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,400,MTT,TetrazoliumSalt,56.96,10.1007/s12010-019-03166-z,69,,47.9,-7.01,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2070,MgO,Sphere,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,600,MTT,TetrazoliumSalt,49.38,10.1007/s12010-019-03166-z,69,,47.9,-7.01,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2071,MgO,Sphere,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,800,MTT,TetrazoliumSalt,37.09,10.1007/s12010-019-03166-z,69,,47.9,-7.01,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2072,MgO,Sphere,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,1000,MTT,TetrazoliumSalt,28.27,10.1007/s12010-019-03166-z,69,,47.9,-7.01,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2073,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,61.47,10.1007/s12010-019-03166-z,69,,43.8,-7.21,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2074,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,400,MTT,TetrazoliumSalt,54.71,10.1007/s12010-019-03166-z,69,,43.8,-7.21,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2075,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,600,MTT,TetrazoliumSalt,48.15,10.1007/s12010-019-03166-z,69,,43.8,-7.21,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2076,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,800,MTT,TetrazoliumSalt,43.85,10.1007/s12010-019-03166-z,69,,43.8,-7.21,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2077,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,1000,MTT,TetrazoliumSalt,39.75,10.1007/s12010-019-03166-z,69,,43.8,-7.21,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2078,MgO,Rod,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,200,MTT,TetrazoliumSalt,53.07,10.1007/s12010-019-03166-z,69,,12,-9.83,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2079,MgO,Rod,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,400,MTT,TetrazoliumSalt,45.69,10.1007/s12010-019-03166-z,69,,12,-9.83,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2080,MgO,Rod,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,600,MTT,TetrazoliumSalt,38.93,10.1007/s12010-019-03166-z,69,,12,-9.83,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2081,MgO,Rod,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,800,MTT,TetrazoliumSalt,32.17,10.1007/s12010-019-03166-z,69,,12,-9.83,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2082,MgO,Rod,,Sol-Gel Method,Negative,,,100000,A,Mouse,Embryo,Fibroblast,Embryonic,24,1000,MTT,TetrazoliumSalt,22.13,10.1007/s12010-019-03166-z,69,,12,-9.83,3T3-L1,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2083,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Monkey,Kidney,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,77.52,10.1007/s12010-019-03166-z,69,,43.8,-7.21,VERO,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2084,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Monkey,Kidney,Epithelial,Adult,24,400,MTT,TetrazoliumSalt,70.96,10.1007/s12010-019-03166-z,69,,43.8,-7.21,VERO,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2085,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Monkey,Kidney,Epithelial,Adult,24,600,MTT,TetrazoliumSalt,62.54,10.1007/s12010-019-03166-z,69,,43.8,-7.21,VERO,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2086,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Monkey,Kidney,Epithelial,Adult,24,800,MTT,TetrazoliumSalt,57.93,10.1007/s12010-019-03166-z,69,,43.8,-7.21,VERO,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2087,MgO,Hexagon,,Sol-Gel Method,Negative,,,100000,A,Monkey,Kidney,Epithelial,Adult,24,1000,MTT,TetrazoliumSalt,54.61,10.1007/s12010-019-03166-z,69,,43.8,-7.21,VERO,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2019,Cytotoxicity Analysis of Morphologically Different Sol-Gel-Synthesized MgO Nanoparticles and Their In Vitro Insulin Resistance Reversal Ability in Adipose cells,FALSE,FALSE,closed,69_10.1007@s12010-019-03166-z.pdf,0
2189,ZnO,Sphere,,Commercial,,37.77,,10000,H,Human,Liver,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,98.097,10.1016/j.ecoenv.2018.12.096,70,,20,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2190,ZnO,Sphere,,Commercial,,37.77,,10000,H,Human,Liver,Epithelial,Adult,24,8,MTT,TetrazoliumSalt,87.408,10.1016/j.ecoenv.2018.12.096,70,,20,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2191,ZnO,Sphere,,Commercial,,37.77,,10000,H,Human,Liver,Epithelial,Adult,24,16,MTT,TetrazoliumSalt,68.96,10.1016/j.ecoenv.2018.12.096,70,,20,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2192,ZnO,Sphere,,Commercial,,37.77,,10000,H,Human,Liver,Epithelial,Adult,24,40,MTT,TetrazoliumSalt,40.556,10.1016/j.ecoenv.2018.12.096,70,,20,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2193,ZnO,Sphere,,Commercial,,37.77,,10000,H,Human,Liver,Epithelial,Adult,24,80,MTT,TetrazoliumSalt,24.89,10.1016/j.ecoenv.2018.12.096,70,,20,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2194,ZnO,Sphere,,Commercial,,37.77,,10000,H,Human,Liver,Epithelial,Adult,24,160,MTT,TetrazoliumSalt,21.669,10.1016/j.ecoenv.2018.12.096,70,,20,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2195,ZnO,Sphere,,Commercial,,102.2,,10000,H,Human,Liver,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,99.56,10.1016/j.ecoenv.2018.12.096,70,,90,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2196,ZnO,Sphere,,Commercial,,102.2,,10000,H,Human,Liver,Epithelial,Adult,24,8,MTT,TetrazoliumSalt,95.748,10.1016/j.ecoenv.2018.12.096,70,,90,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2197,ZnO,Sphere,,Commercial,,102.2,,10000,H,Human,Liver,Epithelial,Adult,24,16,MTT,TetrazoliumSalt,79.912,10.1016/j.ecoenv.2018.12.096,70,,90,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2198,ZnO,Sphere,,Commercial,,102.2,,10000,H,Human,Liver,Epithelial,Adult,24,40,MTT,TetrazoliumSalt,48.68,10.1016/j.ecoenv.2018.12.096,70,,90,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2199,ZnO,Sphere,,Commercial,,102.2,,10000,H,Human,Liver,Epithelial,Adult,24,80,MTT,TetrazoliumSalt,29.472,10.1016/j.ecoenv.2018.12.096,70,,90,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2200,ZnO,Sphere,,Commercial,,102.2,,10000,H,Human,Liver,Epithelial,Adult,24,160,MTT,TetrazoliumSalt,23.607,10.1016/j.ecoenv.2018.12.096,70,,90,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2201,ZnO,Sphere,,Commercial,,222,,10000,H,Human,Liver,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,99.854,10.1016/j.ecoenv.2018.12.096,70,,200,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2202,ZnO,Sphere,,Commercial,,222,,10000,H,Human,Liver,Epithelial,Adult,24,8,MTT,TetrazoliumSalt,92.982,10.1016/j.ecoenv.2018.12.096,70,,200,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2203,ZnO,Sphere,,Commercial,,222,,10000,H,Human,Liver,Epithelial,Adult,24,16,MTT,TetrazoliumSalt,80.994,10.1016/j.ecoenv.2018.12.096,70,,200,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2204,ZnO,Sphere,,Commercial,,222,,10000,H,Human,Liver,Epithelial,Adult,24,40,MTT,TetrazoliumSalt,63.596,10.1016/j.ecoenv.2018.12.096,70,,200,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2205,ZnO,Sphere,,Commercial,,222,,10000,H,Human,Liver,Epithelial,Adult,24,80,MTT,TetrazoliumSalt,60.234,10.1016/j.ecoenv.2018.12.096,70,,200,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2206,ZnO,Sphere,,Commercial,,222,,10000,H,Human,Liver,Epithelial,Adult,24,160,MTT,TetrazoliumSalt,57.018,10.1016/j.ecoenv.2018.12.096,70,,200,,HepG2,Ecotoxicology and Environmental Safety,Elsevier BV,2019,Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells,FALSE,FALSE,closed,70_10.1016@j.ecoenv.2018.12.096.pdf,0
2207,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,5,CCK-8,TetrazoliumSalt,89.58,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2208,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,5,CCK-8,TetrazoliumSalt,94.698,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2209,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,5,CCK-8,TetrazoliumSalt,98.355,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2210,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,10,CCK-8,TetrazoliumSalt,85.192,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2211,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,10,CCK-8,TetrazoliumSalt,91.59,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2212,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,10,CCK-8,TetrazoliumSalt,94.15,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2213,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,20,CCK-8,TetrazoliumSalt,30.713,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2214,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,20,CCK-8,TetrazoliumSalt,74.771,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2215,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,20,CCK-8,TetrazoliumSalt,93.967,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2216,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,40,CCK-8,TetrazoliumSalt,20.841,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2217,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,40,CCK-8,TetrazoliumSalt,22.121,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2218,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,40,CCK-8,TetrazoliumSalt,28.702,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2219,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,50,CCK-8,TetrazoliumSalt,10.238,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2220,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,50,CCK-8,TetrazoliumSalt,19.927,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2221,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,50,CCK-8,TetrazoliumSalt,20.841,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2222,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,60,CCK-8,TetrazoliumSalt,7.8611,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2223,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,60,CCK-8,TetrazoliumSalt,16.453,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2224,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,60,CCK-8,TetrazoliumSalt,17.185,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2225,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,80,CCK-8,TetrazoliumSalt,7.6782,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2226,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,80,CCK-8,TetrazoliumSalt,10.969,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2227,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,80,CCK-8,TetrazoliumSalt,11.335,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2228,SiO2,Sphere,,Commercial,Negative,14.6,-59.7,,H,Human,Skin,Keratinocyte,Adult,24,100,CCK-8,TetrazoliumSalt,7.4954,10.1007/s11033-011-1287-z,71,,15,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2229,SiO2,Sphere,,Commercial,Negative,20.4,-63.31,,H,Human,Skin,Keratinocyte,Adult,24,100,CCK-8,TetrazoliumSalt,7.6782,10.1007/s11033-011-1287-z,71,,30,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2230,SiO2,Sphere,,Commercial,Negative,169.2,-14.37,,H,Human,Skin,Keratinocyte,Adult,24,100,CCK-8,TetrazoliumSalt,9.5064,10.1007/s11033-011-1287-z,71,,100,,HaCat,Molecular Biology Reports,Springer Science and Business Media LLC,2011,The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells,FALSE,FALSE,closed,71_gong2011.pdf,0
2231,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,71.03,10.1007/s11051-018-4406-0,72,,14.5,-158,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2232,Au,Sphere,CyA,Chemical Reduction,Positive,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,75.567,10.1007/s11051-018-4406-0,72,,6.5,88,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2233,Au,Sphere,GSH,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,72.251,10.1007/s11051-018-4406-0,72,,3.8,-140,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2234,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,83.072,10.1007/s11051-018-4406-0,72,,7,-99,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2235,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,87.053,10.1007/s11051-018-4406-0,72,,14.5,-158,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2236,Au,Sphere,CyA,Chemical Reduction,Positive,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,99.319,10.1007/s11051-018-4406-0,72,,6.5,88,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2237,Au,Sphere,GSH,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,102.21,10.1007/s11051-018-4406-0,72,,3.8,-140,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2238,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,85.349,10.1007/s11051-018-4406-0,72,,7,-99,PBMC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2239,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,93.309,10.1007/s11051-018-4406-0,72,,14.5,-158,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2240,Au,Sphere,CyA,Chemical Reduction,Positive,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,83.457,10.1007/s11051-018-4406-0,72,,6.5,88,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2241,Au,Sphere,GSH,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,47.026,10.1007/s11051-018-4406-0,72,,3.8,-140,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2242,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,15,MTT,TetrazoliumSalt,56.506,10.1007/s11051-018-4406-0,72,,7,-99,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2243,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,99.13,10.1007/s11051-018-4406-0,72,,14.5,-158,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2244,Au,Sphere,CyA,Chemical Reduction,Positive,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,94.261,10.1007/s11051-018-4406-0,72,,6.5,88,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2245,Au,Sphere,GSH,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,89.391,10.1007/s11051-018-4406-0,72,,3.8,-140,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2246,Au,Sphere,Citrate,Chemical Reduction,Negative,,,500000,H,Human,Blood,Lymphoblast,Adult,24,1.5,MTT,TetrazoliumSalt,89.391,10.1007/s11051-018-4406-0,72,,7,-99,Jurkat,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2018,Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles,FALSE,TRUE,hybrid,72_10.1007@s11051-018-4406-0.pdf,1
2247,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Adult,72,1.67,MTT,TetrazoliumSalt,102.43,10.2147/ijn.s214008,73,,5,-10.33,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2248,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Adult,72,2.5,MTT,TetrazoliumSalt,109.53,10.2147/ijn.s214008,73,,5,-10.33,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2249,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Adult,72,5,MTT,TetrazoliumSalt,116.63,10.2147/ijn.s214008,73,,5,-10.33,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2250,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Adult,72,6.25,MTT,TetrazoliumSalt,106.09,10.2147/ijn.s214008,73,,5,-10.33,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2251,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Adult,72,12.5,MTT,TetrazoliumSalt,81.47,10.2147/ijn.s214008,73,,5,-10.33,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2252,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Adult,72,1.67,MTT,TetrazoliumSalt,98.377,10.2147/ijn.s214008,73,,20,-4.58,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2253,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Adult,72,2.5,MTT,TetrazoliumSalt,101.01,10.2147/ijn.s214008,73,,20,-4.58,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2254,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Adult,72,5,MTT,TetrazoliumSalt,106.49,10.2147/ijn.s214008,73,,20,-4.58,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2255,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Adult,72,6.25,MTT,TetrazoliumSalt,107.91,10.2147/ijn.s214008,73,,20,-4.58,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2256,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Adult,72,12.5,MTT,TetrazoliumSalt,98.377,10.2147/ijn.s214008,73,,20,-4.58,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2257,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Adult,72,1.67,MTT,TetrazoliumSalt,102.43,10.2147/ijn.s214008,73,,50,-12.32,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2258,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Adult,72,2.5,MTT,TetrazoliumSalt,102.43,10.2147/ijn.s214008,73,,50,-12.32,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2259,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Adult,72,5,MTT,TetrazoliumSalt,102.03,10.2147/ijn.s214008,73,,50,-12.32,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2260,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Adult,72,6.25,MTT,TetrazoliumSalt,98.377,10.2147/ijn.s214008,73,,50,-12.32,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2261,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Adult,72,12.5,MTT,TetrazoliumSalt,96.349,10.2147/ijn.s214008,73,,50,-12.32,HepG2,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2262,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Embryonic,72,1.67,MTT,TetrazoliumSalt,73.333,10.2147/ijn.s214008,73,,5,-10.33,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2263,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Embryonic,72,2.5,MTT,TetrazoliumSalt,33.725,10.2147/ijn.s214008,73,,5,-10.33,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2264,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Embryonic,72,5,MTT,TetrazoliumSalt,20.784,10.2147/ijn.s214008,73,,5,-10.33,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2265,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Embryonic,72,6.25,MTT,TetrazoliumSalt,10,10.2147/ijn.s214008,73,,5,-10.33,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2266,Au,Sphere,,Commercial,Negative,13.5,-5.88,,H,Human,Liver,Epithelial,Embryonic,72,12.5,MTT,TetrazoliumSalt,6.6667,10.2147/ijn.s214008,73,,5,-10.33,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2267,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Embryonic,72,1.67,MTT,TetrazoliumSalt,92.745,10.2147/ijn.s214008,73,,20,-4.58,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2268,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Embryonic,72,2.5,MTT,TetrazoliumSalt,92.549,10.2147/ijn.s214008,73,,20,-4.58,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2269,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Embryonic,72,5,MTT,TetrazoliumSalt,93.137,10.2147/ijn.s214008,73,,20,-4.58,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2270,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Embryonic,72,6.25,MTT,TetrazoliumSalt,91.569,10.2147/ijn.s214008,73,,20,-4.58,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2271,Au,Sphere,,Commercial,Negative,26.5,-4.46,,H,Human,Liver,Epithelial,Embryonic,72,12.5,MTT,TetrazoliumSalt,94.706,10.2147/ijn.s214008,73,,20,-4.58,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2272,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Embryonic,72,1.67,MTT,TetrazoliumSalt,99.216,10.2147/ijn.s214008,73,,50,-12.32,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2273,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Embryonic,72,2.5,MTT,TetrazoliumSalt,96.078,10.2147/ijn.s214008,73,,50,-12.32,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2274,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Embryonic,72,5,MTT,TetrazoliumSalt,95.686,10.2147/ijn.s214008,73,,50,-12.32,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2275,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Embryonic,72,6.25,MTT,TetrazoliumSalt,96.471,10.2147/ijn.s214008,73,,50,-12.32,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2276,Au,Sphere,,Commercial,Negative,57,-9.84,,H,Human,Liver,Epithelial,Embryonic,72,12.5,MTT,TetrazoliumSalt,93.137,10.2147/ijn.s214008,73,,50,-12.32,L-02,International Journal of Nanomedicine,Dove Medical Press Ltd.,2019,"Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles",TRUE,TRUE,green,73_xia2019.pdf,1
2277,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,99.758,10.1371/journal.pone.0099175,74,,5,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2278,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,102.17,10.1371/journal.pone.0099175,74,,10,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2279,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,107.97,10.1371/journal.pone.0099175,74,,20,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2280,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,113.53,10.1371/journal.pone.0099175,74,,40,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2281,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,85.99,10.1371/journal.pone.0099175,74,,5,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2282,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,102.17,10.1371/journal.pone.0099175,74,,10,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2283,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,105.31,10.1371/journal.pone.0099175,74,,20,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2284,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,112.56,10.1371/journal.pone.0099175,74,,40,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2285,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,70.29,10.1371/journal.pone.0099175,74,,5,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2286,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,100.97,10.1371/journal.pone.0099175,74,,10,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2287,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,107.73,10.1371/journal.pone.0099175,74,,20,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2288,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,117.63,10.1371/journal.pone.0099175,74,,40,,A549,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2289,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,62.53,10.1371/journal.pone.0099175,74,,5,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2290,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,106.21,10.1371/journal.pone.0099175,74,,10,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2291,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,108.59,10.1371/journal.pone.0099175,74,,20,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2292,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,TetrazoliumSalt,108.59,10.1371/journal.pone.0099175,74,,40,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2293,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,63.246,10.1371/journal.pone.0099175,74,,5,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2294,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,102.63,10.1371/journal.pone.0099175,74,,10,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2295,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,107.88,10.1371/journal.pone.0099175,74,,20,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2296,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,TetrazoliumSalt,106.44,10.1371/journal.pone.0099175,74,,40,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2297,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,65.394,10.1371/journal.pone.0099175,74,,5,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2298,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,99.523,10.1371/journal.pone.0099175,74,,10,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2299,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,103.1,10.1371/journal.pone.0099175,74,,20,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2300,Au,Sphere,Citrate,Chemical Reduction,,,,2000,H,Human,Lung,Epithelial,Adult,72,50,CCK-8,TetrazoliumSalt,105.49,10.1371/journal.pone.0099175,74,,40,,95D,PLoS ONE,Public Library of Science (PLoS),2014,Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells,TRUE,TRUE,gold,74_liu2014.pdf,1
2301,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,92.269,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2302,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,81.345,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2303,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,76.975,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2304,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,67.563,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2305,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,90.588,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2306,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,74.286,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2307,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,60.168,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2308,Ag,Sphere,,Commercial,Negative,,,5000,H,Human,Lung,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,48.235,10.1016/j.tiv.2012.08.021,75,,65,-30,A549,Toxicology in Vitro,Elsevier BV,2013,Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways,FALSE,FALSE,closed,75_chairuangkitti2013.pdf,0
2309,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,2.5,CCK-8,TetrazoliumSalt,96.998,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2310,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,5,CCK-8,TetrazoliumSalt,94.934,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2311,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,88.743,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2312,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,20,CCK-8,TetrazoliumSalt,62.477,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2313,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,40,CCK-8,TetrazoliumSalt,48.593,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2314,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,80,CCK-8,TetrazoliumSalt,35.084,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2315,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,35.084,10.1016/j.toxlet.2010.10.003,76,,173.48,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2316,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,2.5,CCK-8,TetrazoliumSalt,96.811,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2317,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,5,CCK-8,TetrazoliumSalt,92.495,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2318,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,81.614,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2319,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,20,CCK-8,TetrazoliumSalt,68.48,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2320,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,40,CCK-8,TetrazoliumSalt,40.525,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2321,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,80,CCK-8,TetrazoliumSalt,38.837,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2322,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,36.21,10.1016/j.toxlet.2010.10.003,76,,60.21,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2323,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,2.5,CCK-8,TetrazoliumSalt,93.996,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2324,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,5,CCK-8,TetrazoliumSalt,90.619,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2325,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,85.741,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2326,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,20,CCK-8,TetrazoliumSalt,67.167,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2327,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,40,CCK-8,TetrazoliumSalt,40.901,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2328,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,80,CCK-8,TetrazoliumSalt,33.021,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2329,ZnO,Rod,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,34.522,10.1016/j.toxlet.2010.10.003,76,,40.44,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2330,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,2.5,CCK-8,TetrazoliumSalt,90.807,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2331,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,5,CCK-8,TetrazoliumSalt,83.677,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2332,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,79.362,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2333,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,20,CCK-8,TetrazoliumSalt,67.73,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2334,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,40,CCK-8,TetrazoliumSalt,36.023,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2335,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,80,CCK-8,TetrazoliumSalt,29.268,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2336,ZnO,Sphere,,Commercial,,,,10000,A,Mouse,BoneMarrow,Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,24.578,10.1016/j.toxlet.2010.10.003,76,,18.76,,Ana-1,Toxicology Letters,Elsevier BV,2010,Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles,FALSE,FALSE,closed,76_song2010.pdf,0
2337,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,24,50,MTT,TetrazoliumSalt,92,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2338,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,24,100,MTT,TetrazoliumSalt,85.4,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2339,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,24,200,MTT,TetrazoliumSalt,66.4,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2340,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,48,50,MTT,TetrazoliumSalt,85.2,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2341,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,48,100,MTT,TetrazoliumSalt,69.1,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2342,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,48,200,MTT,TetrazoliumSalt,44.8,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2343,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,72,50,MTT,TetrazoliumSalt,79.1,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2344,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,72,100,MTT,TetrazoliumSalt,63.3,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2345,TiO2,Sphere,,Commercial,,165.5,,100000,H,Human,Kidney,Epithelial,Embryonic,72,200,MTT,TetrazoliumSalt,32.7,10.1007/s12010-012-9699-3,77,,15,,HEK293,Applied Biochemistry and Biotechnology,Springer Science and Business Media LLC,2012,Nano-TiO2-Induced Apoptosis by Oxidative Stress-Mediated DNA Damage and Activation of p53 in Human Embryonic Kidney Cells,FALSE,FALSE,closed,77_meena2012.pdf,0
2346,TiO2,Round,,Commercial,Negative,342,-11.2,,H,Human,Lung,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,104.88,10.3109/17435390.2016.1141338,78,,24,,A549,Nanotoxicology,Informa UK Limited,2016,Long-term exposure of A549 cells to titanium dioxide nanoparticles induces DNA damage and sensitizes cells towards genotoxic agents,FALSE,FALSE,closed,78_armand2016.pdf,0
2347,TiO2,Round,,Commercial,Negative,342,-11.2,,H,Human,Lung,Epithelial,Adult,24,2.5,MTT,TetrazoliumSalt,101.8,10.3109/17435390.2016.1141338,78,,24,,A549,Nanotoxicology,Informa UK Limited,2016,Long-term exposure of A549 cells to titanium dioxide nanoparticles induces DNA damage and sensitizes cells towards genotoxic agents,FALSE,FALSE,closed,78_armand2016.pdf,0
2348,TiO2,Round,,Commercial,Negative,342,-11.2,,H,Human,Lung,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,101.8,10.3109/17435390.2016.1141338,78,,24,,A549,Nanotoxicology,Informa UK Limited,2016,Long-term exposure of A549 cells to titanium dioxide nanoparticles induces DNA damage and sensitizes cells towards genotoxic agents,FALSE,FALSE,closed,78_armand2016.pdf,0
2349,TiO2,Round,,Commercial,Negative,342,-11.2,,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,105.66,10.3109/17435390.2016.1141338,78,,24,,A549,Nanotoxicology,Informa UK Limited,2016,Long-term exposure of A549 cells to titanium dioxide nanoparticles induces DNA damage and sensitizes cells towards genotoxic agents,FALSE,FALSE,closed,78_armand2016.pdf,0
2350,TiO2,Round,,Commercial,Negative,342,-11.2,,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,91.517,10.3109/17435390.2016.1141338,78,,24,,A549,Nanotoxicology,Informa UK Limited,2016,Long-term exposure of A549 cells to titanium dioxide nanoparticles induces DNA damage and sensitizes cells towards genotoxic agents,FALSE,FALSE,closed,78_armand2016.pdf,0
2351,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,94.962,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2352,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,73.056,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2353,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,56.079,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2354,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,38.116,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2355,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,21.139,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2356,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,48,1,MTT,TetrazoliumSalt,92.662,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2357,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,48,2,MTT,TetrazoliumSalt,60.789,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2358,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,48,5,MTT,TetrazoliumSalt,44.907,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2359,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,28.478,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2360,Ni,Sphere,,Commercial,,176,,10000,H,Human,Lung,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,12.486,10.1016/j.tiv.2011.02.015,79,,65.17,,A549,Toxicology in Vitro,Elsevier BV,2011,Toxic response of nickel nanoparticles in human lung epithelial A549 cells,FALSE,FALSE,closed,79_ahamed2011.pdf,0
2470,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,25,CellTiterGlo,LuciferaseEnzyme,96.919,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2471,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,50,CellTiterGlo,LuciferaseEnzyme,87.441,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2472,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,100,CellTiterGlo,LuciferaseEnzyme,82.227,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2473,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,200,CellTiterGlo,LuciferaseEnzyme,78.436,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2474,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,400,CellTiterGlo,LuciferaseEnzyme,57.109,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2475,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,25,CellTiterGlo,LuciferaseEnzyme,97.867,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2476,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,50,CellTiterGlo,LuciferaseEnzyme,91.469,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2477,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,100,CellTiterGlo,LuciferaseEnzyme,86.256,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2478,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,200,CellTiterGlo,LuciferaseEnzyme,77.962,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2479,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,400,CellTiterGlo,LuciferaseEnzyme,55.924,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2480,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,25,CellTiterGlo,LuciferaseEnzyme,90.047,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2481,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,50,CellTiterGlo,LuciferaseEnzyme,87.441,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2482,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,100,CellTiterGlo,LuciferaseEnzyme,77.962,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2483,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,200,CellTiterGlo,LuciferaseEnzyme,68.483,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2484,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,400,CellTiterGlo,LuciferaseEnzyme,43.365,10.1039/c0nr00204f,80,,4,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2485,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,25,CellTiterGlo,LuciferaseEnzyme,98.832,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2486,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,50,CellTiterGlo,LuciferaseEnzyme,90.888,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2487,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,100,CellTiterGlo,LuciferaseEnzyme,89.486,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2488,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,200,CellTiterGlo,LuciferaseEnzyme,79.907,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2489,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,400,CellTiterGlo,LuciferaseEnzyme,54.206,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2490,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,25,CellTiterGlo,LuciferaseEnzyme,96.262,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2491,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,50,CellTiterGlo,LuciferaseEnzyme,89.486,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2492,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,100,CellTiterGlo,LuciferaseEnzyme,84.112,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2493,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,200,CellTiterGlo,LuciferaseEnzyme,78.972,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2494,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,400,CellTiterGlo,LuciferaseEnzyme,54.673,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2495,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,25,CellTiterGlo,LuciferaseEnzyme,98.131,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2496,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,50,CellTiterGlo,LuciferaseEnzyme,88.318,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2497,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,100,CellTiterGlo,LuciferaseEnzyme,85.28,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2498,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,200,CellTiterGlo,LuciferaseEnzyme,65.187,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2499,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,400,CellTiterGlo,LuciferaseEnzyme,47.897,10.1039/c0nr00204f,80,,4,-8,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2500,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,25,CellTiterGlo,LuciferaseEnzyme,98.293,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2501,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,50,CellTiterGlo,LuciferaseEnzyme,93.902,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2502,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,100,CellTiterGlo,LuciferaseEnzyme,87.317,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2503,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,200,CellTiterGlo,LuciferaseEnzyme,79.268,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2504,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,400,CellTiterGlo,LuciferaseEnzyme,50,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2505,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,25,CellTiterGlo,LuciferaseEnzyme,92.927,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2506,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,50,CellTiterGlo,LuciferaseEnzyme,95.61,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2507,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,100,CellTiterGlo,LuciferaseEnzyme,91.951,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2508,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,200,CellTiterGlo,LuciferaseEnzyme,74.878,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2509,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,400,CellTiterGlo,LuciferaseEnzyme,54.39,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2510,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,25,CellTiterGlo,LuciferaseEnzyme,91.951,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2511,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,50,CellTiterGlo,LuciferaseEnzyme,76.585,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2512,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,100,CellTiterGlo,LuciferaseEnzyme,70.488,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2513,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,200,CellTiterGlo,LuciferaseEnzyme,70.488,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2514,Pt,Sphere,PVP,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,400,CellTiterGlo,LuciferaseEnzyme,41.951,10.1039/c0nr00204f,80,,4,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2515,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,25,CellTiterGlo,LuciferaseEnzyme,83.575,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2516,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,50,CellTiterGlo,LuciferaseEnzyme,77.536,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2517,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,100,CellTiterGlo,LuciferaseEnzyme,69.324,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2518,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,200,CellTiterGlo,LuciferaseEnzyme,50.242,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2519,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,24,400,CellTiterGlo,LuciferaseEnzyme,35.024,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2520,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,25,CellTiterGlo,LuciferaseEnzyme,80.918,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2521,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,50,CellTiterGlo,LuciferaseEnzyme,70.048,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2522,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,100,CellTiterGlo,LuciferaseEnzyme,58.454,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2523,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,200,CellTiterGlo,LuciferaseEnzyme,44.203,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2524,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,48,400,CellTiterGlo,LuciferaseEnzyme,29.952,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2525,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,25,CellTiterGlo,LuciferaseEnzyme,66.667,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2526,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,50,CellTiterGlo,LuciferaseEnzyme,54.831,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2527,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,100,CellTiterGlo,LuciferaseEnzyme,44.928,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2528,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,200,CellTiterGlo,LuciferaseEnzyme,31.643,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2529,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Cervix,Epithelial,Adult,72,400,CellTiterGlo,LuciferaseEnzyme,19.807,10.1039/c0nr00204f,80,,12.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2530,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,25,CellTiterGlo,LuciferaseEnzyme,78.385,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2531,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,50,CellTiterGlo,LuciferaseEnzyme,64.371,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2532,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,100,CellTiterGlo,LuciferaseEnzyme,47.506,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2533,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,200,CellTiterGlo,LuciferaseEnzyme,34.204,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2534,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,24,400,CellTiterGlo,LuciferaseEnzyme,19.002,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2535,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,25,CellTiterGlo,LuciferaseEnzyme,65.321,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2536,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,50,CellTiterGlo,LuciferaseEnzyme,50.356,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2537,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,100,CellTiterGlo,LuciferaseEnzyme,37.53,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2538,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,200,CellTiterGlo,LuciferaseEnzyme,26.128,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2539,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,48,400,CellTiterGlo,LuciferaseEnzyme,16.865,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2540,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,25,CellTiterGlo,LuciferaseEnzyme,44.893,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2541,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,50,CellTiterGlo,LuciferaseEnzyme,34.204,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2542,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,100,CellTiterGlo,LuciferaseEnzyme,24.466,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2543,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,200,CellTiterGlo,LuciferaseEnzyme,16.39,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2544,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Breast,Epithelial,Adult,72,400,CellTiterGlo,LuciferaseEnzyme,11.164,10.1039/c0nr00204f,80,,12.5,-40.5,MCF-7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2545,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,25,CellTiterGlo,LuciferaseEnzyme,79.426,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2546,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,50,CellTiterGlo,LuciferaseEnzyme,59.809,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2547,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,100,CellTiterGlo,LuciferaseEnzyme,50.239,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2548,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,200,CellTiterGlo,LuciferaseEnzyme,33.971,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2549,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,24,400,CellTiterGlo,LuciferaseEnzyme,19.856,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2550,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,25,CellTiterGlo,LuciferaseEnzyme,59.809,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2551,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,50,CellTiterGlo,LuciferaseEnzyme,48.086,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2552,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,100,CellTiterGlo,LuciferaseEnzyme,39.234,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2553,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,200,CellTiterGlo,LuciferaseEnzyme,29.665,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2554,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,48,400,CellTiterGlo,LuciferaseEnzyme,16.029,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2555,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,25,CellTiterGlo,LuciferaseEnzyme,45.215,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2556,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,50,CellTiterGlo,LuciferaseEnzyme,38.278,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2557,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,100,CellTiterGlo,LuciferaseEnzyme,29.665,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2558,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,200,CellTiterGlo,LuciferaseEnzyme,23.206,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2559,Pt,Sphere,FA,Chemical Reduction,Negative,,,5000,H,Human,Lung,Fibroblast,Adult,72,400,CellTiterGlo,LuciferaseEnzyme,14.593,10.1039/c0nr00204f,80,,12.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
2560,Fe3O4,Sphere,PEI,Commercial,Positive,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,3.125,MTS,TetrazoliumSalt,98.282,10.1038/s41598-018-19628-z,81,,10,29.28,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2561,Fe3O4,Sphere,PEI,Commercial,Positive,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,6.25,MTS,TetrazoliumSalt,82.646,10.1038/s41598-018-19628-z,81,,10,29.28,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2562,Fe3O4,Sphere,PEI,Commercial,Positive,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,12.5,MTS,TetrazoliumSalt,15.636,10.1038/s41598-018-19628-z,81,,10,29.28,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2563,Fe3O4,Sphere,PEI,Commercial,Positive,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,25,MTS,TetrazoliumSalt,5.4983,10.1038/s41598-018-19628-z,81,,10,29.28,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2564,Fe3O4,Sphere,PEI,Commercial,Positive,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,50,MTS,TetrazoliumSalt,2.921,10.1038/s41598-018-19628-z,81,,10,29.28,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2565,Fe3O4,Sphere,PEI,Commercial,Positive,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,MTS,TetrazoliumSalt,1.2027,10.1038/s41598-018-19628-z,81,,10,29.28,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2566,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,3.125,MTS,TetrazoliumSalt,100.86,10.1038/s41598-018-19628-z,81,,10,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2567,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,6.25,MTS,TetrazoliumSalt,101.89,10.1038/s41598-018-19628-z,81,,10,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2568,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,12.5,MTS,TetrazoliumSalt,103.78,10.1038/s41598-018-19628-z,81,,10,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2569,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,25,MTS,TetrazoliumSalt,101.2,10.1038/s41598-018-19628-z,81,,10,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2570,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,50,MTS,TetrazoliumSalt,83.333,10.1038/s41598-018-19628-z,81,,10,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2571,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,MTS,TetrazoliumSalt,56.701,10.1038/s41598-018-19628-z,81,,10,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2572,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,3.125,MTS,TetrazoliumSalt,97.595,10.1038/s41598-018-19628-z,81,,30,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2573,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,6.25,MTS,TetrazoliumSalt,97.079,10.1038/s41598-018-19628-z,81,,30,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2574,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,12.5,MTS,TetrazoliumSalt,103.26,10.1038/s41598-018-19628-z,81,,30,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2575,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,25,MTS,TetrazoliumSalt,107.73,10.1038/s41598-018-19628-z,81,,30,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2576,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,50,MTS,TetrazoliumSalt,88.144,10.1038/s41598-018-19628-z,81,,30,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2577,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,MTS,TetrazoliumSalt,73.196,10.1038/s41598-018-19628-z,81,,30,-0.52,RAW264.7,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2578,Fe3O4,Sphere,PEI,Commercial,Positive,,,,H,Human,Ovary,Epithelial,Adult,48,3.125,MTS,TetrazoliumSalt,70.872,10.1038/s41598-018-19628-z,81,,10,29.28,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2579,Fe3O4,Sphere,PEI,Commercial,Positive,,,,H,Human,Ovary,Epithelial,Adult,48,6.25,MTS,TetrazoliumSalt,8.9054,10.1038/s41598-018-19628-z,81,,10,29.28,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2580,Fe3O4,Sphere,PEI,Commercial,Positive,,,,H,Human,Ovary,Epithelial,Adult,48,12.5,MTS,TetrazoliumSalt,7.0501,10.1038/s41598-018-19628-z,81,,10,29.28,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2581,Fe3O4,Sphere,PEI,Commercial,Positive,,,,H,Human,Ovary,Epithelial,Adult,48,25,MTS,TetrazoliumSalt,3.525,10.1038/s41598-018-19628-z,81,,10,29.28,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2582,Fe3O4,Sphere,PEI,Commercial,Positive,,,,H,Human,Ovary,Epithelial,Adult,48,50,MTS,TetrazoliumSalt,2.7829,10.1038/s41598-018-19628-z,81,,10,29.28,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2583,Fe3O4,Sphere,PEI,Commercial,Positive,,,,H,Human,Ovary,Epithelial,Adult,48,100,MTS,TetrazoliumSalt,1.4842,10.1038/s41598-018-19628-z,81,,10,29.28,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2584,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,3.125,MTS,TetrazoliumSalt,101.11,10.1038/s41598-018-19628-z,81,,10,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2585,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,6.25,MTS,TetrazoliumSalt,102.23,10.1038/s41598-018-19628-z,81,,10,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2586,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,12.5,MTS,TetrazoliumSalt,105.38,10.1038/s41598-018-19628-z,81,,10,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2587,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,25,MTS,TetrazoliumSalt,91.466,10.1038/s41598-018-19628-z,81,,10,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2588,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,50,MTS,TetrazoliumSalt,77.922,10.1038/s41598-018-19628-z,81,,10,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2589,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,100,MTS,TetrazoliumSalt,56.215,10.1038/s41598-018-19628-z,81,,10,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2590,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,3.125,MTS,TetrazoliumSalt,98.33,10.1038/s41598-018-19628-z,81,,30,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2591,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,6.25,MTS,TetrazoliumSalt,99.629,10.1038/s41598-018-19628-z,81,,30,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2592,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,12.5,MTS,TetrazoliumSalt,100,10.1038/s41598-018-19628-z,81,,30,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2593,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,25,MTS,TetrazoliumSalt,98.887,10.1038/s41598-018-19628-z,81,,30,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2594,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,50,MTS,TetrazoliumSalt,82.56,10.1038/s41598-018-19628-z,81,,30,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2595,Fe3O4,Sphere,PEG,Commercial,Neutral,,,,H,Human,Ovary,Epithelial,Adult,48,100,MTS,TetrazoliumSalt,66.605,10.1038/s41598-018-19628-z,81,,30,-0.52,SKOV-3,Scientific Reports,Springer Science and Business Media LLC,2018,"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings",TRUE,TRUE,gold,81_feng2018.pdf,1
2596,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,0.001,MTT,TetrazoliumSalt,97.03,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2597,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,0.01,MTT,TetrazoliumSalt,100,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2598,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,0.1,MTT,TetrazoliumSalt,100,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2599,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,1,MTT,TetrazoliumSalt,97.03,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2600,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,5,MTT,TetrazoliumSalt,93.399,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2601,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,10,MTT,TetrazoliumSalt,93.399,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2602,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,20,MTT,TetrazoliumSalt,92.739,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2603,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,50,MTT,TetrazoliumSalt,86.799,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2604,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,12,100,MTT,TetrazoliumSalt,73.597,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2605,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,0.001,MTT,TetrazoliumSalt,96.37,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2606,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,0.01,MTT,TetrazoliumSalt,95.05,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2607,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,0.1,MTT,TetrazoliumSalt,97.69,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2608,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,1,MTT,TetrazoliumSalt,99.67,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2609,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,5,MTT,TetrazoliumSalt,95.38,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2610,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,10,MTT,TetrazoliumSalt,96.37,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2611,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,20,MTT,TetrazoliumSalt,94.719,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2612,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,50,MTT,TetrazoliumSalt,97.03,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2613,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,12,100,MTT,TetrazoliumSalt,91.749,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2614,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,0.001,MTT,TetrazoliumSalt,98.02,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2615,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,0.01,MTT,TetrazoliumSalt,95.71,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2616,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,0.1,MTT,TetrazoliumSalt,96.04,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2617,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,1,MTT,TetrazoliumSalt,99.01,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2618,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,5,MTT,TetrazoliumSalt,82.838,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2619,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,10,MTT,TetrazoliumSalt,63.366,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2620,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,20,MTT,TetrazoliumSalt,45.215,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2621,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,50,MTT,TetrazoliumSalt,16.172,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2622,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,12,100,MTT,TetrazoliumSalt,14.191,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2623,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,0.001,MTT,TetrazoliumSalt,95.724,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2624,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,0.01,MTT,TetrazoliumSalt,97.368,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2625,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,0.1,MTT,TetrazoliumSalt,100.33,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2626,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,1,MTT,TetrazoliumSalt,98.355,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2627,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,5,MTT,TetrazoliumSalt,91.776,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2628,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,10,MTT,TetrazoliumSalt,75,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2629,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,20,MTT,TetrazoliumSalt,63.816,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2630,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,50,MTT,TetrazoliumSalt,36.184,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2631,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,12,100,MTT,TetrazoliumSalt,33.224,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2632,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,0.001,MTT,TetrazoliumSalt,95.066,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2633,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,0.01,MTT,TetrazoliumSalt,95.066,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2634,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,0.1,MTT,TetrazoliumSalt,97.039,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2635,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,1,MTT,TetrazoliumSalt,97.039,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2636,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,5,MTT,TetrazoliumSalt,99.013,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2637,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,10,MTT,TetrazoliumSalt,99.013,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2638,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,20,MTT,TetrazoliumSalt,96.711,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2639,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,50,MTT,TetrazoliumSalt,98.355,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2640,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,12,100,MTT,TetrazoliumSalt,95.724,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2641,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,0.001,MTT,TetrazoliumSalt,99.013,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2642,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,0.01,MTT,TetrazoliumSalt,95.395,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2643,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,0.1,MTT,TetrazoliumSalt,98.355,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2644,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,1,MTT,TetrazoliumSalt,100.33,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2645,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,5,MTT,TetrazoliumSalt,97.039,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2646,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,10,MTT,TetrazoliumSalt,100,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2647,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,20,MTT,TetrazoliumSalt,97.039,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2648,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,50,MTT,TetrazoliumSalt,99.013,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2649,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,12,100,MTT,TetrazoliumSalt,97.039,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2650,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,0.001,MTT,TetrazoliumSalt,99.016,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2651,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,0.01,MTT,TetrazoliumSalt,98.361,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2652,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,0.1,MTT,TetrazoliumSalt,98.361,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2653,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,95.41,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2654,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,87.213,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2655,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,85.246,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2656,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,82.295,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2657,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,72.131,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2658,MgO,Sphere,,Commercial,Positive,639,11.6,50000,H,Human,Heart,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,62.623,10.1007/s10565-011-9191-9,82,,39.2,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2659,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,0.001,MTT,TetrazoliumSalt,92.459,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2660,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,0.01,MTT,TetrazoliumSalt,96.066,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2661,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,0.1,MTT,TetrazoliumSalt,93.77,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2662,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,97.377,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2663,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,94.426,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2664,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,95.738,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2665,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,91.803,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2666,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,91.803,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2667,Al2O3,Sphere,,Commercial,Positive,267,36.3,50000,H,Human,Heart,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,82.295,10.1007/s10565-011-9191-9,82,,39.7,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2668,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,0.001,MTT,TetrazoliumSalt,95.738,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2669,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,0.01,MTT,TetrazoliumSalt,99.672,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2670,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,0.1,MTT,TetrazoliumSalt,95.082,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2671,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,96.066,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2672,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,74.754,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2673,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,42.951,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2674,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,14.426,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2675,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,12.787,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2676,CuO,Sphere,,Commercial,Positive,239,42.8,50000,H,Human,Heart,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,12.787,10.1007/s10565-011-9191-9,82,,46.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2677,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,0.001,MTT,TetrazoliumSalt,92.131,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2678,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,0.01,MTT,TetrazoliumSalt,97.705,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2679,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,0.1,MTT,TetrazoliumSalt,96.066,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2680,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,97.049,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2681,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,71.475,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2682,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,60.984,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2683,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,42.623,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2684,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,27.869,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2685,ZnO,Sphere,,Commercial,Positive,310,32.7,50000,H,Human,Heart,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,21.639,10.1007/s10565-011-9191-9,82,,45.3,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2686,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,0.001,MTT,TetrazoliumSalt,95.738,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2687,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,0.01,MTT,TetrazoliumSalt,96.721,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2688,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,0.1,MTT,TetrazoliumSalt,98.033,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2689,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,93.77,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2690,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,88.525,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2691,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,88.852,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2692,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,92.131,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2693,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,92.131,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2694,Fe3O4,Sphere,,Commercial,Negative,957,-8.2,50000,H,Human,Heart,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,89.508,10.1007/s10565-011-9191-9,82,,42.5,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2695,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,0.001,MTT,TetrazoliumSalt,98.689,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2696,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,0.01,MTT,TetrazoliumSalt,100.66,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2697,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,0.1,MTT,TetrazoliumSalt,92.787,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2698,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,95.738,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2699,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,91.148,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2700,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,92.787,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2701,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,89.18,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2702,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,89.18,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2703,Fe3O4,Sphere,,Commercial,Positive,1025,1.7,50000,H,Human,Heart,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,92.787,10.1007/s10565-011-9191-9,82,,46.8,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
2785,C,Nanotube,,Chemical Vapor Deposition,,,,2000,H,Human,UrinaryBladder,Epithelial,Adult,48,50,CytoTox-Glo,Dead-Cell-Protease,94.167,10.1016/j.ijpharm.2015.01.017,83,,11,,UM-UC-3,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2786,C,Nanotube,,Chemical Vapor Deposition,,,,2000,H,Human,UrinaryBladder,Epithelial,Adult,48,50,CytoTox-Glo,Dead-Cell-Protease,75.417,10.1016/j.ijpharm.2015.01.017,83,,11,,UM-UC-3,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2787,C,Nanotube,,Chemical Vapor Deposition,,,,2000,H,Human,UrinaryBladder,Epithelial,Adult,48,50,CytoTox-Glo,Dead-Cell-Protease,75.833,10.1016/j.ijpharm.2015.01.017,83,,18,,UM-UC-3,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2788,C,Nanotube,,Chemical Vapor Deposition,,,,2000,H,Human,UrinaryBladder,Epithelial,Adult,48,50,CytoTox-Glo,Dead-Cell-Protease,65.625,10.1016/j.ijpharm.2015.01.017,83,,18,,UM-UC-3,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2789,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,48,100,WST-1,TetrazoliumSalt,39.61,10.1016/j.ijpharm.2015.01.017,83,,11,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2790,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,72,100,WST-1,TetrazoliumSalt,70.779,10.1016/j.ijpharm.2015.01.017,83,,11,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2791,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,96,100,WST-1,TetrazoliumSalt,68.571,10.1016/j.ijpharm.2015.01.017,83,,11,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2792,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,48,100,WST-1,TetrazoliumSalt,29.351,10.1016/j.ijpharm.2015.01.017,83,,11,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2793,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,72,100,WST-1,TetrazoliumSalt,47.273,10.1016/j.ijpharm.2015.01.017,83,,11,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2794,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,96,100,WST-1,TetrazoliumSalt,44.416,10.1016/j.ijpharm.2015.01.017,83,,11,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2795,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,48,100,WST-1,TetrazoliumSalt,50.26,10.1016/j.ijpharm.2015.01.017,83,,18,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2796,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,72,100,WST-1,TetrazoliumSalt,82.078,10.1016/j.ijpharm.2015.01.017,83,,18,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2797,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,96,100,WST-1,TetrazoliumSalt,78.961,10.1016/j.ijpharm.2015.01.017,83,,18,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2798,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,48,100,WST-1,TetrazoliumSalt,38.052,10.1016/j.ijpharm.2015.01.017,83,,18,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2799,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,72,100,WST-1,TetrazoliumSalt,66.623,10.1016/j.ijpharm.2015.01.017,83,,18,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2800,C,Nanotube,,Chemical Vapor Deposition,,,,300,H,Human,UrinaryBladder,Epithelial,Adult,96,100,WST-1,TetrazoliumSalt,56.234,10.1016/j.ijpharm.2015.01.017,83,,18,,EJ28,International Journal of Pharmaceutics,Elsevier BV,2015,Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer,FALSE,FALSE,closed,83_rieger2015.pdf,0
2801,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,5,NRU,NeutralRed,100,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2802,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,10,NRU,NeutralRed,98.443,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2803,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,25,NRU,NeutralRed,89.619,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2804,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,50,NRU,NeutralRed,80.45,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2805,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,100,NRU,NeutralRed,64.187,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2806,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,84.201,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2807,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,76.302,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2808,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,72.89,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2809,TiO2,Irregular,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,61.4,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2810,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,5,NRU,NeutralRed,98.789,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2811,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,10,NRU,NeutralRed,100.69,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2812,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,25,NRU,NeutralRed,99.308,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2813,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,50,NRU,NeutralRed,93.08,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2814,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,100,NRU,NeutralRed,75.606,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2815,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,81.149,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2816,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,74.506,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2817,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,67.684,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2818,Al2O3,Sphere,,Commercial,,,,25000,A,Hamster,Ovary,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,79.713,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
2819,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,10,EZ4U,TetrazoliumSalt,101.8,10.1016/j.tiv.2011.07.010,85,,78,11.4,L929,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2820,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,50,EZ4U,TetrazoliumSalt,98.561,10.1016/j.tiv.2011.07.010,85,,78,11.4,L929,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2821,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,100,EZ4U,TetrazoliumSalt,97.482,10.1016/j.tiv.2011.07.010,85,,78,11.4,L929,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2822,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,200,EZ4U,TetrazoliumSalt,94.604,10.1016/j.tiv.2011.07.010,85,,78,11.4,L929,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2823,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,400,EZ4U,TetrazoliumSalt,91.547,10.1016/j.tiv.2011.07.010,85,,78,11.4,L929,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2824,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,H,Human,Skin,Fibroblast,Adult,24,10,EZ4U,TetrazoliumSalt,97.482,10.1016/j.tiv.2011.07.010,85,,78,11.4,BJ,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2825,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,H,Human,Skin,Fibroblast,Adult,24,50,EZ4U,TetrazoliumSalt,97.482,10.1016/j.tiv.2011.07.010,85,,78,11.4,BJ,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2826,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,H,Human,Skin,Fibroblast,Adult,24,100,EZ4U,TetrazoliumSalt,97.482,10.1016/j.tiv.2011.07.010,85,,78,11.4,BJ,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2827,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,H,Human,Skin,Fibroblast,Adult,24,200,EZ4U,TetrazoliumSalt,98.741,10.1016/j.tiv.2011.07.010,85,,78,11.4,BJ,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2828,Al2O3,Sphere,,Thermal Decomposition,Positive,92,-10.6,,H,Human,Skin,Fibroblast,Adult,24,400,EZ4U,TetrazoliumSalt,96.583,10.1016/j.tiv.2011.07.010,85,,78,11.4,BJ,Toxicology in Vitro,Elsevier BV,2011,Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells,FALSE,FALSE,closed,85_radziun2011.pdf,0
2829,Al2O3,Sphere,,Commercial,,186.8,,10000,H,Human,Lung,Fibroblast,Fetus,48,250,MTT,TetrazoliumSalt,90.875,10.3967/0895-3988.2011.06.011,86,,13,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2830,Al2O3,Sphere,,Commercial,,186.8,,10000,H,Human,Lung,Fibroblast,Fetus,48,500,MTT,TetrazoliumSalt,88.454,10.3967/0895-3988.2011.06.011,86,,13,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2831,Al2O3,Sphere,,Commercial,,186.8,,10000,H,Human,Lung,Fibroblast,Fetus,48,750,MTT,TetrazoliumSalt,85.475,10.3967/0895-3988.2011.06.011,86,,13,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2832,Al2O3,Sphere,,Commercial,,186.8,,10000,H,Human,Lung,Fibroblast,Fetus,48,1000,MTT,TetrazoliumSalt,78.212,10.3967/0895-3988.2011.06.011,86,,13,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2833,Al2O3,Sphere,,Commercial,,186.8,,10000,H,Human,Lung,Fibroblast,Fetus,48,1500,MTT,TetrazoliumSalt,70.95,10.3967/0895-3988.2011.06.011,86,,13,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2834,SiO2,Sphere,,Commercial,,113.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,250,MTT,TetrazoliumSalt,76.723,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2835,SiO2,Sphere,,Commercial,,113.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,500,MTT,TetrazoliumSalt,64.804,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2836,SiO2,Sphere,,Commercial,,113.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,750,MTT,TetrazoliumSalt,56.425,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2837,SiO2,Sphere,,Commercial,,113.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,1000,MTT,TetrazoliumSalt,50.652,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2838,SiO2,Sphere,,Commercial,,113.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,1500,MTT,TetrazoliumSalt,42.458,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2839,TiO2,Sphere,,Commercial,,163.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,250,MTT,TetrazoliumSalt,67.598,10.3967/0895-3988.2011.06.011,86,,21,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2840,TiO2,Sphere,,Commercial,,163.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,500,MTT,TetrazoliumSalt,57.542,10.3967/0895-3988.2011.06.011,86,,21,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2841,TiO2,Sphere,,Commercial,,163.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,750,MTT,TetrazoliumSalt,50.279,10.3967/0895-3988.2011.06.011,86,,21,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2842,TiO2,Sphere,,Commercial,,163.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,1000,MTT,TetrazoliumSalt,39.106,10.3967/0895-3988.2011.06.011,86,,21,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2843,TiO2,Sphere,,Commercial,,163.4,,10000,H,Human,Lung,Fibroblast,Fetus,48,1500,MTT,TetrazoliumSalt,34.264,10.3967/0895-3988.2011.06.011,86,,21,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2844,ZnO,Sphere,,Commercial,,327.9,,10000,H,Human,Lung,Fibroblast,Fetus,48,250,MTT,TetrazoliumSalt,59.777,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2845,ZnO,Sphere,,Commercial,,327.9,,10000,H,Human,Lung,Fibroblast,Fetus,48,500,MTT,TetrazoliumSalt,43.948,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2846,ZnO,Sphere,,Commercial,,327.9,,10000,H,Human,Lung,Fibroblast,Fetus,48,750,MTT,TetrazoliumSalt,39.665,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2847,ZnO,Sphere,,Commercial,,327.9,,10000,H,Human,Lung,Fibroblast,Fetus,48,1000,MTT,TetrazoliumSalt,31.471,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2848,ZnO,Sphere,,Commercial,,327.9,,10000,H,Human,Lung,Fibroblast,Fetus,48,1500,MTT,TetrazoliumSalt,28.492,10.3967/0895-3988.2011.06.011,86,,20,,HFL1,Biomedical and Environmental Sciences,Elsevier BV,2011,"ZnO, TiO2, SiO2, and Al2O3 Nanoparticles-induced Toxic Effects on Human Fetal Lung Fibroblasts",FALSE,FALSE,closed,86_bes201106011.pdf,0
2849,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,3,25,MTT,TetrazoliumSalt,100,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2850,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,3,100,MTT,TetrazoliumSalt,92.517,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2851,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,3,200,MTT,TetrazoliumSalt,98.413,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2852,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,3,300,MTT,TetrazoliumSalt,89.569,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2853,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,3,400,MTT,TetrazoliumSalt,93.424,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2854,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,3,500,MTT,TetrazoliumSalt,74.376,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2855,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,6,25,MTT,TetrazoliumSalt,95.465,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2856,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,6,100,MTT,TetrazoliumSalt,92.971,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2857,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,6,200,MTT,TetrazoliumSalt,68.934,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2858,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,6,300,MTT,TetrazoliumSalt,52.834,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2859,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,6,400,MTT,TetrazoliumSalt,63.946,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2860,Fe3O4,Sphere,Tween80,Precipitation,,,,,,,,Macrophage,,6,500,MTT,TetrazoliumSalt,60.317,10.2147/ijn.s13244,87,,30,,J774A.1,International Journal of Nanomedicine,Dove Medical Press Ltd.,2010,Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress,TRUE,TRUE,green,87_naqvi2010.pdf,1
2897,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Lung,Epithelial,Embryonic,24,5,MTT,TetrazoliumSalt,94.712,10.1155/2016/4023852,88,,94.5,17.5,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2898,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Lung,Epithelial,Embryonic,24,25,MTT,TetrazoliumSalt,73.558,10.1155/2016/4023852,88,,94.5,17.5,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2899,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Lung,Epithelial,Embryonic,24,50,MTT,TetrazoliumSalt,29.487,10.1155/2016/4023852,88,,94.5,17.5,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2900,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Lung,Epithelial,Embryonic,24,100,MTT,TetrazoliumSalt,21.314,10.1155/2016/4023852,88,,94.5,17.5,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2901,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Blood,Monocyte,Adult,24,10,MTT,TetrazoliumSalt,57.358,10.1155/2016/4023852,88,,94.5,17.5,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2902,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Blood,Monocyte,Adult,24,20,MTT,TetrazoliumSalt,45.652,10.1155/2016/4023852,88,,94.5,17.5,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2903,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Blood,Monocyte,Adult,24,40,MTT,TetrazoliumSalt,36.957,10.1155/2016/4023852,88,,94.5,17.5,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2904,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Blood,Monocyte,Adult,24,80,MTT,TetrazoliumSalt,24.582,10.1155/2016/4023852,88,,94.5,17.5,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2905,ZnO,Sphere,,Commercial,Positive,253.6,,1000000,H,Human,Blood,Monocyte,Adult,24,100,MTT,TetrazoliumSalt,21.07,10.1155/2016/4023852,88,,94.5,17.5,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2906,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Lung,Epithelial,Embryonic,24,100,MTT,TetrazoliumSalt,89.482,10.1155/2016/4023852,88,,19.1,-36.74,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2907,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Lung,Epithelial,Embryonic,24,200,MTT,TetrazoliumSalt,77.832,10.1155/2016/4023852,88,,19.1,-36.74,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2908,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Lung,Epithelial,Embryonic,24,300,MTT,TetrazoliumSalt,47.087,10.1155/2016/4023852,88,,19.1,-36.74,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2909,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Lung,Epithelial,Embryonic,24,400,MTT,TetrazoliumSalt,35.275,10.1155/2016/4023852,88,,19.1,-36.74,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2910,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Lung,Epithelial,Embryonic,24,500,MTT,TetrazoliumSalt,31.877,10.1155/2016/4023852,88,,19.1,-36.74,L-132,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2911,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Blood,Monocyte,Adult,24,10,MTT,TetrazoliumSalt,92.573,10.1155/2016/4023852,88,,19.1,-36.74,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2912,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Blood,Monocyte,Adult,24,50,MTT,TetrazoliumSalt,71.33,10.1155/2016/4023852,88,,19.1,-36.74,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2913,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Blood,Monocyte,Adult,24,100,MTT,TetrazoliumSalt,47.323,10.1155/2016/4023852,88,,19.1,-36.74,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2914,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Blood,Monocyte,Adult,24,150,MTT,TetrazoliumSalt,30.225,10.1155/2016/4023852,88,,19.1,-36.74,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2915,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Blood,Monocyte,Adult,24,200,MTT,TetrazoliumSalt,23.143,10.1155/2016/4023852,88,,19.1,-36.74,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2916,SiO2,Sphere,,Commercial,Negative,98.5,,1000000,H,Human,Blood,Monocyte,Adult,24,250,MTT,TetrazoliumSalt,12.781,10.1155/2016/4023852,88,,19.1,-36.74,THP-1,Journal of Nanoscience,Wiley,2016,<i>In Vitro</i> Cytotoxicity of Nanoparticles: A Comparison between Particle Size and Cell Type,FALSE,TRUE,hybrid,88_10.1155@2016@4023852.pdf,1
2917,C,Sphere,,Commercial,Negative,235.5,,,H,Human,Blood,Monocyte,Adult,24,50,MTT,TetrazoliumSalt,87.918,10.1155/2014/827019,89,,53.7,-39.9,THP-1,International Journal of Inflammation,Wiley,2014,Carbon Black Particle Exhibits Size Dependent Toxicity in Human Monocytes,TRUE,TRUE,gold,89_sahu2014.pdf,1
2918,C,Sphere,,Commercial,Negative,235.5,,,H,Human,Blood,Monocyte,Adult,24,100,MTT,TetrazoliumSalt,81.877,10.1155/2014/827019,89,,53.7,-39.9,THP-1,International Journal of Inflammation,Wiley,2014,Carbon Black Particle Exhibits Size Dependent Toxicity in Human Monocytes,TRUE,TRUE,gold,89_sahu2014.pdf,1
2919,C,Sphere,,Commercial,Negative,235.5,,,H,Human,Blood,Monocyte,Adult,24,200,MTT,TetrazoliumSalt,77.763,10.1155/2014/827019,89,,53.7,-39.9,THP-1,International Journal of Inflammation,Wiley,2014,Carbon Black Particle Exhibits Size Dependent Toxicity in Human Monocytes,TRUE,TRUE,gold,89_sahu2014.pdf,1
2920,C,Sphere,,Commercial,Negative,235.5,,,H,Human,Blood,Monocyte,Adult,24,400,MTT,TetrazoliumSalt,56.684,10.1155/2014/827019,89,,53.7,-39.9,THP-1,International Journal of Inflammation,Wiley,2014,Carbon Black Particle Exhibits Size Dependent Toxicity in Human Monocytes,TRUE,TRUE,gold,89_sahu2014.pdf,1
2921,C,Sphere,,Commercial,Negative,235.5,,,H,Human,Blood,Monocyte,Adult,24,800,MTT,TetrazoliumSalt,40.617,10.1155/2014/827019,89,,53.7,-39.9,THP-1,International Journal of Inflammation,Wiley,2014,Carbon Black Particle Exhibits Size Dependent Toxicity in Human Monocytes,TRUE,TRUE,gold,89_sahu2014.pdf,1
2922,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,24,0.2,MTS,TetrazoliumSalt,46.853,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2923,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,24,0.4,MTS,TetrazoliumSalt,71.562,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2924,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,24,2,MTS,TetrazoliumSalt,75.524,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2925,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,24,4,MTS,TetrazoliumSalt,79.487,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2926,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,24,20,MTS,TetrazoliumSalt,72.494,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2927,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,24,40,MTS,TetrazoliumSalt,2.0979,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2928,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,96,0.2,MTS,TetrazoliumSalt,86.247,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2929,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,96,0.4,MTS,TetrazoliumSalt,59.441,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2930,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,96,2,MTS,TetrazoliumSalt,81.818,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2931,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,96,4,MTS,TetrazoliumSalt,84.149,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2932,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,H,Human,Skin,Fibroblast,Fetus,96,20,MTS,TetrazoliumSalt,82.284,10.1002/jbm.a.35491,90,,61.46,-32.66,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2934,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,24,0.2,MTS,TetrazoliumSalt,99.394,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2935,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,24,0.4,MTS,TetrazoliumSalt,81.212,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2936,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,24,2,MTS,TetrazoliumSalt,94.242,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2937,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,24,4,MTS,TetrazoliumSalt,90.303,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2938,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,24,20,MTS,TetrazoliumSalt,23.03,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2939,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,24,40,MTS,TetrazoliumSalt,1.2121,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2940,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,96,0.2,MTS,TetrazoliumSalt,120,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2941,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,96,0.4,MTS,TetrazoliumSalt,119.7,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2942,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,96,2,MTS,TetrazoliumSalt,109.39,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2943,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,96,4,MTS,TetrazoliumSalt,118.79,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2944,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,96,20,MTS,TetrazoliumSalt,6.6667,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2945,Au,Sphere,,Commercial,Negative,102.8,-23.98,5000,A,Rat,FatPad,Endothelial,Adult,96,40,MTS,TetrazoliumSalt,1.2121,10.1002/jbm.a.35491,90,,61.46,-32.66,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2946,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,0.2,MTS,TetrazoliumSalt,108.99,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2947,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,0.4,MTS,TetrazoliumSalt,135.36,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2948,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,2,MTS,TetrazoliumSalt,131.59,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2949,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,4,MTS,TetrazoliumSalt,153.91,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2950,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,20,MTS,TetrazoliumSalt,145.22,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2951,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,40,MTS,TetrazoliumSalt,140,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2952,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,200,MTS,TetrazoliumSalt,137.68,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2953,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,24,400,MTS,TetrazoliumSalt,128.7,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2954,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,0.2,MTS,TetrazoliumSalt,78.261,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2955,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,0.4,MTS,TetrazoliumSalt,78.551,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2956,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,2,MTS,TetrazoliumSalt,88.406,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2957,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,4,MTS,TetrazoliumSalt,92.174,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2958,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,20,MTS,TetrazoliumSalt,99.13,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2959,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,40,MTS,TetrazoliumSalt,98.841,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2960,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,200,MTS,TetrazoliumSalt,94.203,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2961,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,H,Human,Skin,Fibroblast,Fetus,96,400,MTS,TetrazoliumSalt,85.507,10.1002/jbm.a.35491,90,,33.69,-24.52,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2962,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,24,0.2,MTS,TetrazoliumSalt,120.51,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2963,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,24,0.4,MTS,TetrazoliumSalt,117.66,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2964,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,24,2,MTS,TetrazoliumSalt,121.65,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2965,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,24,4,MTS,TetrazoliumSalt,105.13,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2966,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,24,20,MTS,TetrazoliumSalt,116.24,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2967,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,40,MTS,TetrazoliumSalt,116.24,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2968,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,200,MTS,TetrazoliumSalt,121.08,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2969,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,400,MTS,TetrazoliumSalt,126.78,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2970,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,0.2,MTS,TetrazoliumSalt,78.632,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2971,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,0.4,MTS,TetrazoliumSalt,85.755,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2972,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,2,MTS,TetrazoliumSalt,106.84,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2973,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,4,MTS,TetrazoliumSalt,92.308,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2974,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,20,MTS,TetrazoliumSalt,110.54,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2975,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,40,MTS,TetrazoliumSalt,113.39,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2976,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,200,MTS,TetrazoliumSalt,108.26,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2977,Au,Star,,Chemical Reduction,Negative,206.7,-23.76,5000,A,Rat,FatPad,Endothelial,Adult,96,400,MTS,TetrazoliumSalt,70.94,10.1002/jbm.a.35491,90,,33.69,-24.52,RFPEC,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars,FALSE,FALSE,closed,90_favi2015.pdf,0
2978,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,9,MTS,TetrazoliumSalt,3.1208,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2979,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,9,MTS,TetrazoliumSalt,97.286,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2980,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,1.82,MTS,TetrazoliumSalt,3.7946,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2981,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,5.81,MTS,TetrazoliumSalt,3.7946,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2982,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,9,MTS,TetrazoliumSalt,2.6786,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2983,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,13,MTS,TetrazoliumSalt,1.3393,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2984,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,18,MTS,TetrazoliumSalt,1.3393,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2985,Au,Sphere,CTAB,Commercial,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,28.9,MTS,TetrazoliumSalt,14.286,10.3109/17435390.2010.528847,91,,42.9,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2986,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,1.82,MTS,TetrazoliumSalt,90.402,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2987,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,5.91,MTS,TetrazoliumSalt,95.312,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2988,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,9.45,MTS,TetrazoliumSalt,96.205,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2989,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,14,MTS,TetrazoliumSalt,59.152,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2990,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,19,MTS,TetrazoliumSalt,53.571,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2991,Au,Rod,CTAB,Seed-Mediated Growth Method,,,,12000,A,Dog,Kidney,Epithelial,Adult,24,30.6,MTS,TetrazoliumSalt,53.571,10.3109/17435390.2010.528847,91,,17.2,,MDCK-II,Nanotoxicology,Informa UK Limited,2010,Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells,FALSE,FALSE,closed,91_tarantola2010.pdf,0
2992,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Colon,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,72.5,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2993,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Colon,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,62.4,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2994,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Colon,Epithelial,Adult,24,150,MTT,TetrazoliumSalt,51.1,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2995,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Colon,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,43.6,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2996,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,68.45,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2997,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,56.88,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2998,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Lung,Epithelial,Adult,24,150,MTT,TetrazoliumSalt,48.84,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
2999,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,H,Human,Lung,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,38,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3000,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,A,Monkey,Kidney,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,93.61,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,VERO,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3001,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,A,Monkey,Kidney,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,76.74,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,VERO,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3002,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,A,Monkey,Kidney,Epithelial,Adult,24,150,MTT,TetrazoliumSalt,65.42,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,VERO,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3003,ZrO2,Sphere,,Green Synthesis,Negative,,,10000,A,Monkey,Kidney,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,61.08,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,VERO,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3004,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Colon,Epithelial,Adult,24,50,Live/Dead,TrypanBlue,72.74,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3005,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Colon,Epithelial,Adult,24,100,Live/Dead,TrypanBlue,58.52,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3006,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Colon,Epithelial,Adult,24,150,Live/Dead,TrypanBlue,52.62,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3007,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Colon,Epithelial,Adult,24,200,Live/Dead,TrypanBlue,42.93,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,HCT-116,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3008,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,50,Live/Dead,TrypanBlue,67.1,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3009,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,100,Live/Dead,TrypanBlue,55.78,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3010,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,150,Live/Dead,TrypanBlue,46.88,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3011,ZrO2,Sphere,,Green Synthesis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,200,Live/Dead,TrypanBlue,36.98,10.1016/j.jphotobiol.2017.04.004,92,,10,-45.5,A549,Journal of Photochemistry and Photobiology B: Biology,Elsevier BV,2017,Nano-zirconia ГўВЂВ“ Evaluation of its antioxidant and anticancer activity,FALSE,FALSE,closed,92_balaji2017.pdf,0
3012,ZrO2,Sphere,,Ball Mill-Aided Precipitation,Positive,50,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,12.5,MTT,TetrazoliumSalt,96.921,10.1016/j.ecoenv.2013.04.004,93,,39,11.8,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3013,ZrO2,Sphere,,Ball Mill-Aided Precipitation,Positive,50,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,25,MTT,TetrazoliumSalt,88.71,10.1016/j.ecoenv.2013.04.004,93,,39,11.8,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3014,ZrO2,Sphere,,Ball Mill-Aided Precipitation,Positive,50,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,50,MTT,TetrazoliumSalt,81.085,10.1016/j.ecoenv.2013.04.004,93,,39,11.8,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3015,ZrO2,Sphere,,Ball Mill-Aided Precipitation,Positive,50,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,100,MTT,TetrazoliumSalt,77.126,10.1016/j.ecoenv.2013.04.004,93,,39,11.8,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3016,ZrO2,Sphere,,Ball Mill-Aided Precipitation,Positive,50,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,200,MTT,TetrazoliumSalt,73.314,10.1016/j.ecoenv.2013.04.004,93,,39,11.8,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3017,TiO2,Sphere,,Ball Mill-Aided Precipitation,Negative,65,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,12.5,MTT,TetrazoliumSalt,99.707,10.1016/j.ecoenv.2013.04.004,93,,50,-22,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3018,TiO2,Sphere,,Ball Mill-Aided Precipitation,Negative,65,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,25,MTT,TetrazoliumSalt,90.029,10.1016/j.ecoenv.2013.04.004,93,,50,-22,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3019,TiO2,Sphere,,Ball Mill-Aided Precipitation,Negative,65,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,50,MTT,TetrazoliumSalt,83.724,10.1016/j.ecoenv.2013.04.004,93,,50,-22,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3020,TiO2,Sphere,,Ball Mill-Aided Precipitation,Negative,65,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,100,MTT,TetrazoliumSalt,77.273,10.1016/j.ecoenv.2013.04.004,93,,50,-22,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3021,TiO2,Sphere,,Ball Mill-Aided Precipitation,Negative,65,,10000,A,Mouse,Embryo,Fibroblast,Embryonic,48,200,MTT,TetrazoliumSalt,68.915,10.1016/j.ecoenv.2013.04.004,93,,50,-22,NIH3T3,Ecotoxicology and Environmental Safety,Elsevier BV,2013,"Screening of in vitro cytotoxicity, antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles",FALSE,FALSE,closed,93_karunakaran2013.pdf,0
3022,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,0.625,MTT,TetrazoliumSalt,90.4,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3023,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,1.25,MTT,TetrazoliumSalt,82.5,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3024,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,2.5,MTT,TetrazoliumSalt,80,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3025,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,5,MTT,TetrazoliumSalt,75.7,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3026,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,10,MTT,TetrazoliumSalt,75.5,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3027,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,0.625,NRU,NeutralRed,98.3,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3028,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,1.25,NRU,NeutralRed,93.8,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3029,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,2.5,NRU,NeutralRed,86.9,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3030,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,5,NRU,NeutralRed,80.3,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3031,TiO2,Sphere,,Sonomechanical Method,,152,,10000,H,Human,Amnion,Epithelial,Embryonic,24,10,NRU,NeutralRed,57.5,10.1016/j.tiv.2011.12.011,94,,30.6,,WISH,Toxicology in Vitro,Elsevier BV,2012,"Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells",FALSE,FALSE,closed,94_saquib2012.pdf,0
3032,Ag,Sphere,Citrate,Commercial,Negative,136,-35,,H,Human,Lung,Epithelial,Adult,48,0.5,AlamarBlue,AlamarBlue,99.551,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3033,Ag,Sphere,Citrate,Commercial,Negative,136,-35,,H,Human,Lung,Epithelial,Adult,48,10,AlamarBlue,AlamarBlue,97.079,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3034,Ag,Sphere,Citrate,Commercial,Negative,136,-35,,H,Human,Lung,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,97.079,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3035,Ag,Sphere,Citrate,Commercial,Negative,136,-35,,H,Human,Lung,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,87.191,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3036,Ag,Sphere,Citrate,Commercial,Negative,77,-37,,H,Human,Lung,Epithelial,Adult,48,0.5,AlamarBlue,AlamarBlue,99.551,10.1093/mutage/gex027,95,,47.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3037,Ag,Sphere,Citrate,Commercial,Negative,77,-37,,H,Human,Lung,Epithelial,Adult,48,10,AlamarBlue,AlamarBlue,97.079,10.1093/mutage/gex027,95,,47.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3038,Ag,Sphere,Citrate,Commercial,Negative,77,-37,,H,Human,Lung,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,95.281,10.1093/mutage/gex027,95,,47.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3039,Ag,Sphere,Citrate,Commercial,Negative,77,-37,,H,Human,Lung,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,89.663,10.1093/mutage/gex027,95,,47.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3040,Au,Sphere,Citrate,Commercial,Negative,220,-30,,H,Human,Lung,Epithelial,Adult,48,0.5,AlamarBlue,AlamarBlue,100.46,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3041,Au,Sphere,Citrate,Commercial,Negative,220,-30,,H,Human,Lung,Epithelial,Adult,48,10,AlamarBlue,AlamarBlue,100,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3042,Au,Sphere,Citrate,Commercial,Negative,220,-30,,H,Human,Lung,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,98.169,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3043,Au,Sphere,Citrate,Commercial,Negative,220,-30,,H,Human,Lung,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,96.796,10.1093/mutage/gex027,95,,5.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3044,Au,Sphere,Citrate,Commercial,Negative,300,-37,,H,Human,Lung,Epithelial,Adult,48,0.5,AlamarBlue,AlamarBlue,98.627,10.1093/mutage/gex027,95,,49.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3045,Au,Sphere,Citrate,Commercial,Negative,300,-37,,H,Human,Lung,Epithelial,Adult,48,10,AlamarBlue,AlamarBlue,100,10.1093/mutage/gex027,95,,49.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3046,Au,Sphere,Citrate,Commercial,Negative,300,-37,,H,Human,Lung,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,101.14,10.1093/mutage/gex027,95,,49.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3047,Au,Sphere,Citrate,Commercial,Negative,300,-37,,H,Human,Lung,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,102.29,10.1093/mutage/gex027,95,,49.2,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3048,Pt,Sphere,Citrate,Commercial,Negative,195,-43,,H,Human,Lung,Epithelial,Adult,48,0.5,AlamarBlue,AlamarBlue,100,10.1093/mutage/gex027,95,,4.8,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3049,Pt,Sphere,Citrate,Commercial,Negative,195,-43,,H,Human,Lung,Epithelial,Adult,48,10,AlamarBlue,AlamarBlue,98.789,10.1093/mutage/gex027,95,,4.8,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3050,Pt,Sphere,Citrate,Commercial,Negative,195,-43,,H,Human,Lung,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,99.274,10.1093/mutage/gex027,95,,4.8,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3051,Pt,Sphere,Citrate,Commercial,Negative,195,-43,,H,Human,Lung,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,93.705,10.1093/mutage/gex027,95,,4.8,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3052,Pt,Sphere,Citrate,Commercial,Negative,130,-29,,H,Human,Lung,Epithelial,Adult,48,0.5,AlamarBlue,AlamarBlue,100.48,10.1093/mutage/gex027,95,,44.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3053,Pt,Sphere,Citrate,Commercial,Negative,130,-29,,H,Human,Lung,Epithelial,Adult,48,10,AlamarBlue,AlamarBlue,101.21,10.1093/mutage/gex027,95,,44.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3054,Pt,Sphere,Citrate,Commercial,Negative,130,-29,,H,Human,Lung,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,101.21,10.1093/mutage/gex027,95,,44.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3055,Pt,Sphere,Citrate,Commercial,Negative,130,-29,,H,Human,Lung,Epithelial,Adult,48,50,AlamarBlue,AlamarBlue,100.48,10.1093/mutage/gex027,95,,44.3,,HEBC3-KT,Mutagenesis,Oxford University Press (OUP),2017,"Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry",FALSE,TRUE,hybrid,95_oup-accepted-manuscript-2017.pdf,1
3056,Ag,Sphere,Citrate,Chemical Reduction,Negative,110,-10,3000,H,Human,Skin,Fibroblast,Adult,24,12.5,MTS,,87.98,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3057,Ag,Sphere,Citrate,Chemical Reduction,Negative,110,-10,3000,H,Human,Skin,Fibroblast,Adult,24,25,MTS,,84.143,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3058,Ag,Sphere,Citrate,Chemical Reduction,Negative,110,-10,3000,H,Human,Skin,Fibroblast,Adult,24,50,MTS,,66.752,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3059,Ag,Sphere,Citrate,Chemical Reduction,Negative,110,-10,3000,H,Human,Skin,Fibroblast,Adult,24,100,MTS,,50.639,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3060,Ag,Sphere,Citrate,Chemical Reduction,Negative,111,-9,3000,H,Human,Lung,Epithelial,Adult,24,12.5,MTS,,96.419,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3061,Ag,Sphere,Citrate,Chemical Reduction,Negative,111,-9,3000,H,Human,Lung,Epithelial,Adult,24,25,MTS,,94.373,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3062,Ag,Sphere,Citrate,Chemical Reduction,Negative,111,-9,3000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,68.031,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3063,Ag,Sphere,Citrate,Chemical Reduction,Negative,111,-9,3000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,41.432,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3064,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,195,-9,3000,H,Human,Skin,Fibroblast,Adult,24,12.5,MTS,,98.721,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3065,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,195,-9,3000,H,Human,Skin,Fibroblast,Adult,24,25,MTS,,96.164,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3066,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,195,-9,3000,H,Human,Skin,Fibroblast,Adult,24,50,MTS,,78.772,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3067,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,195,-9,3000,H,Human,Skin,Fibroblast,Adult,24,100,MTS,,62.404,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3068,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,123,-9,3000,H,Human,Lung,Epithelial,Adult,24,12.5,MTS,,96.675,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3069,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,123,-9,3000,H,Human,Lung,Epithelial,Adult,24,25,MTS,,95.908,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3070,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,123,-9,3000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,74.936,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3071,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,123,-9,3000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,44.757,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3072,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,210,-11,3000,H,Human,Skin,Fibroblast,Adult,24,12.5,MTS,,99.233,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3073,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,210,-11,3000,H,Human,Skin,Fibroblast,Adult,24,25,MTS,,96.675,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3074,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,210,-11,3000,H,Human,Skin,Fibroblast,Adult,24,50,MTS,,79.795,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3075,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,210,-11,3000,H,Human,Skin,Fibroblast,Adult,24,100,MTS,,79.795,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3076,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,132,-9,3000,H,Human,Lung,Epithelial,Adult,24,12.5,MTS,,98.465,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3077,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,132,-9,3000,H,Human,Lung,Epithelial,Adult,24,25,MTS,,96.419,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3078,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,132,-9,3000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,77.238,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3079,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,132,-9,3000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,77.238,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3080,Ag,Sphere,Citrate,Chemical Reduction,Negative,127,-12,3000,H,Human,Skin,Fibroblast,Adult,48,12.5,MTS,,66.334,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3081,Ag,Sphere,Citrate,Chemical Reduction,Negative,127,-12,3000,H,Human,Skin,Fibroblast,Adult,48,25,MTS,,54.863,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3082,Ag,Sphere,Citrate,Chemical Reduction,Negative,127,-12,3000,H,Human,Skin,Fibroblast,Adult,48,50,MTS,,43.89,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3083,Ag,Sphere,Citrate,Chemical Reduction,Negative,127,-12,3000,H,Human,Skin,Fibroblast,Adult,48,100,MTS,,26.185,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3084,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-7,3000,H,Human,Lung,Epithelial,Adult,48,12.5,MTS,,77.556,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3085,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-7,3000,H,Human,Lung,Epithelial,Adult,48,25,MTS,,66.334,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3086,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-7,3000,H,Human,Lung,Epithelial,Adult,48,50,MTS,,58.603,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3087,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-7,3000,H,Human,Lung,Epithelial,Adult,48,100,MTS,,31.671,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3088,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,213,-11,3000,H,Human,Skin,Fibroblast,Adult,48,12.5,MTS,,98.753,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3089,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,213,-11,3000,H,Human,Skin,Fibroblast,Adult,48,25,MTS,,92.768,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3090,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,213,-11,3000,H,Human,Skin,Fibroblast,Adult,48,50,MTS,,66.334,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3091,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,213,-11,3000,H,Human,Skin,Fibroblast,Adult,48,100,MTS,,40.15,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3092,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,48,12.5,MTS,,97.007,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3093,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,48,25,MTS,,78.803,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3094,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,48,50,MTS,,70.324,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3095,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,48,100,MTS,,35.162,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3096,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,225,-13,3000,H,Human,Skin,Fibroblast,Adult,48,12.5,MTS,,80.05,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3097,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,225,-13,3000,H,Human,Skin,Fibroblast,Adult,48,25,MTS,,79.551,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3098,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,225,-13,3000,H,Human,Skin,Fibroblast,Adult,48,50,MTS,,70.324,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3099,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,225,-13,3000,H,Human,Skin,Fibroblast,Adult,48,100,MTS,,70.574,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3100,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,144,-9,3000,H,Human,Lung,Epithelial,Adult,48,12.5,MTS,,93.766,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3101,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,144,-9,3000,H,Human,Lung,Epithelial,Adult,48,25,MTS,,75.561,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3102,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,144,-9,3000,H,Human,Lung,Epithelial,Adult,48,50,MTS,,66.584,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3103,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,144,-9,3000,H,Human,Lung,Epithelial,Adult,48,100,MTS,,70.324,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3104,Ag,Sphere,Citrate,Chemical Reduction,Negative,132,-9,3000,H,Human,Skin,Fibroblast,Adult,72,12.5,MTS,,61.954,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3105,Ag,Sphere,Citrate,Chemical Reduction,Negative,132,-9,3000,H,Human,Skin,Fibroblast,Adult,72,25,MTS,,53.985,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3106,Ag,Sphere,Citrate,Chemical Reduction,Negative,132,-9,3000,H,Human,Skin,Fibroblast,Adult,72,50,MTS,,28.792,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3107,Ag,Sphere,Citrate,Chemical Reduction,Negative,132,-9,3000,H,Human,Skin,Fibroblast,Adult,72,100,MTS,,19.023,10.1088/0957-4484/23/37/375102,96,,50,-35,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3108,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-5,3000,H,Human,Lung,Epithelial,Adult,72,12.5,MTS,,77.635,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3109,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-5,3000,H,Human,Lung,Epithelial,Adult,72,25,MTS,,41.902,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3110,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-5,3000,H,Human,Lung,Epithelial,Adult,72,50,MTS,,40.103,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3111,Ag,Sphere,Citrate,Chemical Reduction,Negative,114,-5,3000,H,Human,Lung,Epithelial,Adult,72,100,MTS,,28.278,10.1088/0957-4484/23/37/375102,96,,50,-35,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3112,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,218,-8,3000,H,Human,Skin,Fibroblast,Adult,72,12.5,MTS,,98.715,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3113,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,218,-8,3000,H,Human,Skin,Fibroblast,Adult,72,25,MTS,,84.319,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3114,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,218,-8,3000,H,Human,Skin,Fibroblast,Adult,72,50,MTS,,50.129,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3115,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,218,-8,3000,H,Human,Skin,Fibroblast,Adult,72,100,MTS,,28.278,10.1088/0957-4484/23/37/375102,96,,50,-31,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3116,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,72,12.5,MTS,,95.373,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3117,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,72,25,MTS,,66.838,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3118,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,72,50,MTS,,67.352,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3119,Ag,Sphere,Citrate-Lactose,Chemical Reduction,Negative,130,-9,3000,H,Human,Lung,Epithelial,Adult,72,100,MTS,,33.676,10.1088/0957-4484/23/37/375102,96,,50,-31,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3120,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,230,-9,3000,H,Human,Skin,Fibroblast,Adult,72,12.5,MTS,,82.262,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3121,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,230,-9,3000,H,Human,Skin,Fibroblast,Adult,72,25,MTS,,75.064,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3122,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,230,-9,3000,H,Human,Skin,Fibroblast,Adult,72,50,MTS,,41.388,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3123,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,230,-9,3000,H,Human,Skin,Fibroblast,Adult,72,100,MTS,,32.648,10.1088/0957-4484/23/37/375102,96,,50,-30,HDF,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3124,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,146,-10,3000,H,Human,Lung,Epithelial,Adult,72,12.5,MTS,,75.064,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3125,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,146,-10,3000,H,Human,Lung,Epithelial,Adult,72,25,MTS,,67.352,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3126,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,146,-10,3000,H,Human,Lung,Epithelial,Adult,72,50,MTS,,67.095,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3127,Ag,Sphere,Citrate-Oligonucleotide,Chemical Reduction,Negative,146,-10,3000,H,Human,Lung,Epithelial,Adult,72,100,MTS,,59.126,10.1088/0957-4484/23/37/375102,96,,50,-30,A549,Nanotechnology,IOP Publishing,2012,The influence of the surface chemistry of silver nanoparticles on cell death,FALSE,FALSE,closed,96_sur2012.pdf,0
3128,Al2O3,Sphere,,Commercial,Negative,,,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,200,CCK-8,TetrazoliumSalt,54.026,10.1016/j.dental.2015.02.009,97,,13,-16.8,RAW264.7,Dental Materials,Elsevier BV,2015,Cytotoxic and genotoxic characterization of aluminum and silicon oxide nanoparticles in macrophages,FALSE,FALSE,closed,97_hashimoto2015.pdf,0
3129,Al2O3,Sphere,,Commercial,Negative,,,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,400,CCK-8,TetrazoliumSalt,54.319,10.1016/j.dental.2015.02.009,97,,13,-16.8,RAW264.7,Dental Materials,Elsevier BV,2015,Cytotoxic and genotoxic characterization of aluminum and silicon oxide nanoparticles in macrophages,FALSE,FALSE,closed,97_hashimoto2015.pdf,0
3130,SiO2,Sphere,,Commercial,Negative,,,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,200,CCK-8,TetrazoliumSalt,26.061,10.1016/j.dental.2015.02.009,97,,12,-9.9,RAW264.7,Dental Materials,Elsevier BV,2015,Cytotoxic and genotoxic characterization of aluminum and silicon oxide nanoparticles in macrophages,FALSE,FALSE,closed,97_hashimoto2015.pdf,0
3131,SiO2,Sphere,,Commercial,Negative,,,10000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,400,CCK-8,TetrazoliumSalt,24.89,10.1016/j.dental.2015.02.009,97,,12,-9.9,RAW264.7,Dental Materials,Elsevier BV,2015,Cytotoxic and genotoxic characterization of aluminum and silicon oxide nanoparticles in macrophages,FALSE,FALSE,closed,97_hashimoto2015.pdf,0
3132,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,83.404,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3133,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,69.094,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3134,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,51.412,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3135,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,34.027,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3136,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,27.935,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3137,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,2,NRU,NeutralRed,81.395,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3138,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,5,NRU,NeutralRed,66.202,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3139,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,10,NRU,NeutralRed,51.163,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3140,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,25,NRU,NeutralRed,40.155,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3141,CuO,Sphere,,Precipitation,Negative,167.48,-25.41,10000,H,Human,Liver,Epithelial,Adult,24,50,NRU,NeutralRed,33.333,10.1371/journal.pone.0069534,98,,22.83,-20.36,HepG2,PLoS ONE,Public Library of Science (PLoS),2013,Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells,TRUE,TRUE,gold,98_siddiqui2013.pdf,1
3142,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,84.453,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3143,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,77.543,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3144,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,20,MTT,TetrazoliumSalt,76.967,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3145,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,40,MTT,TetrazoliumSalt,63.916,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3146,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,80,MTT,TetrazoliumSalt,45.873,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3147,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,160,MTT,TetrazoliumSalt,52.207,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3148,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,5,NRU,NeutralRed,95.385,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3149,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,10,NRU,NeutralRed,81.346,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3150,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,20,NRU,NeutralRed,77.692,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3151,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,40,NRU,NeutralRed,70,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3152,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,80,NRU,NeutralRed,67.308,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3153,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,160,NRU,NeutralRed,55.192,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3154,C,Sphere,Dextran,Commercial,Negative,,,1000000,A,Rat,Brain,Fibroblast,Adult,24,5,Live/Dead,CalceinAM,97.922,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3155,C,Sphere,Dextran,Commercial,Negative,,,1000000,A,Rat,Brain,Fibroblast,Adult,24,100,Live/Dead,CalceinAM,86.919,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3156,C,Sphere,Dextran,Commercial,Negative,,,1000000,A,Rat,Brain,Fibroblast,Adult,24,200,Live/Dead,CalceinAM,82.885,10.1016/j.eurpolymj.2020.109572,99,,30.29,-10.1,C6,European Polymer Journal,Elsevier BV,2020,Effect of polymer functionalized fullerene soot on C6 glial cells,FALSE,FALSE,closed,99_10.1016@j.eurpolymj.2020.109572.pdf,0
3157,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,99.04,10.1016/j.apsusc.2019.03.167,100,,76,-36,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3158,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,88.196,10.1016/j.apsusc.2019.03.167,100,,76,-36,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3159,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,20,MTT,TetrazoliumSalt,75.24,10.1016/j.apsusc.2019.03.167,100,,76,-36,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3160,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,92.898,10.1016/j.apsusc.2019.03.167,100,,57,-35,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3161,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,89.251,10.1016/j.apsusc.2019.03.167,100,,57,-35,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3162,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,20,MTT,TetrazoliumSalt,96.065,10.1016/j.apsusc.2019.03.167,100,,57,-35,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3163,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,81.862,10.1016/j.apsusc.2019.03.167,100,,7,-25,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3164,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,80.902,10.1016/j.apsusc.2019.03.167,100,,7,-25,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3165,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,20,MTT,TetrazoliumSalt,48.752,10.1016/j.apsusc.2019.03.167,100,,7,-25,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3166,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,5,MTT,TetrazoliumSalt,80.998,10.1016/j.apsusc.2019.03.167,100,,8,-20,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3167,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,79.942,10.1016/j.apsusc.2019.03.167,100,,8,-20,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3168,C,Sphere,,Commercial,Negative,,,10000,A,Hamster,Lung,Fibroblast,Adult,24,20,MTT,TetrazoliumSalt,57.102,10.1016/j.apsusc.2019.03.167,100,,8,-20,V79,Applied Surface Science,Elsevier BV,2019,State of aggregation and toxicity of aqueous fullerene solutions,FALSE,FALSE,closed,100_kyzyma2019.pdf,0
3169,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,25,MTT,TetrazoliumSalt,87.81,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3170,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,77.479,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3171,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,75.413,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3172,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,200,MTT,TetrazoliumSalt,69.835,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3173,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,400,MTT,TetrazoliumSalt,63.636,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3174,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,25,NRU,NeutralRed,97.028,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3175,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,50,NRU,NeutralRed,90.658,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3176,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,100,NRU,NeutralRed,84.076,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3177,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,200,NRU,NeutralRed,71.338,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3178,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Rat,Brain,Fibroblast,Adult,24,400,NRU,NeutralRed,48.62,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3179,C,Sphere,Dextran,Commercial,Negative,,,1000000,A,Rat,Brain,Fibroblast,Adult,24,50,Live/Dead,CalceinAM,91.331,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3180,C,Sphere,Dextran,Commercial,Negative,,,1000000,A,Rat,Brain,Fibroblast,Adult,24,100,Live/Dead,CalceinAM,87.546,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3181,C,Sphere,Dextran,Commercial,Negative,,,1000000,A,Rat,Brain,Fibroblast,Adult,24,200,Live/Dead,CalceinAM,80.952,10.1016/j.brainresbull.2019.11.014,101,,30,-16.9,C6,Brain Research Bulletin,Elsevier BV,2020,Toxicity of dextran stabilized fullerene C60 against C6 Glial cells,FALSE,FALSE,closed,101_biby2019.pdf,0
3182,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,96.02,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3183,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,20,MTT,TetrazoliumSalt,91.67,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3184,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,40,MTT,TetrazoliumSalt,88.145,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3185,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,80,MTT,TetrazoliumSalt,85.68,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3186,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,10,NRU,NeutralRed,94.62,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3187,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,20,NRU,NeutralRed,92.25,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3188,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,40,NRU,NeutralRed,89.58,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3189,C,Sphere,Dextran,Commercial,Negative,,,10000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,80,NRU,NeutralRed,83.27,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3190,C,Sphere,Dextran,Commercial,Negative,,,300000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,10,Live/Dead,CalceinAM,95.468,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3191,C,Sphere,Dextran,Commercial,Negative,,,300000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,40,Live/Dead,CalceinAM,89.023,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3192,C,Sphere,Dextran,Commercial,Negative,,,300000,A,Mouse,SubcutaneousConnectiveTissue,Fibroblast,Adult,24,80,Live/Dead,CalceinAM,83.686,10.1016/j.colsurfb.2019.110530,102,,15,-20.7,L929,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2019,Conformity of dextran-coated fullerene C70 with L929 fibroblast cells,FALSE,FALSE,closed,102_ashtami2019.pdf,0
3193,C,Sphere,,Emulsion-Solvent Evaporation,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,3.6,MTT,TetrazoliumSalt,100,10.1080/1536383x.2019.1634055,103,,125,-25.3,HEK293,"Fullerenes, Nanotubes and Carbon Nanostructures",Taylor & Francis,2019,In vitroВ andВ in vivoВ toxicity of pristine C60В fullerene aqueous colloid solution,FALSE,FASLE,hybrid,103_10.1080@1536383X.2019.1634055.pdf,0
3194,C,Sphere,,Emulsion-Solvent Evaporation,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,7.2,MTT,TetrazoliumSalt,96.117,10.1080/1536383x.2019.1634055,103,,125,-25.3,HEK293,"Fullerenes, Nanotubes and Carbon Nanostructures",Taylor & Francis,2019,In vitroВ andВ in vivoВ toxicity of pristine C60В fullerene aqueous colloid solution,FALSE,FASLE,hybrid,103_10.1080@1536383X.2019.1634055.pdf,0
3195,C,Sphere,,Emulsion-Solvent Evaporation,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,18,MTT,TetrazoliumSalt,90.049,10.1080/1536383x.2019.1634055,103,,125,-25.3,HEK293,"Fullerenes, Nanotubes and Carbon Nanostructures",Taylor & Francis,2019,In vitroВ andВ in vivoВ toxicity of pristine C60В fullerene aqueous colloid solution,FALSE,FASLE,hybrid,103_10.1080@1536383X.2019.1634055.pdf,0
3196,C,Sphere,,Emulsion-Solvent Evaporation,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,36,MTT,TetrazoliumSalt,79.854,10.1080/1536383x.2019.1634055,103,,125,-25.3,HEK293,"Fullerenes, Nanotubes and Carbon Nanostructures",Taylor & Francis,2019,In vitroВ andВ in vivoВ toxicity of pristine C60В fullerene aqueous colloid solution,FALSE,FASLE,hybrid,103_10.1080@1536383X.2019.1634055.pdf,0
3197,C,Sphere,,Emulsion-Solvent Evaporation,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,72,MTT,TetrazoliumSalt,77.913,10.1080/1536383x.2019.1634055,103,,125,-25.3,HEK293,"Fullerenes, Nanotubes and Carbon Nanostructures",Taylor & Francis,2019,In vitroВ andВ in vivoВ toxicity of pristine C60В fullerene aqueous colloid solution,FALSE,FASLE,hybrid,103_10.1080@1536383X.2019.1634055.pdf,0
3198,C,Sphere,,Emulsion-Solvent Evaporation,Negative,,,10000,H,Human,Kidney,Epithelial,Embryonic,24,144,MTT,TetrazoliumSalt,73.058,10.1080/1536383x.2019.1634055,103,,125,-25.3,HEK293,"Fullerenes, Nanotubes and Carbon Nanostructures",Taylor & Francis,2019,In vitroВ andВ in vivoВ toxicity of pristine C60В fullerene aqueous colloid solution,FALSE,FASLE,hybrid,103_10.1080@1536383X.2019.1634055.pdf,0
3199,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,0.1,MTT,TetrazoliumSalt,88.923,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3200,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,1,MTT,TetrazoliumSalt,85.077,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3201,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,10,MTT,TetrazoliumSalt,92.462,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3202,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,50,MTT,TetrazoliumSalt,100,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3203,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,100,MTT,TetrazoliumSalt,98.923,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3204,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,0.1,MTT,TetrazoliumSalt,69.902,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3205,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,77.778,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3206,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,80.028,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3207,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,78.622,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3208,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,72.152,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3209,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,0.1,MTT,TetrazoliumSalt,74.348,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3210,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,76.377,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3211,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,71.594,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3212,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,50,MTT,TetrazoliumSalt,76.377,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3213,C,Sphere,,Commercial,Negative,142,-37.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,100,MTT,TetrazoliumSalt,75.797,10.1080/01480545.2016.1199563,104,,34.64,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3214,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,6,0.1,MTT,TetrazoliumSalt,91.846,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3215,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,6,1,MTT,TetrazoliumSalt,87.846,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3216,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,6,10,MTT,TetrazoliumSalt,87.077,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3217,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,6,50,MTT,TetrazoliumSalt,82,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3218,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,6,100,MTT,TetrazoliumSalt,72.462,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3219,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,24,0.1,MTT,TetrazoliumSalt,61.041,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3220,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,56.962,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3221,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,72.152,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3222,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,76.793,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3223,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,64.276,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3224,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,48,0.1,MTT,TetrazoliumSalt,61.159,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3225,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,66.377,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3226,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,77.681,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3227,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,48,50,MTT,TetrazoliumSalt,71.594,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3228,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,A,Mouse,Skin,Fibroblast,Adult,48,100,MTT,TetrazoliumSalt,62.029,10.1080/01480545.2016.1199563,104,,9,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3229,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,0.1,MTT,TetrazoliumSalt,83.538,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3230,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,1,MTT,TetrazoliumSalt,90.462,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3231,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,10,MTT,TetrazoliumSalt,85.385,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3232,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,50,MTT,TetrazoliumSalt,87.538,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3233,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,6,100,MTT,TetrazoliumSalt,80,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3234,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,0.1,MTT,TetrazoliumSalt,87.482,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3235,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,100,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3236,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,88.326,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3237,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,85.654,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3238,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,76.371,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3239,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,0.1,MTT,TetrazoliumSalt,41.739,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3240,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,76.377,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3241,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,84.348,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3242,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,50,MTT,TetrazoliumSalt,74.783,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3243,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,A,Mouse,Skin,Fibroblast,Adult,48,100,MTT,TetrazoliumSalt,63.478,10.1080/01480545.2016.1199563,104,,28.33,,mDF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3244,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,6,0.1,MTT,TetrazoliumSalt,74.644,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3245,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,6,1,MTT,TetrazoliumSalt,74.217,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3246,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,6,10,MTT,TetrazoliumSalt,77.066,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3247,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,6,50,MTT,TetrazoliumSalt,78.49,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3248,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,6,100,MTT,TetrazoliumSalt,74.644,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3249,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,24,0.1,MTT,TetrazoliumSalt,45.416,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3250,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,50.776,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3251,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,52.186,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3252,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,52.609,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3253,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,48.801,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3254,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,48,0.1,MTT,TetrazoliumSalt,59.746,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3255,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,63.559,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3256,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,56.921,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3257,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,48,50,MTT,TetrazoliumSalt,51.695,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3258,C,Sphere,,Commercial,Negative,142,-37.4,10000,H,Human,Teeth,Fibroblast,Adult,48,100,MTT,TetrazoliumSalt,62.571,10.1080/01480545.2016.1199563,104,,34.64,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3259,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,6,0.1,MTT,TetrazoliumSalt,81.339,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3260,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,6,1,MTT,TetrazoliumSalt,78.775,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3261,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,6,10,MTT,TetrazoliumSalt,61.681,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3262,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,6,50,MTT,TetrazoliumSalt,55.84,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3263,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,6,100,MTT,TetrazoliumSalt,48.86,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3264,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,24,0.1,MTT,TetrazoliumSalt,39.21,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3265,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,42.172,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3266,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,47.814,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3267,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,45.98,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3268,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,38.787,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3269,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,48,0.1,MTT,TetrazoliumSalt,47.458,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3270,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,52.542,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3271,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,62.994,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3272,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,48,50,MTT,TetrazoliumSalt,50.282,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3273,C,Nanotube,,Commercial,Positive,112.9,12.9,10000,H,Human,Teeth,Fibroblast,Adult,48,100,MTT,TetrazoliumSalt,48.305,10.1080/01480545.2016.1199563,104,,9,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3274,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,6,0.1,MTT,TetrazoliumSalt,76.068,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3275,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,6,1,MTT,TetrazoliumSalt,100,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3276,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,6,10,MTT,TetrazoliumSalt,94.302,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3277,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,6,50,MTT,TetrazoliumSalt,95.726,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3278,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,6,100,MTT,TetrazoliumSalt,86.61,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3279,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,24,0.1,MTT,TetrazoliumSalt,49.647,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3280,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,24,1,MTT,TetrazoliumSalt,55.289,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3281,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,24,10,MTT,TetrazoliumSalt,53.032,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3282,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,24,50,MTT,TetrazoliumSalt,55.007,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3283,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,24,100,MTT,TetrazoliumSalt,51.622,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3284,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,48,0.1,MTT,TetrazoliumSalt,51.13,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3285,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,48,1,MTT,TetrazoliumSalt,52.119,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3286,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,48,10,MTT,TetrazoliumSalt,48.87,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3287,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,48,50,MTT,TetrazoliumSalt,43.644,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3288,Fe3O4,Sphere,,Commercial,Negative,316.6,-18.4,10000,H,Human,Teeth,Fibroblast,Adult,48,100,MTT,TetrazoliumSalt,39.831,10.1080/01480545.2016.1199563,104,,28.33,,hPDLF,Drug and Chemical Toxicology,Informa UK Limited,2016,"A comparative study on the<i>in vitro</i>cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles",FALSE,FALSE,closed,104_10.1080@01480545.2016.1199563.pdf,0
3289,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,6,MTT,TetrazoliumSalt,76.548,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3290,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,12.5,MTT,TetrazoliumSalt,61.924,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3291,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,25,MTT,TetrazoliumSalt,47.826,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3292,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,50,MTT,TetrazoliumSalt,41.765,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3293,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,100,MTT,TetrazoliumSalt,26.482,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3294,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,200,MTT,TetrazoliumSalt,11.726,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3295,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,6,MTT,TetrazoliumSalt,51.779,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3296,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,12.5,MTT,TetrazoliumSalt,46.245,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3297,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,25,MTT,TetrazoliumSalt,44.005,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3298,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,50,MTT,TetrazoliumSalt,31.094,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3299,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,100,MTT,TetrazoliumSalt,27.8,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3300,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,200,MTT,TetrazoliumSalt,18.05,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3301,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,6,MTT,TetrazoliumSalt,88.921,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3302,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,12.5,MTT,TetrazoliumSalt,73.381,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3303,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,25,MTT,TetrazoliumSalt,58.417,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3304,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,50,MTT,TetrazoliumSalt,45.755,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3305,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,100,MTT,TetrazoliumSalt,12.086,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3306,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,200,MTT,TetrazoliumSalt,0.14388,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3307,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,6,MTT,TetrazoliumSalt,74.82,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3308,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,12.5,MTT,TetrazoliumSalt,64.604,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3309,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,25,MTT,TetrazoliumSalt,53.669,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3310,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,50,MTT,TetrazoliumSalt,43.309,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3311,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,100,MTT,TetrazoliumSalt,4.6043,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3312,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,200,MTT,TetrazoliumSalt,2.446,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3313,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,6,AlamarBlue,AlamarBlue,70.014,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3314,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,12.5,AlamarBlue,AlamarBlue,63.989,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3315,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,25,AlamarBlue,AlamarBlue,51.076,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3316,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,50,AlamarBlue,AlamarBlue,40.459,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3317,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,100,AlamarBlue,AlamarBlue,24.534,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3318,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,200,AlamarBlue,AlamarBlue,8.4648,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3319,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,6,AlamarBlue,AlamarBlue,70.588,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3320,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,12.5,AlamarBlue,AlamarBlue,69.01,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3321,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,25,AlamarBlue,AlamarBlue,41.607,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3322,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,50,AlamarBlue,AlamarBlue,32.281,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3323,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,100,AlamarBlue,AlamarBlue,23.529,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3324,C,Nanotube,,Commercial,Negative,217.2,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,200,AlamarBlue,AlamarBlue,13.056,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3325,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,6,AlamarBlue,AlamarBlue,103.13,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3326,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,12.5,AlamarBlue,AlamarBlue,85.755,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3327,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,25,AlamarBlue,AlamarBlue,65.67,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3328,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,50,AlamarBlue,AlamarBlue,53.704,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3329,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,100,AlamarBlue,AlamarBlue,45.299,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3330,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,4,200,AlamarBlue,AlamarBlue,11.396,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3331,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,6,AlamarBlue,AlamarBlue,65.242,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3332,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,12.5,AlamarBlue,AlamarBlue,69.373,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3333,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,25,AlamarBlue,AlamarBlue,53.134,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3334,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,50,AlamarBlue,AlamarBlue,40.456,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3335,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,100,AlamarBlue,AlamarBlue,15.385,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3336,C,Nanotube,,Commercial,Negative,601.7,-13.005,500000,A,Rat,Lung,Macrophage,Adult,24,200,AlamarBlue,AlamarBlue,1.567,10.1002/jat.3765,105,,,,NR8383,Journal of Applied Toxicology,Wiley,2019,Single wall and multiwall carbon nanotubes induce different toxicological responses in rat alveolar macrophages,FALSE,TRUE,hybrid,105_nahle2019.pdf,1
3337,C,Sphere,,Commercial,,,,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,5,WST-1,,98.923,10.1371/journal.pone.0065756,106,,21,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3338,C,Sphere,,Commercial,,,,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,25,WST-1,,97.981,10.1371/journal.pone.0065756,106,,21,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3339,C,Sphere,,Commercial,,,,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,50,WST-1,,95.155,10.1371/journal.pone.0065756,106,,21,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3340,C,Sphere,,Commercial,,,,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,75,WST-1,,94.886,10.1371/journal.pone.0065756,106,,21,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3341,C,Sphere,,Commercial,,,,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,100,WST-1,,93.809,10.1371/journal.pone.0065756,106,,21,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3342,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,5,WST-1,,97.981,10.1371/journal.pone.0065756,106,,24.6,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3343,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,25,WST-1,,91.117,10.1371/journal.pone.0065756,106,,24.6,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3344,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,50,WST-1,,76.312,10.1371/journal.pone.0065756,106,,24.6,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3345,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,75,WST-1,,59.758,10.1371/journal.pone.0065756,106,,24.6,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3346,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,100,WST-1,,44.684,10.1371/journal.pone.0065756,106,,24.6,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3347,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,5,WST-1,,98.654,10.1371/journal.pone.0065756,106,,27.3,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3348,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,25,WST-1,,96.904,10.1371/journal.pone.0065756,106,,27.3,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3349,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,50,WST-1,,84.253,10.1371/journal.pone.0065756,106,,27.3,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3350,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,75,WST-1,,68.775,10.1371/journal.pone.0065756,106,,27.3,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3351,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,100,WST-1,,66.622,10.1371/journal.pone.0065756,106,,27.3,,RAW264.7,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3352,C,Sphere,,Commercial,,,,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,5,WST-1,,99.038,10.1371/journal.pone.0065756,106,,21,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3353,C,Sphere,,Commercial,,,,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,25,WST-1,,95.879,10.1371/journal.pone.0065756,106,,21,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3354,C,Sphere,,Commercial,,,,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,50,WST-1,,94.918,10.1371/journal.pone.0065756,106,,21,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3355,C,Sphere,,Commercial,,,,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,75,WST-1,,94.918,10.1371/journal.pone.0065756,106,,21,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3356,C,Sphere,,Commercial,,,,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,100,WST-1,,93.819,10.1371/journal.pone.0065756,106,,21,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3357,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,5,WST-1,,95.604,10.1371/journal.pone.0065756,106,,24.6,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3358,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,25,WST-1,,90.385,10.1371/journal.pone.0065756,106,,24.6,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3359,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,50,WST-1,,79.808,10.1371/journal.pone.0065756,106,,24.6,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3360,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,75,WST-1,,59.753,10.1371/journal.pone.0065756,106,,24.6,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3361,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,,-20.2,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,100,WST-1,,55.632,10.1371/journal.pone.0065756,106,,24.6,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3362,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,5,WST-1,,96.566,10.1371/journal.pone.0065756,106,,27.3,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3363,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,25,WST-1,,91.484,10.1371/journal.pone.0065756,106,,27.3,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3364,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,50,WST-1,,84.615,10.1371/journal.pone.0065756,106,,27.3,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3365,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,75,WST-1,,79.808,10.1371/journal.pone.0065756,106,,27.3,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3366,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-35.6,100000,A,Mouse,Peritoneal Cavity,Macrophage,Adult,24,100,WST-1,,62.637,10.1371/journal.pone.0065756,106,,27.3,,Macrophages,PLoS ONE,Public Library of Science (PLoS),2013,Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes,TRUE,TRUE,gold,106_jiang2013.pdf,1
3367,C,Nanotube,,Chemical Vapor Deposition,Negative,16.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,107.27,10.1093/toxsci/kfu260,107,,1.5,-9.72,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3368,C,Nanotube,,Chemical Vapor Deposition,Negative,16.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,96.364,10.1093/toxsci/kfu260,107,,1.5,-9.72,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3369,C,Nanotube,,Chemical Vapor Deposition,Negative,16.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,87.879,10.1093/toxsci/kfu260,107,,1.5,-9.72,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3370,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,15.7,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,90.909,10.1093/toxsci/kfu260,107,,1.5,-8.1,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3371,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,15.7,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,55.455,10.1093/toxsci/kfu260,107,,1.5,-8.1,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3372,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,15.7,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,35.455,10.1093/toxsci/kfu260,107,,1.5,-8.1,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3373,C,Nanotube,,Chemical Vapor Deposition,Negative,26.8,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,100,10.1093/toxsci/kfu260,107,,8,-6.96,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3374,C,Nanotube,,Chemical Vapor Deposition,Negative,26.8,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,82.424,10.1093/toxsci/kfu260,107,,8,-6.96,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3375,C,Nanotube,,Chemical Vapor Deposition,Negative,26.8,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,56.364,10.1093/toxsci/kfu260,107,,8,-6.96,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3376,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,16.3,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,95.152,10.1093/toxsci/kfu260,107,,8,-9.64,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3377,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,16.3,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,87.879,10.1093/toxsci/kfu260,107,,8,-9.64,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3378,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,16.3,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,76.364,10.1093/toxsci/kfu260,107,,8,-9.64,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3379,C,Nanotube,,Chemical Vapor Deposition,Negative,124.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,105.76,10.1093/toxsci/kfu260,107,,25,-9.78,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3380,C,Nanotube,,Chemical Vapor Deposition,Negative,124.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,99.091,10.1093/toxsci/kfu260,107,,25,-9.78,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3381,C,Nanotube,,Chemical Vapor Deposition,Negative,124.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,100.3,10.1093/toxsci/kfu260,107,,25,-9.78,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3382,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,38.8,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,101.21,10.1093/toxsci/kfu260,107,,25,-10.3,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3383,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,38.8,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,91.818,10.1093/toxsci/kfu260,107,,25,-10.3,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3384,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,38.8,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,75.152,10.1093/toxsci/kfu260,107,,25,-10.3,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3385,C,Nanotube,,Chemical Vapor Deposition,Negative,51.9,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,109.09,10.1093/toxsci/kfu260,107,,50,-7.28,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3386,C,Nanotube,,Chemical Vapor Deposition,Negative,51.9,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,98.182,10.1093/toxsci/kfu260,107,,50,-7.28,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3387,C,Nanotube,,Chemical Vapor Deposition,Negative,51.9,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,101.82,10.1093/toxsci/kfu260,107,,50,-7.28,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3388,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,50.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,50,MTS,,95.152,10.1093/toxsci/kfu260,107,,50,-11,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3389,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,50.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,100,MTS,,91.818,10.1093/toxsci/kfu260,107,,50,-11,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3390,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,50.4,,16000,A,Hamster,Lung,Fibroblast,Adult,24,200,MTS,,79.394,10.1093/toxsci/kfu260,107,,50,-11,V79,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3391,C,Nanotube,,Chemical Vapor Deposition,Negative,16.4,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,100.3,10.1093/toxsci/kfu260,107,,1.5,-9.72,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3392,C,Nanotube,,Chemical Vapor Deposition,Negative,16.4,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,90.719,10.1093/toxsci/kfu260,107,,1.5,-9.72,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3393,C,Nanotube,,Chemical Vapor Deposition,Negative,16.4,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,87.126,10.1093/toxsci/kfu260,107,,1.5,-9.72,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3394,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,15.7,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,89.222,10.1093/toxsci/kfu260,107,,1.5,-8.1,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3395,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,15.7,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,84.431,10.1093/toxsci/kfu260,107,,1.5,-8.1,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3396,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,15.7,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,61.078,10.1093/toxsci/kfu260,107,,1.5,-8.1,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3397,C,Nanotube,,Chemical Vapor Deposition,Negative,26.8,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,99.401,10.1093/toxsci/kfu260,107,,8,-6.96,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3398,C,Nanotube,,Chemical Vapor Deposition,Negative,26.8,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,94.91,10.1093/toxsci/kfu260,107,,8,-6.96,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3399,C,Nanotube,,Chemical Vapor Deposition,Negative,26.8,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,87.725,10.1093/toxsci/kfu260,107,,8,-6.96,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3400,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,16.3,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,102.99,10.1093/toxsci/kfu260,107,,8,-9.64,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3401,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,16.3,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,94.91,10.1093/toxsci/kfu260,107,,8,-9.64,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3402,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,16.3,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,70.659,10.1093/toxsci/kfu260,107,,8,-9.64,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3403,C,Nanotube,,Chemical Vapor Deposition,Negative,124.4,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,100.3,10.1093/toxsci/kfu260,107,,25,-9.78,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3404,C,Nanotube,,Chemical Vapor Deposition,Negative,124.4,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,90.719,10.1093/toxsci/kfu260,107,,25,-9.78,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3405,C,Nanotube,,Chemical Vapor Deposition,Negative,124.4,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,90.12,10.1093/toxsci/kfu260,107,,25,-9.78,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3406,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,38.8,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,95.509,10.1093/toxsci/kfu260,107,,25,-10.3,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3407,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,38.8,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,92.515,10.1093/toxsci/kfu260,107,,25,-10.3,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3408,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,38.8,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,80.838,10.1093/toxsci/kfu260,107,,25,-10.3,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3409,C,Nanotube,,Chemical Vapor Deposition,Negative,51.9,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,98.204,10.1093/toxsci/kfu260,107,,50,-7.28,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3410,C,Nanotube,,Chemical Vapor Deposition,Negative,51.9,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,93.114,10.1093/toxsci/kfu260,107,,50,-7.28,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3411,C,Nanotube,,Chemical Vapor Deposition,Negative,51.9,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,93.114,10.1093/toxsci/kfu260,107,,50,-7.28,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3412,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,50.4,,12000,H,Human,Lung,Epithelial,Adult,24,50,MTS,,96.407,10.1093/toxsci/kfu260,107,,50,-11,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3413,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,50.4,,12000,H,Human,Lung,Epithelial,Adult,24,100,MTS,,98.204,10.1093/toxsci/kfu260,107,,50,-11,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3414,C,Nanotube,COOH,Chemical Vapor Deposition,Negative,50.4,,12000,H,Human,Lung,Epithelial,Adult,24,200,MTS,,86.228,10.1093/toxsci/kfu260,107,,50,-11,A549,Toxicological Sciences,Oxford University Press (OUP),2014,Carboxylated Short Single-Walled Carbon Nanotubes But Not Plain and Multi-Walled Short Carbon Nanotubes Show in vitro Genotoxicity,FALSE,TRUE,green,107_mrakovcic2014.pdf,1
3415,C,Nanotube,,Commercial,Negative,304.9,-9.48,40000,H,Human,Umbilical Vein,Endothelial,,24,4,CCK-8,,94.479,10.1016/j.fct.2019.02.026,108,,10.33,-8.7,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3416,C,Nanotube,,Commercial,Negative,304.9,-9.48,40000,H,Human,Umbilical Vein,Endothelial,,24,8,CCK-8,,94.479,10.1016/j.fct.2019.02.026,108,,10.33,-8.7,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3417,C,Nanotube,,Commercial,Negative,304.9,-9.48,40000,H,Human,Umbilical Vein,Endothelial,,24,16,CCK-8,,84.227,10.1016/j.fct.2019.02.026,108,,10.33,-8.7,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3418,C,Nanotube,,Commercial,Negative,304.9,-9.48,40000,H,Human,Umbilical Vein,Endothelial,,24,32,CCK-8,,82.019,10.1016/j.fct.2019.02.026,108,,10.33,-8.7,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3419,C,Nanotube,,Commercial,Negative,304.9,-9.48,40000,H,Human,Umbilical Vein,Endothelial,,24,64,CCK-8,,63.249,10.1016/j.fct.2019.02.026,108,,10.33,-8.7,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3420,C,Nanotube,,Commercial,Negative,205.9,-8.02,40000,H,Human,Umbilical Vein,Endothelial,,24,4,CCK-8,,93.533,10.1016/j.fct.2019.02.026,108,,21.55,-21.47,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3421,C,Nanotube,,Commercial,Negative,205.9,-8.02,40000,H,Human,Umbilical Vein,Endothelial,,24,8,CCK-8,,95.741,10.1016/j.fct.2019.02.026,108,,21.55,-21.47,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3422,C,Nanotube,,Commercial,Negative,205.9,-8.02,40000,H,Human,Umbilical Vein,Endothelial,,24,16,CCK-8,,89.432,10.1016/j.fct.2019.02.026,108,,21.55,-21.47,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3423,C,Nanotube,,Commercial,Negative,205.9,-8.02,40000,H,Human,Umbilical Vein,Endothelial,,24,32,CCK-8,,91.325,10.1016/j.fct.2019.02.026,108,,21.55,-21.47,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3424,C,Nanotube,,Commercial,Negative,205.9,-8.02,40000,H,Human,Umbilical Vein,Endothelial,,24,64,CCK-8,,78.707,10.1016/j.fct.2019.02.026,108,,21.55,-21.47,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3425,C,Nanotube,,Commercial,Negative,205.9,-8.57,40000,H,Human,Umbilical Vein,Endothelial,,24,4,CCK-8,,98.107,10.1016/j.fct.2019.02.026,108,,38.8,-25.1,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3426,C,Nanotube,,Commercial,Negative,205.9,-8.57,40000,H,Human,Umbilical Vein,Endothelial,,24,8,CCK-8,,98.738,10.1016/j.fct.2019.02.026,108,,38.8,-25.1,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3427,C,Nanotube,,Commercial,Negative,205.9,-8.57,40000,H,Human,Umbilical Vein,Endothelial,,24,16,CCK-8,,95.426,10.1016/j.fct.2019.02.026,108,,38.8,-25.1,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3428,C,Nanotube,,Commercial,Negative,205.9,-8.57,40000,H,Human,Umbilical Vein,Endothelial,,24,32,CCK-8,,96.845,10.1016/j.fct.2019.02.026,108,,38.8,-25.1,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3429,C,Nanotube,,Commercial,Negative,205.9,-8.57,40000,H,Human,Umbilical Vein,Endothelial,,24,64,CCK-8,,98.738,10.1016/j.fct.2019.02.026,108,,38.8,-25.1,HUVEC,Food and Chemical Toxicology,Elsevier BV,2019,The toxicity of multi-walled carbon nanotubes (MWCNTs) to human endothelial cells: The influence of diameters of MWCNTs,FALSE,FALSE,closed,108_10.1016@j.fct.2019.02.026.pdf,0
3430,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,2,CCK-8,TetrazoliumSalt,97.09,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3431,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,4,CCK-8,TetrazoliumSalt,95.865,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3432,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,8,CCK-8,TetrazoliumSalt,92.496,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3433,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,16,CCK-8,TetrazoliumSalt,90.812,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3434,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,32,CCK-8,TetrazoliumSalt,85.452,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3435,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,2,CCK-8,TetrazoliumSalt,92.496,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3436,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,4,CCK-8,TetrazoliumSalt,93.262,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3437,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,8,CCK-8,TetrazoliumSalt,89.587,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3438,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,16,CCK-8,TetrazoliumSalt,85.911,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3439,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,32,CCK-8,TetrazoliumSalt,81.317,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3440,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,2,NRU,NeutralRed,101.23,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3441,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,4,NRU,NeutralRed,104.63,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3442,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,8,NRU,NeutralRed,104.63,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3443,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,16,NRU,NeutralRed,102.47,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3444,C,Nanotube,,Commercial,Neutral,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,32,NRU,NeutralRed,107.1,10.1186/s12951-017-0318-x,109,,17.6,0.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3445,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,2,NRU,NeutralRed,100.46,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3446,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,4,NRU,NeutralRed,99.691,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3447,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,8,NRU,NeutralRed,100,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3448,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,16,NRU,NeutralRed,96.296,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3449,C,Nanotube,,Commercial,Negative,,,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,32,NRU,NeutralRed,86.883,10.1186/s12951-017-0318-x,109,,17.4,-18.9,HUVEC,Journal of Nanobiotechnology,Springer Science and Business Media LLC,2017,The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs,TRUE,TRUE,gold,109_long2017.pdf,1
3450,C,Sphere,,Explosion,Negative,,,10000,H,Human,Brain,,,2,20,MTT,TetrazoliumSalt,98.956,10.1371/journal.pone.0122579,110,,4,-35.6,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3451,C,Sphere,,Explosion,Negative,,,10000,H,Human,Brain,,,2,50,MTT,TetrazoliumSalt,100.42,10.1371/journal.pone.0122579,110,,4,-35.6,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3452,C,Sphere,,Explosion,Negative,,,10000,H,Human,Brain,,,2,100,MTT,TetrazoliumSalt,102.92,10.1371/journal.pone.0122579,110,,4,-35.6,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3453,C,Sphere,,Explosion,Positive,,,10000,H,Human,Brain,,,2,20,MTT,TetrazoliumSalt,70.146,10.1371/journal.pone.0122579,110,,4,31.4,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3454,C,Sphere,,Explosion,Positive,,,10000,H,Human,Brain,,,2,50,MTT,TetrazoliumSalt,78.288,10.1371/journal.pone.0122579,110,,4,31.4,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3455,C,Sphere,,Explosion,Positive,,,10000,H,Human,Brain,,,2,100,MTT,TetrazoliumSalt,66.806,10.1371/journal.pone.0122579,110,,4,31.4,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3456,C,Sphere,,Explosion,Negative,,,30000,H,Human,Liver,,,2,20,MTT,TetrazoliumSalt,113.14,10.1371/journal.pone.0122579,110,,4,-35.6,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3457,C,Sphere,,Explosion,Negative,,,30000,H,Human,Liver,,,2,50,MTT,TetrazoliumSalt,118.48,10.1371/journal.pone.0122579,110,,4,-35.6,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3458,C,Sphere,,Explosion,Negative,,,30000,H,Human,Liver,,,2,100,MTT,TetrazoliumSalt,113.14,10.1371/journal.pone.0122579,110,,4,-35.6,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3459,C,Sphere,,Explosion,Positive,,,30000,H,Human,Liver,,,2,20,MTT,TetrazoliumSalt,89.528,10.1371/journal.pone.0122579,110,,4,31.4,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3460,C,Sphere,,Explosion,Positive,,,30000,H,Human,Liver,,,2,50,MTT,TetrazoliumSalt,110.06,10.1371/journal.pone.0122579,110,,4,31.4,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3461,C,Sphere,,Explosion,Positive,,,30000,H,Human,Liver,,,2,100,MTT,TetrazoliumSalt,99.179,10.1371/journal.pone.0122579,110,,4,31.4,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3462,C,Sphere,,Explosion,Negative,,,10000,H,Human,Brain,,,24,20,MTT,TetrazoliumSalt,90.947,10.1371/journal.pone.0122579,110,,4,-35.6,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3463,C,Sphere,,Explosion,Negative,,,10000,H,Human,Brain,,,24,50,MTT,TetrazoliumSalt,96.091,10.1371/journal.pone.0122579,110,,4,-35.6,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3464,C,Sphere,,Explosion,Negative,,,10000,H,Human,Brain,,,24,100,MTT,TetrazoliumSalt,103.09,10.1371/journal.pone.0122579,110,,4,-35.6,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3465,C,Sphere,,Explosion,Positive,,,10000,H,Human,Brain,,,24,20,MTT,TetrazoliumSalt,75.309,10.1371/journal.pone.0122579,110,,4,31.4,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3466,C,Sphere,,Explosion,Positive,,,10000,H,Human,Brain,,,24,50,MTT,TetrazoliumSalt,68.724,10.1371/journal.pone.0122579,110,,4,31.4,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3467,C,Sphere,,Explosion,Positive,,,10000,H,Human,Brain,,,24,100,MTT,TetrazoliumSalt,57.613,10.1371/journal.pone.0122579,110,,4,31.4,U87,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3468,C,Sphere,,Explosion,Negative,,,30000,H,Human,Liver,,,24,20,MTT,TetrazoliumSalt,100.85,10.1371/journal.pone.0122579,110,,4,-35.6,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3469,C,Sphere,,Explosion,Negative,,,30000,H,Human,Liver,,,24,50,MTT,TetrazoliumSalt,106.13,10.1371/journal.pone.0122579,110,,4,-35.6,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3470,C,Sphere,,Explosion,Negative,,,30000,H,Human,Liver,,,24,100,MTT,TetrazoliumSalt,110.36,10.1371/journal.pone.0122579,110,,4,-35.6,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3471,C,Sphere,,Explosion,Positive,,,30000,H,Human,Liver,,,24,20,MTT,TetrazoliumSalt,103.81,10.1371/journal.pone.0122579,110,,4,31.4,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3472,C,Sphere,,Explosion,Positive,,,30000,H,Human,Liver,,,24,50,MTT,TetrazoliumSalt,101.27,10.1371/journal.pone.0122579,110,,4,31.4,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3473,C,Sphere,,Explosion,Positive,,,30000,H,Human,Liver,,,24,100,MTT,TetrazoliumSalt,96.617,10.1371/journal.pone.0122579,110,,4,31.4,C3A,PLOS ONE,Public Library of Science (PLoS),2015,"Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines",TRUE,TRUE,gold,110_zakrzewska2015.pdf,1
3474,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,0.2,MTS,TetrazoliumSalt,86.637,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3475,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,0.4,MTS,TetrazoliumSalt,90.869,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3476,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,2,MTS,TetrazoliumSalt,88.864,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3477,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,4,MTS,TetrazoliumSalt,91.537,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3478,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,20,MTS,TetrazoliumSalt,89.755,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3479,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,40,MTS,TetrazoliumSalt,89.755,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3480,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,200,MTS,TetrazoliumSalt,89.31,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3481,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,24,400,MTS,TetrazoliumSalt,69.71,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3482,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,0.2,MTS,TetrazoliumSalt,89.978,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3483,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,0.4,MTS,TetrazoliumSalt,96.659,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3484,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,2,MTS,TetrazoliumSalt,112.25,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3485,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,4,MTS,TetrazoliumSalt,104.9,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3486,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,20,MTS,TetrazoliumSalt,103.34,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3487,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,40,MTS,TetrazoliumSalt,109.13,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3488,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,200,MTS,TetrazoliumSalt,110.47,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3489,Ag,Rod,,EBPVD,Negative,,-29.3,5000,H,Human,Skin,Fibroblast,,96,400,MTS,TetrazoliumSalt,45.88,10.1002/jbm.a.35518,111,,47,-34.1,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3490,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,0.2,MTS,TetrazoliumSalt,72.444,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3491,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,0.4,MTS,TetrazoliumSalt,83.778,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3492,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,2,MTS,TetrazoliumSalt,75.778,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3493,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,4,MTS,TetrazoliumSalt,89.111,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3494,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,20,MTS,TetrazoliumSalt,86,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3495,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,40,MTS,TetrazoliumSalt,90.889,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3496,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,200,MTS,TetrazoliumSalt,83.333,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3497,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,24,400,MTS,TetrazoliumSalt,79.556,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3498,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,0.2,MTS,TetrazoliumSalt,77.333,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3499,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,0.4,MTS,TetrazoliumSalt,80.444,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3500,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,2,MTS,TetrazoliumSalt,83.111,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3501,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,4,MTS,TetrazoliumSalt,72.444,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3502,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,20,MTS,TetrazoliumSalt,77.333,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3503,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,40,MTS,TetrazoliumSalt,77.556,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3504,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,200,MTS,TetrazoliumSalt,83.556,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3505,Au,Rod,,EBPVD,Negative,,-32.8,5000,H,Human,Skin,Fibroblast,,96,400,MTS,TetrazoliumSalt,62,10.1002/jbm.a.35518,111,,65,-23.3,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3506,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,24,0.5,MTS,TetrazoliumSalt,116.19,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3507,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,24,1,MTS,TetrazoliumSalt,109.29,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3508,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,24,5,MTS,TetrazoliumSalt,109.29,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3509,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,24,10,MTS,TetrazoliumSalt,118.57,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3510,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,96,0.5,MTS,TetrazoliumSalt,102.86,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3511,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,96,1,MTS,TetrazoliumSalt,101.43,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3512,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,96,5,MTS,TetrazoliumSalt,43.571,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3513,Ag,Sphere,Citrate,Commercial,Negative,,-23,5000,H,Human,Skin,Fibroblast,,96,10,MTS,TetrazoliumSalt,4.7619,10.1002/jbm.a.35518,111,,39.94,-23.5,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3514,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,0.5,MTS,TetrazoliumSalt,91.608,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3515,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,1,MTS,TetrazoliumSalt,94.172,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3516,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,5,MTS,TetrazoliumSalt,107.46,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3517,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,10,MTS,TetrazoliumSalt,79.254,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3518,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,15,MTS,TetrazoliumSalt,92.541,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3519,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,20,MTS,TetrazoliumSalt,70.163,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3520,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,24,25,MTS,TetrazoliumSalt,62.704,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3521,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,0.5,MTS,TetrazoliumSalt,126.34,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3522,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,1,MTS,TetrazoliumSalt,126.34,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3523,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,5,MTS,TetrazoliumSalt,111.89,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3524,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,10,MTS,TetrazoliumSalt,113.05,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3525,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,15,MTS,TetrazoliumSalt,100.7,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3526,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,20,MTS,TetrazoliumSalt,71.562,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3527,Au,Sphere,Citrate,Commercial,Negative,,-28.4,5000,H,Human,Skin,Fibroblast,,96,25,MTS,TetrazoliumSalt,40.093,10.1002/jbm.a.35518,111,,61.06,-32.7,CCL-110,Journal of Biomedical Materials Research Part A,Wiley,2015,Shape and surface chemistry effects on the cytotoxicity and cellular uptake of metallic nanorods and nanospheres,FALSE,FALSE,closed,111_favi2015.pdf,0
3528,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,25,AlamarBlue,AlamarBlue,100.34,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3529,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,50,AlamarBlue,AlamarBlue,64.655,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3530,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,100,AlamarBlue,AlamarBlue,33.966,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3531,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,200,AlamarBlue,AlamarBlue,23.103,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3532,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,400,AlamarBlue,AlamarBlue,9.1379,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3533,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,600,AlamarBlue,AlamarBlue,5.1724,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3534,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,800,AlamarBlue,AlamarBlue,6.7241,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3535,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,1000,AlamarBlue,AlamarBlue,4.4828,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3536,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,25,AlamarBlue,AlamarBlue,61.897,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3537,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,50,AlamarBlue,AlamarBlue,38.103,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3538,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,100,AlamarBlue,AlamarBlue,22.069,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3539,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,200,AlamarBlue,AlamarBlue,14.31,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3540,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,400,AlamarBlue,AlamarBlue,9.1379,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3541,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,600,AlamarBlue,AlamarBlue,4.8276,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3542,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,800,AlamarBlue,AlamarBlue,5.1724,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3543,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,1000,AlamarBlue,AlamarBlue,3.7931,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3544,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,25,AlamarBlue,AlamarBlue,54.828,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3545,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,50,AlamarBlue,AlamarBlue,35,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3546,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,100,AlamarBlue,AlamarBlue,16.724,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3547,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,200,AlamarBlue,AlamarBlue,8.1034,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3548,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,400,AlamarBlue,AlamarBlue,4.4828,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3549,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,600,AlamarBlue,AlamarBlue,4.4828,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3550,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,800,AlamarBlue,AlamarBlue,3.7931,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3551,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,1000,AlamarBlue,AlamarBlue,2.7586,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3552,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,20,AlamarBlue,AlamarBlue,92.346,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3553,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,40,AlamarBlue,AlamarBlue,57.571,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3554,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,60,AlamarBlue,AlamarBlue,50.749,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3555,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,80,AlamarBlue,AlamarBlue,48.087,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3556,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,100,AlamarBlue,AlamarBlue,40.1,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3557,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,150,AlamarBlue,AlamarBlue,38.769,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3558,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,200,AlamarBlue,AlamarBlue,36.439,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3559,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,250,AlamarBlue,AlamarBlue,32.113,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3560,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,20,AlamarBlue,AlamarBlue,31.448,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3561,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,40,AlamarBlue,AlamarBlue,10.649,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3562,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,60,AlamarBlue,AlamarBlue,1.9967,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3563,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,80,AlamarBlue,AlamarBlue,1.6639,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3564,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,100,AlamarBlue,AlamarBlue,0.99834,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3565,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,150,AlamarBlue,AlamarBlue,0.66556,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3566,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,200,AlamarBlue,AlamarBlue,0,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3567,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,250,AlamarBlue,AlamarBlue,0,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3568,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,20,AlamarBlue,AlamarBlue,15.308,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3569,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,40,AlamarBlue,AlamarBlue,7.9867,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3570,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,60,AlamarBlue,AlamarBlue,1.9967,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3571,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,80,AlamarBlue,AlamarBlue,0.99834,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3572,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,100,AlamarBlue,AlamarBlue,0.99834,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3573,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,150,AlamarBlue,AlamarBlue,0,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3574,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,200,AlamarBlue,AlamarBlue,0,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3575,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,250,AlamarBlue,AlamarBlue,0,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3576,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,25,NRU,NeutralRed,112.01,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3577,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,50,NRU,NeutralRed,68.1,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3578,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,100,NRU,NeutralRed,41.756,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3579,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,200,NRU,NeutralRed,38.53,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3580,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,400,NRU,NeutralRed,34.229,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3581,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,600,NRU,NeutralRed,34.946,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3582,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,800,NRU,NeutralRed,35.305,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3583,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,1000,NRU,NeutralRed,34.946,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3584,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,25,NRU,NeutralRed,104.48,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3585,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,50,NRU,NeutralRed,65.412,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3586,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,100,NRU,NeutralRed,39.247,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3587,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,200,NRU,NeutralRed,28.315,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3588,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,400,NRU,NeutralRed,24.014,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3589,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,600,NRU,NeutralRed,24.014,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3590,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,800,NRU,NeutralRed,21.505,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3591,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,1000,NRU,NeutralRed,22.939,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3592,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,25,NRU,NeutralRed,92.115,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3593,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,50,NRU,NeutralRed,46.595,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3594,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,100,NRU,NeutralRed,25.448,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3595,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,200,NRU,NeutralRed,20.43,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3596,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,400,NRU,NeutralRed,18.996,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3597,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,600,NRU,NeutralRed,20.43,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3598,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,800,NRU,NeutralRed,21.505,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3599,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,1000,NRU,NeutralRed,22.939,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3600,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,20,NRU,NeutralRed,86.111,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3601,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,40,NRU,NeutralRed,71.759,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3602,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,60,NRU,NeutralRed,67.284,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3603,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,80,NRU,NeutralRed,66.358,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3604,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,100,NRU,NeutralRed,61.265,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3605,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,150,NRU,NeutralRed,53.395,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3606,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,200,NRU,NeutralRed,49.846,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3607,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,250,NRU,NeutralRed,43.519,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3608,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,20,NRU,NeutralRed,48.92,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3609,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,40,NRU,NeutralRed,45.833,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3610,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,60,NRU,NeutralRed,33.642,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3611,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,80,NRU,NeutralRed,30.864,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3612,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,100,NRU,NeutralRed,29.167,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3613,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,150,NRU,NeutralRed,26.389,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3614,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,200,NRU,NeutralRed,27.623,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3615,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,250,NRU,NeutralRed,22.222,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3616,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,20,NRU,NeutralRed,45.062,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3617,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,40,NRU,NeutralRed,40.741,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3618,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,60,NRU,NeutralRed,30.864,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3619,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,80,NRU,NeutralRed,27.932,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3620,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,100,NRU,NeutralRed,27.623,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3621,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,150,NRU,NeutralRed,25.463,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3622,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,200,NRU,NeutralRed,25.463,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3623,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,250,NRU,NeutralRed,20.37,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3624,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,25,MTT,TetrazoliumSalt,70.14,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3625,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,50,MTT,TetrazoliumSalt,60.342,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3626,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,100,MTT,TetrazoliumSalt,18.663,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3627,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,200,MTT,TetrazoliumSalt,11.975,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3628,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,400,MTT,TetrazoliumSalt,6.5319,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3629,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,600,MTT,TetrazoliumSalt,8.2426,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3630,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,800,MTT,TetrazoliumSalt,11.042,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3631,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,24,1000,MTT,TetrazoliumSalt,11.353,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3632,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,25,MTT,TetrazoliumSalt,59.72,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3633,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,50,MTT,TetrazoliumSalt,43.079,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3634,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,100,MTT,TetrazoliumSalt,20.218,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3635,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,200,MTT,TetrazoliumSalt,8.8647,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3636,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,400,MTT,TetrazoliumSalt,4.3546,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3637,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,600,MTT,TetrazoliumSalt,4.3546,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3638,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,800,MTT,TetrazoliumSalt,5.9098,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3639,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,48,1000,MTT,TetrazoliumSalt,7.3095,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3640,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,25,MTT,TetrazoliumSalt,55.21,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3641,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,50,MTT,TetrazoliumSalt,38.103,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3642,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,100,MTT,TetrazoliumSalt,17.729,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3643,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,200,MTT,TetrazoliumSalt,5.9098,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3644,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,400,MTT,TetrazoliumSalt,4.9767,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3645,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,600,MTT,TetrazoliumSalt,4.9767,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3646,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,800,MTT,TetrazoliumSalt,6.5319,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3647,Ag,Sphere,,Commercial,Negative,68.55,-15.83,10000,H,Human,Skin,Keratinocyte,Adult,72,1000,MTT,TetrazoliumSalt,9.4868,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HaCat,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3648,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,20,MTT,TetrazoliumSalt,101.44,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3649,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,40,MTT,TetrazoliumSalt,61.798,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3650,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,60,MTT,TetrazoliumSalt,59.23,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3651,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,80,MTT,TetrazoliumSalt,18.78,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3652,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,16.533,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3653,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,150,MTT,TetrazoliumSalt,13.483,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3654,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,12.841,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3655,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,24,250,MTT,TetrazoliumSalt,11.236,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3656,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,20,MTT,TetrazoliumSalt,9.6308,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3657,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,40,MTT,TetrazoliumSalt,8.6677,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3658,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,60,MTT,TetrazoliumSalt,7.3836,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3659,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,80,MTT,TetrazoliumSalt,6.4205,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3660,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,4.8154,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3661,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,150,MTT,TetrazoliumSalt,4.4944,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3662,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,200,MTT,TetrazoliumSalt,4.4944,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3663,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,48,250,MTT,TetrazoliumSalt,4.4944,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3664,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,20,MTT,TetrazoliumSalt,7.3836,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3665,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,40,MTT,TetrazoliumSalt,7.7047,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3666,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,60,MTT,TetrazoliumSalt,5.7785,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3667,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,80,MTT,TetrazoliumSalt,4.8154,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3668,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,100,MTT,TetrazoliumSalt,2.8892,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3669,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,150,MTT,TetrazoliumSalt,2.5682,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3670,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,200,MTT,TetrazoliumSalt,3.5313,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3671,Ag,Sphere,,Commercial,Negative,65.45,-20.67,10000,H,Human,Cervix,Epithelial,Adult,72,250,MTT,TetrazoliumSalt,3.8523,10.1016/j.tiv.2011.12.004,112,,29.57,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
3672,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,24,0.5,MTT,TetrazoliumSalt,87.183,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3673,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,86.44,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3674,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,84.582,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3675,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,48,0.5,MTT,TetrazoliumSalt,77.523,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3676,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,48,2,MTT,TetrazoliumSalt,72.693,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3677,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,48,4,MTT,TetrazoliumSalt,65.263,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3678,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,72,0.5,MTT,TetrazoliumSalt,75.294,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3679,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,72,2,MTT,TetrazoliumSalt,50.217,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3680,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Cervix,Epithelial,Adult,72,4,MTT,TetrazoliumSalt,42.229,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3681,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,24,0.5,MTT,TetrazoliumSalt,93.499,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3682,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,87.74,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3683,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,86.44,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3684,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,48,0.5,MTT,TetrazoliumSalt,92.941,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3685,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,48,2,MTT,TetrazoliumSalt,83.653,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3686,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,48,4,MTT,TetrazoliumSalt,78.824,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3687,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,72,0.5,MTT,TetrazoliumSalt,90.712,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3688,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,72,2,MTT,TetrazoliumSalt,80.31,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3689,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Cervix,Epithelial,Adult,72,4,MTT,TetrazoliumSalt,71.022,10.1016/j.toxrep.2014.11.002,113,,8,11,HeLa,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3690,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,0.5,MTT,TetrazoliumSalt,97.447,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3691,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,94.681,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3692,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,91.277,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3693,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,48,0.5,MTT,TetrazoliumSalt,92.766,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3694,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,48,2,MTT,TetrazoliumSalt,80.426,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3695,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,48,4,MTT,TetrazoliumSalt,63.404,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3696,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,72,0.5,MTT,TetrazoliumSalt,85.745,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3697,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,72,2,MTT,TetrazoliumSalt,71.915,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3698,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Lung,Epithelial,Adult,72,4,MTT,TetrazoliumSalt,45.319,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3699,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,24,0.5,MTT,TetrazoliumSalt,100,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3700,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,95.532,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3701,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,24,4,MTT,TetrazoliumSalt,93.192,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3702,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,48,0.5,MTT,TetrazoliumSalt,96.596,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3703,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,48,2,MTT,TetrazoliumSalt,90.426,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3704,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,48,4,MTT,TetrazoliumSalt,83.191,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3705,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,72,0.5,MTT,TetrazoliumSalt,92.34,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3706,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,72,2,MTT,TetrazoliumSalt,88.085,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3707,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Lung,Epithelial,Adult,72,4,MTT,TetrazoliumSalt,74.468,10.1016/j.toxrep.2014.11.002,113,,8,11,A549,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3708,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Kidney,Epithelial,Embryonic,24,0.5,MTT,TetrazoliumSalt,93.8,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3709,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Kidney,Epithelial,Embryonic,24,2,MTT,TetrazoliumSalt,88.875,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3710,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Kidney,Epithelial,Embryonic,24,4,MTT,TetrazoliumSalt,74.468,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3711,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Kidney,Epithelial,Embryonic,48,0.5,MTT,TetrazoliumSalt,87.052,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3712,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Kidney,Epithelial,Embryonic,48,2,MTT,TetrazoliumSalt,75.198,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3713,Fe3O4,Sphere,,Pyrolysis,Negative,,,100000,H,Human,Kidney,Epithelial,Embryonic,48,4,MTT,TetrazoliumSalt,67.173,10.1016/j.toxrep.2014.11.002,113,,6,-36.5,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3714,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Kidney,Epithelial,Embryonic,24,0.5,MTT,TetrazoliumSalt,98.9,10.1016/j.toxrep.2014.11.002,113,,8,11,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3715,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Kidney,Epithelial,Embryonic,24,2,MTT,TetrazoliumSalt,97.629,10.1016/j.toxrep.2014.11.002,113,,8,11,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3716,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Kidney,Epithelial,Embryonic,24,4,MTT,TetrazoliumSalt,95.988,10.1016/j.toxrep.2014.11.002,113,,8,11,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3717,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Kidney,Epithelial,Embryonic,48,0.5,MTT,TetrazoliumSalt,98.941,10.1016/j.toxrep.2014.11.002,113,,8,11,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3718,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Kidney,Epithelial,Embryonic,48,2,MTT,TetrazoliumSalt,97.629,10.1016/j.toxrep.2014.11.002,113,,8,11,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3719,Fe3O4,Sphere,Chitosan,Pyrolysis,Positive,,,100000,H,Human,Kidney,Epithelial,Embryonic,48,4,MTT,TetrazoliumSalt,95.076,10.1016/j.toxrep.2014.11.002,113,,8,11,HEK293,Toxicology Reports,Elsevier BV,2015,In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles,TRUE,TRUE,gold,113_shukla2015.pdf,1
3720,C,Nanotube,,Commercial,Negative,201.1,-26.03,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,8,CCK-8,TetrazoliumSalt,93.005,10.1016/j.ecoenv.2018.06.025,114,,25,-28.4,HUVEC,Ecotoxicology and Environmental Safety,Elsevier BV,2018,"Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes",FALSE,FALSE,closed,114_chang2018.pdf,0
3721,C,Nanotube,,Commercial,Negative,201.1,-26.03,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,32,CCK-8,TetrazoliumSalt,85.215,10.1016/j.ecoenv.2018.06.025,114,,25,-28.4,HUVEC,Ecotoxicology and Environmental Safety,Elsevier BV,2018,"Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes",FALSE,FALSE,closed,114_chang2018.pdf,0
3722,C,Nanotube,,Commercial,Negative,201.1,-26.03,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,128,CCK-8,TetrazoliumSalt,59.936,10.1016/j.ecoenv.2018.06.025,114,,25,-28.4,HUVEC,Ecotoxicology and Environmental Safety,Elsevier BV,2018,"Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes",FALSE,FALSE,closed,114_chang2018.pdf,0
3723,C,Nanotube,COOH,Commercial,Negative,221.9,-5.5,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,8,CCK-8,TetrazoliumSalt,81.24,10.1016/j.ecoenv.2018.06.025,114,,25,-5.63,HUVEC,Ecotoxicology and Environmental Safety,Elsevier BV,2018,"Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes",FALSE,FALSE,closed,114_chang2018.pdf,0
3724,C,Nanotube,COOH,Commercial,Negative,221.9,-5.5,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,32,CCK-8,TetrazoliumSalt,72.973,10.1016/j.ecoenv.2018.06.025,114,,25,-5.63,HUVEC,Ecotoxicology and Environmental Safety,Elsevier BV,2018,"Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes",FALSE,FALSE,closed,114_chang2018.pdf,0
3725,C,Nanotube,COOH,Commercial,Negative,221.9,-5.5,40000,H,Human,Umbilical Vein,Endothelial,Embryonic,24,128,CCK-8,TetrazoliumSalt,46.741,10.1016/j.ecoenv.2018.06.025,114,,25,-5.63,HUVEC,Ecotoxicology and Environmental Safety,Elsevier BV,2018,"Cytotoxicity, cytokine release and ER stress-autophagy gene expression in endothelial cells and alveolar-endothelial co-culture exposed to pristine and carboxylated multi-walled carbon nanotubes",FALSE,FALSE,closed,114_chang2018.pdf,0
3726,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,95.017,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3727,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,73.09,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3728,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,60.133,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3729,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,49.169,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3730,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,39.092,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3731,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,48,5,MTT,TetrazoliumSalt,93.245,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3732,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,48,10,MTT,TetrazoliumSalt,60.908,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3733,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,48,25,MTT,TetrazoliumSalt,47.841,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3734,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,48,50,MTT,TetrazoliumSalt,37.874,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3735,ZnO,Rod,,Sol-Gel Method,Negative,97,-29,10000,H,Human,Lung,Epithelial,Adult,48,100,MTT,TetrazoliumSalt,26.91,10.1016/j.nano.2011.04.011,115,,52,,A549,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2011,"ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress",FALSE,FALSE,closed,115_ahamed2011.pdf,0
3736,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,5,MTS,TetrazoliumSalt,101.65,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3737,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,10,MTS,TetrazoliumSalt,82.234,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3738,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,25,MTS,TetrazoliumSalt,71.827,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3739,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,50,MTS,TetrazoliumSalt,59.518,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3740,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,100,MTS,TetrazoliumSalt,39.848,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3741,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,5,NRU,NeutralRed,97.387,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3742,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,10,NRU,NeutralRed,95.873,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3743,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,25,NRU,NeutralRed,92.71,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3744,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,50,NRU,NeutralRed,85.282,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3745,NiO,Sphere,,Commercial,Positive,197,-11.5,10000,H,Human,Liver,Epithelial,Adult,24,100,NRU,NeutralRed,81.568,10.1016/j.chemosphere.2019.125488,116,,21.6,25.3,HepG2,Chemosphere,Elsevier BV,2020,High-throughput transcriptomics: An insight on the pathways affected in HepG2 cells exposed to nickel oxide nanoparticles,FALSE,FALSE,closed,116_10.1016@j.chemosphere.2019.125488.pdf,0
3746,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,94.911,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3747,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,80.407,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3748,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,79.262,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3749,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,58.779,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3750,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,43.13,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3751,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,20.229,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3752,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,11.196,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3753,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,93.13,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3754,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,2,MTT,TetrazoliumSalt,75.064,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3755,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,5,MTT,TetrazoliumSalt,70.483,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3756,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,48.219,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3757,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,33.461,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3758,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,16.031,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3759,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,8.7786,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3760,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,1,NRU,NeutralRed,98.588,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3761,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,2,NRU,NeutralRed,84.339,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3762,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,5,NRU,NeutralRed,69.576,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3763,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,10,NRU,NeutralRed,53.017,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3764,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,25,NRU,NeutralRed,38.768,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3765,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,50,NRU,NeutralRed,25.546,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3766,NiO,Sphere,,Commercial,,151,,10000,H,Human,Cervix,Epithelial,Adult,24,100,NRU,NeutralRed,15.661,10.1016/j.fct.2012.01.017,117,,22,,HEp-2,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3767,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,1,NRU,NeutralRed,94.095,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3768,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,2,NRU,NeutralRed,77.535,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3769,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,5,NRU,NeutralRed,58.28,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3770,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,10,NRU,NeutralRed,44.673,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3771,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,25,NRU,NeutralRed,33.761,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3772,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,50,NRU,NeutralRed,20.796,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3773,NiO,Sphere,,Commercial,,151,,10000,H,Human,Breast,Epithelial,Adult,24,100,NRU,NeutralRed,13.992,10.1016/j.fct.2012.01.017,117,,22,,MCF-7,Food and Chemical Toxicology,Elsevier BV,2012,"Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin",FALSE,FALSE,closed,117_siddiqui2012.pdf,0
3774,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,0.5,CCK-8,,109.73,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3775,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,1,CCK-8,,103.7,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3776,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,5,CCK-8,,97.86,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3777,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,20,CCK-8,,84.241,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3778,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,30,CCK-8,,56.42,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3779,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,40,CCK-8,,19.844,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3780,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,50,CCK-8,,4.2802,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3781,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,24,100,CCK-8,,3.3074,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3782,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,0.5,CCK-8,,104.67,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3783,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,1,CCK-8,,101.36,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3784,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,5,CCK-8,,65.564,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3785,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,20,CCK-8,,27.821,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3786,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,30,CCK-8,,2.9183,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3787,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,40,CCK-8,,2.5292,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3788,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,50,CCK-8,,1.1673,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3789,CuO,Sphere,,Commercial,Negative,185.2,-7.05,5000,H,Human,Lung,Epithelial,Adult,48,100,CCK-8,,0.7782,10.1021/tx3002093,118,,30,-29.1,A549,Chemical Research in Toxicology,American Chemical Society (ACS),2012,"CuO Nanoparticle Interaction with Human Epithelial Cells: Cellular Uptake, Location, Export, and Genotoxicity",FALSE,FALSE,closed,118_wang2012.pdf,0
3790,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,PropidiumIodide,89.744,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3791,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,PropidiumIodide,85.755,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3792,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,PropidiumIodide,7.9772,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3793,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,1000,Live/Dead,PropidiumIodide,9.6866,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3794,Au,Sphere,Citrate,Commercial,Negative,146.1,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,PropidiumIodide,100.28,10.2147/ijn.s72580,119,,4.7,-57.5,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3795,Au,Sphere,Citrate,Commercial,Negative,146.1,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,PropidiumIodide,98.86,10.2147/ijn.s72580,119,,4.7,-57.5,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3796,Au,Sphere,Citrate,Commercial,Negative,146.1,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,PropidiumIodide,53.561,10.2147/ijn.s72580,119,,4.7,-57.5,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3797,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,PropidiumIodide,100.28,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3798,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,PropidiumIodide,89.744,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3799,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,PropidiumIodide,25.926,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3800,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,1000,Live/Dead,PropidiumIodide,23.077,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3801,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,PropidiumIodide,93.162,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3802,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,PropidiumIodide,94.872,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3803,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,PropidiumIodide,94.872,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3804,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,1000,Live/Dead,PropidiumIodide,88.604,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3805,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,CalceinAM,86.005,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3806,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,CalceinAM,84.224,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3807,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,CalceinAM,14.249,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3808,SiO2,Sphere,,Commercial,Negative,27.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,1000,Live/Dead,CalceinAM,7.888,10.2147/ijn.s72580,119,,9,-26.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3809,Au,Sphere,Citrate,Commercial,Negative,146.1,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,CalceinAM,100.25,10.2147/ijn.s72580,119,,4.7,-57.5,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3810,Au,Sphere,Citrate,Commercial,Negative,146.1,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,CalceinAM,82.952,10.2147/ijn.s72580,119,,4.7,-57.5,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3811,Au,Sphere,Citrate,Commercial,Negative,146.1,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,CalceinAM,68.957,10.2147/ijn.s72580,119,,4.7,-57.5,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3812,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,CalceinAM,98.982,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3813,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,CalceinAM,82.952,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3814,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,CalceinAM,27.481,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3815,SiO2,Sphere,,Commercial,Negative,14.3,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,1000,Live/Dead,CalceinAM,10.941,10.2147/ijn.s72580,119,,280,-73.8,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3816,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,5,Live/Dead,CalceinAM,93.893,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3817,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,10,Live/Dead,CalceinAM,86.005,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3818,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,100,Live/Dead,CalceinAM,79.644,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3819,Au,Sphere,Citrate,Commercial,Negative,167.2,,6000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,48,1000,Live/Dead,CalceinAM,52.672,10.2147/ijn.s72580,119,,270,-45.96,RAW264.7,International Journal of Nanomedicine,Dove Medical Press Ltd.,2014,"Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro",TRUE,TRUE,green,119_tyner2014.pdf,1
3895,CaHCO3,Rod,,Precipitation,Negative,,-11.7,10000,A,Mouse,Bone,Osteoblast,Adult,72,50,MTT,TetrazoliumSalt,95.017,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3896,CaHCO3,Rod,,Precipitation,Negative,,-11.7,10000,A,Mouse,Bone,Osteoblast,Adult,72,100,MTT,TetrazoliumSalt,99.336,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3897,CaHCO3,Rod,,Precipitation,Negative,,-11.7,10000,A,Mouse,Bone,Osteoblast,Adult,72,500,MTT,TetrazoliumSalt,81.063,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3898,CaHCO3,Rod,,Precipitation,Negative,,-11.7,10000,A,Mouse,Bone,Osteoblast,Adult,72,1000,MTT,TetrazoliumSalt,87.043,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3899,CaHCO3,Rod,NH2,Precipitation,Positive,,48.6,10000,A,Mouse,Bone,Osteoblast,Adult,72,1000,MTT,TetrazoliumSalt,196.68,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3900,CaHCO3,Rod,COOH,Precipitation,Negative,,-28.3,10000,A,Mouse,Bone,Osteoblast,Adult,72,1000,MTT,TetrazoliumSalt,88.704,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3901,CaHCO3,Rod,CH3,Precipitation,Negative,,-11.4,10000,A,Mouse,Bone,Osteoblast,Adult,72,1000,MTT,TetrazoliumSalt,92.359,10.1088/0957-4484/22/10/105708,120,,50,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3902,CaHCO3,Rod,,Precipitation,Negative,,-11.7,10000,A,Mouse,Bone,Osteoblast,Adult,72,1000,MTT,TetrazoliumSalt,98.339,10.1088/0957-4484/22/10/105708,120,,20,,MC3T3-E1,Nanotechnology,IOP Publishing,2011,The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells,FALSE,TRUE,green,120_chen2011.pdf,1
3903,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,0.5,MTT,TetrazoliumSalt,102.52,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3904,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,5,MTT,TetrazoliumSalt,87.815,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3905,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,10,MTT,TetrazoliumSalt,79.503,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3906,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,25,MTT,TetrazoliumSalt,73.748,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3907,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,50,MTT,TetrazoliumSalt,39.645,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3908,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,75,MTT,TetrazoliumSalt,14.494,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3909,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,24,100,MTT,TetrazoliumSalt,14.92,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3910,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,0.5,MTT,TetrazoliumSalt,102.52,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3911,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,5,MTT,TetrazoliumSalt,96.128,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3912,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,10,MTT,TetrazoliumSalt,85.258,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3913,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,25,MTT,TetrazoliumSalt,73.108,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3914,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,50,MTT,TetrazoliumSalt,35.169,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3915,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,75,MTT,TetrazoliumSalt,6.1812,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3916,Ag,Sphere,Citrate,Commercial,Negative,64.8,-8.5,,H,Human,Skin,Keratinocyte,Adult,48,100,MTT,TetrazoliumSalt,7.8863,10.1016/j.toxlet.2016.03.005,121,,27.1,-42.7,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3917,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,0.5,MTT,TetrazoliumSalt,107.48,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3918,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,5,MTT,TetrazoliumSalt,100.62,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3919,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,10,MTT,TetrazoliumSalt,101.25,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3920,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,25,MTT,TetrazoliumSalt,97.921,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3921,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,50,MTT,TetrazoliumSalt,99.792,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3922,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,75,MTT,TetrazoliumSalt,111.64,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3923,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,24,100,MTT,TetrazoliumSalt,112.06,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3924,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,0.5,MTT,TetrazoliumSalt,107.48,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3925,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,5,MTT,TetrazoliumSalt,85.031,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3926,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,10,MTT,TetrazoliumSalt,85.031,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3927,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,25,MTT,TetrazoliumSalt,71.726,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3928,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,50,MTT,TetrazoliumSalt,69.231,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3929,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,75,MTT,TetrazoliumSalt,65.073,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3930,Ag,Sphere,PEG,Commercial,Negative,57.7,-6.5,,H,Human,Skin,Keratinocyte,Adult,48,100,MTT,TetrazoliumSalt,66.528,10.1016/j.toxlet.2016.03.005,121,,27.7,-12.1,HaCat,Toxicology Letters,Elsevier BV,2016,The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line,FALSE,FALSE,closed,121_bastos2016.pdf,0
3931,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,7.8125,MTT,TetrazoliumSalt,75.638,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3932,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,15.625,MTT,TetrazoliumSalt,70.281,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3933,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,31.25,MTT,TetrazoliumSalt,73.852,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3934,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,62.5,MTT,TetrazoliumSalt,73.214,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3935,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,125,MTT,TetrazoliumSalt,68.75,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3936,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,250,MTT,TetrazoliumSalt,24.49,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3937,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,500,MTT,TetrazoliumSalt,23.852,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3938,Cu,Sphere,AscorbicAcid,Chemical Reduction,Negative,,,10000,H,Human,Gingiva,Fibroblast,Adult,24,1000,MTT,TetrazoliumSalt,32.398,10.1155/2019/5287632,122,,250,-24.7,HGF,Journal of Nanomaterials,Wiley,2019,"Synthesis, Characterization, and In Situ Antifungal and Cytotoxicity Evaluation of Ascorbic Acid-Capped Copper Nanoparticles",FALSE,TRUE,green,122_10.1155@2019@5287632.pdf,1
3939,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,1.56,MTT,TetrazoliumSalt,98.236,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3940,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,3.12,MTT,TetrazoliumSalt,98.236,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3941,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,6.25,MTT,TetrazoliumSalt,96.649,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3942,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,12.5,MTT,TetrazoliumSalt,95.414,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3943,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,95.414,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3944,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,98.236,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3945,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,96.12,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3946,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,200,MTT,TetrazoliumSalt,89.065,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3947,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,400,MTT,TetrazoliumSalt,79.365,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3948,CeO2,Sphere,,Biosynthesis,,,,,H,Human,Colon,Epithelial,Adult,24,800,MTT,TetrazoliumSalt,77.601,10.1002/aoc.5308,123,,12.5,,HT29,Applied Organometallic Chemistry,Wiley,2019,Biosynthesis of cerium oxide nanoparticles and its cytotoxicity survey against colon cancer cell line,FALSE,FALSE,closed,123_10.1002@aoc.5308.pdf,0
3949,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,25,MTT,TetrazoliumSalt,102.01,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3950,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,50,MTT,TetrazoliumSalt,104.01,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3951,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,100,MTT,TetrazoliumSalt,104.01,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3952,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,200,MTT,TetrazoliumSalt,106.02,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3953,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,,,,24,25,MTT,TetrazoliumSalt,102.01,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3954,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,,,,24,50,MTT,TetrazoliumSalt,98.997,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3955,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,,,,24,100,MTT,TetrazoliumSalt,106.02,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3956,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,,,,24,200,MTT,TetrazoliumSalt,107.02,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3957,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,25,NRU,NeutralRed,100,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3958,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,50,NRU,NeutralRed,104.05,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3959,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,100,NRU,NeutralRed,116.04,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3960,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Breast,,,24,200,NRU,NeutralRed,112,10.1016/j.jcis.2015.04.049,124,,25,-13,MCF-7,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3961,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Connective Tissue,,,24,25,NRU,NeutralRed,105.14,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3962,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Connective Tissue,,,24,50,NRU,NeutralRed,107.94,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3963,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Connective Tissue,,,24,100,NRU,NeutralRed,114.95,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3964,CeO2,Cubic,,Commercial,Negative,245,-20,30000,H,Human,Connective Tissue,,,24,200,NRU,NeutralRed,111.06,10.1016/j.jcis.2015.04.049,124,,25,-13,HT-1080,Journal of Colloid and Interface Science,Elsevier BV,2015,Glutathione replenishing potential of CeO 2 nanoparticles in human breast and fibrosarcoma cells,FALSE,FALSE,closed,124_akhtar2015.pdf,0
3965,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,81.774,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3966,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,6.25,MTT,TetrazoliumSalt,67.672,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3967,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,57.295,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3968,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,52.639,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3969,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,48.248,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3970,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,75,MTT,TetrazoliumSalt,37.206,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3971,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,29.357,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3972,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,83.636,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3973,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,6.25,MTT,TetrazoliumSalt,70.333,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3974,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,67.672,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3975,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,60.355,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3976,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,57.029,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3977,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,75,MTT,TetrazoliumSalt,56.098,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3978,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,49.978,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3979,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,75.122,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3980,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,6.25,MTT,TetrazoliumSalt,73.126,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3981,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,70.2,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3982,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,69.8,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3983,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,61.286,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3984,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,75,MTT,TetrazoliumSalt,63.016,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3985,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,48.381,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3986,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,1,MTT,TetrazoliumSalt,74.989,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3987,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,6.25,MTT,TetrazoliumSalt,70.2,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3988,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,10,MTT,TetrazoliumSalt,63.282,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3989,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,25,MTT,TetrazoliumSalt,52.106,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3990,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,50,MTT,TetrazoliumSalt,49.978,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3991,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,75,MTT,TetrazoliumSalt,49.712,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3992,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,100,MTT,TetrazoliumSalt,49.18,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3993,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,1,NRU,NeutralRed,87.835,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3994,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,6.25,NRU,NeutralRed,84.433,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3995,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,10,NRU,NeutralRed,82.474,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3996,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,12.5,NRU,NeutralRed,80.103,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3997,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,25,NRU,NeutralRed,76.289,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3998,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,50,NRU,NeutralRed,65.258,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
3999,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,75,NRU,NeutralRed,59.691,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4000,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Liver,Epithelial,Adult,24,100,NRU,NeutralRed,45.567,10.1016/j.chemosphere.2016.11.018,125,,149.1,,HepG2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4001,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,1,NRU,NeutralRed,84.33,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4002,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,6.25,NRU,NeutralRed,77.01,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4003,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,10,NRU,NeutralRed,81.031,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4004,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,12.5,NRU,NeutralRed,82.474,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4005,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,25,NRU,NeutralRed,71.856,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4006,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,50,NRU,NeutralRed,65.876,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4007,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,75,NRU,NeutralRed,58.144,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4008,Bi2O3,Sphere,,Commercial,,183,,,A,Rat,Kidney,Epithelial,Adult,24,100,NRU,NeutralRed,46.701,10.1016/j.chemosphere.2016.11.018,125,,149.1,,NRK-52E,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4009,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,1,NRU,NeutralRed,78.866,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4010,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,6.25,NRU,NeutralRed,70.412,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4011,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,10,NRU,NeutralRed,68.144,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4012,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,12.5,NRU,NeutralRed,68.041,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4013,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,25,NRU,NeutralRed,68.041,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4014,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,50,NRU,NeutralRed,55.464,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4015,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,75,NRU,NeutralRed,52.062,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4016,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Colon,Epithelial,Adult,24,100,NRU,NeutralRed,45.567,10.1016/j.chemosphere.2016.11.018,125,,149.1,,Caco-2,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4017,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,1,NRU,NeutralRed,83.402,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4018,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,6.25,NRU,NeutralRed,80,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4019,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,10,NRU,NeutralRed,78.454,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4020,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,12.5,NRU,NeutralRed,77.216,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4021,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,25,NRU,NeutralRed,75.052,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4022,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,50,NRU,NeutralRed,61.134,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4023,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,75,NRU,NeutralRed,44.124,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4024,Bi2O3,Sphere,,Commercial,,183,,,H,Human,Lung,Epithelial,Adult,24,100,NRU,NeutralRed,40.722,10.1016/j.chemosphere.2016.11.018,125,,149.1,,A549,Chemosphere,Elsevier BV,2017,Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines,FALSE,FALSE,closed,125_abudayyak2017.pdf,0
4039,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,0.1,MTT,TetrazoliumSalt,83.045,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4040,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,1,MTT,TetrazoliumSalt,48.789,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4041,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,10,MTT,TetrazoliumSalt,39.1,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4042,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,100,MTT,TetrazoliumSalt,25.087,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4043,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,0.1,MTT,TetrazoliumSalt,84.602,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4044,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,1,MTT,TetrazoliumSalt,61.419,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4045,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,10,MTT,TetrazoliumSalt,54.152,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4046,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,100,MTT,TetrazoliumSalt,46.367,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4047,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,0.1,XTT,TetrazoliumSalt,101.74,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4048,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,1,XTT,TetrazoliumSalt,98.364,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4049,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,10,XTT,TetrazoliumSalt,92.127,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4050,C,Nanotube,,Chemical Vapor Deposition,Negative,,-15.53,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,100,XTT,TetrazoliumSalt,76.892,10.1021/nn2016259,126,,1.15,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4051,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,0.1,XTT,TetrazoliumSalt,99.489,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4052,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,1,XTT,TetrazoliumSalt,98.875,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4053,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,10,XTT,TetrazoliumSalt,95.808,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4054,C,Nanotube,PEG,Chemical Vapor Deposition,Negative,,-30.14,10000,A,Rat,Adrenal Gland,Irregular,Adult,24,100,XTT,TetrazoliumSalt,88.139,10.1021/nn2016259,126,,3,,PC12,ACS Nano,American Chemical Society (ACS),2011,Mechanistic Toxicity Evaluation of Uncoated and PEGylated Single-Walled Carbon Nanotubes in Neuronal PC12 Cells,FALSE,FALSE,closed,126_zhang2011.pdf,0
4055,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Lung,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,94.7,10.3109/17435390.2010.503943,127,,25,-0.4,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4056,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Lung,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,98.396,10.3109/17435390.2010.503943,127,,30,-5.7,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4057,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Lung,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,99.861,10.3109/17435390.2010.503943,127,,20,-5.3,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4058,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Lung,Epithelial,Adult,24,30,CCK-8,TetrazoliumSalt,92.748,10.3109/17435390.2010.503943,127,,25,-0.4,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4059,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Lung,Epithelial,Adult,24,30,CCK-8,TetrazoliumSalt,97.211,10.3109/17435390.2010.503943,127,,30,-5.7,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4060,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Lung,Epithelial,Adult,24,30,CCK-8,TetrazoliumSalt,94.561,10.3109/17435390.2010.503943,127,,20,-5.3,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4061,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Lung,Epithelial,Adult,24,100,CCK-8,TetrazoliumSalt,97.211,10.3109/17435390.2010.503943,127,,25,-0.4,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4062,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Lung,Epithelial,Adult,24,100,CCK-8,TetrazoliumSalt,97.559,10.3109/17435390.2010.503943,127,,30,-5.7,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4063,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Lung,Epithelial,Adult,24,100,CCK-8,TetrazoliumSalt,96.025,10.3109/17435390.2010.503943,127,,20,-5.3,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4064,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Lung,Epithelial,Adult,24,300,CCK-8,TetrazoliumSalt,91.423,10.3109/17435390.2010.503943,127,,25,-0.4,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4065,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Lung,Epithelial,Adult,24,300,CCK-8,TetrazoliumSalt,100.35,10.3109/17435390.2010.503943,127,,30,-5.7,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4066,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Lung,Epithelial,Adult,24,300,CCK-8,TetrazoliumSalt,98.047,10.3109/17435390.2010.503943,127,,20,-5.3,BEAS-2B,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4067,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,98.467,10.3109/17435390.2010.503943,127,,25,-0.4,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4068,CaHCO3,Rod,,Precipitation,Negative,109,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,104.89,10.3109/17435390.2010.503943,127,,30,-5.7,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4069,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,10,CCK-8,TetrazoliumSalt,104.89,10.3109/17435390.2010.503943,127,,20,-5.3,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4070,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,30,CCK-8,TetrazoliumSalt,101.15,10.3109/17435390.2010.503943,127,,25,-0.4,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4071,CaHCO3,Rod,,Precipitation,Negative,109,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,30,CCK-8,TetrazoliumSalt,91.667,10.3109/17435390.2010.503943,127,,30,-5.7,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4072,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,30,CCK-8,TetrazoliumSalt,110.82,10.3109/17435390.2010.503943,127,,20,-5.3,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4073,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,111.49,10.3109/17435390.2010.503943,127,,25,-0.4,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4074,CaHCO3,Rod,,Precipitation,Negative,109,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,105.75,10.3109/17435390.2010.503943,127,,30,-5.7,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4075,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,100,CCK-8,TetrazoliumSalt,115.9,10.3109/17435390.2010.503943,127,,20,-5.3,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4076,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,300,CCK-8,TetrazoliumSalt,120.98,10.3109/17435390.2010.503943,127,,25,-0.4,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4077,CaHCO3,Rod,,Precipitation,Negative,109,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,300,CCK-8,TetrazoliumSalt,115.9,10.3109/17435390.2010.503943,127,,30,-5.7,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4078,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,A,Mouse,Ascites,Monocyte/Macrophage,Adult,24,300,CCK-8,TetrazoliumSalt,108.62,10.3109/17435390.2010.503943,127,,20,-5.3,RAW264.7,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4079,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Liver,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,102.89,10.3109/17435390.2010.503943,127,,25,-0.4,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4080,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Liver,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,99.036,10.3109/17435390.2010.503943,127,,30,-5.7,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4081,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Liver,Epithelial,Adult,24,10,CCK-8,TetrazoliumSalt,100.37,10.3109/17435390.2010.503943,127,,20,-5.3,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4082,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Liver,Epithelial,Adult,24,30,CCK-8,TetrazoliumSalt,101.71,10.3109/17435390.2010.503943,127,,25,-0.4,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4083,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Liver,Epithelial,Adult,24,30,CCK-8,TetrazoliumSalt,98.887,10.3109/17435390.2010.503943,127,,30,-5.7,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4084,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Liver,Epithelial,Adult,24,30,CCK-8,TetrazoliumSalt,99.555,10.3109/17435390.2010.503943,127,,20,-5.3,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4085,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Liver,Epithelial,Adult,24,100,CCK-8,TetrazoliumSalt,100.52,10.3109/17435390.2010.503943,127,,25,-0.4,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4086,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Liver,Epithelial,Adult,24,100,CCK-8,TetrazoliumSalt,97.329,10.3109/17435390.2010.503943,127,,30,-5.7,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4087,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Liver,Epithelial,Adult,24,100,CCK-8,TetrazoliumSalt,102,10.3109/17435390.2010.503943,127,,20,-5.3,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4088,CaHCO3,Rod,,Precipitation,Neutral,116,,50000,H,Human,Liver,Epithelial,Adult,24,300,CCK-8,TetrazoliumSalt,102.67,10.3109/17435390.2010.503943,127,,25,-0.4,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4089,CaHCO3,Rod,,Precipitation,Negative,109,,50000,H,Human,Liver,Epithelial,Adult,24,300,CCK-8,TetrazoliumSalt,97.997,10.3109/17435390.2010.503943,127,,30,-5.7,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4090,CaHCO3,Rod,,Surfactant-based Synthesis,Negative,195,,50000,H,Human,Liver,Epithelial,Adult,24,300,CCK-8,TetrazoliumSalt,99.703,10.3109/17435390.2010.503943,127,,20,-5.3,HepG2,Nanotoxicology,Informa UK Limited,2010,<i>In vitro</i>assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas,FALSE,FALSE,closed,127_zhao2010.pdf,0
4111,CeO2,,,,,,,,A,Mouse,Areolar tissue,Fibroblast,A,24,,MTT,tetrazolium salt,105.5892,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
4112,CeO2,,,,,,,,A,Mouse,Areolar tissue,Fibroblast,A,24,,MTT,tetrazolium salt,103.0262,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
4113,CeO2,,,,,,,,A,Mouse,Areolar tissue,Fibroblast,A,24,,MTT,tetrazolium salt,104.8575,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
4114,CeO2,,,,,,,,A,Mouse,Areolar tissue,Fibroblast,A,24,,MTT,tetrazolium salt,100.0967,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
4115,CeO2,,,,,,,,A,Mouse,Areolar tissue,Fibroblast,A,24,,MTT,tetrazolium salt,97.53237,10.1016/j.ceramint.2014.09.095,63,,20.3,,L929,Ceramics International,Elsevier BV,2015,Bioorganic polymer-based synthesis of cerium oxide nanoparticles and their cell viability assays,FALSE,FALSE,closed,63_kargar2015.pdf,0
4116,Se,,,,,,,,H,Human,Prostate,Epithelial,A,24,,XTT,tetrazolium salt,91.09037,10.4172/2157-7439.1000194,128,,79.6,0,PC3,Journal of Nanomedicine &amp; Nanotechnology,OMICS Publishing Group,2014,Improved Extraction of Intracellular Biogenic Selenium Nanoparticles and their Specificity for Cancer Chemoprevention,FALSE,TRUE,bronze,128_sonkusre2014.pdf,1
4117,Se,,,,,,,,H,Human,Prostate,Epithelial,A,24,,XTT,tetrazolium salt,77.62113,10.4172/2157-7439.1000194,128,,79.6,0,PC3,Journal of Nanomedicine &amp; Nanotechnology,OMICS Publishing Group,2014,Improved Extraction of Intracellular Biogenic Selenium Nanoparticles and their Specificity for Cancer Chemoprevention,FALSE,TRUE,bronze,128_sonkusre2014.pdf,1
4118,Se,,,,,,,,H,Human,Prostate,Epithelial,A,24,,XTT,tetrazolium salt,54.2135,10.4172/2157-7439.1000194,128,,79.6,0,PC3,Journal of Nanomedicine &amp; Nanotechnology,OMICS Publishing Group,2014,Improved Extraction of Intracellular Biogenic Selenium Nanoparticles and their Specificity for Cancer Chemoprevention,FALSE,TRUE,bronze,128_sonkusre2014.pdf,1
4119,Se,,,,,,,,H,Human,Prostate,Epithelial,A,24,,XTT,tetrazolium salt,44.06236,10.4172/2157-7439.1000194,128,,79.6,0,PC3,Journal of Nanomedicine &amp; Nanotechnology,OMICS Publishing Group,2014,Improved Extraction of Intracellular Biogenic Selenium Nanoparticles and their Specificity for Cancer Chemoprevention,FALSE,TRUE,bronze,128_sonkusre2014.pdf,1
4120,CuO,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,74.58716,10.1016/j.bbrc.2010.04.156,59,,52.51,-39.67,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
4121,CuO,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,66.05505,10.1016/j.bbrc.2010.04.156,59,,52.51,-39.67,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
4122,CuO,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,48.16514,10.1016/j.bbrc.2010.04.156,59,,52.51,-39.67,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
4123,CuO,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,84.71387,10.1016/j.bbrc.2010.04.156,59,,52.51,-39.67,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
4124,CuO,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,68.67281,10.1016/j.bbrc.2010.04.156,59,,52.51,-39.67,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
4125,CuO,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,45.37968,10.1016/j.bbrc.2010.04.156,59,,52.51,-39.67,A549,Biochemical and Biophysical Research Communications,Elsevier BV,2010,Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,FALSE,FALSE,closed,59_ahamed2010.pdf,0
4126,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4127,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4128,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4129,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4130,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,84.26966,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4131,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,65.16854,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4132,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,46.06742,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4133,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,16.85393,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4134,CuO,,,,,,,,H,Human,,Endothelial,A,12,,MTT,tetrazolium salt,14.60674,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4135,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4136,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,100,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4137,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,95.50562,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4138,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4139,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,75.2809,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4140,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,43.82023,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4141,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,15.73034,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4142,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,13.48315,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4143,CuO,,,,,,,,H,Human,,Endothelial,A,24,,MTT,tetrazolium salt,13.48315,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4144,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,46.29435,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4145,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,44.39032,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4146,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,44.36371,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4147,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,33.08468,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4148,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,27.43549,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4149,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,12.40403,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4150,CuO,,,,,,,,H,Human,,Endothelial,A,12,,LDH,LDH activity assay kit,12.37742,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4153,CuO,,,,,,,,H,Human,,Endothelial,A,24,,LDH,LDH activity assay kit,43.3742,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4154,CuO,,,,,,,,H,Human,,Endothelial,A,24,,LDH,LDH activity assay kit,41.47016,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4155,CuO,,,,,,,,H,Human,,Endothelial,A,24,,LDH,LDH activity assay kit,45.19597,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4156,CuO,,,,,,,,H,Human,,Endothelial,A,24,,LDH,LDH activity assay kit,30.16451,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4157,CuO,,,,,,,,H,Human,,Endothelial,A,24,,LDH,LDH activity assay kit,11.39032,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4158,CuO,,,,,,,,H,Human,,Endothelial,A,24,,LDH,LDH activity assay kit,5.73629,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4162,CuO,,,,,,,,H,Human,,Epithelial,A,48,,MTS,tetrazolium salt,34.99993,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4163,CuO,,,,,,,,H,Human,,Epithelial,A,48,,MTS,tetrazolium salt,32.00679,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4164,CuO,,,,,,,,H,Human,,Epithelial,A,48,,MTS,tetrazolium salt,37.4078,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4165,CuO,,,,,,,,H,Human,,Epithelial,A,48,,MTS,tetrazolium salt,41.71446,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4167,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,71.82643,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4168,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,59.05612,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4169,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,68.19899,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4170,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,38.42558,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4172,CuO,,,,,,,,H,Human,,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.65237,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4173,CuO,,,,,,,,H,Human,,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.91648,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4174,CuO,,,,,,,,H,Human,,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.65237,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4175,CuO,,,,,,,,H,Human,,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",89.75169,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4176,CuO,,,,,,,,H,Human,,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",41.08352,10.1080/17458080802235765,129,,33,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4177,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.28442,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4178,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.60045,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4179,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.33634,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4180,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",90.06772,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4181,CuO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",60.6772,10.1080/17458080802235765,129,,33,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4182,CuS,,,,,,,,H,Human,Kidney,,E,48,,WST-1,tetrazolium salt,97.88231,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4183,CuS,,,,,,,,H,Human,Kidney,,,48,,WST-1,tetrazolium salt,96.61061,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4184,CuS,,,,,,,,H,Human,Kidney,,E,48,,WST-1,tetrazolium salt,95.93676,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4185,CuS,,,,,,,,H,Human,Kidney,,E,48,,WST-1,tetrazolium salt,100.7634,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4186,CuS,,,,,,,,H,Human,Kidney,,E,48,,WST-1,tetrazolium salt,101.5267,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4187,CuS,,,,,,,,H,Human,Kidney,,E,48,,WST-1,tetrazolium salt,100,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4188,CuS,,,,,,,,H,Human,Kidney,,,48,,WST-1,tetrazolium salt,103.3079,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4189,CuS,,,,,,,,H,Human,Kidney,,E,48,,WST-1,tetrazolium salt,97.96438,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4190,CuS,,,,,,,,H,Human,Kidney,,,48,,WST-1,tetrazolium salt,89.31298,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4191,CuS,,,,,,,,H,Human,Kidney,,,48,,WST-1,tetrazolium salt,52.92621,10.2217/nnm.10.85,130,,3,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
4192,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,MTT,tetrazolium salt,100.4819,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4193,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,MTT,tetrazolium salt,96.14458,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4194,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,MTT,tetrazolium salt,91.08434,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4195,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,MTT,tetrazolium salt,86.02409,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4196,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,MTT,tetrazolium salt,86.02409,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4197,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,MTT,tetrazolium salt,69.39759,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4198,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,96.14458,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4199,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,93.97591,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4200,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,90.36144,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4201,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,85.30121,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4202,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,76.6265,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4203,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,63.61446,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4204,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,99.75903,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4205,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,88.19277,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4206,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,86.02409,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4207,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,52.04819,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4208,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,26.0241,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4209,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,7.228916,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4210,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,90.36144,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4211,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,88.19277,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4212,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,86.02409,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4213,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,41.92771,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4214,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,9.397591,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4215,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,6.506024,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4216,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,NR,neutral red,100.5223,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4217,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,NR,neutral red,97.6419,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4218,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,NR,neutral red,98.22968,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4219,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,NR,neutral red,104.3638,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4220,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,NR,neutral red,101.4834,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4221,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,3,,NR,neutral red,99.29382,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4222,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,99.02918,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4223,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,98.22968,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4224,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,95.34369,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4225,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,92.46326,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4226,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,82.64085,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4227,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,63.11581,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4228,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,101.8038,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4229,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,101.0015,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4230,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,97.42461,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4231,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,88.99784,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4232,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,54.89797,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4233,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,48.54934,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4234,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,93.47726,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4235,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,91.98412,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4236,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,96.73376,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4237,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,69.57309,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4238,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,43.79971,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4239,ZnO,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,34.67651,10.1016/j.toxlet.2009.01.008,131,,165,-26,A431,Toxicology Letters,Elsevier BV,2009,DNA damaging potential of zinc oxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,131_sharma2009.pdf,0
4240,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,124.0664,10.1016/j.tiv.2011.12.006,132,,10,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4241,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,136.3089,10.1016/j.tiv.2011.12.006,132,,11,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4242,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,76.85051,10.1016/j.tiv.2011.12.006,132,,12,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4243,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,31.54318,10.1016/j.tiv.2011.12.006,132,,13,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4244,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,27.74783,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4245,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,27.09331,10.1016/j.tiv.2011.12.006,132,,15,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4246,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,52.85945,10.1016/j.tiv.2011.12.006,132,,16,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4247,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,54.383,10.1016/j.tiv.2011.12.006,132,,17,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4248,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,54.39138,10.1016/j.tiv.2011.12.006,132,,18,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4249,ZnO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,52.12703,10.1016/j.tiv.2011.12.006,132,,19,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4250,ZnO,,,,,,,,H,Human,Colon,Epithelial,A,24,,,Sytox Red,98,10.1021/tx400231u,133,,112,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4251,ZnO,,,,,,,,H,Human,Colon,Epithelial,A,24,,,Annexin V,100,10.1021/tx400231u,133,,112,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4252,ZnO,,,,,,,,H,Human,Colon,Epithelial,A,24,,LDH,LDH activity assay kit,81.05264,10.1021/tx400231u,133,,112,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4253,ZnO,,,,,,,,H,Human,Colon,Epithelial,A,24,,MTT,tetrazolium salt,69.63232,10.1021/tx400231u,133,,112,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4271,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4272,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4273,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,101.1236,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4274,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4275,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,92.13483,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4276,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,75.2809,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4277,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,64.04495,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4278,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,35.95506,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4279,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,32.58427,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4280,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4281,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4282,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4283,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4284,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,71.91011,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4285,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,60.67416,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4286,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,43.82023,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4287,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,28.08989,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4288,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,22.47191,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4289,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,95.76786,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4290,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,97.60808,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4291,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,95.70998,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4292,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,90.07597,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4293,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,75.09376,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4294,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,47.02985,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4295,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,43.265,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4296,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,30.14954,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4297,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,11.43382,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4298,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,94.72596,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4299,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,94.69702,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4300,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,90.92976,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4301,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,68.47332,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4302,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,59.09858,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4303,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,47.8571,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4304,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,31.00814,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4305,ZnO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,10.41845,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4307,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,100.0391,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4308,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,90.41096,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4309,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,34.28571,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4310,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,24.4227,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4311,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,7.279843,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4312,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,7.514677,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4313,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,11.74168,10.1088/1742-6596/304/1/012044,135,,24,43.8,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4314,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,91.11546,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4315,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,89.70646,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4316,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,56.12524,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4317,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,7.749511,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4318,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,8.688846,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4319,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,11.97652,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4320,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,22.54403,10.1088/1742-6596/304/1/012044,135,,24,-44.6,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4321,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,100.9785,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4322,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,101.683,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4323,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,66.45792,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4324,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,55.18591,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4325,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,25.1272,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4326,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,10.09785,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4327,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,9.393347,10.1088/1742-6596/304/1/012044,135,,67,44.1,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4328,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,97.6908,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4329,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,99.80431,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4330,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,62.46575,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4331,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,10.09785,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4332,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,9.158513,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4333,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,14.55969,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4334,ZnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,WST-1,tetrazolium salt,27.2407,10.1088/1742-6596/304/1/012044,135,,67,45.2,A549,Journal of Physics: Conference Series,IOP Publishing,2011,Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge,TRUE,TRUE,gold,135_baek2011.pdf,1
4335,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,79.84496,10.1007/s11671-009-9413-8,136,,8,,CD3+ T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4336,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,72.48062,10.1007/s11671-009-9413-8,136,,8,,CD3+ T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4337,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,64.72868,10.1007/s11671-009-9413-8,136,,8,,CD3+ T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4338,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,43.79845,10.1007/s11671-009-9413-8,136,,8,,CD3+ T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4339,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,14.72868,10.1007/s11671-009-9413-8,136,,8,,CD3+ T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4340,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,69.37985,10.1007/s11671-009-9413-8,136,,8,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4341,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,68.21706,10.1007/s11671-009-9413-8,136,,8,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4342,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,64.34109,10.1007/s11671-009-9413-8,136,,8,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4343,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,47.67442,10.1007/s11671-009-9413-8,136,,8,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4344,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,24.8062,10.1007/s11671-009-9413-8,136,,8,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4345,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,89.14729,10.1007/s11671-009-9413-8,136,,8,,B cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4346,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,81.00775,10.1007/s11671-009-9413-8,136,,8,,B cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4347,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,67.05426,10.1007/s11671-009-9413-8,136,,8,,B cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4348,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,43.41085,10.1007/s11671-009-9413-8,136,,8,,B cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4349,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,21.31783,10.1007/s11671-009-9413-8,136,,8,,B cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4350,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,62.7907,10.1007/s11671-009-9413-8,136,,8,,NK cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4351,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,44.57364,10.1007/s11671-009-9413-8,136,,8,,NK cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4352,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,26.74419,10.1007/s11671-009-9413-8,136,,8,,NK cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4353,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,13.56589,10.1007/s11671-009-9413-8,136,,8,,NK cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4354,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,3.100775,10.1007/s11671-009-9413-8,136,,8,,NK cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4355,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,25.1938,10.1007/s11671-009-9413-8,136,,8,,Monocytes,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4356,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,6.976744,10.1007/s11671-009-9413-8,136,,8,,Monocytes,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4357,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,34.63439,10.1007/s11671-009-9413-8,136,,8,,T cells (all types),Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4358,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,44.3355,10.1007/s11671-009-9413-8,136,,8,,Naive T-cell,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4359,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,18.08616,10.1007/s11671-009-9413-8,136,,8,,Memory T-cell,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4360,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,19.89648,10.1007/s11671-009-9413-8,136,,4,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4361,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,29.9326,10.1007/s11671-009-9413-8,136,,3,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4362,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,55.32121,10.1007/s11671-009-9413-8,136,,20,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4363,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,62.23176,10.1007/s11671-009-9413-8,136,,4,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4364,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,19.74249,10.1007/s11671-009-9413-8,136,,4,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4365,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,2.575107,10.1007/s11671-009-9413-8,136,,4,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4366,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,77.25322,10.1007/s11671-009-9413-8,136,,20,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4367,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,50.64378,10.1007/s11671-009-9413-8,136,,20,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4368,ZnO,,,,,,,,H,Human,Blood,,A,24,,,propidium iodide,12.87554,10.1007/s11671-009-9413-8,136,,20,,CD4+T cells,Nanoscale Research Letters,Springer Science and Business Media LLC,2009,The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction,TRUE,TRUE,gold,136_hanley2009.pdf,1
4369,ZnO,,,,,,,,H,Human,Blood,,A,3,,MTT,tetrazolium salt,95.5024,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4370,ZnO,,,,,,,,H,Human,Blood,,A,3,,MTT,tetrazolium salt,105.8373,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4371,ZnO,,,,,,,,H,Human,Blood,,A,3,,MTT,tetrazolium salt,75.21531,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4372,ZnO,,,,,,,,H,Human,Blood,,A,3,,MTT,tetrazolium salt,49.1866,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4373,ZnO,,,,,,,,H,Human,Blood,,A,3,,Live/Dead,trypan blue,85.55024,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4374,ZnO,,,,,,,,H,Human,Blood,,A,3,,Live/Dead,trypan blue,84.01914,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4375,ZnO,,,,,,,,H,Human,Blood,,A,3,,Live/Dead,trypan blue,74.06699,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4376,ZnO,,,,,,,,H,Human,Blood,,A,3,,Live/Dead,trypan blue,61.43541,10.1007/s00449-013-0982-7,14,,75,,Lymphocytes,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2013,Biosynthesis and safety evaluation of ZnO nanoparticles,FALSE,FALSE,closed,14_sarkar2013.pdf,0
4377,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,88.0639,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4378,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,78.45094,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4379,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,39.97198,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4380,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,68.17292,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4381,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,49.62644,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4382,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,24.89259,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4383,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,33.85015,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4384,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,4.992589,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4385,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,4.314925,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4386,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,20.14473,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4387,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,0.223082,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4388,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,2.292755,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4389,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,10.56303,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4390,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,0.263369,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4391,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,2.333643,10.1007/s00204-012-0840-4,6,,20,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4392,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,108.202,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4393,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,99.96482,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4394,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,96.53802,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4395,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,100.6852,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4396,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,90.38612,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4397,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,64.96619,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4398,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,93.85622,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4399,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,81.49471,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4400,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,43.70364,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4401,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,73.28096,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4402,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,54.73388,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4403,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,26.56421,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4404,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,43.0837,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4405,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,36,,CellTiterBlue,Alamar blue,25.91059,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4406,ZnO,,l-cysteine l-lysine l-lysine,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,5.989543,10.1007/s00204-012-0840-4,6,,40,,Caco-2,Archives of Toxicology,Springer Science and Business Media LLC,2012,Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2,FALSE,FALSE,closed,6_10.1007@s00204-012-0840-4.pdf,0
4407,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,100.6931,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4408,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,92.22611,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4409,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,68.79509,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4410,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,55.58357,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4411,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,0.035337,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4412,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,110.3649,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4413,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,107.4188,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4414,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,97.29278,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4415,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,89.43314,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4416,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,46.81454,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4417,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.67841,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4418,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.67841,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4419,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.37004,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4420,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.67841,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4421,ZnO,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.44493,10.1080/17458080802235765,129,,60,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4422,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.9119,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4423,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.37004,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4424,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.67841,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4425,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.60352,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4426,ZnO,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",94.97797,10.1080/17458080802235765,129,,60,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4427,ZnO,,,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,25.25253,10.1016/j.nano.2014.01.006,15,,18,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4428,ZnO,,,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,14.14141,10.1016/j.nano.2014.01.006,15,,18,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4429,ZnO,,,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,44.68116,10.1016/j.nano.2014.01.006,15,,18,,Macrophages,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4430,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,96.25,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4431,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,103.5417,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4432,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,90.41666,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4433,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,95.52084,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4434,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,102.8125,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4435,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,91.14584,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4436,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,97.70834,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4437,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,103.5417,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4438,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,96.25,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4439,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,96.25,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4440,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,104.2708,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4441,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,94.79166,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4442,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,99.16666,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4443,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,107.1875,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4444,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,99.89584,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4445,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,74.375,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4446,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,74.375,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4447,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,86.04166,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4448,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,MTT,tetrazolium salt,92.61745,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4449,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,MTT,tetrazolium salt,93.42282,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4450,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,MTT,tetrazolium salt,90.20134,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4451,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,MTT,tetrazolium salt,93.42282,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4452,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,MTT,tetrazolium salt,87.78523,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4453,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,MTT,tetrazolium salt,49.12752,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4454,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,24,,NR,neutral red,93.12741,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4455,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,48,,NR,neutral red,91.73745,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4456,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,72,,NR,neutral red,95.90733,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4457,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,96,,NR,neutral red,95.44402,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4458,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,168,,NR,neutral red,93.59074,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4459,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,216,,NR,neutral red,94.05405,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4460,Fe3O4,,Dextran,,,,,,H,Human,Blood,Monocyte,A,336,,NR,neutral red,82.47104,10.1016/j.biomaterials.2006.12.003,137,,30,,Monocytes,Biomaterials,Elsevier BV,2007,Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro,FALSE,FALSE,closed,137_10.1016@j.biomaterials.2006.12.003.pdf,0
4461,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,89.08297,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4462,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,117.9039,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4463,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,136.2445,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4464,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,124.8908,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4465,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,119.6507,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4466,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,112.6638,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4467,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,157.2053,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4468,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,169.4323,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4469,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,179.0393,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4470,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,144.1048,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4471,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterGlo,luciferase,138.8646,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4472,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterGlo,luciferase,119.6507,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4473,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterGlo,luciferase,68.12227,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4474,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterGlo,luciferase,48.9083,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4475,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,CellTiterGlo,luciferase,26.20087,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4476,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,62.00873,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4477,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,41.9214,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4478,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,32.31441,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4479,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,23.58079,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4480,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,14.84716,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4481,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,MTS,tetrazolium salt,146.7742,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4482,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,MTS,tetrazolium salt,129.8387,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4483,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,MTS,tetrazolium salt,125,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4484,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,MTS,tetrazolium salt,104.8387,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4485,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,MTS,tetrazolium salt,100,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4486,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,104.8387,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4487,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,102.4194,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4488,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,99.19355,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4489,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,96.77419,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4490,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,100,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4491,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,131.4516,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4492,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,115.3226,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4493,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,106.4516,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4494,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,85.48387,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4495,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,CellTiterBlue,Alamar blue,58.06452,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4496,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,82.85078,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4497,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,67.31019,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4498,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,56.04981,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4499,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,42.64823,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4500,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,39.94391,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4501,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,60.18815,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4502,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,40.90646,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4503,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,31.24816,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4504,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,22.66155,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4505,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,13.54236,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4506,Fe3O4,,PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,42.34047,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4507,Fe3O4,,PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,32.68435,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4508,Fe3O4,,PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,24.09774,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4509,Fe3O4,,PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,20.32609,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4510,Fe3O4,,PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,10.66561,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4511,Fe3O4,,PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,38.93333,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4512,Fe3O4,,PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,27.67077,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4513,Fe3O4,,PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,19.61891,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4514,Fe3O4,,PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,14.23863,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4515,Fe3O4,,PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,0.841418,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4516,Fe3O4,,PEI,,,,,,A,Mouse,,,A,24,,Live/Dead,trypan blue,98.2479,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4517,Fe3O4,,PEI,,,,,,A,Mouse,,,A,24,,Live/Dead,trypan blue,98.80087,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4518,Fe3O4,,PEI,,,,,,A,Mouse,,,A,24,,Live/Dead,trypan blue,81.53774,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4519,Fe3O4,,PEI,,,,,,A,Mouse,,,A,24,,Live/Dead,trypan blue,90.13358,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4520,Fe3O4,,PEI,,,,,,A,Mouse,,,A,24,,Live/Dead,trypan blue,82.64213,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4521,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,Live/Dead,trypan blue,96.38087,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4522,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,Live/Dead,trypan blue,84.86487,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4523,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,Live/Dead,trypan blue,76.22088,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4524,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,Live/Dead,trypan blue,75.62442,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4525,Fe3O4,,PEI,,,,,,A,Mouse,,,A,72,,Live/Dead,trypan blue,67.55669,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4526,Fe3O4,,PEI,,,,,,A,Mouse,,,A,120,,Live/Dead,trypan blue,92.78658,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4527,Fe3O4,,PEI,,,,,,A,Mouse,,,A,120,,Live/Dead,trypan blue,82.42156,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4528,Fe3O4,,PEI,,,,,,A,Mouse,,,A,120,,Live/Dead,trypan blue,77.22585,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4529,Fe3O4,,PEI,,,,,,A,Mouse,,,A,120,,Live/Dead,trypan blue,62.26157,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4530,Fe3O4,,PEI,,,,,,A,Mouse,,,A,120,,Live/Dead,trypan blue,63.3877,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4531,Fe3O4,,PEI,,,,,,A,Mouse,,,A,168,,Live/Dead,trypan blue,74.25443,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4532,Fe3O4,,PEI,,,,,,A,Mouse,,,A,168,,Live/Dead,trypan blue,68.484,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4533,Fe3O4,,PEI,,,,,,A,Mouse,,,A,168,,Live/Dead,trypan blue,59.84001,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4534,Fe3O4,,PEI,,,,,,A,Mouse,,,A,168,,Live/Dead,trypan blue,46.02516,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4535,Fe3O4,,PEI,,,,,,A,Mouse,,,A,168,,Live/Dead,trypan blue,39.68158,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4536,Fe3O4,,PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,88.38983,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4537,Fe3O4,,PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,88.38983,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4538,Fe3O4,,PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,88.38983,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4539,Fe3O4,,PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,88.38983,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4540,Fe3O4,,PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,87.11864,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4541,Fe3O4,,PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,75.25424,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4542,Fe3O4,,PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,76.94915,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4543,Fe3O4,,PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,78.22034,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4544,Fe3O4,,PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,77.79661,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4545,Fe3O4,,PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,75.67797,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4546,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,66.77966,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4547,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,65.93221,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4548,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,65.93221,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4549,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,64.23729,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4550,Fe3O4,,PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,57.45763,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4551,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,53.64407,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4552,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,48.55932,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4553,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,49.74576,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4554,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,49.83051,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4555,Fe3O4,,PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,47.28814,10.1186/1556-276x-7-77,138,,145.8,17.7,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4556,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,95.47009,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4557,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,95.04274,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4558,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,95.04274,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4559,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,94.18803,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4560,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,94.18803,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4561,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,93.76068,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4562,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,95.04274,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4563,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,95.47009,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4564,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,95.04274,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4565,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,94.18803,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4566,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,93.76068,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4567,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,94.18803,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4568,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,94.18803,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4569,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,94.18803,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4570,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,94.61538,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4571,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,93.76068,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4572,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,93.76068,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4573,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,93.76068,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4574,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,92.47863,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4575,Fe3O4,,PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,92.47863,10.1186/1556-276x-7-77,138,,145.8,17.7,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4576,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,95.91124,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4577,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,101.4378,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4578,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,114.3818,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4579,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,162.8682,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4580,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,MTS,tetrazolium salt,163.8035,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4581,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,240.8863,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4582,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,248.2997,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4583,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,323.3777,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4584,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,401.9854,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4585,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,404.8117,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4586,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,103.4386,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4587,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,88.25786,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4588,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,63.54501,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4589,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,21.65069,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4590,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,CellTiterBlue,Alamar blue,24.47699,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4591,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,MTS,tetrazolium salt,100.049,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4592,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,MTS,tetrazolium salt,93.75041,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4593,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,MTS,tetrazolium salt,85.11987,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4594,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,MTS,tetrazolium salt,100.3968,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4595,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,MTS,tetrazolium salt,129.3651,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4596,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,104.8093,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4597,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,110.4154,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4598,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,115.277,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4599,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,108.3333,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4600,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,107.9365,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4601,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,96.08073,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4602,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,86.60592,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4603,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,75.59442,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4604,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,73.4127,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4605,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,CellTiterBlue,Alamar blue,73.80953,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4606,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,95.48023,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4607,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,64.40678,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4608,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,57.06215,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4609,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,56.49717,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4610,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,Live/Dead,trypan blue,55.93221,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4611,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,61.01695,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4612,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,37.28814,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4613,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,23.72881,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4614,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,13.55932,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4615,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,Live/Dead,trypan blue,2.824859,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4616,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,56.49717,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4617,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,33.8983,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4618,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,17.51412,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4619,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,10.16949,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4620,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,120,,Live/Dead,trypan blue,3.954802,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4621,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,38.41808,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4622,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,28.24859,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4623,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,14.12429,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4624,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,0,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4625,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,168,,Live/Dead,trypan blue,0,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4626,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,Live/Dead,trypan blue,100.5682,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4627,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,Live/Dead,trypan blue,84.09091,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4628,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,Live/Dead,trypan blue,83.52273,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4629,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,Live/Dead,trypan blue,79.54546,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4630,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,Live/Dead,trypan blue,55.68182,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4631,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,Live/Dead,trypan blue,98.86364,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4632,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,Live/Dead,trypan blue,86.36364,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4633,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,Live/Dead,trypan blue,82.95454,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4634,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,Live/Dead,trypan blue,60.79546,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4635,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,Live/Dead,trypan blue,55.11364,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4636,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,120,,Live/Dead,trypan blue,92.61364,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4637,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,120,,Live/Dead,trypan blue,75.56818,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4638,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,120,,Live/Dead,trypan blue,74.43182,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4639,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,120,,Live/Dead,trypan blue,53.40909,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4640,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,120,,Live/Dead,trypan blue,43.75,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4641,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,168,,Live/Dead,trypan blue,69.88636,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4642,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,168,,Live/Dead,trypan blue,61.93182,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4643,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,168,,Live/Dead,trypan blue,55.11364,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4644,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,168,,Live/Dead,trypan blue,50.56818,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4645,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,168,,Live/Dead,trypan blue,32.95454,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4646,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,92.11166,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4647,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,92.12788,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4648,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,92.14161,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4649,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,90.74149,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4650,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,1,,LDH,LDH activity assay kit,91.70111,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4651,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,93.64406,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4652,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,93.65903,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4653,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,95.08785,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4654,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,95.10532,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4655,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,4,,LDH,LDH activity assay kit,91.82091,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4656,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,96.12234,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4657,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,97.55116,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4658,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,96.15229,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4659,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,94.75217,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4660,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,24,,LDH,LDH activity assay kit,85.33568,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4661,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,23.12519,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4662,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,23.14016,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4663,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,28.81801,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4664,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,38.26695,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4665,Fe3O4,,PEG to the PEI,,,,,,H,Human,,,A,72,,LDH,LDH activity assay kit,34.50958,10.1186/1556-276x-7-77,138,,361.4,12.1,SH-SY5Y,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4666,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,94.85577,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4667,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,93.98008,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4668,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,93.99593,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4669,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,93.11628,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4670,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,1,,LDH,LDH activity assay kit,93.13345,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4671,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,93.63271,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4672,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,93.19949,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4673,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,94.10952,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4674,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,92.78741,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4675,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,4,,LDH,LDH activity assay kit,96.37204,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4676,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,93.30119,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4677,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,92.86929,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4678,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,92.43607,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4679,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,91.11396,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4680,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,91.13245,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4681,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,88.05896,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4682,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,88.07217,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4683,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,89.87109,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4684,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,90.33337,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4685,Fe3O4,,PEG to the PEI,,,,,,A,Mouse,,Monocyte/Macrophage,A,72,,LDH,LDH activity assay kit,91.68983,10.1186/1556-276x-7-77,138,,361.4,12.1,RAW 264.7,Nanoscale Research LettersВ,Springer New York,2012,Dilemmas in the reliable estimation of theВ in-vitroВ cell viability in magnetic nanoparticle engineering: which tests and what protocols?,TRUE,TRUE,green,138_hoskins2012.pdf,1
4686,Fe3O4,,PEG,,,,,,H,Human,Skin,Endothelial-like,E,24,,ATPLite,luciferase,109.8165,10.3762/bjnano.6.28,139,,16,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
4687,Fe3O4,,PEG,,,,,,H,Human,Skin,Endothelial-like,E,72,,ATPLite,luciferase,111.4815,10.3762/bjnano.6.28,139,,16,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
4688,Fe3O4,,PEG-NH2,,,,,,H,Human,Skin,Endothelial-like,E,24,,ATPLite,luciferase,86.69725,10.3762/bjnano.6.28,139,,16,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
4689,Fe3O4,,PEG-NH2,,,,,,H,Human,Skin,Endothelial-like,E,72,,ATPLite,luciferase,79.07407,10.3762/bjnano.6.28,139,,16,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
4690,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,94.38202,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4691,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,94.38202,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4692,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4693,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4694,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,100,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4695,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4696,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4697,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4698,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,95.50562,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4699,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4700,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4701,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4702,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4703,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,88.76405,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4704,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,89.88764,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4705,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,92.13483,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4706,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,92.13483,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4707,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,89.88764,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4708,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,95.4905,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4709,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,99.20229,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4710,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,95.43503,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4711,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,95.40609,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4712,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,87.90534,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4713,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,87.87398,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4714,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,85.97829,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4715,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,91.55924,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4716,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,87.79198,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4717,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,98.18692,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4718,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,98.15797,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4719,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,94.39313,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4720,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,86.88996,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4721,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,86.86102,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4722,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,86.83208,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4723,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,83.06964,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4724,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,84.90986,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4725,Fe3O4,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,83.01417,10.1007/s10565-011-9191-9,82,,957,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
4726,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,Alamar Blue,Alamar blue,96.3466,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4727,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,Alamar Blue,Alamar blue,95.28805,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4728,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,Alamar Blue,Alamar blue,95.04239,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4729,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,Alamar Blue,Alamar blue,91.27052,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4730,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,Alamar Blue,Alamar blue,93.7379,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4731,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,Alamar Blue,Alamar blue,88.29703,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4732,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,LDH,LDH activity assay kit,97.32284,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4733,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,LDH,LDH activity assay kit,91.02362,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4735,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,Live/Dead,"propidium iodide, Annexin V",99.49775,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4736,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,Live/Dead,"propidium iodide, Annexin V",99.48388,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4737,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,Live/Dead,"propidium iodide, Annexin V",98.21392,10.3390/ijms140815546,140,,196.4,,A549,International Journal of Molecular Sciences,MDPI AG,2013,Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells,TRUE,TRUE,gold,140_watanabe2013.pdf,1
4738,Fe3O4,,BSA,,,,,,H,Human,Cervix,Epithelial,A,6,,Alamar Blue,Alamar blue,116.6805,10.1039/b901616c,141,,12,,HeLa,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4739,Fe3O4,,BSA,,,,,,H,Human,Cervix,Epithelial,A,6,,Alamar Blue,Alamar blue,125.7634,10.1039/b901616c,141,,12,,HeLa,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4740,Fe3O4,,BSA,,,,,,H,Human,Cervix,Epithelial,A,6,,Alamar Blue,Alamar blue,118.4266,10.1039/b901616c,141,,12,,HeLa,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4741,Fe3O4,,BSA,,,,,,H,Human,Cervix,Epithelial,A,6,,Alamar Blue,Alamar blue,106.3353,10.1039/b901616c,141,,12,,HeLa,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4742,Fe3O4,,BSA,,,,,,H,Human,Cervix,Epithelial,A,6,,Alamar Blue,Alamar blue,60.54085,10.1039/b901616c,141,,12,,HeLa,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4743,Fe3O4,,BSA,,,,,,A,Mouse,embryo,Fibroblast,E,6,,Alamar Blue,Alamar blue,95.12975,10.1039/b901616c,141,,12,,MEF,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4744,Fe3O4,,BSA,,,,,,A,Mouse,embryo,Fibroblast,E,6,,Alamar Blue,Alamar blue,97.29847,10.1039/b901616c,141,,12,,MEF,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4745,Fe3O4,,BSA,,,,,,A,Mouse,embryo,Fibroblast,E,6,,Alamar Blue,Alamar blue,100.3308,10.1039/b901616c,141,,12,,MEF,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4746,Fe3O4,,BSA,,,,,,A,Mouse,embryo,Fibroblast,E,6,,Alamar Blue,Alamar blue,83.9204,10.1039/b901616c,141,,12,,MEF,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4747,Fe3O4,,BSA,,,,,,A,Mouse,embryo,Fibroblast,E,6,,Alamar Blue,Alamar blue,52.38526,10.1039/b901616c,141,,12,,MEF,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4748,Fe3O4,,BSA,,,,,,H,Human,liver,Epithelial,A,6,,Alamar Blue,Alamar blue,80.49265,10.1039/b901616c,141,,12,,HepG2,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4749,Fe3O4,,BSA,,,,,,H,Human,liver,Epithelial,A,6,,Alamar Blue,Alamar blue,86.55028,10.1039/b901616c,141,,12,,HepG2,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4750,Fe3O4,,BSA,,,,,,H,Human,liver,Epithelial,A,6,,Alamar Blue,Alamar blue,79.64488,10.1039/b901616c,141,,12,,HepG2,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4751,Fe3O4,,BSA,,,,,,H,Human,liver,Epithelial,A,6,,Alamar Blue,Alamar blue,75.76418,10.1039/b901616c,141,,12,,HepG2,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4752,Fe3O4,,BSA,,,,,,H,Human,liver,Epithelial,A,6,,Alamar Blue,Alamar blue,38.17963,10.1039/b901616c,141,,12,,HepG2,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4753,Fe3O4,,BSA,,,,,,A,Rat,pituitary gland,Epithelial,A,6,,Alamar Blue,Alamar blue,99.99025,10.1039/b901616c,141,,12,,GH3,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4754,Fe3O4,,BSA,,,,,,A,Rat,pituitary gland,Epithelial,A,6,,Alamar Blue,Alamar blue,108.2096,10.1039/b901616c,141,,12,,GH3,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4755,Fe3O4,,BSA,,,,,,A,Rat,pituitary gland,Epithelial,A,6,,Alamar Blue,Alamar blue,114.2673,10.1039/b901616c,141,,12,,GH3,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4756,Fe3O4,,BSA,,,,,,A,Rat,pituitary gland,Epithelial,A,6,,Alamar Blue,Alamar blue,97.42418,10.1039/b901616c,141,,12,,GH3,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4757,Fe3O4,,BSA,,,,,,A,Rat,pituitary gland,Epithelial,A,6,,Alamar Blue,Alamar blue,54.22169,10.1039/b901616c,141,,12,,GH3,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4758,Fe3O4,,BSA,,,,,,H,Human,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,106.5274,10.1039/b901616c,141,,12,,MCF7,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4759,Fe3O4,,BSA,,,,,,H,Human,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,101.7825,10.1039/b901616c,141,,12,,MCF7,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4760,Fe3O4,,BSA,,,,,,H,Human,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,105.6783,10.1039/b901616c,141,,12,,MCF7,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4761,Fe3O4,,BSA,,,,,,H,Human,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,100.0699,10.1039/b901616c,141,,12,,MCF7,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4762,Fe3O4,,BSA,,,,,,H,Human,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,47.36115,10.1039/b901616c,141,,12,,MCF7,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4763,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,95.7779,10.1039/b901616c,141,,12,,CDBgeo,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4764,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,98.81082,10.1039/b901616c,141,,12,,CDBgeo,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4765,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,97.95483,10.1039/b901616c,141,,12,,CDBgeo,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4766,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,92.77783,10.1039/b901616c,141,,12,,CDBgeo,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4767,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,27.53884,10.1039/b901616c,141,,12,,CDBgeo,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4768,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,100.5866,10.1039/b901616c,141,,12,,TD,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4769,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,104.9133,10.1039/b901616c,141,,12,,TD,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4770,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,100.169,10.1039/b901616c,141,,12,,TD,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4771,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,98.01674,10.1039/b901616c,141,,12,,TD,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4772,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,56.11055,10.1039/b901616c,141,,12,,TD,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4773,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,98.91,10.1039/b901616c,141,,12,,V14,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4774,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,100.2145,10.1039/b901616c,141,,12,,V14,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4775,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,95.03816,10.1039/b901616c,141,,12,,V14,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4776,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,91.15683,10.1039/b901616c,141,,12,,V14,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4777,Fe3O4,,BSA,,,,,,A,Mouse,Breast,Epithelial,A,6,,Alamar Blue,Alamar blue,65.6711,10.1039/b901616c,141,,12,,V14,Journal of Materials Chemistry,Royal Society of Chemistry (RSC),2009,"Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4nanoparticles",FALSE,FALSE,closed,141_bajaj2009.pdf,0
4778,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,12,,Alamar blue,Alamar blue,125,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4779,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,36,,Alamar blue,Alamar blue,104.9645,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4780,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,60,,Alamar blue,Alamar blue,96.4539,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4781,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,12,,Alamar blue,Alamar blue,97.87234,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4782,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,36,,Alamar blue,Alamar blue,81.56029,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4783,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,60,,Alamar blue,Alamar blue,74.11347,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4784,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,24,,Alamar blue,Alamar blue,84.69324,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4785,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,48,,Alamar blue,Alamar blue,74.03898,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4786,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,72,,Alamar blue,Alamar blue,67.57632,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4787,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,96,,Alamar blue,Alamar blue,68.59861,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4788,Fe3O4,,alginate,,,,,,A,Pig,Aorta,Endothelial,A,144,,Alamar blue,Alamar blue,64.98035,10.1089/ten.tec.2009.0280,142,,30,,PAECs,Tissue Engineering Part C: Methods,Mary Ann Liebert Inc,2010,Bioprinted Nanoparticles for Tissue Engineering Applications,FALSE,FALSE,closed,142_buyukhatipoglu2010.pdf,0
4789,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",63.07054,10.1007/s00449-009-0354-5,143,,14,,A549,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
4790,Fe3O4,,,,,,,,H,Human,Breast,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",73.02905,10.1007/s00449-009-0354-5,143,,14,,MCF7,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
4791,Fe3O4,,,,,,,,H,Human,Brain,Fibroblast,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",76.34855,10.1007/s00449-009-0354-5,143,,14,,T98G,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
4792,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",81.47948,10.1007/s00449-009-0354-5,143,,14,,A549,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
4793,Fe3O4,,,,,,,,H,Human,Breast,Epithelial,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.01502,10.1007/s00449-009-0354-5,143,,14,,MCF7,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
4794,Fe3O4,,,,,,,,H,Human,Brain,Fibroblast,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",93.21722,10.1007/s00449-009-0354-5,143,,14,,T98G,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
4795,Fe3O4,,COOH,,,,,,H,Human,Cervix,Epithelial,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.80393,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4796,Fe3O4,,COOH,,,,,,H,Human,Cervix,Epithelial,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",92.54902,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4797,Fe3O4,,COOH,,,,,,H,Human,Cervix,Epithelial,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",88.03922,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4798,Fe3O4,,COOH,,,,,,H,Human,Bone,Fibroblast,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.43137,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4799,Fe3O4,,COOH,,,,,,H,Human,Bone,Fibroblast,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",91.56863,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4800,Fe3O4,,COOH,,,,,,H,Human,Bone,Fibroblast,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",82.15686,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4801,Fe3O4,,NH2,,,,,,H,Human,Cervix,Epithelial,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.24219,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4802,Fe3O4,,NH2,,,,,,H,Human,Cervix,Epithelial,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",90.625,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4803,Fe3O4,,NH2,,,,,,H,Human,Cervix,Epithelial,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",79.29688,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4804,Fe3O4,,NH2,,,,,,H,Human,Bone,Fibroblast,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.80469,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4805,Fe3O4,,NH2,,,,,,H,Human,Bone,Fibroblast,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",94.72656,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4806,Fe3O4,,NH2,,,,,,H,Human,Bone,Fibroblast,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",88.67188,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
4807,Fe3O4,,,,,,,,H,Human,Foreskin,Fibroblast,A,24,,MTT,tetrazolium salt,97.3923,10.1109/tnb.2003.820277,144,,12.5,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4808,Fe3O4,,,,,,,,H,Human,Foreskin,Fibroblast,A,25,,MTT,tetrazolium salt,84.94128,10.1109/tnb.2003.820277,144,,12.5,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4809,Fe3O4,,,,,,,,H,Human,Foreskin,Fibroblast,A,26,,MTT,tetrazolium salt,72.86762,10.1109/tnb.2003.820277,144,,12.5,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4810,Fe3O4,,,,,,,,H,Human,Foreskin,Fibroblast,A,27,,MTT,tetrazolium salt,67.59135,10.1109/tnb.2003.820277,144,,12.5,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4811,Fe3O4,,,,,,,,H,Human,Foreskin,Fibroblast,A,28,,MTT,tetrazolium salt,49.81495,10.1109/tnb.2003.820277,144,,12.5,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4812,Fe3O4,,PEG,,,,,,H,Human,Foreskin,Fibroblast,A,29,,MTT,tetrazolium salt,138.7218,10.1109/tnb.2003.820277,144,,45,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4813,Fe3O4,,PEG,,,,,,H,Human,Foreskin,Fibroblast,A,30,,MTT,tetrazolium salt,131.8888,10.1109/tnb.2003.820277,144,,45,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4814,Fe3O4,,PEG,,,,,,H,Human,Foreskin,Fibroblast,A,31,,MTT,tetrazolium salt,128.6427,10.1109/tnb.2003.820277,144,,45,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4815,Fe3O4,,PEG,,,,,,H,Human,Foreskin,Fibroblast,A,32,,MTT,tetrazolium salt,127.7789,10.1109/tnb.2003.820277,144,,45,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4816,Fe3O4,,PEG,,,,,,H,Human,Foreskin,Fibroblast,A,33,,MTT,tetrazolium salt,113.2134,10.1109/tnb.2003.820277,144,,45,,hTERT-BJ1,IEEE Transactions on Nanobioscience,Institute of Electrical and Electronics Engineers Inc.,2004,"Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies",FALSE,FALSE,closed,144_gupta2004.pdf,0
4817,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",69,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4818,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",95.45,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4819,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",90.26,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4820,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",74.53416,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4821,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",73.37662,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4822,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",70.77922,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4823,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,144,,Live/Dead,"Calcein AM, Ethidium homodimer-1",18.63354,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4824,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,144,,Live/Dead,"Calcein AM, Ethidium homodimer-1",4.545455,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4825,Fe3O4,,dimercaptosuccinic,,,,,,A,Rat,Adrenal gland,Irregular,A,144,,Live/Dead,"Calcein AM, Ethidium homodimer-1",11.68831,10.1016/j.biomaterials.2007.01.043,145,,8.5,,PC12,Biomaterials,Elsevier BV,2007,Nanotoxicity of iron oxide nanoparticle internalization in growing neurons,FALSE,FALSE,closed,145_pisanic2007.pdf,0
4826,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,84.26982,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4827,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,82.37157,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4828,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,61.13089,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4829,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,69.08662,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4830,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,MTS,tetrazolium salt,78.13834,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4831,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,101.6735,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4832,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,93.43899,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4833,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,87.84634,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4834,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,84.52071,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4835,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,MTS,tetrazolium salt,86.86433,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4836,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.64653,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4837,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.49284,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4838,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",96.61733,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4839,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.58113,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4840,Fe3O4,,,,,,,,H,Human,Bone Marrow,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.00887,10.1080/17458080802235765,129,,13.5,,SH-SY5Y,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4841,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",100.0477,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4842,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.98777,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4843,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.92608,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4844,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.65619,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4845,Fe3O4,,,,,,,,H,Human,Brain,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.80574,10.1080/17458080802235765,129,,13.5,,H4,Journal of Experimental Nanoscience,Informa UK Limited,2008,Differential cytotoxicity of metal oxide nanoparticles,FALSE,TRUE,bronze,129_chen2008.pdf,1
4846,Fe3O4,,PEG,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,76.6265,10.1002/jbm.b.33068,3,,120,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4847,Fe3O4,,PEG,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,71.56626,10.1002/jbm.b.33068,3,,120,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4848,Fe3O4,,PEG,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,44.09639,10.1002/jbm.b.33068,3,,120,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4849,Fe3O4,,PEG,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,31.08434,10.1002/jbm.b.33068,3,,120,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4850,Fe3O4,,PEG,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,27.46988,10.1002/jbm.b.33068,3,,120,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4851,Fe3O4,,PEG,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,99.13043,10.1002/jbm.b.33068,3,,120,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4852,Fe3O4,,PEG,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,113.0435,10.1002/jbm.b.33068,3,,120,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4853,Fe3O4,,PEG,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,113.0435,10.1002/jbm.b.33068,3,,120,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4854,Fe3O4,,PEG,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,97.3913,10.1002/jbm.b.33068,3,,120,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4855,Fe3O4,,PEG,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,116.5217,10.1002/jbm.b.33068,3,,120,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4856,Fe3O4,,Dextran,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,100.4819,10.1002/jbm.b.33068,3,,170,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4857,Fe3O4,,Dextran,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,104.0964,10.1002/jbm.b.33068,3,,170,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4858,Fe3O4,,Dextran,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,98.31326,10.1002/jbm.b.33068,3,,170,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4859,Fe3O4,,Dextran,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,98.31326,10.1002/jbm.b.33068,3,,170,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4860,Fe3O4,,Dextran,,,,,,A,Monkey (Cercopithecus aethiops),kidney,Epithelial,A,24,,MTT,tetrazolium salt,76.6265,10.1002/jbm.b.33068,3,,170,,VERO,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4861,Fe3O4,,Dextran,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,86.95652,10.1002/jbm.b.33068,3,,170,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4862,Fe3O4,,Dextran,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,75.65218,10.1002/jbm.b.33068,3,,170,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4863,Fe3O4,,Dextran,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,24.34783,10.1002/jbm.b.33068,3,,170,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4864,Fe3O4,,Dextran,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,22.6087,10.1002/jbm.b.33068,3,,170,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4865,Fe3O4,,Dextran,,,,,,A,Canine,Kidney,Epithelial,A,24,,MTT,tetrazolium salt,22.6087,10.1002/jbm.b.33068,3,,170,,MDCK,Journal of Biomedical Materials Research Part B: Applied Biomaterials,Wiley,2014,<i>In vitro</i> and <i>in vivo</i> experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targeting,FALSE,TRUE,green,3_mojicapisciotti2014.pdf,1
4866,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,89.89899,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4867,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,90.40404,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4868,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,93.93939,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4869,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,91.91919,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4870,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,80.80808,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4871,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,74.74748,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4872,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,105.5556,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4873,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,96.9697,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4874,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,94.44444,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4875,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,89.39394,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4876,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,87.37374,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4877,Fe3O4,,PEG,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,82.82829,10.1016/j.nano.2014.01.006,15,,18.4,,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4878,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,88.35954,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4879,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,87.29121,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4880,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,86.72798,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4881,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,90.6835,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4882,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,88.11021,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4883,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,85.53436,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4884,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,97.88402,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4885,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,98.82833,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4886,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,92.73359,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4887,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,92.67159,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4888,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,88.08567,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4889,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,86.01491,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4890,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,97.06741,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4891,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,83.56256,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4892,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,83.12418,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4893,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,81.67816,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4894,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,81.74228,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4895,Fe3O4,,folic acid with intermediate organic (PEG) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,79.79507,10.1016/j.nano.2014.01.006,15,,326.5,-23.5,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4896,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,87.87878,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4897,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,86.36364,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4898,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,83.33334,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4899,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,91.91919,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4900,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,85.85859,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4901,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,83.83839,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4902,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,93.43434,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4903,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,87.37374,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4904,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,88.38384,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4905,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,89.39394,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4906,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,85.35354,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4907,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Ovary,Epithelial,A,48,,MTT,tetrazolium salt,83.33334,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,SKOV-3,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4908,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,97.09096,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4909,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,82.5811,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4910,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,77.61755,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4911,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,77.68298,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4912,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,91.81465,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4913,Fe3O4,,folic acid with intermediate inorganic (silica) coating,,,,,,H,Human,Blood,Monocyte,A,24,,LDH,LDH activity assay kit,91.87615,10.1016/j.nano.2014.01.006,15,,274.1,-27.7,Monocytes,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2014,Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum,FALSE,FALSE,closed,15_krais2014.pdf,0
4914,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,84.31279,10.1016/j.colsurfb.2014.06.064,7,,36,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
4915,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,72.735,10.1016/j.colsurfb.2014.06.064,7,,36,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
4916,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,56.7293,10.1016/j.colsurfb.2014.06.064,7,,36,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
4917,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,86.00683,10.1016/j.colsurfb.2014.06.064,7,,36,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
4918,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,78.22526,10.1016/j.colsurfb.2014.06.064,7,,36,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
4919,Fe3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,65.52901,10.1016/j.colsurfb.2014.06.064,7,,36,,A549,Colloids and Surfaces B: Biointerfaces,Elsevier BV,2014,"Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells",FALSE,FALSE,closed,7_dwivedi2014.pdf,0
4920,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,100.8696,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4921,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,99.56522,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4922,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,90,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4923,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,81.30434,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4924,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,64.78261,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4925,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,84.36847,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4926,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,76.58599,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4927,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,72.82463,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4928,TiO2,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,61.35191,10.1016/j.jhazmat.2009.12.089,84,,20,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
4929,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,99.68254,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4930,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,97.77778,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4931,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,97.14286,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4932,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,98.4127,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4933,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,99.68254,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4934,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,95.87302,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4935,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,97.14286,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4936,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,88.25397,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4937,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,85.71429,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4938,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,95.2381,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4939,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,83.80953,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4940,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,73.6508,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4941,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,MTT,tetrazolium salt,92.69841,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4942,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTT,tetrazolium salt,80.63492,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4943,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTT,tetrazolium salt,67.93651,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4944,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,98.57143,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4945,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,98.57143,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4946,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,97.85714,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4947,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,100,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4948,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,94.28571,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4949,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,92.85714,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4950,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,92.14286,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4951,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,87.85714,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4952,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,85.71429,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4953,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,91.42857,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4954,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,85.71429,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4955,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,75,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4956,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,6,,NR,neutral red,92.14286,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4957,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,24,,NR,neutral red,77.85714,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4958,TiO2,,,,,,,,H,Human,Skin,Epithelial,A,48,,NR,neutral red,65,10.1016/j.tiv.2010.11.008,9,,124.9,-17.6,A431,Toxicology in Vitro,Elsevier BV,2011,ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells,FALSE,FALSE,closed,9_shukla2011.pdf,0
4959,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,96.41419,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4960,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,114.3171,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4961,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,115.2366,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4962,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,142.5758,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4963,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,169.9106,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4964,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,23.41443,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4965,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,21.14867,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4966,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,18.50552,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4967,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,18.8927,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4968,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,21.55262,10.1016/j.tiv.2011.12.006,132,,50,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4969,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,106.6482,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4970,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,113.2281,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4971,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,119.808,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4972,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,131.1093,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4973,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,147.1254,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4974,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,21.1948,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4975,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,20.06681,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4976,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,19.69641,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4977,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,17.43205,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4978,TiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,17.44044,10.1016/j.tiv.2011.12.006,132,,170,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
4979,TiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Sytox Red,100,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4980,TiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Annexin V,100,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4981,TiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,LDH,LDH activity assay kit,100.2105,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4982,TiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,MTT,tetrazolium salt,99.42357,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4983,TiO2,,Digestive enzymes,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Sytox Red,100.6091,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4984,TiO2,,Digestive enzymes,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Annexin V,100,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
4985,TiO2,,Digestive enzymes,,,,,,H,Human,Colon,Epithelial,A,24,,MTT,tetrazolium salt,89.2683,10.1021/tx400231u,133,,115,,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5004,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,99.10314,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5005,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,93.72197,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5006,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,95.5157,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5007,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,92.82511,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5008,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,93.27354,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5009,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,93.27354,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5010,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,90.58296,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5011,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,83.40807,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5012,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,78.92377,10.1186/1743-8977-5-22,146,,11.69,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5013,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5014,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5015,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,97.30942,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5016,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5017,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5018,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5019,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,97.75785,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5020,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,61.43498,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5021,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,30.9417,10.1186/1743-8977-5-22,146,,11.69,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5022,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5023,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,99.55157,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5024,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,94.61883,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5025,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,94.1704,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5026,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,94.61883,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5027,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,93.27354,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5028,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,92.37668,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5029,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,90.13453,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5030,TiO2,,,,,,,,H,Human,Kidney,Spindle,A,24,,WST-1,tetrazolium salt,89.6861,10.1186/1743-8977-5-22,146,,47.83,,IP15,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5031,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5032,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5033,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5034,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5035,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5036,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,100,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5037,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,92.82511,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5038,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,90.13453,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5039,TiO2,,,,,,,,A,Pig,Kidney,Epithelial,A,24,,WST-1,tetrazolium salt,73.99103,10.1186/1743-8977-5-22,146,,47.83,,LLC-PK1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2008,In vitro effects of nanoparticles on renal cells,TRUE,TRUE,gold,146_10.1186@1743-8977-5-22.pdf,1
5064,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,WST-8,tetrazolium salt,87.06105,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5065,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,WST-8,tetrazolium salt,78.76518,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5066,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,WST-8,tetrazolium salt,76.39516,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5067,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,WST-8,tetrazolium salt,68.59472,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5068,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,ATP,luciferase,86.71875,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5069,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,ATP,luciferase,78.51563,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5070,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,ATP,luciferase,69.53125,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5071,TiO2,,,,,,,,H,Human,Lung,Epithelial,A,4,,ATP,luciferase,56.64063,10.1016/j.etap.2013.03.006,148,,35,,A549,Environmental Toxicology and Pharmacology,Elsevier BV,2013,Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats,FALSE,FALSE,closed,148_tang2013.pdf,0
5072,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,MTT,tetrazolium salt,56,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5073,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,MTT,tetrazolium salt,68,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5074,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,MTT,tetrazolium salt,62,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5075,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,WST-1,tetrazolium salt,72,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5076,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,WST-1,tetrazolium salt,61,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5077,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,WST-1,tetrazolium salt,56,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5078,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,Live/Dead,trypan blue,92.13014,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5079,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,Live/Dead,trypan blue,88.62117,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5080,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,Live/Dead,trypan blue,92.93233,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5081,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,NR,neutral red,108,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5082,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,NR,neutral red,125,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5083,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,NR,neutral red,100,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5084,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,Resazurin,Alamar blue,85.19,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5085,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,Resazurin,Alamar blue,81.48,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5086,TiO2,,,,,,,,H,Human,Blood,Lymphoblast,A,3,,Resazurin,Alamar blue,92.59,10.1002/jat.2863,149,,100,,Lymphocytes,Journal of Applied Toxicology,Wiley,2013,"Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO<sub>2</sub>) nanoparticles on human erythrocyte and lymphocyte cells <i>in vitro</i>",FALSE,FALSE,closed,149_ghosh2013.pdf,0
5087,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,87.81818,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5088,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,90,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5089,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,90,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5090,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,84.54546,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5091,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,100.3636,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5092,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,88.36364,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5093,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,98.72727,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5094,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,97.63636,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5095,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,96,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5096,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,91.63636,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5097,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,100.3636,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5098,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,103.0909,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5099,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,luciferase,103.6364,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5100,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,luciferase,97.09091,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5101,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,luciferase,95.45454,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5102,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,luciferase,91.63636,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5103,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,luciferase,81.27273,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5104,TiO2,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,luciferase,80.18182,10.1016/j.tiv.2014.12.007,150,,38,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5105,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,87.81818,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5106,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,89.45454,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5107,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,88.90909,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5108,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,88.90909,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5109,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,97.09091,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5110,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,88.36364,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5111,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,99.81818,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5112,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,98.72727,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5113,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,95.45454,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5114,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,91.09091,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5115,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,100.3636,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5116,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,98.18182,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5117,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,99.81818,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5118,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,98.72727,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5119,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,94.90909,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5120,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,91.63636,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5121,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,81.27273,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5122,TiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,79.63636,10.1016/j.tiv.2014.12.007,150,,38,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5123,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,119.3198,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5124,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,97.16019,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5125,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,111.735,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5126,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,120.0993,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5127,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,102.0981,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5128,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,113.2058,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5129,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,116.0273,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5130,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,106.3446,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5131,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,107.0563,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5132,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,120.2738,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5133,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,107.8138,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5134,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,113.3787,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5135,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,115.507,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5136,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,115.5257,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5137,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,120.3958,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5138,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,123.9086,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5139,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,118.3861,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5140,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,123.2562,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5141,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,108.0578,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5142,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,127.4807,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5143,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,99.77657,10.1016/j.biopha.2013.08.006,67,,420.7,-9.96,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5144,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,104.8,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5145,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,135.2,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5146,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,108,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5147,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,103.2,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5148,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,132,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5149,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,110.4,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5150,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,104,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5151,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,134.4,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5152,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,109.6,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5153,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,107.2,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5154,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,128.8,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5155,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,118.4,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5156,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,98.4,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5157,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,139.2,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5158,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,118.4,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5159,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,94.4,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5160,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,135.2,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5161,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,124,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5162,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,3,,MTS,tetrazolium salt,101.6,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5163,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,6,,MTS,tetrazolium salt,128,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5164,TiO2,,,,,,,,H,Human,stomach,Epithelial,A,24,,MTS,tetrazolium salt,111.2,10.1016/j.biopha.2013.08.006,67,,160.5,-27.8,AGS,Biomedicine &amp; Pharmacotherapy,Elsevier BV,2014,Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro,FALSE,TRUE,green,67_botelho2014.67_pdf.pdf,1
5165,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Alamar blue,Alamar blue,95.34737,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5166,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Alamar blue,Alamar blue,91.82195,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5167,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",85.55193,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5168,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",86.51579,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5169,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",84.39386,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5170,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",84.74174,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5171,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",89.71928,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5172,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.47331,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5173,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",108.9317,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5174,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",91.81586,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5175,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",81.32993,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5176,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",79.53964,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5177,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",81.84143,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5178,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",82.35294,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5179,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",85.9335,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5180,Ti,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",91.81586,10.1088/1748-6041/4/2/025018,151,,35,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5181,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Alamar blue,Alamar blue,92.74123,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5182,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Alamar blue,Alamar blue,85.08701,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5183,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",76.29261,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5184,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",68.61509,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5185,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",75.13519,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5186,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",73.63055,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5187,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",75.521,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5188,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",87.28806,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5189,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",102.4502,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5190,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",89.25831,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5191,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",83.63171,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5192,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",79.7954,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5193,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",77.74936,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5194,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",81.07417,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5195,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",82.09718,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5196,Cr,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",85.16624,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5197,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Alamar blue,Alamar blue,25.23952,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5198,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Alamar blue,Alamar blue,2.833962,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5199,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",79.0704,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5200,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",71.39288,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5201,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",74.82655,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5202,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",67.45833,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5203,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",69.96541,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5204,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",46.23906,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5205,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",8.005127,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5206,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",88.7468,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5207,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",81.84143,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5208,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",80.81841,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5209,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",80.30691,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5210,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",79.02813,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5211,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",5.882353,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5212,Co,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",0.767263,10.1088/1748-6041/4/2/025018,151,,30,,RAW 264.7,Biomedical Materials,IOP Publishing,2009,Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages<i>in vitro</i>,FALSE,FALSE,closed,151_kwon2009.pdf,0
5213,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,102.0815,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5214,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,95.02262,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5215,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,78.73303,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5216,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,65.15837,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5217,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,41.80996,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5218,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,ApoToxTriplex,Caspase-GloReagent,25.52036,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5219,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,102.0815,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5220,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,100.4525,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5221,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,103.7104,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5222,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,97.73756,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5223,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,103.1674,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5224,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CytoToxOne,LDH activity assay kit,102.0815,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5225,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,,79.27602,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5226,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,,66.78733,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5227,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,,61.90045,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5228,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,,47.23982,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5229,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,,37.46606,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5230,Co,,,,,,,,H,Human,Aorta,Endothelial,A,24,,CellTiterGlo,,28.23529,10.1016/j.tiv.2014.12.007,150,,17,,HAEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5231,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,94.47964,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5232,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,78.73303,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5233,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,73.30317,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5234,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,67.87331,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5235,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,48.32579,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5236,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,ApoToxTriplex,Caspase-GloReagent,22.26244,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5237,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,92.85068,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5238,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,91.22172,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5239,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,94.47964,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5240,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,89.04977,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5241,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,89.04977,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5242,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CytoToxOne,LDH activity assay kit,66.78733,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5243,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,87.9638,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5244,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,79.81901,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5245,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,70.58823,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5246,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,51.58371,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5247,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,29.86425,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5248,Co,,,,,,,,H,Human,Umbilical cord,Endothelial,E,24,,CellTiterGlo,,17.91855,10.1016/j.tiv.2014.12.007,150,,17,,HUVEC,Toxicology in Vitro,Elsevier BV,2015,Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells,FALSE,FALSE,closed,150_alinovi2015.pdf,0
5249,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,99.41581,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5250,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,100.1718,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5251,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,97.52577,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5252,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,97.90378,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5253,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,98.28178,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5254,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,97.52577,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5255,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,,Trypan Blue,91.09966,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5256,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,CellTiterGlo,luciferase,95.20689,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5257,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,CellTiterGlo,luciferase,90.65517,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5258,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,CellTiterGlo,luciferase,88,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5259,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,CellTiterGlo,luciferase,84.58621,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5260,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,CellTiterGlo,luciferase,79.65517,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5261,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,24,,CellTiterGlo,luciferase,78.51724,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5262,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,CellTiterGlo,luciferase,96.15646,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5263,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,CellTiterGlo,luciferase,93.53742,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5264,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,CellTiterGlo,luciferase,86.42857,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5265,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,CellTiterGlo,luciferase,79.31973,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5266,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,CellTiterGlo,luciferase,68.46939,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5267,Co3O4,,,,,,,,H,Human,Lung,Epithelial,A,72,,CellTiterGlo,luciferase,44.14966,10.1016/j.tiv.2013.04.008,152,,200,,BEAS-2B,Toxicology in Vitro,Elsevier BV,2013,In vitro assessment of cobalt oxide particle toxicity: Identifying and circumventing interference,FALSE,FALSE,closed,152_darolles2013.pdf,0
5268,CdO,,,,,,,,A,Mouse,Brain,Neuronal,A,24,,MTT,tetrazolium salt,14.60621,10.1021/jp066387v,153,,179.3,,Neuro-2a,The Journal of Physical Chemistry B,American Chemical Society (ACS),2006,Are Diamond Nanoparticles Cytotoxic?,FALSE,FALSE,closed,153_schrand2007.pdf,0
5269,CdO,,,,,,,,A,Mouse,Brain,Neuronal,A,24,,MTT,tetrazolium salt,13.74702,10.1021/jp066387v,153,,179.3,,Neuro-2a,The Journal of Physical Chemistry B,American Chemical Society (ACS),2006,Are Diamond Nanoparticles Cytotoxic?,FALSE,FALSE,closed,153_schrand2007.pdf,0
5270,CdO,,,,,,,,A,Mouse,Brain,Neuronal,A,24,,MTT,tetrazolium salt,2.577566,10.1021/jp066387v,153,,179.3,,Neuro-2a,The Journal of Physical Chemistry B,American Chemical Society (ACS),2006,Are Diamond Nanoparticles Cytotoxic?,FALSE,FALSE,closed,153_schrand2007.pdf,0
5271,CdO,,,,,,,,A,Mouse,Brain,Neuronal,A,24,,MTT,tetrazolium salt,2.577566,10.1021/jp066387v,153,,179.3,,Neuro-2a,The Journal of Physical Chemistry B,American Chemical Society (ACS),2006,Are Diamond Nanoparticles Cytotoxic?,FALSE,FALSE,closed,153_schrand2007.pdf,0
5272,CdO,,,,,,,,A,Mouse,Brain,Neuronal,A,24,,MTT,tetrazolium salt,1.145585,10.1021/jp066387v,153,,179.3,,Neuro-2a,The Journal of Physical Chemistry B,American Chemical Society (ACS),2006,Are Diamond Nanoparticles Cytotoxic?,FALSE,FALSE,closed,153_schrand2007.pdf,0
5273,MnO,,PEG,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,64.94846,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5274,MnO,,PEG,,,,,,A,Human,,Endothelial,A,72,,ATPLite,,7,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5275,MnO,,PEG-NH2,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,62.7835,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5276,MnO,,PEG-NH2,,,,,,A,Human,,Endothelial,A,72,,ATPLite,,2.8,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5277,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,94.58823,10.3762/bjnano.6.28,139,,10,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5278,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,82.58823,10.3762/bjnano.6.28,139,,10,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5279,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,89.64706,10.3762/bjnano.6.28,139,,10,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5280,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,79.76471,10.3762/bjnano.6.28,139,,10,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5281,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,43.76471,10.3762/bjnano.6.28,139,,10,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5282,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,89.64706,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5283,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,93.17647,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5284,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,67.76471,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5285,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,50.11765,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5286,MnO,,,,,,,,A,Human,,Endothelial,A,24,,ATPLite,,2.117647,10.3762/bjnano.6.28,139,,24,,HMEC-1,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5287,MnO,,,,,,,,H,Human,Lung,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",32.53112,10.1007/s00449-009-0354-5,143,,14,,A549,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
5288,MnO,,,,,,,,H,Human,Breast,Epithelial,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",60.41494,10.1007/s00449-009-0354-5,143,,14,,MCF7,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
5289,MnO,,,,,,,,H,Human,Brain,Fibroblast,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",29.87552,10.1007/s00449-009-0354-5,143,,14,,T98G,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
5290,MnO,,,,,,,,H,Human,Lung,Epithelial,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",77.44945,10.1007/s00449-009-0354-5,143,,14,,A549,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
5291,MnO,,,,,,,,H,Human,Breast,Epithelial,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",78.98499,10.1007/s00449-009-0354-5,143,,14,,MCF7,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
5292,MnO,,,,,,,,H,Human,Brain,Fibroblast,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.18919,10.1007/s00449-009-0354-5,143,,14,,T98G,Bioprocess and Biosystems Engineering,Springer Science and Business Media LLC,2009,In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines,FALSE,FALSE,closed,143_choi2009.pdf,0
5293,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.05882,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5294,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",85.88236,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5295,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",55.88236,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5296,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.83041,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5297,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",87.13451,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5298,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",71.34503,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5299,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,95.54656,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5300,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,87.04453,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5301,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,54.25101,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5302,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,96.76113,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5303,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,93.11741,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5304,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,68.0162,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5305,Bi,,,,,,,,H,Human,,,A,12,,Live/Dead,"Calcein AM, Ethidium homodimer-1",90.95965,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5306,Bi,,,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",75.72383,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5307,Bi,,,,,,,,H,Human,,,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",55.57843,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5308,Bi,,,,,,,,H,Human,,,A,72,,Live/Dead,"Calcein AM, Ethidium homodimer-1",34.6066,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5309,Bi,,,,,,,,H,Human,,,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",23.14157,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5310,Bi,,,,,,,,H,Human,,,A,12,,MTT,tetrazolium salt,93.75,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5311,Bi,,,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,82.5,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5312,Bi,,,,,,,,H,Human,,,A,48,,MTT,tetrazolium salt,71.25,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5313,Bi,,,,,,,,H,Human,,,A,72,,MTT,tetrazolium salt,54.16667,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5314,Bi,,,,,,,,H,Human,,,A,96,,MTT,tetrazolium salt,45.83333,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5315,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.41177,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5316,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",83.52941,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5317,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",59.41177,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5318,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",97.66082,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5319,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",93.56725,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5320,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",76.60819,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5321,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,99.19029,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5322,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,91.90283,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5323,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,63.96761,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5324,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,97.97571,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5325,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,93.52227,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5326,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,75.30364,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5327,Bi,,silica,,,,,,H,Human,,,A,12,,Live/Dead,"Calcein AM, Ethidium homodimer-1",90.95965,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5328,Bi,,silica,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",82.33531,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5329,Bi,,silica,,,,,,H,Human,,,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",58.88417,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5330,Bi,,silica,,,,,,H,Human,,,A,72,,Live/Dead,"Calcein AM, Ethidium homodimer-1",46.58991,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5331,Bi,,silica,,,,,,H,Human,,,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",32.64417,10.1007/s10856-012-4716-1,4,,30,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5332,Bi,,silica,,,,,,H,Human,,,A,12,,MTT,tetrazolium salt,93.33334,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5333,Bi,,silica,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,92.91666,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5334,Bi,,silica,,,,,,H,Human,,,A,48,,MTT,tetrazolium salt,76.66666,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5335,Bi,,silica,,,,,,H,Human,,,A,72,,MTT,tetrazolium salt,62.91667,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5336,Bi,,silica,,,,,,H,Human,,,A,96,,MTT,tetrazolium salt,57.5,10.1007/s10856-012-4716-1,4,,30,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5337,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.41177,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5338,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",70,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5339,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",48.23529,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5340,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",99.41177,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5341,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",82.35294,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5342,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",77.64706,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5343,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,92.72727,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5344,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,77.57576,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5345,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,47.87879,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5346,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,93.33334,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5347,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,83.63636,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5348,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,71.51515,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5349,Bi,,NH2,,,,,,H,Human,,,A,12,,Live/Dead,"Calcein AM, Ethidium homodimer-1",91.49671,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5350,Bi,,NH2,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",69.99874,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5351,Bi,,NH2,,,,,,H,Human,,,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",48.04087,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5352,Bi,,NH2,,,,,,H,Human,,,A,72,,Live/Dead,"Calcein AM, Ethidium homodimer-1",22.37024,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5353,Bi,,NH2,,,,,,H,Human,,,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",5.360862,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5354,Bi,,NH2,,,,,,H,Human,,,A,12,,MTT,tetrazolium salt,92.8719,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5355,Bi,,NH2,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,82.0248,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5356,Bi,,NH2,,,,,,H,Human,,,A,48,,MTT,tetrazolium salt,69.93802,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5357,Bi,,NH2,,,,,,H,Human,,,A,72,,MTT,tetrazolium salt,58.16116,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5358,Bi,,NH2,,,,,,H,Human,,,A,96,,MTT,tetrazolium salt,34.60744,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5359,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.23529,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5360,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",87.05882,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5361,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",66.47059,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5362,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",98.23529,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5363,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",91.76471,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5364,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",78.23529,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5365,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,98.78788,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5366,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,91.51515,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5367,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,63.63636,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5368,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,96.9697,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5369,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,91.51515,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5370,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,78.18182,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5371,Bi,,PEG,,,,,,H,Human,,,A,12,,Live/Dead,"Calcein AM, Ethidium homodimer-1",90.67196,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5372,Bi,,PEG,,,,,,H,Human,,,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",84.43183,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5373,Bi,,PEG,,,,,,H,Human,,,A,48,,Live/Dead,"Calcein AM, Ethidium homodimer-1",66.18533,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5374,Bi,,PEG,,,,,,H,Human,,,A,72,,Live/Dead,"Calcein AM, Ethidium homodimer-1",54.94919,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5375,Bi,,PEG,,,,,,H,Human,,,A,96,,Live/Dead,"Calcein AM, Ethidium homodimer-1",45.77212,10.1007/s10856-012-4716-1,4,,20,,HeLa,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5376,Bi,,PEG,,,,,,H,Human,,,A,12,,MTT,tetrazolium salt,95.97108,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5377,Bi,,PEG,,,,,,H,Human,,,A,24,,MTT,tetrazolium salt,91.0124,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5378,Bi,,PEG,,,,,,H,Human,,,A,48,,MTT,tetrazolium salt,77.68595,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5379,Bi,,PEG,,,,,,H,Human,,,A,72,,MTT,tetrazolium salt,66.83884,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5380,Bi,,PEG,,,,,,H,Human,,,A,96,,MTT,tetrazolium salt,54.13223,10.1007/s10856-012-4716-1,4,,20,,MG-63,Journal of Materials Science: Materials in Medicine,Springer Science and Business Media LLC,2012,In vitro cytotoxicity of surface modified bismuth nanoparticles,FALSE,FALSE,closed,4_luo2012.pdf,0
5381,Mo,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,100.9709,10.1093/toxsci/kfi256,154,,30,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
5382,Mo,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,100.9709,10.1093/toxsci/kfi256,154,,30,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
5383,Mo,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,121.1651,10.1093/toxsci/kfi256,154,,30,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
5384,Mo,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,61.35922,10.1093/toxsci/kfi256,154,,30,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
5385,Mo,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,42.71845,10.1093/toxsci/kfi256,154,,30,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
5386,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,97.2973,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5387,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,96.93694,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5388,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,89.72973,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5389,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,86.12613,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5390,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,91.89189,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5391,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,88.28829,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5392,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,81.8018,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5393,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,85.4054,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5394,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,76.75676,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5395,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,77.47748,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5396,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,78.1982,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5397,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,68.10811,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5398,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,57.2973,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5399,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,56.57658,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5400,Pt,,PVP,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,43.6036,10.1039/c0nr00204f,80,,13.5,-8,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5401,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,99.79081,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5402,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,96.18182,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5403,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,99.84555,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5404,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,91.18671,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5405,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,91.21017,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5406,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,89.7869,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5407,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,89.84946,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5408,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,84.78593,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5409,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,86.99511,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5410,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,81.2434,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5411,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,80.5435,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5412,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,66.75269,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5413,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,55.1828,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5414,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,56.66667,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5415,Pt,,PVP,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,49.41935,10.1039/c0nr00204f,80,,13.5,-8,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5416,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,98.54265,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5417,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,92.61021,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5418,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,92.64051,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5419,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,94.19583,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5420,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,96.45812,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5421,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,77.11155,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5422,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,87.60895,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5423,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,92.11533,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5424,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,71.27001,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5425,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,78.7921,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5426,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,75.09367,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5427,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,70.64788,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5428,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,50.59031,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5429,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,54.34934,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5430,Pt,,PVP,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,43.19548,10.1039/c0nr00204f,80,,13.5,-8,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5431,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,84,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5432,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,81.75,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5433,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,67.5,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5434,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,77.25,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5435,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,70.5,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5436,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,54.75,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5437,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,69.75,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5438,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,58.5,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5439,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,45,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5440,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,50.25,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5441,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,44.25,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5442,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,32.25,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5443,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,24,,CellTiterGlo,luciferase,36,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5444,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,48,,CellTiterGlo,luciferase,30,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5445,Pt,,Folic acid,,,,,,H,Human,Cervix,Epithelial,A,72,,CellTiterGlo,luciferase,21,10.1039/c0nr00204f,80,,13.5,-40.5,HeLa,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5446,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,79.00621,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5447,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,64.84472,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5448,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,44.7205,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5449,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,64.09938,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5450,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,49.93789,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5451,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,35.7764,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5452,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,47.70186,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5453,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,38.01242,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5454,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,24.59627,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5455,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,34.28571,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5456,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,26.08696,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5457,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,17.14286,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5458,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,24,,CellTiterGlo,luciferase,19.37888,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5459,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,48,,CellTiterGlo,luciferase,17.8882,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5460,Pt,,Folic acid,,,,,,H,Human,Breast,Epithelial,A,72,,CellTiterGlo,luciferase,12.67081,10.1039/c0nr00204f,80,,13.5,-40.5,MCF7,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5461,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,77.93636,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5462,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,59.44394,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5463,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,45.39998,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5464,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,58.79956,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5465,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,47.71655,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5466,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,38.11904,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5467,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,50.03714,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5468,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,38.95012,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5469,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,29.34859,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5470,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,33.86129,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5471,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,29.44495,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5472,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,23.54713,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5473,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,24,,CellTiterGlo,luciferase,19.91167,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5474,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,48,,CellTiterGlo,luciferase,16.23407,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5475,Pt,,Folic acid,,,,,,H,Human,Lung,Fibroblast,A,72,,CellTiterGlo,luciferase,14.7847,10.1039/c0nr00204f,80,,13.5,-40.5,IMR90,Nanoscale,Royal Society of Chemistry (RSC),2010,Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles,FALSE,FALSE,closed,80_teow2010.pdf,0
5476,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,59.1195,10.1016/j.biomaterials.2009.02.044,155,,49,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5477,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,49.55975,10.1016/j.biomaterials.2009.02.044,155,,49,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5478,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,38.49057,10.1016/j.biomaterials.2009.02.044,155,,49,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5479,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,27.92453,10.1016/j.biomaterials.2009.02.044,155,,49,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5480,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,24.40252,10.1016/j.biomaterials.2009.02.044,155,,49,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5481,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",37.13592,10.1016/j.biomaterials.2009.02.044,155,,49,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5482,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,89.62026,10.1016/j.biomaterials.2009.02.044,155,,50,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5483,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,82.02531,10.1016/j.biomaterials.2009.02.044,155,,50,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5484,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,70.63291,10.1016/j.biomaterials.2009.02.044,155,,50,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5485,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,49.36709,10.1016/j.biomaterials.2009.02.044,155,,50,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5486,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,47.8481,10.1016/j.biomaterials.2009.02.044,155,,50,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5487,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",7.645631,10.1016/j.biomaterials.2009.02.044,155,,50,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5488,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,85.35565,10.1016/j.biomaterials.2009.02.044,155,,170,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5489,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,97.90795,10.1016/j.biomaterials.2009.02.044,155,,170,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5490,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,85.35565,10.1016/j.biomaterials.2009.02.044,155,,170,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5491,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,76.31799,10.1016/j.biomaterials.2009.02.044,155,,170,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5492,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,MTT,tetrazolium salt,70.79498,10.1016/j.biomaterials.2009.02.044,155,,170,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5493,CaHCO3,,,,,,,,H,Human,Blood,Monocyte/Macrophage,A,24,,Live/Dead,"Calcein AM, Ethidium homodimer-1",6.990291,10.1016/j.biomaterials.2009.02.044,155,,170,,HMM,Biomaterials,Elsevier BV,2009,Hydroxyapatite nano and microparticles: Correlation of particle properties with cytotoxicity and biostability,FALSE,FALSE,closed,155_motskin2009.pdf,0
5494,CaHCO3,,,,,,,,H,Human,liver,Epithelial,E,48,,MTT,tetrazolium salt,96.61489,10.1016/j.biomaterials.2009.09.088,58,,26,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5495,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,53.34962,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5496,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,24,,MTT,tetrazolium salt,69.78607,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5497,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,47.96583,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5498,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,72,,MTT,tetrazolium salt,42.22602,10.1016/j.biomaterials.2009.09.088,58,,26,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5499,CaHCO3,,,,,,,,H,Human,liver,Epithelial,E,48,,MTT,tetrazolium salt,95.09554,10.1016/j.biomaterials.2009.09.088,58,,45,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5500,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,22.3603,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5501,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,24,,MTT,tetrazolium salt,47.17277,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5502,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,13.96223,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5503,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,72,,MTT,tetrazolium salt,12.24253,10.1016/j.biomaterials.2009.09.088,58,,45,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5504,CaHCO3,,,,,,,,H,Human,liver,Epithelial,E,48,,MTT,tetrazolium salt,94.21198,10.1016/j.biomaterials.2009.09.088,58,,78,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5505,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,65.57665,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5506,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,24,,MTT,tetrazolium salt,80.84137,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5507,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,70.57893,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5508,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,72,,MTT,tetrazolium salt,67.68671,10.1016/j.biomaterials.2009.09.088,58,,78,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5509,CaHCO3,,,,,,,,H,Human,liver,Epithelial,E,48,,MTT,tetrazolium salt,94.60315,10.1016/j.biomaterials.2009.09.088,58,,175,,L-02,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5510,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,90.55953,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5511,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,24,,MTT,tetrazolium salt,94.40923,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5512,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,48,,MTT,tetrazolium salt,88.83693,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5513,CaHCO3,,,,,,,,H,Human,liver,Epithelial,A,72,,MTT,tetrazolium salt,85.44218,10.1016/j.biomaterials.2009.09.088,58,,175,,HepG2,Biomaterials,Elsevier BV,2010,Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells,FALSE,FALSE,closed,58_yuan2010.pdf,0
5514,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,96.39751,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5515,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,94.90683,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5516,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,94.90683,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5517,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,102.8571,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5518,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,95.90062,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5519,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,103.354,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5520,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,77.01863,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5521,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,69.06832,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5522,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,94.40994,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5523,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,NR,neutral red,78.01242,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5524,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,95.40373,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5525,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,96.89441,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5526,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,94.40994,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5527,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,82.48447,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5528,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,54.65839,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5529,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,43.22981,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5530,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,20.86957,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5531,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,23.35404,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5532,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,31.30435,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5533,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,NR,neutral red,42.73292,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5534,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,107.3292,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5535,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,113.7888,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5536,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,112.795,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5537,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,119.2547,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5538,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,110.8075,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5539,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,93.41615,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5540,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,11.42857,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5541,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,0,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5542,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,0,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5543,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,3,,MTT,tetrazolium salt,0,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5544,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,108.323,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5545,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,95.40373,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5546,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,101.8634,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5547,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,101.8634,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5548,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,96.39751,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5549,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,67.08074,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5550,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,13.91304,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5551,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,3.975155,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5552,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,3.975155,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5553,Cu2O,,,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,0,10.1186/1743-8977-6-14,156,,88.5,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5554,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,NR,neutral red,113.8624,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5555,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,4,,NR,neutral red,109.2064,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5556,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,5,,NR,neutral red,84.2328,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5557,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,6,,NR,neutral red,93.1217,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5558,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,7,,NR,neutral red,92.27513,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5559,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,8,,NR,neutral red,113.0159,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5560,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,9,,NR,neutral red,98.20106,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5561,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,10,,NR,neutral red,96.93121,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5562,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,11,,NR,neutral red,79.15344,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5563,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,12,,NR,neutral red,74.07407,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5564,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,109.6296,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5565,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,103.7037,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5566,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,93.1217,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5567,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,68.14815,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5568,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,30.05291,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5569,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,22.85714,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5570,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,17.77778,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5571,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,18.62434,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5572,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,21.16402,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5573,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,NR,neutral red,25.82011,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5574,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,105.3968,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5575,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,109.2064,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5576,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,95.2381,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5577,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,104.5503,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5578,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,93.54498,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5579,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,85.07937,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5580,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,11.85185,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5581,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,13.12169,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5582,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,3.386243,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5583,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,3,,MTT,tetrazolium salt,0,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5584,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,106.6667,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5585,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,88.04233,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5586,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,95.2381,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5587,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,83.80953,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5588,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,46.98413,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5589,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,31.74603,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5590,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,10.15873,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5591,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,10.15873,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5592,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,5.925926,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5593,Cu2O,,,,,,,,H,Human,Blood,Macrophage,A,24,,MTT,tetrazolium salt,5.68E-14,10.1186/1743-8977-6-14,156,,88.5,,PMA activated THP-1,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,TRUE,TRUE,gold,156_lanone2009.pdf,1
5594,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,106.9373,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5595,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,99.36831,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5596,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,106.8916,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5597,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,113.4759,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5598,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,116.2844,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5599,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,23.73871,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5600,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,23.74709,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5601,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,24.89185,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5602,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,24.52144,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5603,MgO,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,21.12072,10.1016/j.tiv.2011.12.006,132,,8,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5604,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5605,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5606,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5607,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5608,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5609,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5610,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5611,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,87.64045,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5612,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,73.03371,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5613,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5614,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5615,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5616,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,95.50562,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5617,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,87.64045,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5618,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,86.51685,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5619,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,82.02247,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5620,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,70.78651,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5621,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,62.92135,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5622,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,46.84597,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5623,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,46.81936,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5624,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,44.91774,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5625,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,37.38871,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5626,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,37.3621,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5627,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,35.45806,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5628,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,27.93145,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5629,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,14.77742,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5630,MgO,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,12.87581,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5631,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,42.05081,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5632,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,45.77419,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5633,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,41.99758,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5634,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,32.59597,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5635,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,32.56693,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5636,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,26.9129,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5637,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,21.25887,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5638,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,4.35726,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5639,MgO,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,2.45564,10.1007/s10565-011-9191-9,82,,639,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5640,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,99.13043,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5641,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,100.8696,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5642,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,99.56522,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5643,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,93.91304,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5644,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,NR,neutral red,76.08696,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5645,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,80.66091,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5646,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,73.54821,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5647,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,67.09848,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5648,Al2O3,,,,,,,,A,hamster,Ovary,Epithelial,A,24,,MTT,tetrazolium salt,79.43144,10.1016/j.jhazmat.2009.12.089,84,,28,,CHO-K1,Journal of Hazardous Materials,Elsevier BV,2010,Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells,FALSE,FALSE,closed,84_divirgilio2010.pdf,0
5649,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5650,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,95.50562,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5651,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5652,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,101.1236,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5653,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5654,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5655,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,95.50562,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5656,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,98.8764,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5657,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5658,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,93.25843,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5659,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5660,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,94.38202,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5661,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,97.75281,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5662,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,95.50562,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5663,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,96.62921,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5664,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,92.13483,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5665,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,92.13483,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5666,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,MTT,tetrazolium salt,83.14607,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5667,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,42.82016,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5668,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,40.91613,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5669,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,44.63952,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5670,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,37.1129,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5671,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,33.33629,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5672,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,35.18226,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5673,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,35.15323,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5674,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,33.25161,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5675,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,12,,LDH,LDH activity assay kit,33.22258,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5676,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,43.65,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5677,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,45.49597,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5678,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,43.59436,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5679,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,34.19274,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5680,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,36.03871,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5681,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,32.2621,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5682,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,32.23548,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5683,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,26.58145,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5684,Al2O3,,,,,,,,H,Human,Heart,Endothelial,A,24,,LDH,LDH activity assay kit,26.55242,10.1007/s10565-011-9191-9,82,,239,,HCMEC,Cell Biology and Toxicology,Springer Science and Business Media LLC,2011,"Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells",FALSE,FALSE,closed,82_sun2011.pdf,0
5685,Al2O3,,,,,,,,H,Human,Bone marrow,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,57.90178,10.1039/c5nr03598h,157,,45,,SH-SY5Y,Nanoscale,Royal Society of Chemistry (RSC),2015,Nanoscale-alumina induces oxidative stress and accelerates amyloid beta (A?) production in ICR female mice,FALSE,FALSE,closed,157_shah2015.pdf,0
5686,Al2O3,,,,,,,,H,Human,Bone marrow,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,46.72481,10.1039/c5nr03598h,157,,45,,SH-SY5Y,Nanoscale,Royal Society of Chemistry (RSC),2015,Nanoscale-alumina induces oxidative stress and accelerates amyloid beta (A?) production in ICR female mice,FALSE,FALSE,closed,157_shah2015.pdf,0
5687,Al2O3,,,,,,,,H,Human,Bone marrow,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,38.63421,10.1039/c5nr03598h,157,,45,,SH-SY5Y,Nanoscale,Royal Society of Chemistry (RSC),2015,Nanoscale-alumina induces oxidative stress and accelerates amyloid beta (A?) production in ICR female mice,FALSE,FALSE,closed,157_shah2015.pdf,0
5772,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,111.0022,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5773,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,127.9596,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5774,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,107.1829,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5775,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,75.0876,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5776,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,WST-1,tetrazolium salt,64.68624,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5777,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,20.22126,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5778,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,22.88049,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5779,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,33.11622,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5780,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,40.70041,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5781,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,41.84517,10.1016/j.tiv.2011.12.006,132,,14,,RAW 264.7,Toxicology in Vitro,Elsevier BV,2012,Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: Facts and artefacts,FALSE,FALSE,closed,132_wilhelmi2012.pdf,0
5782,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Sytox Red,100,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5783,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Annexin V,100,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5784,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,LDH,LDH activity assay kit,105.3684,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5785,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,24,,MTT,LDH activity assay kit,106.9953,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5786,SiO2,,Digestive enzymes,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Sytox Red,100.5043,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5787,SiO2,,Digestive enzymes,,,,,,H,Human,Colon,Epithelial,A,24,,Live/Dead,Annexin V,100,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5788,SiO2,,Digestive enzymes,,,,,,H,Human,Colon,Epithelial,A,24,,MTT,tetrazolium salt,96.58537,10.1021/tx400231u,133,,96,-11,Caco-2,Chemical Research in Toxicology,American Chemical Society (ACS),2013,Minimal Intestinal Epithelial Cell Toxicity in Response to Short- and Long-Term Food-Relevant Inorganic Nanoparticle Exposure,FALSE,TRUE,green,133_mccracken2013.pdf,1
5789,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,68.14815,10.1021/nn304439f,158,,598.2,87,primary tissue Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5790,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,115.5556,10.1021/nn304439f,158,,598.2,87,primary tissue Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5791,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,69.92593,10.1021/nn304439f,158,,598.2,87,primary alveolar Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5792,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,87.70371,10.1021/nn304439f,158,,598.2,87,primary alveolar Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5793,SiO2,,,,,,,,H,Human,lung,Epithelial,A,24,,Vialight,luciferase,82.02531,10.1021/nn304439f,158,,598.2,87,primary alveolar Epithelial cells,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5794,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Vialight,luciferase,44.39791,10.1021/nn304439f,158,,598.2,87,RAW 264.7,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5795,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Vialight,luciferase,62.82723,10.1021/nn304439f,158,,598.2,87,RAW 264.7,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5796,SiO2,,,,,,,,H,Human,Lung,Epithelial,A,24,,Vialight,luciferase,104.2424,10.1021/nn304439f,158,,598.2,87,A549,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5797,SiO2,,,,,,,,H,Human,Lung,Epithelial,A,24,,Vialight,luciferase,121.2121,10.1021/nn304439f,158,,598.2,87,A549,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5798,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,108.4444,10.1021/nn304439f,158,,240,58,primary tissue Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5799,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,142.2222,10.1021/nn304439f,158,,240,58,primary tissue Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5800,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,87.11112,10.1021/nn304439f,158,,240,58,primary alveolar Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5801,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,104.8889,10.1021/nn304439f,158,,240,58,primary alveolar Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5802,SiO2,,,,,,,,H,Human,lung,Epithelial,A,24,,Vialight,luciferase,87.08861,10.1021/nn304439f,158,,240,58,primary alveolar Epithelial cells,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5803,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Vialight,luciferase,76.23037,10.1021/nn304439f,158,,240,58,RAW 264.7,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5804,SiO2,,,,,,,,H,Human,Lung,Epithelial,A,24,,Vialight,luciferase,113.9394,10.1021/nn304439f,158,,240,58,A549,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5805,SiO2,,,,,,,,H,Human,Lung,Epithelial,A,24,,Vialight,luciferase,112.3232,10.1021/nn304439f,158,,240,58,A549,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5806,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,3.555556,10.1021/nn304439f,158,,369,79,primary tissue Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5807,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,121.7778,10.1021/nn304439f,158,,369,79,primary tissue Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5808,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,34.66667,10.1021/nn304439f,158,,369,79,primary alveolar Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5809,SiO2,,,,,,,,H,Human,lung,Macrophage,A,24,,Vialight,luciferase,95.11112,10.1021/nn304439f,158,,369,79,primary alveolar Macrophage,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5810,SiO2,,,,,,,,H,Human,lung,Epithelial,A,24,,Vialight,luciferase,87.08861,10.1021/nn304439f,158,,369,79,primary alveolar epithelial cells,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5811,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Vialight,luciferase,77.90576,10.1021/nn304439f,158,,369,79,RAW 264.7,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5812,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Vialight,luciferase,32.67016,10.1021/nn304439f,158,,369,79,RAW 264.7,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5813,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Vialight,luciferase,59.47644,10.1021/nn304439f,158,,369,79,RAW 264.7,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5814,SiO2,,,,,,,,H,Human,Lung,Epithelial,A,24,,Vialight,luciferase,96.9697,10.1021/nn304439f,158,,369,79,A549,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5815,SiO2,,,,,,,,H,Human,Lung,Epithelial,A,24,,Vialight,luciferase,123.6364,10.1021/nn304439f,158,,369,79,A549,ACS Nano,American Chemical Society (ACS),2013,Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake,FALSE,TRUE,green,158_herd2013.pdf,1
5816,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,103.3514,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5817,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,103.3514,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5818,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,104,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5819,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,100.5405,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5820,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,88.64865,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5821,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,39.78378,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5822,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,16.86486,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5823,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,12.97297,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5824,SiO2,,,,,,,,H,Human,Colon,Epithelial,A,4,,Vialight,luciferase,15.35135,10.1080/17435390802513204,159,,29.5,,Caco-2,Nanotoxicology,Informa UK Limited,2008,Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles,FALSE,FALSE,closed,159_wahl2008.pdf,0
5825,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,CellTiterBlue,Alamar blue,107.1956,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5826,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,CellTiterBlue,Alamar blue,100.5946,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5827,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,CellTiterBlue,Alamar blue,69.8427,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5828,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,CellTiterBlue,Alamar blue,22.48542,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5829,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,XTT,tetrazolium salt,123.0784,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5830,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,XTT,tetrazolium salt,114.2165,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5831,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,XTT,tetrazolium salt,82.70829,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5832,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,XTT,tetrazolium salt,24.78658,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5833,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,3.117029,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5834,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,5.571066,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5835,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,22.36634,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5836,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,LDH,LDH activity assay kit,70.10661,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5837,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,Propidium iodide,95.2263,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5838,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,Propidium iodide,85.60647,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5839,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,Propidium iodide,69.19419,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5840,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,Propidium iodide,9.763044,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5841,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,calcein AM,93.75227,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5842,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,calcein AM,91.6796,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5843,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,calcein AM,71.49213,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5844,SiO2,,,,,,,,A,Mouse,Blood,Monocyte/Macrophage,A,24,,Live/Dead,calcein AM,45.27015,10.5402/2012/454072,2,,13,-27,RAW 264.7,ISRN Nanotechnology,Hindawi Limited,2012,"Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles <i>In Vitro</i> via Plate-Based, Flow Cytometry, and Coulter Counter Assays",TRUE,TRUE,gold,2_International Scholarly Research Notices - 2012 - Bancos - Evaluation of Viability and Proliferation Profiles on.pdf,1
5845,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,108.2927,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5846,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,103.4146,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5847,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,109.2683,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5848,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,107.3171,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5849,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,104.5161,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5850,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,112.9032,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5851,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,112.9032,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5852,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,105.8065,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5853,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,LDH,LDH activity assay kit,98.41272,10.1007/s11051-013-2229-6,160,,25,30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5854,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,108.2927,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5855,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,110.2439,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5856,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,105.3659,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5857,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,109.2683,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5858,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,100.6452,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5859,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,98.06451,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5860,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,103.871,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5861,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,103.871,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5862,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,LDH,LDH activity assay kit,100.0335,10.1007/s11051-013-2229-6,160,,60,32,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5863,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,102.996,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5864,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,102.996,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5865,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,108.8259,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5866,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,104.9393,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5867,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,104.2915,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5868,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,108.1781,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5869,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,111.417,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5870,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,82.2672,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5871,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,LDH,LDH activity assay kit,101.3927,10.1007/s11051-013-2229-6,160,,60,-30,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5872,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,90.68826,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5873,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,101.0526,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5874,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,90.68826,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5875,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,48,,Alamar blue,Alamar blue,82.91498,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5876,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,104.2915,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5877,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,101.7004,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5878,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,86.15385,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5879,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,Alamar blue,Alamar blue,75.78947,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5880,SiO2,,,,,,,,H,Human,Umbilical cord,Endothelial,E,96,,LDH,LDH activity assay kit,99.82557,10.1007/s11051-013-2229-6,160,,115,-48,HUVEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity,FALSE,FALSE,closed,160_guarnieri2014.pdf,0
5881,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,113.4783,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5882,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,97.17391,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5883,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,108.2609,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5884,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,97.82609,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5885,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,98.47826,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5886,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,100.4348,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5887,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,95.86957,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5888,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,79.56522,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5889,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,94.56522,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5890,SiO2,,CTAB,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,79.56522,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5891,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,105.2632,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5892,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,120.7018,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5893,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,117.193,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5894,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,105.9649,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5895,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,84.91228,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5896,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,95.4386,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5897,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,94.03509,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5898,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,103.8597,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5899,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,79.29825,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5900,SiO2,,CTAB,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,63.85965,10.3109/15376516.2015.1070229,1,,386.9,-35.9,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5901,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,97.82609,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5902,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,95.21739,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5903,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,89.34782,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5904,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,106.3043,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5905,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,95.21739,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5906,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,96.52174,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5907,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,93.91304,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5908,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,72.3913,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5909,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,71.08696,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5910,SiO2,,Phosphonate,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,71.73913,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5911,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,103.1579,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5912,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,96.14035,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5913,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,110.1754,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5914,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,122.1053,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5915,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,103.8597,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5916,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,118.5965,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5917,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,94.03509,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5918,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,102.4561,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5919,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,105.9649,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5920,SiO2,,Phosphonate,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,80,10.3109/15376516.2015.1070229,1,,375.4,-26.8,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5921,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,120,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5922,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,119.3478,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5923,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,108.913,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5924,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,111.5217,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5925,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,114.1304,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5926,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,116.087,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5927,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,106.9565,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5928,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,74.34782,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5929,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,93.91304,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5930,SiO2,,NH2,,,,,,A,Rat,,,,12,,MTT,tetrazolium salt,76.95652,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5931,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,103.8597,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5932,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,103.1579,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5933,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,101.0526,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5934,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,94.03509,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5935,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,89.82456,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5936,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,90.52631,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5937,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,100.3509,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5938,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,96.14035,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5939,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,103.8597,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5940,SiO2,,NH2,,,,,,A,Rat,,,,24,,MTT,tetrazolium salt,85.61404,10.3109/15376516.2015.1070229,1,,437,21.7,PC12,Toxicology Mechanism and Methods,Taylor & Francis,2015,Effect of mesoporous silica nanoparticles on cell viability and markers of oxidative stress,FALSE,FASLE,hybrid,1_10.3109@15376516.2015.1070229.pdf,0
5941,Au,,PEG-OCH3,,,,,,A,Mouse,axillary lymph node,Endothelial,A,24,,ATPLite,luciferase,44.33333,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5942,Au,,PEG-OCH3,,,,,,A,Mouse,axillary lymph node,Endothelial,A,72,,ATPLite,luciferase,75.09091,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5943,Au,,PEG-OCH3,,,,,,A,Mouse,axillary lymph node,Endothelial,A,24,,ATPLite,luciferase,25.24242,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5944,Au,,PEG-OCH3,,,,,,A,Mouse,axillary lymph node,Endothelial,A,72,,ATPLite,luciferase,45.81818,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5945,Au,,PEG-COOH,,,,,,A,Mouse,axillary lymph node,Endothelial,A,24,,ATPLite,luciferase,27.78788,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5946,Au,,PEG-COOH,,,,,,A,Mouse,axillary lymph node,Endothelial,A,72,,ATPLite,luciferase,5.090909,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5947,Au,,PEG-COOH,,,,,,A,Mouse,axillary lymph node,Endothelial,A,24,,ATPLite,luciferase,27.78788,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5948,Au,,PEG-COOH,,,,,,A,Mouse,axillary lymph node,Endothelial,A,72,,ATPLite,luciferase,42,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5949,Au,,PEG-NH2,,,,,,A,Mouse,axillary lymph node,Endothelial,A,24,,ATPLite,luciferase,43.06061,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5950,Au,,PEG-NH2,,,,,,A,Mouse,axillary lymph node,Endothelial,A,72,,ATPLite,luciferase,98,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5951,Au,,PEG-NH2,,,,,,A,Mouse,axillary lymph node,Endothelial,A,24,,ATPLite,luciferase,23.9697,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5952,Au,,PEG-NH2,,,,,,A,Mouse,axillary lymph node,Endothelial,A,72,,ATPLite,luciferase,47.09091,10.3762/bjnano.6.28,139,,40,,SVEC4-10,Beilstein Journal of Nanotechnology,Beilstein Institut,2015,Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization,TRUE,TRUE,gold,139_landgraf2015.pdf,1
5953,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,98.4,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5954,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,98.66666,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5955,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,100.8,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5956,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,96.53333,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5957,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,100.8,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5958,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,97.6,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5959,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,96.53333,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5960,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,93.06667,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5961,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,96.8,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5962,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,99.2,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5963,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,94.4,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5964,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,94.66666,10.1186/1743-8977-6-18,161,,21.2,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5965,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,99.68819,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5966,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,99.68819,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5967,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,99.42094,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5968,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,95.41203,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5969,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,98.88641,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5970,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,100.49,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5971,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,99.15367,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5972,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,99.42094,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5973,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,105.5679,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5974,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,98.88641,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5975,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,100.49,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5976,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,107.9733,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5977,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,97.81738,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5978,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,100.49,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5979,Au,,PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,105.5679,10.1186/1743-8977-6-18,161,,21.2,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5980,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,95.94655,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5981,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,95.67929,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5982,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,95.41203,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5983,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,97.55011,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5984,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,98.88641,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5985,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,91.67038,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5986,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,97.81738,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5987,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,98.35189,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5988,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,94.07572,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5989,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,94.34299,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5990,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,88.73052,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5991,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,81.78174,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5992,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,85.52338,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5993,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,79.64365,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5994,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,63.34076,10.1186/1743-8977-6-18,161,,27.17,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5995,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,99.42094,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5996,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,101.8263,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5997,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,101.0245,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5998,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,100.2227,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
5999,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,103.4299,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6000,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,102.6281,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6001,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,102.6281,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6002,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,101.559,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6003,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,101.559,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6004,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,101.0245,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6005,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,102.8953,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6006,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,99.95546,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6007,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,98.35189,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6008,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,92.47216,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6009,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,90.06682,10.1186/1743-8977-6-18,161,,27.17,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6010,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,98.35189,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6011,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,100.2227,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6012,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,96.21381,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6013,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,97.55011,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6014,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,100.7572,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6015,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,94.34299,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6016,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,95.67929,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6017,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,98.61916,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6018,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,94.8775,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6019,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,99.68819,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6020,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,93.27394,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6021,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,89.79955,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6022,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,89.5323,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6023,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,84.45435,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6024,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,71.09132,10.1186/1743-8977-6-18,161,,28.18,,A549,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6025,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,98.88641,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6026,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,101.2918,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6027,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,100.7572,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6028,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,99.95546,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6029,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,103.9644,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6030,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,99.95546,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6031,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,101.2918,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6032,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,106.1025,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6033,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,102.0935,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6034,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,101.8263,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6035,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,105.3007,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6036,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,104.7661,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6037,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,24,,MTT,tetrazolium salt,101.8263,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6038,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,48,,MTT,tetrazolium salt,95.94655,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6039,Au,,Citrate and PVP,,,,,,H,Human,Lung,Epithelial,A,72,,MTT,tetrazolium salt,97.55011,10.1186/1743-8977-6-18,161,,28.18,,NCIH441,Particle and Fibre Toxicology,Springer Science and Business Media LLC,2009,Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441,TRUE,TRUE,gold,161_uboldi2009.pdf,1
6040,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,100.1143,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6041,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,99.08572,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6042,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,92.22857,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6043,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,87.08572,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6044,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,79.2,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6045,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,94.70085,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6046,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,36,,NR,neutral red,91.62393,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6047,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,48,,NR,neutral red,86.49573,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6048,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,60,,NR,neutral red,86.83761,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6049,Au,,Citrate,,,,,,H,Human,Ovary,Epithelial,A,72,,NR,neutral red,85.81197,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6050,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,100.1143,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6051,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,96,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6052,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,96.34286,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6053,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,90.51428,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6054,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,77.14286,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6055,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,96.75214,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6056,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,36,,NR,neutral red,96.75214,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6057,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,48,,NR,neutral red,93.67522,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6058,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,60,,NR,neutral red,91.28205,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6059,Au,,Starch,,,,,,H,Human,Ovary,Epithelial,A,72,,NR,neutral red,89.91453,10.1155/2012/734398,162,,21,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6060,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,99.77143,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6061,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,100.4571,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6062,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,97.71429,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6063,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,93.94286,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6064,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,89.14286,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6065,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,24,,NR,neutral red,98.80342,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6066,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,36,,NR,neutral red,98.80342,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6067,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,48,,NR,neutral red,97.77778,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6068,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,60,,NR,neutral red,95.72649,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6069,Au,,Gum Arabic,,,,,,H,Human,Ovary,Epithelial,A,72,,NR,neutral red,94.70085,10.1155/2012/734398,162,,20,,CHO22,Journal of Nanomaterials,Wiley,2012,<i>In Vitro</i> Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents,FALSE,TRUE,hybrid,162_vijayakumar2012.pdf,1
6070,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,100.7595,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6071,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,101.519,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6072,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,101.519,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6073,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,100.2532,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6074,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,94.17722,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6075,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,88.10127,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6076,Au,,,,,,,,H,Human,Kidney,Epithelial,E,48,,WST-1,tetrazolium salt,42.92598,10.2217/nnm.10.85,130,,20,,HEK-293,Nanomedicine,Informa UK Limited,2010,Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells,FALSE,FALSE,closed,130_li2010.pdf,0
6077,Au,,Star anise,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,94.21053,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6078,Au,,Star anise,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,92.63158,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6079,Au,,Star anise,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,90.52631,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6080,Au,,Star anise,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,88.42105,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6081,Au,,Star anise,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,80.52631,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6082,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,93.68421,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6083,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,89.47369,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6084,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,84.21053,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6085,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,81.57895,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6086,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,74.73684,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6087,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,92.63158,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6088,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,89.47369,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6089,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,82.10526,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6090,Au,,Citrate,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,74.73684,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6091,Au,,Sodium borohydride,,,,,,H,Human,Lung,Epithelial,A,48,,ApoToxTriplex,Caspase-GloReagent,69.47369,10.1016/j.ecoenv.2014.03.020,163,,35,,A549,Ecotoxicology and Environmental Safety,Elsevier BV,2015,Biosynthesis of gold nanoparticles and related cytotoxicity evaluation using A549 cells,FALSE,FALSE,closed,163_sathishkumar2015.pdf,0
6092,Au,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,62.41379,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6093,Au,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,66.20689,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6094,Au,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,77.58621,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6095,Au,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,80,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6096,Au,,PEG,,,,,,A,,,,,24,,MTT,,91.45107,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6097,Au,,PEG,,,,,,A,,,,,24,,MTT,,93.26634,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6098,Au,,PEG,,,,,,A,,,,,24,,MTT,,95.39359,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6099,Au,,PEG,,,,,,A,,,,,24,,MTT,,92.55768,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6100,Au,,PEG,,,,,,A,,,Endothelial,,24,,MTT,,88.172,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6101,Au,,PEG,,,,,,A,,,Endothelial,,24,,MTT,,82.23656,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6102,Au,,PEG,,,,,,A,,,Endothelial,,24,,MTT,,71.33922,10.1002/ppsc.201300357,10,,21.7,-7.6,C17.2,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6103,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,95.48146,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6104,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,96.98729,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6105,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,94.15328,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6106,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,91.93752,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6107,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,85.69136,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6108,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,72.00394,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6109,Au,,PEG,,,,,,H,Human,Umbilical cord,Endothelial,,24,,MTT,,53.66471,10.1002/ppsc.201300357,10,,21.7,-7.6,HUVEC,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6110,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,96.72178,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6111,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,96.3684,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6112,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,94.15264,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6113,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,92.24696,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6114,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,95.30382,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6115,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,84.09704,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6116,Au,,PEG,,,,,,A,Rat,,,,24,,MTT,,77.5408,10.1002/ppsc.201300357,10,,21.7,-7.6,PC12,Particle &amp; Particle Systems Characterization,Wiley,2014,The Cellular Interactions of PEGylated Gold Nanoparticles: Effect of PEGylation on Cellular Uptake and Cytotoxicity,FALSE,TRUE,green,10_soenen2014.pdf,1
6117,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,129.8658,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6118,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,137.892,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6119,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,159.0096,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6120,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,103.3432,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6121,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,97.01994,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6122,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,58.97643,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6123,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,50.38746,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6124,Ag,,PEI,,,,,,H,Human,liver,Epithelial,A,24,,NR,neutral red,42.80549,10.1021/es900754q,165,,8.5,,HepG2,Environmental Science &amp; Technology,American Chemical Society (ACS),2009,In Vitro Toxicity of Silver Nanoparticles at Noncytotoxic Doses to HepG2 Human Hepatoma Cells,FALSE,FALSE,closed,165_kawata-et-al-2009-in-vitro-toxicity-of-silver-nanoparticles-at-noncytotoxic-doses-to-hepg2-human-hepatoma-cells,0
6125,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,MTT,tetrazolium salt,92.70501,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6126,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,MTT,tetrazolium salt,86.40675,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6127,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,MTT,tetrazolium salt,37.00493,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6128,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,MTT,tetrazolium salt,8.664321,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6129,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,MTT,tetrazolium salt,6.769624,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6130,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,MTT,tetrazolium salt,5.370866,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6131,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,105.5767,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6132,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,97.50804,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6133,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,83.15533,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6134,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,49.94349,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6135,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,37.87301,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6136,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,15.51844,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6137,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,Alamar Blue,Alamar blue,9.164071,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6138,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,LDH,LDH activity assay kit,98.04878,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6139,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,LDH,LDH activity assay kit,96.58537,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6140,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,LDH,LDH activity assay kit,74.63415,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6141,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,LDH,LDH activity assay kit,13.65854,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6142,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,LDH,LDH activity assay kit,11.70731,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6143,Ag,,,,,,,,H,Human,liver,Epithelial,A,28,,LDH,LDH activity assay kit,13.17073,10.1016/j.tiv.2009.06.001,166,,7.5,,HepG2,Toxicology in Vitro,Elsevier BV,2009,Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells,FALSE,FALSE,closed,166_kim2009.pdf,0
6144,Ag,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,112.9858,10.1093/toxsci/kfi256,154,,15,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
6145,Ag,,,,,,,,A,Mouse,Testis,Fibroblast,A,48,,MTS,tetrazolium salt,23.50711,10.1093/toxsci/kfi256,154,,15,,C18-4,Toxicological Sciences,Oxford University Press (OUP),2005,In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells,FALSE,TRUE,bronze,154_braydich-stolle2005.pdf,1
6146,Ag,,,,,,,,H,Human,Bone marrow,Mesenchymal,A,24,,Live/Dead,calcein AM,88.54839,10.1039/b914875b,167,,100,-20,hMSCs,Journal of material chemistry,Royal Society of Chemistry (RSC),2010,The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles,FALSE,FALSE,closed,167_kittler2010.pdf,0
6147,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,96.42857,10.1007/s12030-009-9029-1,168,,100,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6148,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,90,10.1007/s12030-009-9029-1,168,,100,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6149,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,27.14286,10.1007/s12030-009-9029-1,168,,100,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6150,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,2.142857,10.1007/s12030-009-9029-1,168,,100,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6151,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,0,10.1007/s12030-009-9029-1,168,,100,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6152,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,106.4286,10.1007/s12030-009-9029-1,168,,35,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6153,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,92.85714,10.1007/s12030-009-9029-1,168,,35,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6154,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,90.71429,10.1007/s12030-009-9029-1,168,,35,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6155,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,76.42857,10.1007/s12030-009-9029-1,168,,35,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6156,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,51.42857,10.1007/s12030-009-9029-1,168,,35,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6157,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,107.8571,10.1007/s12030-009-9029-1,168,,10,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6158,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,95,10.1007/s12030-009-9029-1,168,,10,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6159,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,92.14286,10.1007/s12030-009-9029-1,168,,10,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6160,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,82.14286,10.1007/s12030-009-9029-1,168,,10,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6161,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,ATP,luciferase,53.57143,10.1007/s12030-009-9029-1,168,,10,,HeLa,NanoBiotechnology,Springer Science and Business Media LLC,2009,Silver Nanoparticles Toxicity and Bactericidal Effect Against Methicillin-Resistant Staphylococcus aureus: Nanoscale Does Matter,FALSE,FALSE,closed,168_10.1007@s12030-009-9029-1.pdf,0
6162,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,100.8511,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6163,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,62.12766,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6164,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,55.31915,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6165,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,65.10638,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6166,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,38.7234,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6167,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,35.74468,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6168,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,34.46809,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6169,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,22.55319,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6170,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,17.02128,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6171,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,23.82979,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6172,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,14.46809,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6173,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,9.361702,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6174,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,9.787234,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6175,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,8.936171,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6176,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,4.680851,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6177,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,4.255319,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6178,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,4.680851,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6179,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,4.680851,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6180,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,6.808511,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6181,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,5.531915,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6182,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,3.829787,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6183,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,Alamar Blue,Alamar blue,4.255319,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6184,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,Alamar Blue,Alamar blue,4.255319,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6185,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,Alamar Blue,Alamar blue,3.404255,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6186,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,92.5,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6187,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,32.08333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6188,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,15.83333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6189,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,57.91667,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6190,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,10.83333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6191,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,7.916667,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6192,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,50.83333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6193,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,2.083333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6194,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,2.083333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6195,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,48.33333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6196,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,1.25,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6197,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,1.25,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6198,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,40,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6199,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,1.25,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6200,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,1.25,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6201,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,39.16667,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6202,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,0.416667,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6203,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,0,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6204,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,36.25,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6205,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,0.833333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6206,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,0.833333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6207,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,Alamar Blue,Alamar blue,32.08333,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6208,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,Alamar Blue,Alamar blue,0,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6209,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,Alamar Blue,Alamar blue,0,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6210,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,112.6384,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6211,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,104.43,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6212,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,92.57329,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6213,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,68.40391,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6214,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,65.66776,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6215,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,46.97068,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6216,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,41.49837,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6217,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,39.21824,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6218,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,25.08143,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6219,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,38.76222,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6220,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,28.72964,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6221,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,20.52117,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6222,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,34.20195,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6223,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,24.16938,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6224,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,19.1531,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6225,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,34.65798,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6226,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,23.71335,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6227,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,20.52117,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6228,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,35.57003,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6229,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,21.88925,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6230,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,22.34528,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6231,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,NR,neutral red,35.11401,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6232,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,NR,neutral red,23.25733,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6233,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,NR,neutral red,22.8013,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6234,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,85.82781,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6235,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,48.47682,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6236,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,44.90066,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6237,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,71.12583,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6238,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,45.29801,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6239,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,40.13245,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6240,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,67.15232,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6241,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,33.37748,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6242,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,30.19868,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6243,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,65.96027,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6244,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,29.40397,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6245,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,27.81457,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6246,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,60.7947,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6247,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,28.60927,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6248,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,27.81457,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6249,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,53.24503,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6250,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,26.62252,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6251,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,25.82781,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6252,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,49.66887,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6253,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,27.01987,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6254,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,25.43046,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6255,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,NR,neutral red,43.31126,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6256,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,NR,neutral red,22.25166,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6257,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,NR,neutral red,19.86755,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6258,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,70.16612,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6259,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,59.40199,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6260,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,55.01661,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6261,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,60.19934,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6262,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,43.45515,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6263,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,38.6711,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6264,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,18.73754,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6265,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,20.7309,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6266,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,17.9402,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6267,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,12.3588,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6268,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,9.169436,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6269,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,5.980066,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6270,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,6.378737,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6271,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,3.189369,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6272,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,3.986711,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6273,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,8.372093,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6274,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,4.385382,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6275,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,4.385382,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6276,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,9.568107,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6277,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,5.980066,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6278,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,6.777409,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6279,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,24,,MTT,tetrazolium salt,11.56146,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6280,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,48,,MTT,tetrazolium salt,6.777409,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6281,Ag,,,,,,,,H,Human,Skin,Keratinocyte,A,72,,MTT,tetrazolium salt,9.169436,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HaCaT,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6282,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,101.2881,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6283,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,9.355932,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6284,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,6.915254,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6285,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,61.42373,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6286,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,8.135593,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6287,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,7.322034,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6288,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,58.98305,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6289,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,6.915254,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6290,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,5.288136,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6291,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,18.30508,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6292,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,5.694915,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6293,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,4.881356,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6294,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,16.27119,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6295,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,4.474577,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6296,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,2.847458,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6297,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,13.01695,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6298,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,4.067797,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6299,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,2.847458,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6300,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,12.61017,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6301,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,3.661017,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6302,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,3.254237,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6303,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,24,,MTT,tetrazolium salt,10.98305,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6304,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,48,,MTT,tetrazolium salt,4.067797,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6305,Ag,,,,,,,,H,Human,Cervix,Epithelial,A,72,,MTT,tetrazolium salt,3.661017,10.1016/j.tiv.2011.12.004,112,,28.41,-33.33,HeLa,Toxicology in Vitro,Elsevier BV,2012,Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines,FALSE,FALSE,closed,112_mukherjee2012.pdf,0
6306,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,110.4516,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6307,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,114.0645,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6308,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,108.9032,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6309,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,53.67742,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6310,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,99.6129,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6311,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,99.09677,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6312,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,91.87096,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6313,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,8.258064,10.1016/j.tiv.2014.06.005,169,,10,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6314,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,116.6452,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6315,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,114.5806,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6316,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,109.4194,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6317,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,85.67742,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6318,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,99.09677,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6319,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,92.90323,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6320,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,89.80645,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6321,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,28.90323,10.1016/j.tiv.2014.06.005,169,,20,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6322,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,91.87096,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6323,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,101.6774,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6324,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,104.2581,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6325,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,90.83871,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6326,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,96.51613,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6327,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,94.96774,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6328,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,99.09677,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6329,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,48.51613,10.1016/j.tiv.2014.06.005,169,,40,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6330,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,89.80645,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6331,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,107.3548,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6332,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,110.4516,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6333,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,93.93549,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6334,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,100.129,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6335,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,87.74194,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6336,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,91.87096,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6337,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,35.6129,10.1016/j.tiv.2014.06.005,169,,60,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6338,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,107.871,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6339,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,111.4839,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6340,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,130.0645,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6341,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,CellTiterBlue,Alamar blue,112.5161,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6342,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,98.58064,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6343,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,91.35484,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6344,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,89.80645,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6345,Ag,,,,,,,,H,Human,Colon,Epithelial,A,48,,CellTiterBlue,Alamar blue,51.09678,10.1016/j.tiv.2014.06.005,169,,100,,LoVo,Toxicology in Vitro,Elsevier BV,2014,Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells,FALSE,FALSE,closed,169_miethling-graff2014.pdf,0
6346,Ag,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,84.47542,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6347,Ag,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,85.84981,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6348,Ag,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,82.16748,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6349,Ag,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,85.56888,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6350,Ag,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,77.49469,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6351,Ag,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,84.273,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6352,Ag,,,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,26.87556,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6353,Ag,,,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,7.97911,10.1007/s11051-014-2726-2,8,,36.4,-23.1,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6354,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,102.7119,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6355,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,103.0509,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6356,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,95.93221,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6357,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,77.62712,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6358,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,75.25423,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6359,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,32.54237,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6360,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,24,,MTS,tetrazolium salt,17.28814,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6361,Ag,,PVP,,,,,,H,Human,Skin,Epithelial,A,48,,MTS,tetrazolium salt,5.084746,10.1007/s11051-014-2726-2,8,,27.02,-18.4,KEC,Journal of Nanoparticle Research,Springer Science and Business Media LLC,2014,PVP-coated silver nanoparticles showing antifungal improved activity against dermatophytes,FALSE,FALSE,closed,8_silva2014.pdf,0
6362,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,96.02428,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6363,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,96.87405,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6364,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,100.0607,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6365,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,92.2003,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6366,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,72.23065,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6367,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,43.12595,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6368,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,39.30197,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6369,Ag,,,,,,,,H,Human,Colon,Epithelial,A,24,,Promegas CTB Assay,Alamar blue,18.05766,10.3109/17435390.2013.815284,170,,14.7,-20,Caco-2,Nanotoxicology,Informa UK Limited,2013,Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells,FALSE,FALSE,closed,170_10.3109@17435390.2013.815284.pdf,0
6370,Ag,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,62.75862,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6371,Ag,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,73.44827,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6372,Ag,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,80,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6373,Ag,,,,,,,,H,Human,Breast,Epithelial,A,48,,MTT,tetrazolium salt,90.34483,10.1016/j.btre.2014.08.002,164,,25,,MDA-MB-231,Biotechnology Reports,Elsevier BV,2014,"Acalypha indica Linn: Biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells",TRUE,TRUE,gold,164_krishnaraj2014.pdf,1
6374,Ag,,Citrate,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,84.01507,10.1016/j.toxlet.2014.01.015,171,,92,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6375,Ag,,Citrate,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,65.78499,10.1016/j.toxlet.2014.01.015,171,,92,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6376,Ag,,Citrate,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,54.64141,10.1016/j.toxlet.2014.01.015,171,,92,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6377,Ag,,Citrate,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,41.72621,10.1016/j.toxlet.2014.01.015,171,,92,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6378,Ag,,Citrate,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,12.87103,10.1016/j.toxlet.2014.01.015,171,,92,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6379,Ag,,Citrate,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,15.30759,10.1016/j.toxlet.2014.01.015,171,,92,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6380,Ag,,,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,82.85851,10.1016/j.toxlet.2014.01.015,171,,390,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6381,Ag,,,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,74.67915,10.1016/j.toxlet.2014.01.015,171,,390,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6382,Ag,,,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,65.90923,10.1016/j.toxlet.2014.01.015,171,,390,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6383,Ag,,,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,60.68495,10.1016/j.toxlet.2014.01.015,171,,390,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
6384,Ag,,,,,,,,H,Human,,Epithelial,A,24,,WST-1,tetrazolium salt,51.9127,10.1016/j.toxlet.2014.01.015,171,,390,,ECV304,Toxicology Letters,Elsevier BV,2014,Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation,FALSE,FALSE,closed,171_oh2014.pdf,0
